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Abstract
The thesis presents the study of the reaction of glyoxal (ethanedial) with polypeptides. This
reaction is important in the food industry as well as during ageing and diabetes mellitus. To
study this reaction a Fourier transform ion cyclotron resonance mass spectrometer coupled with
electron capture dissociation and collisionally activated dissociation was used. Initially this
reaction was carried out in the neuropeptide Substance P to set up the reaction conditions,
sample preparation, as well as the instrumental parameters in the mass spectrometer.
The results in Substance P revealed two compounds, with mass additions assigned as C2O and
C2H2O2 from glyoxal, were formed. MS/MS results showed that the modification site for both
species could be located at either the arginine residue or at the N−terminus. Thus, in order to
distinguish N−terminus from arginine modification the position of the arginine was varied in
four model peptides. The results indicated that both mass additions C2O, C2H2O2 were located
at the arginine residue. Interestingly, two of those model peptides showed an unusual mass
addition of 21.9843 Da, which was assigned as a new type of glyoxal modification at the arginine
residue showing the addition of two carbon atoms from glyoxal and the loss of two hydrogen
atoms from the peptide (C2−H2), herein referred to as 2-imino-imidazole.
In order to assess the involvement of other residues in the reaction with glyoxal a new set of
experiments in acetylated and non-acetylated undecapeptides were carried out. Unexpectedly,
these experiments revealed that two species with the same mass (16.01092 Da) were being
formed in the non-acetylated peptide. One of the species corresponded to diglycation, where the
results suggest that the glyoxal binding at the lysine residue is crosslinked with the N−terminus.
The second species showing the addition of 116.01092 Da was formed at the arginine residue
forming a species, here called a glyoxal dimer, at the arginine residue. The formation of the
glyoxal dimer species was also observed in the acetylated peptide. Although is clear that
crosslinking between the lysine residue and the N-terminus is not possible in the acetylated
peptide, the results seem to indicate that crosslinking between the amino group of the lysine
and the amide group of glutamine could occur. However, a systematic study varying the position
of the lysine relative to the glutamine residue and also relative to the N-terminus needs to be
addressed in the future in order to determine the extent of the involvement of the N−terminus
and amide group in the glyoxal glycation reaction.
xxi
1
Introduction and Background
1.1 Motivation
The structure and function of proteins is altered during patho-physiological processes
like uremia and diabetes mellitus. Advanced stages of diabetes often result in kidney dis-
ease,[1] referred to as end stage renal disease (ESRD) or diabetic nephropathy. Diabetic
nephropathy has become a major health problem in the UK, U.S.A, and Australia.[2,3] For
instance, a study conducted in 2009 estimated that about 9.2 billion will be spent over
the next 30 years only in Australia to treat ESRD.[3] Part of this cost is associated with
the long term dialysis or kidney transplant required by the patients. However, the major
complication of individuals with ESRD is the high risk of cardiovascular death.[2] It is
clear, then, that diabetes and its complications cause a serious detriment in the quality
of life of the person who suffers it, as well as being a matter of serious concern in the
finances of national health systems.
The development of diabetic nephropathy is often correlated to changes in the structure
of the proteins, which implies that protein function and stability also changes. Alterations
to protein structure can be related to the presence or the loss of post-translational modi-
fications (PTMs). In the case of diabetes mellitus and its complications, the proteins are
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mainly modified by reacting non-enzymatically[4] (in series or in parallel) with glucose
and glucose auto-oxidation products (glyoxal, methylglyoxal and 3-deoxyglucosone).[5]
This reaction forms a complex set of compounds termed as advanced glycation end-
products (AGEs).[6] In this thesis, the PTM known as glycation, and in particular,
glycation by glyoxal was studied in peptides in order to establish the experimental
conditions, which will be later extended to proteins.
A widespread method to characterize PTMs is using mass spectrometry, which coupled
with collisionally activated dissociation (CAD) and electron capture dissociation (ECD),
allow identification of the PTMs binding sites.[7–10] Thus, in this work, fragmentation
techniques like ECD and CAD are used to localise glyoxal-derived advanced glycation
end-products (AGEs). This chapter describes the mass spectrometer used in this work,
including an explanation about the CAD fragmentation technique. The principles of ECD
are reviewed in chapter 2. Chapter 3 to chapter 6 present, in detail, the experiments
used to assign glyoxal-derived AGEs in peptides. A summary of the results is presented
in chapter 7 along with an ongoing project about glycation of proteins. The thesis
conclusions are finally presented in chapter 8.
1.2 Mass spectrometry
Mass spectrometry is an analytical technique used to measure the mass to charge (m/z)
ratio of charged molecules. The initial step in mass spectrometry is to generate the
charged molecules, which is done in the ion source.
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1.3 Ionization sources
Charged molecules are produced using ionization sources, where the neutral molecule is
converted into an ion. There are many different types of ionization sources, but they
all work by adding or removing a charged particle to/from the molecule of interest.[11]
The molecular ion can be generated by electron removal, electron capture, protonation,
cationization, or deprotonation. Common ionization sources are electron ionization
(EI), inductively coupled plasma (ICP), matrix assisted laser desorption (MALDI) and
electrospray ionization (ESI).
1.3.1 Electron ionization (EI)
Electron ionization (EI) utilises high energy electrons usually 70 eV that interact with
a vaporised molecule causing electron removal from the molecule of interest and
subsequently generating ions according to the reaction equation (1.1).[12] This method
only operates in gas phase molecules, in vacuum, so the molecule has to be small, volatile
and thermally stable.[11] Usually, gas chromatography is used to introduce the sample in
the gas form, which also provides analyte separation prior to mass spectrometry (MS)
detection.
M + e−70 eV M
+· + 2 e− (1.1)
EI produces extensive fragmentation so the precursor ion is not always observed.[13]
Moreover, EI decreases effectiveness for molecules above 350− 400MW .[14] Thus, the
extensive fragmentation together with the low volatility of large biomolecules limit
EI application to polypeptides. However, further developments in ionization sources
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brought the development of electrospray ionization (ESI),[15] which made possible the
analysis of protein and peptides by mass spectrometry.
1.3.2 Inductively coupled plasma (ICP)
In a ICP ion source, the analyte solution is converted into a fine aerosol droplet using a
nebulizer, making it easy to ionise in the plasma discharge. This type of source is useful
to detect metals in the analyte solution in parts per billion concentration. The analyte
is introduced into the ICP source as a fine aerosol formed by the high-speed flow of
the nebulizer gas (usually argon), which is later transported to the plasma torch. The
plasma torch consists of three concentric quartz tubes, delivering argon gas and analyte
droplets to the the plasma discharge, where the analyte is ionized. The end of the tubes
are centrally positioned in a radio frequency (RF) coil, typically held at 40 MHz, which
creates an electromagnetic field that confines the plasma discharge.
The plasma discharge is initiated with a high-voltage spark applied to the argon gas
outside of the plasma torch.[16] This causes losses of electrons from the argon atoms.
Consequently, this electrons are accelerated in the magnetic field and collide with more
neutral argon atoms, causing more electron losses. The collisions induce ionization of
the argon atoms, which continues as a chain reaction until a mixture of argon atoms,
argon ions and electrons is obtained forming the inductive coupled plasma. The analyte
aerosol is then introduced into the plasma through the middle tube called the sample
injector. The temperature at the centre of the plasma discharge is around 10, 000K
causing the aerosol sample to decompose into individual atoms, which are ionized by
the plasma.
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1.3.3 Matrix assisted laser desorption ionization (MALDI)
MALDI is an ionization technique often used in the analysis of polypeptides,[17,18] where
the analyte sample (dissolved in MeOH:ACN:formic acid) is mixed with excess (∼ 106) of
weak organic acid. This mixing can be performed in solution or during the crystallisation
process on a metal plate. The crystal is, then, irradiated with a Nd:YAG laser beam
(in the Bruker instrument used in this work), which creates a plasma plume. The
composition of this plasma plume (figure 1.1) can be explained by considering two
different models, the gas protonation model and the lucky survivor model. The gas
protonation model considers that there are in the plasma plume neutral molecules of
the analyte, which are ionized via proton transfer from the protonated matrix ions. In
contrast, the lucky survivor model considers that the analyte has preserve its charge in
the solid phase before desorption.[19] The lucky survivor model is the most accepted
model to date.
Figure 1.1: Illustration of MALDI plume. Figure reprinted with permission from El-Aneed,
A and Cohen, A and Banoub, J[11]
The matrix is an small aromatic compound, which absorbs most of the photons minimis-
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ing sample decomposition and increasing the efficiency of the energy transfer from the
laser to the analyte. Additionally, there is not necessary to adjust the laser wavelength to
match the absorption frequency of each analyte because the matrix absorbs most of the
photons.[13] Thus, MALDI allows desorption and ionization of analyte of high molecular
weight. Once the ions are produced, typically singly charged species ( [M + H]1+), they
are transferred to the mass analyzer.
1.3.4 Electrospray ionization (ESI)
The use of electrospray requires that the protein/peptides are dissolved in solution. The
solution is chosen to allow dissolution of the sample as well as evaporation. Typically, a
mixture of water/acetonitrile or water/methanol, but many others are used, for example
(50:10:39:1) mixture of methanol, isopropanol, water and acetic acid, employed in
this work. The protein/peptide is then protonated, cationized, or deprotonated at
atmospheric pressure.
Commonly, the protein/peptide solution is loaded into a syringe, which is automatically
controlled, to pump at constant flow (∼ 200 µL/min) into a needle. The needle is
grounded (0 Volts) for the Bruker (Bruker Daltonics, Bremen, Germany) ESI sources
and the spray shield is held at -4.0 kV (for positive ion generation) or +4.0 kV (for
negative ion generation), the potential difference causes the charge to accumulate on
the surface of the liquid forming a Taylor cone[20] as shown in figure 1.2. Once the
charge repulsion is bigger than the surface tension, the droplets leave the cone in a fine
mist of droplets.[21] During the migration of the charged molecules towards the spray
shield, evaporation occurs. The decrease of the droplet radius causes an increase in the
surface charge density until the droplet reaches the critical radius, or Rayleigh stability
limit, where the Coulombic repulsion equals the surface tension.[22,23]
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Three of the most accepted models are discussed below to explain the ion formation
from the evaporating droplets (droplet shrinkage, figure 1.2). First, the "charge residue
model (CRM)" described by Dole et al.[24] where a single analyte molecule is separated
from the solvent or other molecules in the droplet by a series of fissions. During this
separation the analyte molecule takes a part of charge excess and is desorbed in the gas
phase. This leaves the analyte with a higher charge/mass ratio than the droplet as a
whole. Consequently, a reduction in the Coulombic repulsion of the droplets is observed.
This model is considered valid for high molecular weight molecules.
The second model was proposed by Thomson and Iribarne,[25] and is called the "ion
evaporation model (IEM)", where a direct emission of the ions from the droplet occurs
after the critical radius has been reached. In other words, when the solvent evaporates,
the macromolecule is left as an ion. This model applies to molecules with a radii < 1 nm.
The difference between these two models lies in the role played by the macromolecule:
in the first one the molecule plays an active role whereas in the second model takes a
passive behaviour.
Figure 1.2: Schematic of ESI models: CRM (charge residue model) and IEM (ion
evaporation model) with the needle grounded.
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These two models are considered valid where no electrical field is present, particularly
when zero voltage is applied to the capillary tip. Interestingly, a third model proposed
that axial charge separation occurs inside the droplet in the presence of strong electrical
fields. This model is called "field-induced droplet ionization (FIDI)", where the inhomo-
geneous distribution of the charge causes prolate ellipsoid droplets with terminating
protrusions.[26] Thus, once Coulombic repulsion is bigger than surface tension, enriched
ions are produced from the protrusions.
In the Warwick FT-ICR-MS lab, a variation of ESI is used in which a glass capillary is
employed to deliver the sample at nL/min flow and is called nanoESI (nESI). 1 This
technique requires lower spray shield voltages, is preferred when the amount of the
sample available is limited, and is more stable than ESI to changes in the composition
of the spray solution. For instance, it is possible to spray directly out of water in nESI
whereas in ESI the spray is not stable.
1.4 Mass analyzers
There are a variety of mass analyzers that differ in their principles of operation as well as
their performance characteristics, like the mass range limit, the dynamic range, the mass
accuracy, the resolving power, the detection sensitivity and the fragmentation capabilities
(MS/MS). The definitions of these concepts are presented below and throughout this
section.
• The mass range is the lowest and highest m/z that can be measured in the mass
analyzer.
• The dynamic range is the ratio of the intensity of the highest signal in the spectrum
1A Triversa NanoMate (Advion Ithaca, NY, U.S.A.) equipment can also deliver a flow at nL/min. [27]
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to the smallest.
• The mass accuracy is given by the measure of the error of the experimental mass
compared to the theoretical value.
• The resolving power (RP ) is measured by the value of a single mass divided by
the full width at half maximum (FWHM). It measures the ability to separate two
ions of a defined mass difference.
RP =
M
∆M(FWHM)
(1.2)
where,
∆M = ((m/z)1 − (m/z)2) (1.3)
• Sensitivity is the degree of response of the mass spectrometer to changes in the
concentration. This response is measured by the ratio of the change of the peak
intensity in the mass spectrum to the change in the concentration. The sensitivity
depends on the ionization, transmission and detection efficiency of the mass
spectrometer, which is defined as the ratio of the number of ions detected to the
number of molecules in the sample.[13]
1.4.1 Quadrupole
The quadrupole consist of four parallel metallic rods of the same length and diameter.
RF potential is applied to the parallel rods, so two opposite rods have one phase (labeled
+, figure 1.3), whereas the other opposite pair have the opposite phase (labeled −,
figure 1.3). This arrangement generates an oscillating electric field, which provides a
pseudopotential. This pseudopotential confines the ions to travel along the the z axis.[28]
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Figure 1.3: Quadrupole.
For instance, a positive ion entering the space between the rods is attracted by the
negative rod, but before it reaches the rod the RF potential changes sign and the ion is
then repelled. The movement of the ions can be predicted by the use of the Mathieu
equations equations (1.4) and (1.5)
au =
8zeU
mωr20
(1.4)
qu =
4zeV
mω2r20
(1.5)
Varying the values of U (DC potential) and V (RF amplitude), while keeping ω (RF
drive frequency) and r0 (distance of the rods divided by 2) constant, the position of a
particular ion in the xy plane can be determined as a function of U and V . Moreover,
as long as the position in x and the position in y do not exceed the r0 the ion can pass
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through the quadrupole without touching the rods. So, stability areas can be represented
in a au, qu diagram.[13] Depending on the position in the stability diagram, quadrupoles
can thus, be used either as ion confinement “pipes” or as mass analyzers or mass filters.
4
2
0
-2
-4
u
u
a
q
x stable region
y stable region
Figure 1.4: Stability areas for and ion along x and y. The four stability areas are labelled
A to D. Figure adapted with permission from De Hoffman and Stroobant.[13]
The quadrupoles, when used as mass analyzers, have a typical mass range up to 4000Da,
a resolving power around 3000, and a mass accuracy of 100 ppm.[13] In the instrument
used in this work an FT-ICR-MS, the quadrupole is not employed as mass analyzer.
Instead, the quadrupole serves as either a mass filter (to perform isolation of the
precursor ion before fragmentation) or to transport the ions from the ion source to the
ICR cell (mass analyzer).
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1.4.2 Time of flight (TOF)
This mass analyzer separates the ions based on their different velocities after acceleration
through a potential V. The velocity, v, is mass dependent and is represented by the
equation 1.6
v =
√
2zeV
m
(1.6)
where, z is charge of the molecule; V is the acceleration voltage applied; and m is
the mass of the molecule. The separation of the ions occurs in a field-free region of
determined length L, also referred to as a drift region, were the ions have a constant
velocity. Thus, the m/z of the ions can be determined by measuring how long they take
to reach the detector equation (1.7)
m
z
=
(
2eV
L2
)
t2 (1.7)
Ions with high m/z ions have less velocity than small ions and will be detected at
different time intervals. Differentiating equation (1.7), it is clear that the resolving
power in a TOF instrument can be expressed as,
R =
m
∆m
=
t
2∆ t
≈ L
2∆x
(1.8)
where ∆x is the thickness of an ion packet. It is clear from equation (1.8) that in
order to increase the resolving power, then, the drift path can be increased. However, a
path too long causes ion loss, so an optimal length is between 1 to 2 m, although this
configuration only reaches about 5000 resolving power and 200 ppm of mass accuracy.
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Another way to improve resolution is by both the use of a delayed extraction and an
electrostatic mirror, also known as a reflectron. The reflectron deflects the ions and send
them back through the drift tube increasing the resolving power to 20, 000 and the mass
accuracy (10 ppm).[13]
1.4.3 Orbitrap
An orbitrap is an electrostatic trap with the external shape of a barrel of 20mm of
diameter, but separated in the middle to allow radial introduction of the ions.[13] The
orbitrap has also a central electrode in an spindle shape with a maximum radius of
8mm.[29] A later development in the external trap allow the introduction of the ions
tangentially to the central electrode. The ions enter the orbitrap at high velocity and are
forced to orbit the centre spindle, which is held a kV potential in the central electrode
while keeping the external electrode at ground potential. The ions then will move in
the radial direction around the centre electrode and oscillate in the axial direction see
figure 1.5.
z
r
Figure 1.5: Orbitrap.
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The axial frequency of the ions oscillating around the spindle is obtained by the equa-
tion (1.9)
ωz =
√
q
m
k (1.9)
where, k is the field curvature. This mass analyzer is also the detector and can achieve a
resolving power of 100, 000 and mass accuracy below 5 ppm.[13]
1.4.4 Ion mobility
The physical principles underlying the operation of an ion mobility mass analyzer
are based on exposing the ions to an electric field suspended in a gas medium. The
application of the external force, from a low electric field, to the ions force them to
move along the direction of the electric field with a drift velocity, controlled by the ions
mobility, referred to as K in cm2/(V s). In an uniform, low, electric field the ion cloud
would travel with constant terminal velocity (equation (1.10)), parallel to the electric
field direction, slowed by collisions with background gas. Hence, there is a reduced
mass after the ions collide with the gas, µ, equation (1.11).
v = KE (1.10)
µ =
mimg
mi +mg
(1.11)
Additionally, the Mason-Schamp equation establish the dependance of the mobility and
the cross section of an ion[30] in a low electric field is given by equation (1.12)
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K =
3q
16
(
2pikBT
µ
)1/2
1
NΩ
(1.12)
where, kB is the Boltzmann constant; T is the gas temperature; N is the gas number
density (molecules/volume); and Ω is the rotationally averaged collision integral or
collision cross section, which depends on the structures of the gas and the diffusing ion.
Thus, in an ion mobility mass analyzer it is possible to separate the ion cloud according
to their cross-section. The separation of the ions by their cross section is performed
in the drift tube. An usual drift tube consisted of guard rings separated by insulating
ceramic spacers connected by a resistor cascade, which provided a homogeneous electric
field gradient throughout the drift tube.
Traveling-wave ion mobility
A popular technology used in the drift tube is the application of a traveling-wave
(TW), which consists in the use of RF-potentials applied to the guard rings as shown in
figure 1.6. These RF-potentials trap the ions radially, with superimposed voltage waves
traveling from lens to lens. The ions ride on the waves back and forth until they fall
behind catching the next wave. Ions with larger cross sections fall behind more often
than ions with lower cross section because they experience more collisions and friction
with the gas. Separation of the ions is then achieved and the time of arrival of the ions
to the detector is measured as the drift time, as shown in figure 1.6 and figure 6.9 in
chapter 6.
The mobility of the ions, in a TW is a function of the maximum velocity, c, which
corresponds to the velocity at the steepest wave slope. The maximum velocity is also
inversely proportional to the wave velocity, s. At c 1 and fixed E (ignoring thermal
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Figure 1.6: Schematic of the ion mobility drift channel and ion mobility spectra. A. B,
and C are ions not isotopically resolved.
ion diffusion), c scales quadratically with the product of the mobility and the electric
field, as shown in equation (1.13).[30] In the situation where c ≈ 1, the ions travel with
a mean velocity, c ≈ s, where ion separation is dependant on the drift velocity while
diffusion determines the ion packet width. In any case c cannot be higher than s and
the limiting factor in equation (1.13) is s/Emax, where Emax is the electric field at the
steepest wave slope.
c =
(KE)2
s
(1.13)
Another situation to be considered, is c at variable E,[30] where E varies with the axial
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coordinate, x, as shown in equation (1.14)
c =
K2
s
∫ b0 E2(x)dxs2−K2E2(x)∫ b
0
dx
s2−K2E2(x)
 (1.14)
where s is the wave velocity; b is the wavelength in space of the traveling-wave.
Additionally, the TW ion mobility drift tube can be coupled to a TOF or quadrupole mass
analyzers, such as the instrument used in this study a Synapt G2 (Waters, Manchester,
U.K.), which was coupled with a TOF mass analyzer. Operated at pressure of 0.5mbar
for the drift gas, (N2), a RF amplitude of 40V and a IMS travelling wave velocities of
500m/s.
1.4.5 Fourier transform ion cyclotron resonance cell (FTICR)
The mass analyzer in an FT-ICR-MS is a cyclotron resonance cell, which performs also as
the detector. This mass analyzer is maintained at ultrahigh vacuum (∼ 9X 10−10 bar) in
a constant magnetic field. In particular, the magnet used in the present work used a 12T
magnetic field. An example of an ICR cell is a cylindrical cell with trapping, excitation
and detection plates as in shown in figure 1.7.
The ions entering the cell are trapped by an electrostatic potential applied between the
trapping plates. This trapping potentials cause an axial motion of the ions inside the cell
with a frequency ωz defined by equation (1.15),[31] The trapping plate voltages used in
this work were maintained below 1V , with typical values of 0.6 to 0.65V .
ωz =
√
2V qα
ma2
(1.15)
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Figure 1.7: Ion cyclotron resonance cell. T indicates trapping plates; E indicates
excitation plates; and, D indicates detection plates.
where, V is the trapping plate voltage; q is the charge of the ions and is equal to z
multiplied by the electron charge or 1.6X 10−19C); α is a geometry factor; m is the
mass of the analyte of interest; and a is the distance in between the front and the back
trapping plates.
The ions in a magnetic field oscillate with a theoretical “unperturbed” cyclotron fre-
quency,[31] which is inversely proportional to the m/z of the ions equation (1.16).[32]
In reality, the cyclotron frequency is reduced (ω+) by the force caused by the trapping
potentials and is then dependent of the axial frequency as in shown in equation (1.17).
ωC =
qB
m
(1.16)
where, B is the magnetic field.
ω± =
ωc
2
±
√(ωc
2
)2
− ω
2
z
2
(1.17)
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ω− is the reduced magnetron frequency. The magnetron motion is responsible for the
reduction of the cyclotron frequency due to causes diffusion of the ions.[31] The balance
of the forces present in the ICR cell and a rearrangement results in a calibration equation
of
m
z
=
C2
ω2+
+
C1
ω+
+ C0 (1.18)
Where, C2, C1, and C0 are calibration constants.[33]
The ions, then, are moving inside the cell following their respective cyclotron, magnetron
and axial trajectories (figure 1.8). When the ion is initially injected into the cell low-
amplitude axial motion allow to cool the ions in the cell. At the same time low-amplitude
cyclotron and magnetron motion are present. Thus, for detection, the ions must be
exited into a high-amplitude (typically ∼ 5 cm diameter) cyclotron orbit. This is usually
done using a frequency sweep or "chirp" through the frequencies of interest, which
contains the band of frequencies corresponding to the desired m/z range.[31] During
this process each ion respond to the RF pulse in accord to its corresponding cyclotron
frequency. Thus, each ion packet is resonantly accelerated increasing its cyclotron radius
to a higher orbit. This radius is independent of the m/z, as indicated in equation (1.19)
Moreover, other excitation pulses can be employed, such as impulse excitation or stored
waveform inverse Fourier transform (SWIFT).[34]
r =
E0Texcitation
2B
(1.19)
where, E0 is generated by the voltage (V0) applied to opposite excitation plates, separated
a distance d
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E0 =
2V0
d
(1.20)
Figure 1.8: Ion motions in an ion cyclotron resonance cell.
The increase in the radius orbit of the ion cloud allows them to get in close proximity to
the detection plates figure 1.9. The ions induce an accumulation of charges with the
opposite sign to the detection plates and as the ions orbit the cell, close to the detection
plates, image charge is induced, which alternates at each opposite plate generating an
alternating voltage. This alternating voltage is amplified to generate a time domain
signal (referred to as transient).[32] This time signal is then converted to represent the
cyclotron frequency of the each individual ion using the mathematical function known
as the Fourier transform (FT). The frequency domain spectrum is then converted by
application of the equation (1.18) to obtain the mass spectrum.
The excited ion packet will eventually lose their energy and spiral back down to the
centre of the cell causing a drop in the intensity of their detected signal, which in turn
results in a fast decay of the transient. Sum up to this loss of energy, further collisions
with background gas cause loss of coherence of the ion packet also affecting the duration
of the transient. The duration of the transient T directly affects the resolving power as
shown in equation (1.21)
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Figure 1.9: Excitation and detection of trapped ions in a cyclotron resonance cell.
RP =
fT
2
(1.21)
where, f is the cyclotron frequency in Hz and is equal to equation (1.22)
f =
ωc
2pi
(1.22)
It seems clear that the resolving power is also dependent on the strength of the magnetic
field. However, many other factors (operational or instrumental) contribute towards the
decrease/increase of the resolving power. Instrumental parameters include the electric
and magnetic field homogeneity, the cell geometry, ion transmission and electronics. In
contrast, operational parameters like a high ion accumulation time of the ions before
entering the cell decreases the resolving power. This, in particular, causes space charge
effects where the collisions among the ions themselves originate almost immediate loss
of coherence and a fast decay of the transient.[33,35] Another operational parameter
that greatly affects resolution is the low-mass cutoff, which, anyway, can be changed as
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desired. A typical low-mass cutoff for the fragmentation analysis of protein/peptides
is m/z 150. In the present work the low-mass cutoff was set to m/z 150, too, although
some minor variations were required for some specific tests. Additionally, this low-mass
cut off is dictated by the sampling frequency, which must satisfy the Nyquist criteria.
Therefore, the lowest m/z, that corresponds to the highest frequency of the ions in
the cell, is set such that the sampling frequency is guaranteed to be at least twice the
highest frequency of the ions. Equally, this sampling frequency is also limited by other
instrumental parameters.
In the instrument employed in this work, at a typical mass of m/z 400, a resolving power
of around 200, 000 is achieved. Moreover, a mass accuracy below 1 ppm is reached, when
internal calibration is used, as shown in appendices A to D. Additionally, this instrument
is coupled with fragmentation capabilities, such as collisionally activated dissociation
(CAD),[9] electron capture dissociation (ECD),[8] and infrared multiphoton dissociation
(IRMPD)-ECD.[36–39] which are described in section 1.5 and chapter 2.
1.5 Fragmentation techniques
Fragmentation of the ions occurs in three steps: first, isolation of the precursor ion fol-
lowed by fragmentation (using CAD, ECD, IRMPD, among others), and finally, detection
of the fragment ions. These three steps can occur in different mass analyzers localised
in different places of the mass spectrometer, process which is referred to as tandem
mass spectrometry (MS/MS) in space. On the contrary, fragmentation in the same mass
analyzer is known as MS/MS in time. For instance, MS/MS in space is performed in
triple quadrupole (QqQ), quadrupole combined with TOF mass analyzers and TOF/TOF.
The instrument used in this work is capable of performing MS/MS in space and MS/MS
in time, as desired. The typical configuration used is performing isolation of the parent
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ion in the quadrupole and fragmentation in the collision cell for CAD or fragmentation
by ECD in the cell.
Fragmentation capabilities in mass spectrometry allow characterisation and identification
of protein/peptides PTMs, such as phosphorylation,[40] glycosylation,[41] carboxymethy-
lation,[42] among others.[43–46] In order to elucidate protein/peptide sequence and
localise PTMs a common nomenclature is adopted,[47,48] as shown in figure 1.10.
C N C C N C C
N C COOH
NH2 C
R1 O
O OR2 R3
R4
x3 y3 z3 x2 y2 z2 x1 y1 z1
a1 b1 c1 a2 b2 c2 a3 b3 c3
HHHHHHHH
nH
+
C-terminus
N-terminus
Figure 1.10: Example of Roepstorff and Biemann’s nomenclature for proteins/peptides.
Once the fragmentation pattern is obtained the identity of the amino acid residue is
then obtained from the mass difference of the same type of fragment ion series (c,
b, and a fragment ions, from the N−terminus; or z·, y or x fragment ions, from
the C−terminus), which must have the same charge. This approach allows one to
determine the complete peptide/protein structure, which can be performed manually or
by database searching. However, some types of modifications added to the protein are
not included in the databases requiring a manual identification like the modifications
studied in this work.
Interestingly, some isomeric amino acid residues like leucine and isoleucine are difficult
to elucidate, unless either high energy collisionally activated dissociation (see section
1.5.1) or hot-electron capture dissociation (HECD, see section 2.4.1) are performed.
Other amino acid residues are easily identifiable by low energy collisionally activated
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dissociation, technique also labeled as CAD.[49] It is convenient to clarify that, regardless
of the level of energy employed in the fragmentation, the technique is just known as
CAD.[50] Even more important is to note that such a fragmentation technique is also,
often, referred to as collision induced dissociation (CID).[9,51] Nevertheless, for simplicity,
it has been deemed convenient to employ, in the this thesis, a single acronym to refer to
such a technique, being CAD the label chosen for the present work. This collisionally
activated dissociation technique, or CAD, is described in the following section 1.5.1.
1.5.1 Collisionally activated dissociation (CAD)/Collision induced
dissociation (CID)
Collisionally Activated Dissociation is the most commonly employed fragmentation
technique used for the analysis of a variety of samples. This technique is based in
the collision of neutral gas molecules with a selected precursor ion.[9] Argon gas is
used in the CAD experiments performed in this work, although other gases can also be
employed. However, in order for the collisions to cause bond cleavage, the kinetic energy
of the precursor ion needs to be raised to generate fragment ions. The kinetic energy of
the precursor ion can vary from 1 eV to > 1000 eV . Thus, CAD can be distiguished as
high-energy CAD and low-energy CAD.[13]
High-energy CAD is performed by a single collision of high kinetic energy (> 1000 eV )
precursor ions with neutral gas molecules. The high kinetic energy of the ions is induced
by accelerating them in TOF-TOF and sector instruments. This type of fragmentation
produces b/y, w, and d fragment ions in peptides and proteins (see figure 1.10). w and
d fragment ions are useful to differentiate leucine and isoleucine amino acid residues,
but also increase the complexity of the spectrum making difficult its interpretation.
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Low energy-CAD, used in this study, is characterised by the low-energy used for frag-
mentation between (1 to 100 eV ), where multiple collisions take place. A fraction of this
translational energy is converted into internal energy and the ion reaches an excited
state (activated ion).[52] The slow-heating mode (∼ 10−2s) in which the energy is trans-
ferred into the ion induces fast energy redistribution (among the degrees of freedom
of the molecule) and the precursor ion is then vibrationally excited.[53] This energy
redistribution is fast compared with the dissociation time, and cleavage of the bond
between the carbonyl carbon and the nitrogen atom is produced. The fragmentation
pattern is characterised by b/y fragment ions and labile side chain losses from the
precursor ion and from the fragment ions. The loss of these labile side chains make it
difficult to directly identify the location of labile PTMs. Nonetheless, such a technique is
widely used in protein/peptide analysis.[54–58]
The proposed reaction for collisionally activated dissociation at high and low energy can
be represented as equation (1.23).
q + [M + nH]n+ + Ar
(
[M + nH]n+
)∗
fragments + Q (1.23)
where, M represents the protein/peptide; q is the amount of translational energy con-
verted into internal energy; andQ is the kinetic energy liberated in the fragmentation.[59]
q is calculated from the conservation laws in a inelastic collision, where the motion of
the system is described by the separation of the particles relative to the centre of mass
(CM) of the system (equation (1.24)).[59,60]
q =
1
2
(
Mm
M +m
)
v2i −
1
2
(
Mm
M +m
)
v2f (1.24)
Where, M is the mass of the parent ion; m is the mass of the target gas; vi is the initial
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relative velocity in the CM frame defined by the difference of the velocity of the parent
ion, v1, and the velocity of the target gas, v2; vf is the final relative velocity in the CM
frame. It can be deduced from equation (1.24) that q has a maximum value when vf is
equal to zero (both particles travel together after a collision, which only happens in an
adduction reaction).
Additionally,considering that the centre of mass collision energy, ECM is given by equa-
tion (1.25)
ECM =
(
m
m+M
)
∆ELAB (1.25)
where, ELAB is the translational energy change of the ion in the laboratory frame of
reference, and can be determined as is shown in equation (1.26)
ELAB = q + ∆Em (1.26)
where, ∆Em is the kinetic energy change of the target gas. Assuming that ∆Em = 0
then, ELAB = q and that vf = 0, the centre of mass collision energy, ECM is dependant
on the reduced mass and the initial kinetic energy of the ion and the gas target.
Mobile proton model and b fragments ions structure
A model has been proposed to explain the prevalent formation of b/y fragment ions
in protonated protein/peptides during low-energy CAD.[61] This model is based on the
mobility of the proton attached at the initial protonation site and then transferred to the
amide backbone functionality. This mechanism is referred to as the mobile proton[62]
and the proposed reaction mechanism is illustrated in figure 1.11 indicating protonation
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at the amide N-terminus. However, protonation at the amide nitrogen atom is less
probable than protonation at the carbonyl oxygen because of the low-gas phase basicity
of this amide nitrogen atom. Nonetheless, the debate is still open whether the same
fragmentation occurs from O−protonated and/or N− protonated peptide/proteins.[62]
In figure 1.11 the protonation at the N-terminus causes an inductive cleavage[12] of
the C−N bond, which subsequently generates an acylium ion. It has been argued that
the acylium ion is not the structure of the b fragment ions, particularly b2 fragment
ions. Instead it is believed that the oxazolone ion is the structure of the b2 fragment
ions. One of the main arguments that support the theory about the formation of the
oxazolone ion is the absence of the b1 fragment ion in the CAD spectra of any protonated
protein/peptide. If the b2 fragment ions would have the acylium ion structure, then b1
fragments ions will be present in the CAD spectra. The absence of the b1 fragment ion is
then explained by the oxazolone ion formation, which requires at least two amino acids
to contribute towards its formation, as shown in figure 1.11.
Another proposed structure for the b2 fragment ion, in peptides containing aliphatic or
simple aromatic amino acid residues, is the structure known as diketopiperazine.[63]
However, Bythell, B. J and Somogyi, A. and Paizs, B.[63] reported that the oxazolone
has a low threshold energy compared to the diketopiperazine, further supporting the
hypothesis about oxazolone ion formation in CAD of aliphatic or simple aromatic amino
acid residues. Other experiments in histidine and lysine containing peptides reported that
b2 fragment ion structure can be both a diketopiperazine and an oxazolone ion, where
the accessibility of an amino nitrogen is essential for diketopiperazine ion formation,[64]
as shown in figure 1.12.
Interestingly, it has been suggested that b5 fragment ion, under CAD conditions, under-
goes a cyclization-reopening mechanism.[65] The cyclization structure contains a mobile
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Figure 1.11: Proposed reaction mechanism for the mobile proton model. Figure adapted
from Wysocki, V. H. and Tsaprailis, G. and Smith, L. L. and Breci, L. A.[62]
Figure 1.12: Proposed reaction mechanism for the formation of diketopiperazine ion in
CAD.
proton allowing changes in the protonation site, which could cause reopening of the
ring at different amide bonds. Consequently, the original sequence of the peptide gets
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scrambled generating a "non-direct sequence" as shown in figure 1.13. The different
fragmentation channels in low-energy CAD have been comprehensively reviewed by
Paizs and Suhai.[66]
Figure 1.13: Proposed reaction mechanism for the cyclization-reopening mechanism in
CAD. Figure adapted from Bleiholder et. al.[65]
1.5.2 Infrared multiphoton dissociation (IRMPD)
In this study, IRMPD was performed by using a low-power, continuous-wave CO2 laser,
which has a wavelength of ∼ 10.6µm. Low energy IRMPD is dependant on laser
intensity, which is the amount of power deposited area (cm2).[53] This implies that the
laser power and irradiance time needs to be adjusted in order to fragment the molecule.
Multiple photon absorption (resonant or non-resonant) generates vibrational excitation
of the protein/peptide. The vibrational excitation is reached when the vibrational energy
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level matches the energy of the laser and incoherent absorption of multiple photos
occurs. Thus, similarly to CAD, the energy is rapidly redistributed into the degrees of
freedom of the protein/peptide.
IRMPD likewise to low-energy CAD generates b/y fragment ions, but IRMPD offer
far greater control on the extent of the dissociation and the production of secondary
fragment ions. The proposed reaction for IRMPD can be represented as equation (1.27).
[M + nH]n+ + n(h ν)
(
[M + nH]n+
)∗
b/y (1.27)
where, M represents the protein/peptide; h is Planck’s constant; and ν is the frequency.
IRMPD has been successfully applied in the fragmentation of phosphorylated peptides
due to the chromophore nature of the phosphate ion, at 10.6µm.[67] The IRMPD spectra
of phosphorylated peptides IRMPD was reported to exhibit abundant low m/z ions
compared to CAD.[68] IRMPD has also been used in the analysis of sulfonated pep-
tides[69] and in the study of glycosylation.[70,71] The use of IRMPD in derivatized species,
particularly derivatized oligosaccharides with boronic acid, was reported to enhance
photon absorption.[72] IRMPD has found a wide range of application as a tool to disrupt
non-covalent interaction in protein/peptides,[73–76] enhancing ECD cleavage coverage
(see sections 2.1.2, 2.4.1).
1.5.3 Electron capture dissociation (ECD)
ECD is another fragmentation technique employed in a variety of analyses, such as:
localization of labile PTMs;[41–43,77–81] peptides sequencing;[82,83] structure elucidation
of small molecules;[84,85] and, analysis of oligomers and cyclic peptides,[86,87] among
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many others. ECD is based in the interaction of low energy electrons (∼ 0.2 eV ) with
protonated species, causing charge neutralisation and generating c/z·fragment ions, as
is described, in detail, in chapter 2.
It is clear, then, that fragmentation (ECD and CAD) in mass spectrometry is useful
to generate amino acid sequences of proteins/peptides. However, sometimes it is not
possible to elucidate the protein sequence due to the absence of fragment ions during
MS/MS experiments.2 This is attributed to the secondary and tertiary conformation of
the proteins. Thus, in order to surpass this limitation, a bottom-up protein approach can
be used, which is discussed in the following section. The top-down analysis of proteins
was also used in this work and is presented in chapter 7.
1.6 Top-down and bottom-up analysis of proteins in mass
spectrometry
In this study two types of analysis (top-down and bottom-up) of proteins were employed
to study the binding site of glyoxal to human serum albumin (HSA). The bottom-up
analysis, used for HSA sequencing, is based on performing an enzymatic digestion of
the protein prior to mass spectrometry analysis.[13] In contrast, sequencing of an intact
protein by mass spectrometry applying MS/MS methods is referred to as the top-down
approach.[88]
The bottom-up analysis of HSA required various steps:
• Determination of the molecular mass of the HSA was made using MALDI or ESI;[13]
as is shown in chapter 7.
2It should be noted that, in any case, absence of fragment ions in proteins can be overcome by
employing additional ion activation methods in conjunction with ECD (see section 2.4.1).
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• Once the molecular mass is approximately known, it was necessary to denature the
protein in order to break the non-covalent interactions, which made the secondary
and tertiary structures of the protein and to expose the disulphide bonds within
the protein. Denaturation was performed by:
– by chemicals, in particular guanidine hydrochloride was used in this study.
– by increasing the temperature until 60 ◦C, which was the temperature where
HSA was denaturated.
– by precipitation with solvents, MeOH/chloroform was employed in this work.
• Reduction (with Dithiothreitol 15mM , or DTT) and alkylation (with iodoacetamide
15mM) of the disulphide bonds is performed after denaturation, to allow full
access of the enzyme.
• Once the protein was purified from all the chemicals employed (DTT, it is ready to
perform enzymatic digestion. The enzyme used in this work was trypsin, which
cleaves on the C−terminal side of lysine (Lys or K) and arginine (Arg or R).
Different ratios of enzyme : protein were employed in this work, ranging from
1 : 20 to 1 : 100 (see chapter 7).
• Finally, the resulting peptides were analysed by MS/MS.
It is noteworthy that the bottom-up and the top-down approaches can be used as com-
plementary techniques, particularly when identifying post-translational modifications
like glycation.
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1.6.1 Glycation
The Maillard reaction, also known as browning reaction,[89] has been widely studied
in heated food because of its importance in the production of flavored and coloured
compounds.[90? ] In the human body this reaction is known as glycation,[91] which is
important when a subject develops hyperglycaemia, a condition that favors the reaction
of glucose with protein/peptides. One of such reactions, for example, is that of glucose
with haemoglobin, whose product is the haemoglobin variant HbA1c, known to be a
marker in the development of diabetes.[92]
During diabetes, glucose autoxidation[93] and other metabolic process[91,94–96] generate
reactive α−dicarbonyl compounds (α−oxoaldehydes), such as glyoxal, methylglyoxal
and 3−deoxyglucosone. Glucose and these glucose derivatives react non-enzymatically
in a complex process of sequential and parallel reactions[97] with amino, guanidino,
and thiol groups of proteins and peptides.[98–100] The variety of reaction pathways with
protein/peptides, leads to a many different glycation products, which are generally
referred to as advanced glycation end-products (AGEs). One of these AGEs is the
compound known as Amadori product, formed from the reaction of glucose with amino
groups of protein/peptides, as shown in scheme 1.1. The degradation of the Amadori
product generates glyoxal, as is also illustrated in scheme 1.1.
The concentration of AGEs and their steady-state presence in the human body is linked
to the development of diabetic complications like retinopathy, neuropathy, high risk
of cardiovascular disease, and stroke.[101–105] For instance, among the variety of AGEs
formed during hyperglycaemia, the glyoxal-derived AGE known as creatinine (see
scheme 1.2f)[106] is considered a marker in the pathophysiology of uremia.[107] Given
the apparently high relevance of these AGEs in a number of human pathologies, it is
not surprising to find a substantial amount of research aiming to determine how the
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Scheme 1.1: Proposed reaction mechanism for the formation of glucose derived-AGEs
(Amadori product) and proposed degradation of the Amadori product to form glyoxal.
precursors of AGEs modify protein and peptides. Such research has also contributed
to determine types and structures of AGEs.[108–111] Nonetheless, multiple factors in
sample preparation and detection methods make it difficult to compare the types of
AGEs observed in protein/peptides.[112] For instance, as an example of the variety of
types of AGEs reported in the literature, it is worth mentioning a few interesting cases:
• AGEs quantitatively formed from methylglyoxal and glyoxal at the arginine residue
are:
– The arginine residue derived hydroimidazolone (N δ-(5-hydro-5-methyl- 4-
imidazolon-2-yl)ornithine (MG-H1));[111,113]
– Nω − carboxymethyl − arginine (CMA);[111]
– 4,5-dihydroxyimidazolidine;[114]
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– 2-amino-3H-5-dihydro-imidazol-4-one (G-H3).[111,115]
Some of these compounds were also detected in this study and are presented in
scheme 1.2.
Scheme 1.2: Glyoxal-derived AGE strucutres. a. Schiff base at the guanidine group
of arginine; b. 3-hydroxyimidazole (left). c. 2-imine-5-hydroxyimidazoline (right); d.
4,5-dihydroxyimidazoline (left); e. 2-imine-4,5-dihydroxyimidazolidine (right); f. 2-
imine- imidazolidinone (creatinine side chain); g. 2-amino-3H-5-dihydro-imidazol-4-one
(G-H3); h. Nω-carboxymethyl-arginine (CMA).
• Lysine residues modified AGEs are:
– N -carboxymethyl-lysine (CML).[113,116–119] CML has been reported in both
the reaction of methylglyoxal with proteins and in the oxidative degradation
of N−fructosyl-lysine residues in proteins glycated by glucose;[92,115,118]
– Lysine residues modified in proteins has been reported with glyoxal in human
serum albumin (HSA), although most of the glyoxal glycation was reported
at the arginine residues;[120]
– Glyoxal-hemiaminal;[121]
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– Pyrazines[122] formed by the reaction of glyoxal with lysine residues.
• N−terminus modified AGE was reported as N−terminal pyrazinones.[123]
• AGE crosslinked species such as:
– The glyoxal-lysine dimer, GOLD (6-{1-[(5S)-5-ammonio-6-oxido- 6-oxohexyl]
imidazolium- 3-yl} -L-norleucinate),[124,125] formed by reaction of glyoxal
with two lysine residues. However, GOLD is believed to be formed during
strong acid and alkaline hydrolysis;[126]
– GODIC (N6-(2-{[(4S)-4-ammonio- 5-oxido-5-oxopentyl]amino}- 3,5-dihydro-
4H-imidazol-4-yli-dene)-L-lysinate),[127,128] formed by the reaction of glyoxal
with one lysine residue and one arginine residue;
– DOGDIC (N6-{2-{[(4S)-4-ammonio-5-oxido- 5-oxopentyl]amino}- 5-[(2S,3R)-
2,3,4-trihydroxybutyl]- 3,5-dihydro-4H-imidazol-4-ylidene}-L-lysinate) is a
crosslinking product derived from 3-deoxyglucosone;[128]
– Pentosidine and glucosepan are crosslinked species formed between lysine,
arginine and a reducing sugar.[129–131]
The crosslinking ability of the reducing sugars and its decomposition products (α-
dicarbonyl compounds) cause damage to protein networks.[132] Other effects, for ex-
ample in long-lived proteins like collagen, is the decrease in flexibility, whereas in
short-lived proteins like HSA, causes insolubility.[133]
Given the variety of products that can be obtained during the glycation reaction, and
the significant number of detection methods used to identify them, it is not difficult to
realize that confusion about the types of AGEs observed in− vivo and in− vitro easily
arises. Moreover, the lack of an standard method for assignment of glycation brings
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about extensive literature of different types of AGEs.
In any case, one method for detection of dicarbonyl derived AGEs in proteins (in− vivo
and in− vitro) is stable isotope dilution analysis with tandem mass spectrometry. This
method requires exhaustive enzymatic hydrolysis of peptide and protein substrates.[113]
Mass spectrometry (MS) has also been used to characterize glycation products within
proteins/peptides.[108,134–136] Moreover, MS coupled with fragmentation techniques such
as collisionally activated dissociation (CAD), electron capture dissociation (ECD) and
electron transfer dissociation (ETD),[137] has also been applied to assign the site of
glycation modifications.[111,138–140]
1.7 Thesis outline and structure
In the present study, mass spectrometry (MS), coupled with CAD and ECD, has been
used to characterize glycation products generated by the glyoxal with peptides/proteins.
In particular, the main focus of this work was to assign the binding sites of glyoxal
within polypeptides. A summary of the general structure and organization of this thesis
is presented below,
Chapter 2 Principles of electron capture dissociation in proteins/peptides.
Chapter 3 Assignment of binding sites glyoxal-derived advanced glycation end-products
for substance P.
Chapter 4 Tandem mass spectrometry for the study of glyoxal- derived advanced glyca-
tion end-products (AGEs) in peptides.
Chapter 5 Tandem mass spectrometry for the study of an unusual glyoxal- derived
advanced glycation end-product.
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Chapter 6 Study of an unexpected crosslinking and diglycation as advanced glycation
end-products by tandem mass spectrometry.
Chapter 7 Summary of results and ongoing projects.
Chapter 8 Conclusions and future work. In this final chapter, general conclusions
are presented, elicited from the different results in the thesis, and ideas about
interesting future work are suggested.
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Principles of electron capture dissociation in
protein/peptides
2.1 Introduction
Electron capture dissociation (ECD) has been widely used, in conjunction with colli-
sionally activated dissociation (CAD), to elucidate protein and peptide structure. The
widespread use of ECD is based on the extensive cleavage coverage giving comple-
mentary fragmentation to CAD and the retention of labile post-translational modifi-
cations (PTMs). This capability allows the location of labile PTM binding sites on
proteins/peptides, which would be lost during other fragmentation techniques such as
CAD and infrared multiphoton dissociation (IRMPD). ECD cleaves the N −Cα backbone
bond in the protein/peptide backbone chain. This chapter addresses some of the aspects
of ECD that have been studied in the decade since its first development. Initially ad-
dressing the terminology employed; followed by some historical aspects about how ECD
became particularly applied to labile PTMs binding site identification in proteomics. A
discussion about common side chain losses usually observed in the ECD spectra along
with the usual fragmentation pattern (c/z·) is covered. A summary about some related
methods, such as electron impact excitation of ions from organics (EIEIO), hot electron
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capture dissociation (HECD), electron induced dissociation (EID), Electron Excitation
Dissociation (EED), electron detachment dissociation (EDD), activated ion electron
capture dissociation (AI-ECD), electron capture induced dissociation (ECID), among
others, are included to discuss the additional capabilities of electron reactions. The
chapter includes a discussion about the ECD fragmentation mechanism on the N − Cα
bond, along with radical-directed dissociations, which have been matter of enthusiastic
debate during the last decade. Finally, the chapter concludes with a discussion about
ECD non-ergodic behaviour. This chapter does not intend to address the questions about
how the electron is captured and the energy released upon electron capture. Moreover,
ECD applications in DNA, RNA, oligomers, histones, metal-protein interactions, synthetic
polymer cations, and the disulphide bond cleavage mechanism are outside the scope of
the present chapter.
2.1.1 Terminology
ECD is considered the reaction of multiply-charged ions, [M+nH]n+, with M representing
the molecule), with low energy electrons (∼ 0.2 eV ).[8] This reaction leads to the
cleavage of the protein/peptide backbone at the N − Cα bond, thus generating low
abundance c and z·fragment ions. Fragments are labelled using the Roepstorff- Biemann
nomenclature.[47,48] In addition to the cleaved polypeptide chain, high abundance of
charge-reduced radical species, represented by [M + nH](n–1)1+·and hydrogen deficient,
even electron charge-reduced species or [M + (n−1)H](n–1)1+ are also generated in
ECD. The charge-reduced radical species has non-covalent bonds that hold the cleaved
polypeptide main-chain fragments together temporarily,[36,141–143] as is illustrated in
structure I on figure 2.1.
Figure 2.1 shows the proposed chemical structures of the charge-reduced species, the c
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fragment ion, and z·radical fragment ion. The hydrogen bonding on the charge-reduced
species is depicted only with the purpose of illustration and is based on structures
proposed by Turecek, F. and Syrstad, E. A. and Seymour, J. L. and Chen, X. and Yao,
C.[144] Moreover, the c fragment ion can be represented as an enol-imine (Structure IIb
in figure 2.1), although the amide moiety (Structure IIa) is thermodynamically more
stable.[43] In contrast, z·radical fragment ions are usually represented as α−carbon
radicals, which are stable in the gas phase.[145–147]
Figure 2.1: Schematic representation of ECD fragmentation at position 2 towards
the N−terminus. The position of the hydrogen bonds can not be ascertained unless
calculations of the dissociation and transition state energies of the radical cation and c2
fragment ion are performed. Structure IIa = c2 fragment enol-imine; Structure IIb = c2
fragment amide. Note that the position of the charges is symbolically representing the
point of largest charge density at the instant of electron capture. Illustration based on
structures proposed by Turecek, F. and Syrstad, E. A. and Seymour, J. L. and Chen, X.
and Yao, C.[144]
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It should be noted that the presence of the [M + (n−1)H](n–1)1+ is caused by the loss of
the radical H·, which is a predominant, non-informative channel during ECD. As from
the charge-reduced species, the reaction can be represented by equation (2.1).[148]
[M + nH]n+ + e– ->
(
[M + nH](n–1)+·)∗ c(fragment ion) + z· (radical fragment ion) (2.1)
Electron capture dissociation also produces c·(c· = c−H, with H = 1.007825Da), and
z fragment ions (z = z·+H) simultaneously with the c/z· species.[149] Abundant z
fragment ions are believed to be formed by hydrogen abstraction from their counter-
part.[142] Another type of fragment ions produced in ECD are called non-standard ECD
fragment ions,[150] such as b/y, a/a·(a· = a−H), w, and u. For instance, the presence of
b fragment ions is a function of the type of charge-carrying amino acid and the peptide
structure.[151–153]
Cooper, H. J.[151] demonstrated that the b fragment ions observed in ECD are not
produced by off-resonance excitation during the precursor ion isolation or black body
infrared irradiation (BIRD) from the electron emitting-cathode. The author proved the
absence of off-resonant excitation by performing isolation of the ions in a quadrupole
instead of in the ICR cell. Additionally, by changing the grid potential to −200V
(instead of +50V during the ECD experiment) the author prevented the electrons
from entering the ICR cell and proved that b ions in ECD are not formed by BIRD
from the cathode. Moreover, b ion generation was proposed to be independent of
the peptide basicity, but dependant on the electron capture site and local structural
features.[151,152] The formation of b fragment ions was not attributed to secondary
fragmentation from the c fragment ions,[151] instead they probably follow a different
fragmentation pathway (mobile proton model[62]) from the charge-reduced hydrogen
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deficient species [M + (n−1)H](n–1)+.
In regard to the presence of a/a·fragment ions in ECD, other authors attributed its
presence to the loss of the CO group from the b fragment ions.[154] Moreover, the
presence of a·fragment ions could be derived via an unobserved b·fragment ion.
Secondary fragments[150] like w and u fragment ions, are apparently derived from
partial side chain losses of the z·radical species. Other side chain losses observed in the
ECD spectra, which can be used as diagnostic ions, are presented in section 2.3.
2.1.2 ECD efficiency vs. cleavage coverage
Reactions with low energy electrons in the ion cyclotron resonance cell leads to the
production of low abundance fragment ions, which are then detected in the mass
spectrometer. The low abundance of the fragment ions is attributed to low fragmentation
efficiency. Efficiency is quantitatively determined by the ratio of output to input, or in
other words, the ratio of the total abundance of all the fragment ions after fragmentation
and the abundance of the precursor ion before fragmentation. This definition has been
applied to measure the fragmentation efficiency of, for example, CAD.
Interestingly, the way that ECD efficiency has been calculated has varied in the literature
through the last decade. In order to understand why there are different ways to
calculate ECD efficiency it is necessary to recapitulate about the observed species in the
ECD spectra and their provenance during ECD. First of all, the charge-reduced radical
species ([M + nH](n–1)+· ) is produced by the capture of an electron on the precursor ion.
Accordingly, the ratio of the intensity of the [M+nH](n–1)+· species to the intensity of the
precursor ion before the experiment is a measure of the capture efficiency. Second, the
fragment ions (e.g. c/z· , c·/z, and a-type fragment ions) observed in the ECD spectra are
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formed from the charge-reduced radical species. Therefore, the ratio of the sum of all the
fragment ions to the intensity of the of [M + nH](n–1)+· species before fragmentation is
a measure of the fragmentation efficiency. Third, a predominant fragmentation channel
is the non-informative loss of hydrogen radical forming the [M + (n−1 )H](n–1)+, which
can further fragment generating, for instance, b-type fragment ions. Therefore, the ratio
of the sum of particular fragment ions, such as b-type fragment ions, to the intensity of
the [M + (n−1 )H](n–1)+ is defined as branching ratio. However, these definitions are
not often used in the literature; instead, other definitions have been adopted, which are
summarised below.
Initially, capture efficiency was performed summing the intensity of all isotopologues of
the fragment ions and then dividing by the charge state of the ions,[43] giving efficiencies
of around 80 ± 15%. On the other hand, a different concept that has been introduced
in order to calculate ECD efficiency is by calculating the proportion of how much of
the precursor ion turns into fragment ions, and which has also been called conversion
efficiency.[155] In particular, this type of efficiency is calculated as the ratio of the sum of
the abundances of the observed fragment ions to the abundance of the precursor ion
before fragmentation.[156,157]
The fragmentation efficiency in ECD has been defined as the sum of the intensities of
the fragment ions (excluding the precursor ion and the charge-reduced species) divided
by the total ion abundance in the ECD spectrum.[158] Additionally, Zubarev et al.[157]
introduced the concept of effective efficiency of ECD per scan, which is calculated by
summing the intensity of the product ions and the dividing such sum by the intensity of
the precursor ion. Equation (2.2) shows another approach to calculate ECD efficiency
by considering the charge state (n) of the precursor ion, with n > 2.[159]
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Efrag−ECD =
[∑
fragment ion abundances− abundance [M + nH]n+
Precursor ion abundance
] (
n
n− 1
)
(2.2)
These different methods of calculating ECD efficiency have made it difficult to compare
published results, particularly when other concepts were also introduced. For instance,
the concept of fragmentation efficiency has also been used as a measure of percentage of
inter-residue backbone bond cleaved.[160,161] This concept is herein defined as cleavage
coverage. It is noteworthy that the concept of sequence coverage, used throughout the
protein mass spectrometry literature, can be misleading given that it is also used to
define the fraction of peptides observed after enzymatic digestion.
Nevertheless, in spite of the variety of calculations for the ECD efficiency, a pattern
emerges. In terms of cleavage coverage, ECD is more efficient than CAD, but in terms
of fragmentation and conversion efficiency CAD can achieve higher values than ECD.
However, the fragmentation efficiency of ECD can be improved by adjusting or modifying
instrumental parameters. A discussion regarding such an improvement by adjustment of
instrumental parameters can be found elsewhere.[156,159,162–164]
Finally, it is convenient to introduce the concept of the probability for dissociation in
ECD, which is calculated by equation (2.3),[165] as well as the concept of probability for
charged species to capture an electron during a defined time, which was introduced by
Mormann et.al.[166] and it is shown in equation (2.4).
Epro−Disso =
[ ∑
(Intensity of ECD fragment ions)∑
(Intensity of ECD fragment ions) + Reduced intensity of the precursor ion
]
(2.3)
45
Eeff =
[ ∑
(Intensity of ECD fragment ions) + Reduced intensity of the precursor ion∑
(Intensity of ECD fragment ions) + Reduced intensity of the precursor ion + Intensity of the precursor ion
]
(2.4)
In this work, where it is possible, clarity about all the different interpretations of ECD
efficiency is made. Furthermore, in order to bring about some degree of contextualisa-
tion, a brief review about the historical aspects of ECD during its first year of existence
is presented below.
2.2 Historical aspects
Fragmentation of small gaseous cations by electrons (3− 9 eV ) in a Fourier transform
ion cyclotron resonance mass spectrometer was developed in 1976.[167] Later on this
technique was called electron impact excitation of ions from organics (EIEIO).[168] The
dissociation produced a fragment cation and a neutral species, similar to those observed
in CAD. This fragmentation pattern was attributed to either the relatively high energy
of the electrons (> 3 eV ) or to the form in which this energy is redistributed in the
molecule. EIEIO was later applied to bigger molecules like Gramicidin S in the ICR
cell, using simultaneously laser and 70 eV electron pulse to induce ionization of the
peptide.[169] Almost twenty years later a modification of this technique was introduced
using multiply charged protein ions interacting with low energy electrons (∼ 0.2 eV ),
which it is referred to as electron capture dissociation (ECD).[8] This development was
made possible by the use of ESI, as a sample introduction method for large biomolecules
into the mass spectrometer.[22]
Zubarev et al.[8] attempted to reproduce previously reported c and z-type fragment ions
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produced upon 193nm (6.4 eV ) dissociation. These ions were documented for masses
between 2.8 kDa and 8.6 kDa, although b/y fragment ions were observed for masses
below 2.8 kDa.[170] Zubarev and co-workers[8] believed that electrons, and not photons,
might be responsible for the observed c/z fragment ions. Therefore, they decided to
employ a heated filament electron gun to produce electrons. Subsequently, they found
that one or more charges, on a multiprotonated protein cation, were neutralised by
electron capture and consequently fragmentation produced c/z· species (figure 2.1).
They proposed a mechanism for ECD, which was based on the high proton affinity of
protonated Arg, Lys, and His that capture the electron (H·). This mechanism is discussed
in section 2.5.1.
Following the introduction of ECD,[8] Axelsson et. al.[171] performed ECD in the neu-
ropeptide Substance P. In that work the authors were trying to increase the kinetic
energy of the electrons by varying the filament voltage (−2V to −15V ). This study
suggested that the electron kinetic energy distribution during electron emission has a
low energy tail, which may increase the probability of electron capture and thus cause
fragmentation. In their work, c/z·, z, and b/y fragment ion series were observed. The
presence of b/y fragment ions was attributed to the high capillary-skimmer voltage
employed (30V to 160V ). The authors observed the charge-reduced species, thus veri-
fying that ECD involved charge neutralisation before dissociation. They also observed
that N−terminal side of proline does not fragment under ECD conditions because this
would require the cleavage of two bonds. This early experiment demonstrated that the
interpretation of ECD spectra was simpler than CAD spectra.
Cleavage coverage was also used for comparison in the early days of ECD. Tested in
model peptides, it was demonstrated that ECD could dissociate more backbone bonds
than CAD.[161] Kruger et. al.[161] had also noticed that one key limitation of ECD was
that the precursor ion must be at least a doubly-charged species in order to observe
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dissociation of the peptide. Abundant c/z· fragment ion together with low abundance
c·/z, a·, and y fragment ions were reported. The presence of those low abundance
species lead the authors think that ECD in peptides was not as specific as ECD in
proteins. The main reason being that Zubarev et. al.[8] reported that ECD in proteins
only produced abundant c/z· fragment ions.
In particular, the c· and z fragment ions are now thought to be characterised by H-atom
abstraction from the z· , and from the c species, respectively. One likely explanation for
the relatively lack of observation of c·fragment ions in proteins is that the initially formed
z·species can abstract a H-atom from anywhere in the molecule, and not necessarily
from “across” the initially cleavage point. If a z·species merely scrambles the radical
position and does not abstract an H-atom from the complementary c species, no mass
change is observed. Since proteins are bigger than peptides, the probability of this
occurring increases, which could explain the non-observation of c· species in ECD of
proteins.[8]
2.2.1 Influence of neighbouring amino acids in ECD
The influence of neighbouring amino acids during ECD experiments in proteins and
peptides was addressed by Kruger et. al.[172] They observed that the C−terminal side
of tryptophan yields nine times more abundant fragment ions, although this cleavage
nearly eliminates c/z· type fragment ions from forming at the next two C−terminal
amino acid residues. Furthermore, cysteine caused a reduction in the abundance of
fragment ions formed from cleavages of one and two residues away in either direction.
Additionally, they found that proline completely blocks c/z· cleavage on its N−terminal
side, because to cleave at this position requires cleavage of two bonds. This has been
referred to as the proline effect. Proline also exhibits the least cleavage abundance of all
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amino acids on its C−terminal side.
Interestingly enough, in a study conducted in 2003 by Cooper[150] revealed C − C
bond cleavage in the proline side chain of glycine rich peptides containing sarcosine.
Additionally, Fung[173] revealed N−terminal cleavage of proline, indicating that the
proline effect is not that cleavage of proline is 100% prohibited, but that it is less common
than other cleavages. Finally, Kruger et. al.[172] observed that CAD and IRMPD are more
affected by the type of the neighbouring amino acid than ECD.
2.2.2 Determining the binding site of post-translational modifica-
tions
A protein can be naturally modified, enzymatically or non-enzymatically, by covalent
attachment of one or more molecules, or by intra- or inter-molecular linkages. The
binding site of some labile post-translational modifications (PTMs) was difficult to detect
by certain tandem mass spectrometry techniques (e.g. CAD and IRMPD), because they
cause the loss of the labile modification. However, ECD demonstrated its capabilities to
identify the binding site of labile PTMs right from the beginning of its development.[8]
Some of those labile modifications are included here as part of the history of ECD during
the first year of introduction.
Carboxylation and sulfation
Carboxylation in synthetic peptides containing γ−carboxyglutamic acid (Gla) residues
were analysed by ECD and compared with CAD and IRMPD.[42] CAD and IRMPD resulted
in loss of CO2 from the modification causing decarboxylation. On the contrary, ECD
retained the modification identifying the binding site at the glutamic acid moiety. Losses
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from the charge-reduced radical species were reported.[42] For instance, loss of the
·CO2H moiety (41.998Da) may be caused by direct electron capture at the modification
site.
S-cysteine sulfation (addition of SO3H) was also considered by Kelleher et al.
[42] They
performed CAD on a modified peptide and observed partially modified b fragment ions,
which made it difficult to identify the binding site. On the contrary, ECD showed that
the fragment ions retained the modification and only losses of H2O and H2SO3 from the
precursor ion were reported.
O-glycosylation
O-glycosylation involves the addition of a sugar chain on the hydroxyl oxygen on the
side chain of either serine, threonine, or, less frequently, tyrosine. ECD was successfully
applied to O−glycosylated peptides where cfragment ions with addition of the modifi-
cation were observed.[10] Even-electron z fragment ions and loss of the modification
from z·radical fragment ions were attributed to some radical-site-initiated reactions.
The authors also noticed that if there was an amino acid residue glycosylated next to a
proline, inhibition of the fragmentation occurs on both sides of proline due to a steric
impediment for the radical hydrogen to be captured by the carbonyl on the protein
backbone. Additionally, they found b fragment ions, which they associated with the
vibrational activation during isolation of the precursor ion. In contrast, CAD caused loss
of the modification, which was attributed to cleavage of the glycosidic bond by a proton
transfer reaction with a low activation barrier.
50
Disulfide bonds
Cysteine engages in disulfide bonds (S − S) providing stability to the tertiary protein
structure. ECD cleaves the disulfide bonds,[174] despite the fact that this was clearly
contradicting the contemporary theory of the ECD mechanism, i.e. the electron should
be captured by the higher proton affinity sites.[8] This contradiction lies in the fact that
proton affinity at the S − S bond is low compared with other protein functional groups,
particularly the charged lysine and arginine residues. Zubarev, R. A. and Kruger, N.
A. and Fridriksson, E. K. and Lewis, M. A. and Horn, D. M. and Carpenter, B. K. and
McLafferty, F. W.[174] attempted to clarify the idea of electron capture at the site of higher
proton affinity by performing ab initio calculations for hydrogen radical atom affinity
of disulfide bonds. They found, for example, that the H·atom affinity for CH3SSCH3
is greater than hydrogen radical atom affinity for amide species (CH3CONHCH3), and
H·affinity for 3-methylindole is greater than for disulfide bonds.
Based on those results, Zubarev, R. A. and Kruger, N. A. and Fridriksson, E. K. and Lewis,
M. A. and Horn, D. M. and Carpenter, B. K. and McLafferty, F. W.[174] proposed that the
electron is captured at the protonated site and the H· is transferred to the site with high
hydrogen radical affinity, which is the disulfide bond. This H·migration would yield a
hypervalent intermediate that should spontaneously cleave (figure 2.2). Hence, they
concluded that H·attachment seems to be independent of the intramolecular distance
between the H·radical generated and the other protein functionalities. This model is
called the “hot hydrogen” model for ECD and is discussed in section 2.5.1. However, the
“hot hydrogen” model is also argued to be not applicable to ECD in disulfide bonds, as
reported in other literature.[175–179]
Additionally, changes in the ECD fragmentation pattern of cyclic peptides with one,
two, and four S − S bonds and non-cyclic peptides were reported depending on the
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Figure 2.2: Schematic representation of the electron capture (H·) at disulfide bonds
by the “hot hydrogen” model. Adapted from Zubarev, R. A. and Kruger, N. A. and
Fridriksson, E. K. and Lewis, M. A. and Horn, D. M. and Carpenter, B. K. and McLafferty,
F. W.[174]
number of S − S bonds.[174] For cyclic peptides with one disulfide bond, Zubarev and
co-workers observed that ECD cleaves at both the backbone N − Cα position and S − S
bond, producing c· and z (even electron species). However, for cyclic species with two
S − S bonds, ECD cleaves those two disulfide bonds, only transferring one hydrogen
atom to the most highly charged species, as shown in figure 2.2. Further fragmentation
(MS3) of the observed products shows z fragment ions as well as a·, and y fragment
ions. Interestingly, on Ribonuclease A, which contains four intrachain disulfide bonds,
ECD did not show any fragment ions, only the charge-reduced radical species. Using gas
phase deuterium exchange experiments, they were able to show that the charge-reduced
species was a more “open” structure (more deuterium exchanged) than the equivalent
precursor ion.[174]
Phosphorylation
Before ECD existed, phosphorylation was analysed by low-energy and high-energy
CAD (see section 1.5.1).[180] Phosphorylation on tyrosine survives CAD fragmentation.
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However, CAD of phosphorylated serine containing species with one or more phospho-
rylation sites becomes difficult due to poor cleavage coverage. ECD, favours backbone
fragmentation without elimination of the modifying group and thus is particularly useful
in successfully identifying phosphorylated sites in peptides.[181] Low intensity b and y
fragment ions were also REPORTED.
Many more studies have been conducted to date using ECD with the aim to identify
the site of post-translational modifications. As a result, many reviews about ECD in
proteomics and the location of PTMs can be found in the literature.[7,79,182–184] This
seems to prove that ECD is a powerful tool used to localise labile PTMs, mainly through
observation of the major c/z· fragment ion series. Additionally, other types of fragment
ions and side chain losses have also been observed. Side chain losses in ECD could
indicate the presence or absence of certain amino acids in the protein/peptide chain and
thus can be used as structurally diagnostic peaks, which can ascertain the present of the
associated amino acid.[185]
The following section is focused on summarising the side chain losses commonly ob-
served in ECD spectra
2.3 Side chain losses
Kruger and co-workers[161] first reported additional small neutral losses from the charge-
reduced radical species in ECD experiments. For example, losses of water, NH3, and
other side chain losses, which are presented in table 2.1. In some cases, side chain losses
can constitute a major fragmentation pathway in ECD.[186] Studies of side chain losses
in ECD spectra from ten peptides containing arginine, histidine, asparagine, glutamine,
methionine and lysine were reported by Cooper et. al.[186] The authors found that some
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particular side chain losses can indicate the presence of one particular amino acid in the
peptide chain and thus it could be used as a structural diagnostic. Table 2.1 presents
these side chain losses. Results from other different authors are also included.
Table 2.1: Side chain losses by ECD.
Amino acid in the
peptide chain
Losses Mass (Da) Comment
Isoaspartic acid zn− 57, c
1−n· +57 These losses in ECD could be useddiagnostically.c
Serine / Threonine
·CH2OH 31.018a
·C2H4NO 58.029h Odd-electron neutral loss from
z· radical fragment ions.h
Methionine
C3H6S 74.019
b
Even-electron neutral loss from charge-
reduced species and from z· radical
fragment ions.hThis loss was not ob-
served in all peptides and thus can not
be used as a diagnostic value.d
·C2H5S 61.012h
Odd-electron neutral loss from
z· radical fragment ions and charge-
reduced species.h
Lysine
C4H11N 73.089
b
This loss was not observed in all pep-
tides and thus can not be used as a di-
agnostic value.d
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Table 2.1: (continued)
Amino acid in the
peptide chain
Losses Mass (Da) Comment
C4H9N 71.073
h
Even-electron neutral loss from charge-
reduced species and from z· radical
fragment ions.h
·C3H8N 58.066h Odd-electron neutral loss from
z· radical fragment ions.
Asparagine /
Glutamine
CH3NO 45.022
b,f These losses in ECD could be used
diagnostically.d
C2H5NO 59.045
f
·CONH2 44.014h Odd-electron neutral loss from
z· radical fragment ions.h·C2H4NO 58.029h
Arginine
CH4N2 44.037
a,b,h Even-electron neutral loss from
charge-reduced species.hThese losses in
ECD could be used diagnostically.d
CH5N3 59.048
a,b,h
C4H11N3 101.095
b,h
·CH3N2 43.029b
·C3H8N3 86.072b
C4H9N3 99.068
b
C3H9N3 87.079
h
Even-electron neutral loss from charge-
reduced species.h
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Table 2.1: (continued)
Amino acid in the
peptide chain
Losses Mass (Da) Comment
Glutamine C3H5NO 71.037
h
Even-electron neutral loss from
z· radical fragment ions.h
Valine ·CH3 15.024h Odd-electron neutral loss from
z· radical fragment ions.h
Tryptophan
C9H9N 131.073
e,h
Even-electron neutral loss from charge-
reduced species.i This loss in ECD could
be used diagnostically.d
C9H7N 129.058
h
Even-electron neutral loss from charge-
reduced speciesh
·C8H6N 116.050h Odd-electron neutral loss from
z· radical fragment ionsh.
Tyrosine
C7H8O 108.058
e
C7H6O 106.042
h
Even-electron neutral loss from
z· radical fragment ions.h
Leucine/isoleucine C4H8 56.063
f,h
Even-electron neutral loss from charge-
reduced species.h
Leucine
·C3H7 43.055h Odd-electron neutral loss from z· radi-
cal fragment ions.h
dn − 43.0055i
Radical losses from d-type fragment
ions under hot-ECD conditions.i
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Table 2.1: (continued)
Amino acid in the
peptide chain
Losses Mass (Da) Comment
Isoleucine
·C2H5 29.039h Odd-electron neutral loss from z· radi-
cal fragment ions.h
dn − 29.039i
Radical losses from d-type fragment
ions under hot-ECD conditions.i
Histidine
·C4H5N2 81.045e
C4H6N2 82.053
b,e,h
Even-electron neutral loss from charge-
reduced species.hThis loss in ECD could
be used diagnostically.d
Glutamic acid
·C2H3O2 59.013h Odd-electron neutral loss from z· radi-
cal fragment ions.h
C3H4O2 72.021
h
Even-electron neutral loss from z· rad-
ical fragment ions.h
Aspartic acid CO2 43.989
h
Even-electron neutral loss from charge-
reduced species.h
Cysteine
R−SH
Cysteine from disulfide bonds.g
·S−R
zn − 91
Alkylated cysteine from either car-
boxymetyl or carbamidomethyl groups.g
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Table 2.1: (continued)
Amino acid in the
peptide chain
Losses Mass (Da) Comment
·CH2S 45.988h
Even-electron neutral loss from
z· radical fragment ions.h
a N. A. Kruger et. al., 1999
b H. J. Cooper et. al., 2002
c Cournoyer, Lin, Bowman, & O’Connor, 2007
d H. J. Cooper et. al., 2003
e K. Haselmann, Budnik, Kjeldsen, Polfer, & Zubarev, 2002
f R. A. Zubarev et. al., 1999
g Chalkley, Brinkworth, & Burlingame, 2006
h Fung & Chan, 2005
i Kjeldsen, 2002
Losses on the arginine side chain (C3H9N
+
3·and C4H10N+3 ) were also observed by Turecek
et. al.[187] Additionally, side chain loss CH5N3 (59.048Da) from arginine was attributed
to an unpaired electron delocalised at the guanidine pi∗-orbital, which is a good acceptor
for an H-atom.[188] The subsequent losses of ·C2H5, and/or C3H6 give total losses of
C4H10N3 and C3H9N3, respectively, which are products of radical migration by a proton
coupled-electron transfer mechanism,[189] where the charge and the electron migrate
separately. Other arginine losses such as C3H9N3 (87.079Da) and CH4N2 (44.037Da)
[173]
were reported in the charge-reduced species of 20 different nonapeptides (RGGGXGGGR,
where X is one of the twenty amino acid residues). Side chain losses from the X amino
acid residue, in the charge-reduced species, were observed after the arginine side chain
was cleaved, with exception of X being tryptophan and histidine. Moreover, the z· radical
fragment ions of these nonapeptides did not exhibit losses of arginine and histidine.[173]
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Histidine side chain loses from b2+ fragment ions were observed in peptides.[190] This
histidine loss was explained, at the time, by the neutralisation of the nearby acylium
ion due to the presence of the histidine close to the C−terminus. However, later
ECD experiments and computational calculations in histidine containing pentapeptides
(AAAHL and AAAHR/K) performed by Turecek, F. and Chung, T. W. and Moss, C. L. and
Wyer, J. A. and Ehlerding, A. and Holm, A. I. S. and Zettergren, H. and Nielsen, S. B.
and Hvelplund, P. and Chamot-Rooke, J. and Bythell, B. and Paizs, B.[187] explained the
histidine side chain losses (82.0526Da, 110.0714Da, 138.0664Da and 155.0929Da), by
the gradient on the dipole moment generated by the positive charge at the histidine
ring, and the negative charge at the COOH group that favoured electron capture at
the histidine ring in the pi∗-orbital. Subsequently, exothermic proton migration from
the COOH or N−terminal group to the imidazolium ring occurs. Thus, an imidazoline
radical-cation and a carboxylate anion are formed (a zwitterion). Stabilisation of the
imidazoline radical-cation leads to further cleavage on the Cα - Cβ bond (loss of C4H6N2,
82.0526Da).
Leucine losses from the z·radical fragment ions have been reported in leucine rich pep-
tides.[150] Interestingly, this reported z· radical fragment ions lost one and two leucine
side chains, which implied cleavage of three covalent bonds under ECD conditions.[150]
Additionally, w fragment ions from leucine residues were also reported in leucine rich
peptides.[150] The w, u and w· fragment ions are suggested to be derived from side
chain losses from the z·radical fragment ions in ECD.[191] The authors explain the
presence of w and u by radical migration from the α-carbon to the β-carbon and along
the side chain as proposed in 2003 by Leymarie, N. and Costello, C. E. and O’Connor, P.
B.[192] see section 2.5.5.
Losses from the phenylalanine side chain, though possible in principle, are not observed
in ECD spectra because cleavage at the bond on the phenylalanine side chain requires a
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greater activation energy than cleavage at the N − Cα backbone.[193] This implies that
the loss of the benzyl group can occur, but N − Cα backbone cleavage is faster and so
side chain loss is not generally observed for phenylalanine.
ECD and computational studies in glutamic acid and asparagine rich peptides show
fragmentation inhibition during ECD experiments.[165] This inhibition was attributed to
a hydrogen bond formed between the carbonyl carbon of the glutamic acid moiety (or
asparagine moiety) and the amide backbone hydrogen. This hydrogen bond provides
extra-stability to the charge-reduced radical species (see figure 2.3). Increase in the
inhibition of the fragmentation is observed if the number of glutamic acid residues in
the peptide is increased, with H·loss as the main fragmentation product.
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Figure 2.3: Schematic of the proposed ECD fragmentation inhibition observed in glu-
tamic acid rich peptides. Adapted with permission from Chan and Chan.[165]
Furthermore, it has been argued that secondary fragmentation, which produces even-
electron and/or odd-electron side chain moieties (as it is shown in table 2.1), can be
driven by radical migration.[173,192] A discussion about radical-directed fragmentation is
presented in section 2.5.5.
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2.4 ECD related methods
Since the implementation of ECD other derived methods such as hot-ECD (HECD),
electron induced dissociation (EID), and electron detachment dissociation (EDD), have
been developed in FTICR mass spectrometer. EID and EDD were developed to overcome
particular limitations of ECD, which are described below. Other techniques, such as
activated ion-ECD (AI-ECD), and SORI-ECD have been used to improve ECD cleavage
coverage and conversion efficiency (discussed in section 2.1.2). These techniques, to
date, can be performed in a FTICR mass spectrometer and in modified quadrupole
mass spectrometers,[194,195] although there are other electron based dissociations used
in other instruments, for instance ECID used in accelerators[196] and electron transfer
dissociation (ETD),[197] which can be used in both FTICR and other commercial mass
spectrometers. Here a brief description of some electron based technique is presented
with the intention of clarifying the key differences with ECD, and they are summarised
in table 2.2.
2.4.1 ECD related methods in a FT-ICR mass spectrometer
Electron impact excitation of ions from organics (EIEIO)
The reaction of small ions (e.g. C6H5CN
+) with low energy electrons (3 − 9 eV ) was
initially studied by Freiser and Beauchamp.[167] During this reaction the trapping ef-
ficiency, in the ICR cell, was affected by the electron emission current. The authors
indicated that the electron excitation proceeds by a pi to pi∗ transition and that the
electron was efficiently captured at around 7 eV .[167] Later this technique was referred to
as EIEIO,[168] where H-atom loss was the predominant product at low electron energies.
Comparison of EIEIO with CAD and photodissociation, in small molecules, revealed that
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similar products were obtained, although some differences were also observed. These
differences in fragmentation products were attributed to both the amount of energy
deposited by the electron and the form in which the energy is delivered (e.g. rotational,
vibrational and electronic). Interestingly, this has been the motive of debate during ECD
years.
All the small molecules used to interact with EIEIO[168] contained a benzene moiety,
which after dissociation converts into a benzyne moiety C6H
+
4 . The benzyne moiety
resonantly stabilises the radical and no further dissociation was reported.[168] Thus,
the fragmentation was similar to CAD and photodissociation. Eleven years later, EIEIO
was applied to Gramicidin S ionized by laser desorption and 70 eV electron prior to
EIEIO.[169] Wang, B. and McLafferty, F. W.[169] were able to observe additional ions to
CAD and photodissociation, but the ionization technique used to produce the ions did
not allow the authors to infer the additional capabilities of low electron fragmentation.
For this reason, the early papers on EIEIO missed the discovery of ECD.
Hot electron capture dissociation (HECD)
HECD can be considered a variant of EIEIO where relatively high energy electrons
(3− 13 eV ) react with polypeptides.[198] The relative high energy of the electron gener-
ates electronic excitation prior to electron capture.[199] c/z· fragment ions along with
extensive b/y, a, and w fragment ions are normally observed in a HECD spectra. The
secondary fragment ions are particularly abundant at lower m/z, and are not attributed
to the excess of kinetic energy of the electrons prior to capture, but depend on the
individual peptide structure.[150] Interestingly, w fragment ions and low abundance d
fragment ions are useful to differentiate leucine from isoleucine moieties in the HECD
spectra,[198,200] see table 2.1 in section 2.3. Low abundance d-type fragment ions are
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derived from the a· fragment ions.[198]
Electron induced dissociation (EID)
As previously discussed (section 2.1.1), ECD neutralises at least one charge; consequently
the cation must have more than one charge in order to undergo fragmentation by ECD.
This condition prevents application of ECD to singly-charged [M+H]1+ species. Electron
induced dissociation (EID) overcomes this limitation by irradiating the singly-charged
ions with fast, high energy electrons (15− 25 eV ), causing both ionization and electronic
excitation to produce a hydrogen-deficient doubly-charged radical species. Subsequently,
dissociation of the [M + H]2+· ion produces c/z· and a/x-type fragment ions.[201]
This technique has been labeled differently throughout the years. For instance, it has
also been reported as electron ionization dissociation,[202] and as electron excitation
dissociation (EED).[58,203,204] In both cases, however, the authors reported that the
interaction of singly-charged precursor ions with fast electrons generates a doubly-
charged intermediate species.
In recent years EID has found application in the analysis of small, singly charged organic
molecules of pharmaceutical interest,[84,85] in the analysis of zwitterionic clusters,[205]
in the study of phosphate containing metabolites,[206] glycosaminoglycan tetrasaccha-
rides,[207] polynuclear metal complexes,[208] and in the analysis of amino acids and small
peptides.[199]
Electron detachment dissociation (EDD)
Another particular limitation of ECD, additional to those mentioned above, is that it
cannot be used in negative precursor ions. Aiming to overcome this drawback, EDD
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was conceived. For instance, the introduction of EDD allowed to perform fragmentation
to deprotonated molecules [M−nH]n–. During EDD experiments the negative precur-
sor ions interact with electrons (15− 20 eV ) to produce a radical anion [M−nH](n–1)–·,
along with a, a·, c, c·, z·, and z fragment ions.[209] EDD was also implemented in
a quadrupole ion trap leading to dominant a·and x fragments ions with increased
frequency of fragmentation in the vicinity of acidic residues.[210] EDD has been success-
fully applied to the analysis of ganglioside,[211] glycosamiglycan tetrasaccharides,[212]
sialylated oligosaccharides,[213] and to the study of DNA.[214,215]
Negative ion electron capture dissociation(niECD)
Negative ion electron capture dissociation has also been implemented to deprotonated
molecules [M−nH]n–. In a typical niECD experiment, the precursor ion is irradiated by
low energy electrons (∼ 4.5 eV ) to yield a charge-increased radical species [M−H]2–· .
As a result, c, and z·, fragment ions are produced.[216]
Sustained off-resonance irradiation-electron capture dissociation (SORI-ECD)
SORI-ECD is composed by two events separated in time, but sequential in a single
analysis. In this technique, SORI is performed first, followed by a typical ECD experiment.
During SORI, an off-resonant excitation frequency (∼ 1 − 2 kHz above the resonant
frequency of the precursor ion) is applied to the precursor ion. This off-resonant
excitation accelerates and decelerates the precursor ion confined in the ICR cell,[217,218]
Gorshkov et al.[156] showed that the use of SORI with ECD can increase capture efficiency
(see equation (2.4)) by increasing the effective overlap of the ion cloud with the electron
beam.
64
In some cases, instead of performing SORI before the ECD experiments, a pre-excitation
of the parent ion[166] can also be used to improve ECD capture efficiency (see equa-
tion (2.4)). This pre-excitation event consists of introducing a single frequency shot
(e.g. m/z 100) at the beginning of the ECD experiments to allow an even better overlap
between the ion cloud and the electron beam. This technique has proven to be useful in
the study of metal-protein complexes binding sites.[219]
Activated ion-electron capture dissociation (AI-ECD)
Horn and co-workers[220] showed that ECD of cytochrome c gave less capture efficiency
(see section 2.1.2) due to the presence of multiple non covalent bonds in the protein
tertiary structure. They proposed a method named activated ion electron capture
dissociation to overcome this limitation. In such a method the activation of the precursor
ion was obtained by using collisions with nitrogen gas, or infrared irradiation (IR), or
black body IR. Activation by collision was the most successful, as reported at that time.
In order to perform the activation by collisions, the gas was introduced into the ICR cell
through a pulsed valve, while the ions and the electrons were admitted to the cell. This
technique was then known as In-beam ECD and later referred to as plasma-ECD.[221]
Plasma-ECD performed varying the electron beam current from 0.1 to 0.33µA, achieved
> 95 % removal of the precursor ion and making secondary electron capture more
probable.[220] This technique generates a large number of similar abundance fragment
ions compared with normal ECD or CAD (c/z· , b/y , and a· fragment ions). The
abundance of b and y fragment ions was linearly dependant on the pressure in the ICR
cell. The increase in the cell pressure (7 × 10−7 to 3 × 10−6 Torr) was considered not
critical for AI-ECD experiments, if the aim was purely to increase c and z·fragment ions
abundance. The use of plasma-ECD provided > 50 % more inter-residue bond cleavages
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(cleavage coverage) than CAD at the N−terminus of larger proteins.
One of the drawbacks of plasma-ECD was the long irradiation period required. Thus,
attention was drawn to implement infrared irradiation as an activation method to couple
with ECD,[37–39,222] today known as IRMPD-ECD. Activation performed with a CO2 laser
at 25W and 0.25 s prior to ECD was enough to open up the protein folded conformation
without inducing significant backbone dissociations.[223] Oh, H. and McLafferty, F. W.[223]
performed IRMPD during the ECD event to prevent re-folding of the molecule when
IRMPD was applied as a single event. They also varied the laser power to 25, 50 or
100 % of full-power and observed an slight increase in cleavage coverage. However,
at higher laser power, secondary fragmentation is observed along with b/y fragment
ions. IRMPD-ECD has been used in the study of amphipatic peptides and proteins,[224]
standard peptides,[73,74] and proteins.[67,75,76]
Blackbody infrared radiative dissociation (BIRD)[225] was also employed as an ion
activation method during ECD. BIRD requires an increase in the temperature ranging
from 25 to 175 ◦C in order to cleave the protein non-covalent bonds.[223,226] At 125 ◦C a
high cleavage coverage (56/72) was achieved for bovine ubiquitin, as reported by. Oh,
H. and McLafferty, F. W.[223] BIRD produced unique cleavages compared to IRMPD/CAD
for larger proteins (∼ 42 kDa), a phenomenon which was attributed by the authors to a
higher dissociation of the protein tertiary structure, caused by the longer reaction time
frame.[225] Additionally, BIRD-ECD favoured the loss of water from larger proteins (e.g.
carbonic anhydrase, thiazole kinase, and thiaminaze I) at low temperatures.
Double resonance-electron capture dissociation (DR-ECD)
Double resonance is performed by resonant ejection of selected ion(s) in the ICR cell,
while the precursor ion or ion of interest is kept within the cell. An excitation frequency
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is applied, in resonance with the frequency of the selected ions to be ejected, so that they
are removed from the cell during the ECD event.[227,228] For example, in the reaction
equation (2.5), when A is ejected from the cell, changes in the intensity of C demonstrate
the interrelationship between A and C.
A+B C +D
E +B C +G
(2.5)
Thus, DR-ECD is performed by ejecting the selected ions during the ECD event. The
ejection of a particular ion allows observation of the effect of this ejection in the
abundance of another ion of a different frequency. For instance, DR-ECD has been
applied when precursor ion decomposition is suspected during quadrupole isolation[73]
and to study the lifetime of intermediate fragment ions.[229] Moreover, double resonance
has also been applied in oligonucleotides during EDD and EID experiments,[214] and can
be used in conjunction with other ion activation methods, such as IRMPD.[230]
Selective excitation of ions for consecutive activation (SEICA)
This fragmentation technique utilises the precursor ion that remains after ECD and
subsequently a vibrational excitation is applied, for instance IRMPD.[157] This method
requires implementation of three steps in the ICR cell. First, usual fragmentation under
ECD conditions is performed. Second, the fragment ions are ejected from the cell while
the precursor ion is kept at the centre of the cell. Finally, the precursor ion is fragmented
by IRMPD. This method provided complementary information to ECD allowing an
increase in effective efficiency of ECD per scan, as the authors argued.
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2.4.2 Fragmentation methods in other instruments
Electron capture induced dissociation (ECID)
In an accelerator mass spectrometer, ions can be accelerated to 50 keV to collide with
a gas target under single-collision conditions.[231] The gas target is usually cesium[232]
or sodium atoms,[233] although xenon[231] and C60
[234] have also been used. ECID, also
referred to as fast collisional electron transfer, results in the formation of charge-reduced
ions[187] by electron capture. In the study of peptides ECID produces c and z· type
fragment ions, z and neutral c fragments.[232] The neutral fragments are converted
to anions due to secondary collisions with the neutral gas. Thus, neutral c fragments
generate an unstable c−· , while stable z− anions are produced by a second electron
transfer from the z· radical fragment ion. Other low abundance losses observed during
ECID are b, y− and x− fragment anions. The y− fragment ions are believed to be derived
from electron capture of neutral y fragment ions generated by the CAD process during
ECID, which correlates well with high abundance of b fragment ions.[232] Insights into
the mechanism of ECID can be found elsewhere.[235]
kEv induced dissociation (KID)
This technique has been implemented in a double quadrupole-time of flight (TOF) mass
spectrometer.[236] The protein ions produced by ESI collide with background gas in the
quadrupole to cool the ions enough to be trapped. Bari et al.[236] performed extraction
of the background gas before the trapped ions interact with 5 keV atomic ions of H+,
He+, and He2+. The dissociation products are separated in the corresponding TOF
section of the instrument in order to be finally detected. KID dissociation in peptides
produced side chain losses and immonium ions detected at low m/z in the spectrum.
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Series of fragment ions including a, b/y, c and z fragment ions are also formed in KID.
A more detailed discussion on the KID mechanism can be found in Bari et al.[236]
Resonant electron capture (REC)
Resonant Electron Capture is based on the interaction of neutral peptides of low volatility
with low energy electrons (1−2 eV ). This results in the formation of negative ions.[237] In
order to perform REC, Vasil’ev, Y. V. and Figard, B. J. and Morré, J. and Deinzer, M. L.[237]
used a heated direct insertion probe to vaporise the peptides and to introduce them into
the magnetic sector instrument. This resonant electron capture causes cleavage of the
N − Cα bond generating c and z· fragment ions.
Electron transfer dissociation (ETD)
ETD involves radical-driven fragmentation of the precursor ion reacting with anions lead-
ing to the cleavage of the N −Cα backbone bond of protein and peptides. Subsequently,
charge-reduced radical species [M+nH](n–1)+·, c and, z·fragment ions are produced.[197]
This technique can be implemented in many commercial mass spectrometers.
2.4.3 Fragmentation methods summary
For clarity purposes, a table summarizing some of the methods previously discussed is
presented below
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Table 2.2: Summary of fragmentation methods.
Technique Proposed reaction Brief description
ECDa [M + nH]n+ + e−<0.2eV
(
[M + nH](n–1)+·)∗ c/z· Reaction of polypeptidecations with ∼ 0.2 eV
electrons.
EIEIOb [AB]+ + e−3 to 9 eV [AB]
* A+ + B
Reaction of positive small
molecules with 3to9 eV
electrons.
HECDc [M+nH]n++ e−13 eV
(
[M + nH](n–1)+·)∗ c/z· , b/y, w Reaction of polypeptidecations with ∼ 3to13 eV
electrons.
EIDd
Step 1:
[M + H]1+ + e−fast≤25eV [M + H]
2+· + e−fast + e−slow:0.2eV
Step 2:
[M + H]2+· + e−slow ([M + H]+)* c/z· , a/x
Step 1: Reaction of
singly-charged polypeptides
with fast electrons to
generate doubly-charged
ions.
EDDc
[M−nH]n– + e−∼20eV
(
[M−nH](n–1)–·)∗ +
2e− c/z· , c·/z, a, a·
Reaction of
negatively-charged
polypeptides with fast
electrons to generate
doubly-charged anions.
niECDc [M−H]1– + e−∼4.5−6.5 eV−>
(
[M−H](2–)–·)∗ c·/z, a· , b/y
Reaction of
negatively-charged
polypeptides with electrons
to generate doubly-charged
anions.
ECIDf [M + nH]n+ + Cs
(
[M + nH]n+
)∗
c/z· , b, y−, x− Single collision of acceleratedions with Cs atoms.
RECg M + e−<2eV (M)
∗
c/z· Neutral molecules interactwith free electrons.
ETDh [M + nH]n+ + A–· ([M + nH](n–1)+·)∗ + A c/z· Multiple collisions of ionswith anions.
CADi [M + nH]n+ + Ar
(
[M + nH]n+
)∗
b/y
Multiple collisions of ions
with Ar gas.
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Table 2.2: (continued)
Technique Proposed reaction Brief description
IRMPDj [M + nH]n+ + n(h ν)
(
[M + nH]n+
)∗
b/y
Reaction of polypeptides with
multi-photons.
EI [AB]+ + e−70eV [AB]
* A+ + B· + 2e−
Reaction of small volatile
molecules with 70 eV
electrons.
a Zubarev, R. A. and Kelleher, N L. and McLafferty, F W. [8]
b Cody, R. B. and Freiser, B. S. [168]
c Kjeldsen, F. and Haselmann, K. F. and Budnik, B. A. and Jense, F. and Zubarev, R. A. [198]
d Nielsen, M. L. and Budnik, B. A. and Haselmann, Kim F. and Olsen, Jesper V. and Zubarev, R. A. [203], Nielsen,
M. L. and Budnik, B. A and Haselmann, K. F. and Zubarev, R. A. [204]
e Budnik, B. A. and Haselmann, K. F. and Zubarev, R. A. [209]
f Boltalina, O. and Hvelplund, P. and Jorgensen, T. and Larsen, M. and Larsson, M. and Sharoitchenko, D. [231]
g Vasil’ev, Y. V. and Figard, B. J. and Morré, J. and Deinzer, M. L. [237]
h Syka, J. E. P. and Coon, J. J. and Schroeder, M. J. and Shabanowitz, J. and Hunt, D. F. [197]
i Jennings, K R [9]
j Thorne, L. R. and Beauchamp, J. L. and in M.T. Bowers (Ed.) [238]
2.5 ECD Mechanism
2.5.1 “Hot Hydrogen” model or Cornell mechanism (McLafferty)
ECD is rooted in the gas phase structure of protonated proteins where energetically
favoured protonation sites, particularly the side chains of arginine, lysine, and histidine,
are stabilised by hydrogen bonds to backbone functionalities,[174] specifically the back-
bone carbonyl oxygen and nitrogen atoms.Zubarev, R. and Haselmann, K. and Budnik,
B. and Kjeldsen, F. and Jensen, F.[239] proposed that during ECD the electron most
probable landing site would be the site with the highest charge density. As the charge
density decreases the probability for electron capture decreases. For example, the second
most likely landing group is the backbone NH group and this would cause immediate
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fragmentation. Other groups, away from the protonation site, could contribute towards
charge density and the electron could be captured at a distance of at least a few amino
acid residues away from the protonation site. After capture, the electron migrates to the
protonation site due to intramolecular potential differences.
Capture of the electron at the protonated site would produce an hypervalent ammonium
radical.[240] Subsequently, a hot hydrogen atom (H·) from the protonation site could
be expelled and could be recaptured by a nearby carbonyl oxygen or a group with
sufficient proton affinity (e.g. S − S bonds, indole group of tryptophan side chain).
The recapture at the carbonyl functionality forms a transient aminoketyl radical,[174]
which dissociates exothermically by cleaving the N − Cα bond.[241] Thus, with the
original ECD experiments, it was thought that the mechanism involved dissociation of
the [M + nH](n–1)+· species via an energetic or “hot H-atom” transfer to the backbone
carbonyl see figure 2.4.
This mechanism did not take into account several factors; for instance, it did not
consider the transition state energies of electron capture by protonated species.[240] The
mechanism proposed did not consider that the positive charge must be close enough (e.g.
within hydrogen bonding distance) to the N − Cα bond, so the H-atom can be released
by the hypervalent radical species and subsequently cause dissociation.[242] Additionally,
as shown in figure 2.4, this mechanism generates only enol-imine c fragment ions, but
not necessarily the amide moiety.[143] Finally, the “hot hydrogen model” cannot explain
loss of the modifications from the z· radical fragment ions and backbone dissociations
at amide groups remote from the charged sites,[188] which are successfully explained by
the radical reaction cascade model (see section 2.5.5).
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Figure 2.4: Schematic representation of the proposed reaction mechanism for electron
capture dissociation based in the “hot hydrogen model” or Cornell mechanism. Figure
adapted from Chen and Turecek.[188]
2.5.2 Utah mechanism (Simons)
ECD mechanisms can be arguably considered as a three step procedure: electron capture,
H-atom dissociation from the protonated functionality (ammonium group), and H-atom
transfer from the protonation site to the carbonyl oxygen. It should be noted that the
last two steps are not necessarily sequential. For instance, the second and third steps
are thought to proceed through a dissociation-recapture mechanism, where H-atom
migration (transfer) generates an aminoketyl radical intermediate.[241] Additionally,
two more steps are considered to develop in the ECD mechanism: the stabilisation of
the aminoketyl radical complex and the cleavage of the N − Cα backbone bond to
produce c and z· fragment ions. These two steps include the migration of a proton
before (Washington mechanism) or after (Utah mechanism) N − Cα backbone bond
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cleavage. The Utah mechanism addresses in detail the first step of the ECD mechanism:
the electron capture. Two theories have been developed regarding the Utah mechanism.
A brief discussion of both is presented below.
Coulomb-stabilised direct attachment mechanism
This theory considers that the electron is captured directly into a Coulomb-stabilised
OCN amide pi∗orbital (see figure 2.5) at Rydberg orbitals having quantum numbers
between 3- 6.[243] However, upon electron capture into a peptide/protein, the amide
pi∗orbital has a ∼ 2.5 eV energetic barrier that the electron must overcome in order to
be captured.[244] The electron energy is not enough to surmount this barrier, but instead
Coulombic interactions of the pi∗orbital with the positive charged sites and the dipole
potentials within the molecule, will lower the barrier of the lowest unoccupied molecular
orbital (LUMO) allowing the electron to be captured.[242,243,245,246] A crude depiction of
the electron captured at a Coulomb-stabilised pi∗orbital is shown in figure 2.6.
H2N
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H
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HHOCN
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Figure 2.5: Schematic representation of the OCN amido pi∗site.
The Coulomb stabilising potential at the OCN pi∗amide group varies inversely with the
distance (Rj) of every positive charge groups (Zj) and can be estimated as is shown in
equation (2.6). This estimation is based on the presence of a nearby positively charged
group, such as −NH+3 or NH2Na+ interacting with a CH–3 anion.[178,247]
74
σpi
σ*
pi*
E
LUMO
HOMO
e
-
exothermic
pi* Coulombically stabilized 
Non Coulombically stabilized 
LUMO
Figure 2.6: Qualitative crude depiction of the bonding and antibonding molecular
orbitals to illustrate the electron captured at the Coulombically stabilised pi∗ LUMO
available for direct electron capture.
c = 14.4(eV Å)
N∑
j=1
Zj
Rj(Å)
(2.6)
where, Zj is the jth charge; N is the number of charges; Rj is the distance between
the jth charge and the OCN amide group; and 14.4 (eV Å) is the value corresponding to
the Coulomb constant times the square of the electron charge. This estimation does
not include the effect of dipoles and its magnitude can fluctuate as the charged sites
undergo dynamic motions.[242] For instance, to overcome a barrier of 2.5 eV , the charge
site on a singly-charged peptide, should be at around 6 Å away from the OCN amide
group. Hence, the electron can be directly captured in a Coulomb-stabilised OCN pi∗
amide group, see figure 2.7. The electron captured at the OCN pi∗ amide group causes
elongation of the N − Cα bond (e.g. through thermal vibrations) and once a small
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energetic barrier is surmounted, the radical centre will move to the N − Cα σ∗ orbital
causing dissociation.[242] This energetic barrier is small due to the presence of the radical
and also the cleavage of the N − Cα1 bond would form a new C−N pi bond.[243]
Figure 2.7: Schematic representation of the proposed direct electron capture by the
Utah mechanism. Figure adapted with permission from Neff, D. and Sobczyk, M. and
Simons, J.[242]
Intramolecular electron transfer mechanism - Through-bond or through-space
electron migration
As discussed above, direct electron capture at the pi∗ orbital requires a Coulomb stabilised
OCN amide group, where the identities of the charged sites are not expected to influence
the degree of stabilisation.[248] However, the charged-sites sites play a more active role
in the capture of an electron. Thus, Skurski, P. and Sobczyk, M. and Jakowski, J. and
Simons, J.[143] proposed that it is possible that the electron can be captured at an excited
Rydberg orbital centred on a positive charged site. This excited Rydberg orbital forms an
excited-state hypervalent species also referred to as a Rydberg species.[143] The excited
1also known as α cleavage. [12]
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Rydberg (hypervalent) are believed to undergo radiative or radiationless relaxation to
the ground state and decay by N−H or N − Cα cleavage.[246]
Once the electron is captured at the excited Rydberg orbital, but before the Rydberg
orbital reaches the ground level,[178] the electron can migrate to a nearby Coulomb
stabilised pi∗ orbital delocalised over an aromatic or amide group. This electron transfer
or migration could occur in a through-space or through-bond manner.[242] Electron
migration through-space is only possible if the Rydberg orbital that captured the electron
comes into spatial overlap with the pi∗ orbital. Alternatively, for the electron to migrate
through-space, it would need the right conditions such as a Coulomb stabilised pi∗ orbital
where the positive charged-site is at approximately 6 Å away. Migration through-space
can also occur from a Rydberg orbital centred at a positively charged-site to another
Rydberg orbital centred at another positively charged-site.[249] Nonetheless, in order
for the electron to migrate between those two Rydberg orbitals, the migrating Rydberg
orbital must be in an excited Rydberg state. Moreover, the LUMO Rydberg orbital
should have a low-energy (or equal energy) to the migrating Rydberg state.[178] These
through-space electron migrations can occur between protonated and fixed charges, or
two protonated charges only if the charged sites are at a distance of ∼ 5 Å.[246]
In contrast, electron migration through-bond would occur if the Rydberg orbital, that
captured the electron, overlaps with orbitals of other functional groups, which subse-
quently overlap with the OCN amide pi∗ orbital.[242] For instance, the electron captured
at the Rydberg orbital centred at a positive site, forms an excited-state hypervalent
species, which can then undergo a through-bond electron transfer to the pi∗ orbital of the
OCN amide group. However, it is important to consider the radial size of the Rydberg
orbital during electron migration, which depends on the quantum number of the orbital,
n. If n is too small, the Rydberg orbital does not extend far enough to overlap with other
orbitals, but if n is too large the highest unoccupied molecular orbital is too close to the
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radial shell of the LUMO orbital and overlap is not favoured.[178]
Thus, so far the Utah mechanisms involves either Coulomb-stabilised direct attachment
or intramolecular electron transfer mechanism during ECD. For both, it is believed
that the Coulomb-stabilised direct attachment occurs in 1-10 % of the electron capture
events, while the intramolecular electron transfer mechanism most likely takes place
in the remainder of the cases of electron capture.[178] Another mechanism proposed by
the research group at the University of Washington addresses in detail the questions
about the structure of the intermediates formed after electron capture in ECD, which is
discussed below.
2.5.3 Washington mechanism (Turecek)
In the study of the ECD mechanism in peptides/proteins it is necessary to establish the
low energy conformers of the protonated peptides in the gas phase. The structures
reported have shown to include solvation of one hydrogen atom, at the protonation site,
to an amide carbonyl.[144,187,241] Thus, the next question to address is where the electron
is captured.
Electron capture
A remote charge in the peptide causes an increase in the electron affinity of the amide
group.[240] Thus, a charge-stabilised electronic state is delocalised over the amide group
specifically at the carbonyl carbon, which captures the electron within the antibonding
pi orbital (pi∗) of the C−O bond.[144]
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N−H bond dissociation and O−H bond formation (Aminoketyl intermediate for-
mation by hydrogen transfer)
After electron capture, a zwitterion is formed within the protonated peptide, where most
of the negative charge density is delocalised at the carbonyl oxygen forming a “super-
base”. This superbase has sufficient proton affinity to weaken the hydrogen bonding
at the protonated amino group, increasing the distance of the N−H bond, up to the
saddle point for dissociation. As a result, an aminoketyl radical intermediate is formed
as is shown in structure II of figure 2.8. This H−atom migration should occur in an
excited state where charge-remote interactions in the peptide are negligible. However, if
H−atom migration were to occur in the ground electronic state, there would be compe-
tition between both H−atom loss, from the protonated amino group, and H−migration
(or H−atom transfer), from the protonated amino group to the carbonyl oxygen. Disso-
ciation and transition state energies for N−H cleavage are exothermic (28 kJ/mol) after
overcoming a low energetic barrier (12 kJ/mol) calculated for an amidated di-glycine
peptide.[193] H−migration is also exothermic (62 kJ/mol) for the amidated di-glycine
peptide. Moreover, H−atom loss and H−atom migration are in competition with NH3
loss. NH3 loss is a product of a highly exothermic isomerisation (115KJ/mol for the
di-glycine peptide), and so is expected to rapidly dissociate. Nonetheless, the rate
limiting process is the NH3 dissociation and so that fragmentation pathway generally
does not compete with H−atom loss and H−atom transfer.[193]
Aminoketyl intermediate stabilisation and N − Cα bond dissociation
The unpaired electron on the aminoketyl carbon can be expected to destabilise the
adjacent bonds.[193] For instance, the N − Cα bond, Cα −H bond, and Cα− Cβ bond.
The cleavage of these bonds depends on their corresponding dissociation and activation
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Figure 2.8: Schematic representation of the proposed reaction mechanism of the forma-
tion and stabilisation of the aminoketyl radical intermediate after electron capture. Utah
mechanism. Figure adapted from structures proposed by Turecek, F. and Syrstad, E. A.
and Seymour, J. L. and Chen, X. and Yao, C.[144] Note that the position of the charges is
symbolically representing the point of largest charge density at the instant of electron
capture. A more accurate picture would include molecular orbital diagrams.
energies. Moreover, N − Cα cleavage does not produce the expected c/z·fragment
ions, because they are bound by a strong hydrogen bond.[193] This hydrogen bond is
formed with a nearby carbonyl oxygen to stabilise the aminoketyl radical intermediate
(structure III of figure 2.8).
This hydrogen bonding can decrease the electron density on the nearby carbonyl oxygen
preventing formation of other hydrogen bonds, particularly from other protonation
sites. The hydrogen bonding can also increase the charge density (increase the basicity)
of the amide carbonyl group causing fast proton migration to the imine nitrogen, or
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fast exothermic isomerisation[193] as shown in structure IV, figure 2.8. Finally, given
sufficient internal energy the stablilised aminoketyl radical complex can dissociate
forming c/z·fragment ions. The N − Cα bond cleavage could generate two structures
for the c fragment ion, as shown in figure 2.8, the enol-imine (structure Va) or the
amide moiety (structure Vb). Nonetheless, results have suggested that proton transfer
takes place after N − Cα bond dissociation generating the amide structure for the c
fragment ion.[250]
2.5.4 Utah-Washington mechanism
The two mechanisms discussed above, Utah and Washington mechanisms, have been
combined and are referred as the U-W mechanism. In the U-W mechanism the electron
can be captured directly at the pi∗orbital delocalised over the amide group or transferred
from the capture site to the pi∗orbital of the amide group. The direct electron attachment
to an amide pi∗-orbital is viable due to stabilisation by Coulomb interactions with
positively charged groups.[178] The aminoketyl radical intermediate formed is in an
electronic excited state, which is stabilised by Coulomb effects of charged groups that
are effective over distances greater than 15 Å. The stabilised-aminoketyl radical complex
formed is extremely basic (proton affinities > 1200 kJ/mol).[188] This superbase amide
can abstract a proton from a nearby proton donor group forming a fragile aminoketyl
intermediate that dissociate into c/z·fragment ions. However, in some cases this
“superbase” does not abstract a proton and dissociate by cleavage of theN−Cα backbone
bond. The dissociation products are the z·radical fragment ion and an enol-imidate
anion, which is also a superbase (proton affinities > 1400 kJ/mol). The enol-imidate
superbase can also intramolecularly abstract a proton to form the c fragment ion. This
mechanism is, to date, the most accepted ECD mechanism and it is independent of the
chemical nature of the charge-carrying groups,[188] see figure 2.9.
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Figure 2.9: Schematic representation of the proposed ECD reaction mechanism by the
Utah-Washington mechanism. Figure adapted from Chen and Turecek.[188]
2.5.5 Free radical reaction cascade model (radical mediated frag-
mentation)
The discussed U-W mechanism does seem to address the provenance of the side chain
losses reported in linear peptides, which were reviewed above in section 2.3. Additionally,
losses of small molecules (e.g. H·, H2O, H2O), amino acid, and side chain losses in cyclic
peptides could not be explained by the mechanisms discussed above.[192] Moreover,
these losses were inconsistent with the premise that if one electron is captured then
one cleaved bond is obtained, because the fragments observed, in those cyclic peptides,
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would require capture of two or more electrons. Thus, the losses observed in cyclic
peptides made Leymarie, N. and Costello, C. E. and O’Connor, P. B.[192] propose the
free radical reaction cascade mechanism to explain the fragmentation observed during
ECD. In order to address this mechanism it is necessary to recapitulate two items. First,
as stated before, the z· radical fragment ion and the charge-reduced radical species
[M + nH](n–1)+· are the odd electron species in a typical ECD fragmentation of linear
peptides.
In cyclic peptides, the z· fragments are indistinguishable from the [M+nH](n–1)+· charge-
reduced radical cation, and the initial cleavage point cannot be determined. Therefore,
in the corresponding ECD spectra, the peak representing this species ([M + nH](n–1)+·)
likely contains cleaved species from all possible N −Cα bonds around the cyclic peptide.
Accordingly with the U-W mechanism, after electron capture, the radical is located at
the α−carbon in both the [M + nH](n–1)+· species and the z· radical fragment ion. Thus,
the free radical reaction cascade mechanism suggests that the radical at the α−carbon
could propagate along the peptide backbone,[192] inducing further fragmentation.
The radical at the α−carbon can migrate along the cyclic peptide backbone by losing
cyclic neutrals (figure 2.10a) and can also propagate by abstraction of an αH−atom from
another amino acid (figure 2.10b). This radical propagation by αH−atom abstraction
is an energetically favourable process due to the formation of one H − Cα bond by
the cleavage of an additional H − Cα bond. Moreover, the energetic barriers can
be minimised if the peptide is sufficiently flexible, which allows stabilisation of the
radical.[192,251] Interestingly, the charge does not play a role in this radical fragmentation
model and it has been assumed to be sequestered elsewhere, as shown in figures 2.10
to 2.12.[251] Therefore, fragmentation of both the charge reduced radical species and the
radical fragment ions is primarily a radical-directed process rather than a charge-directed
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process, although an exception is made for arginine containing peptides.[251]
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Figure 2.10: Schematic illustration of the radical mediated fragmentation pathway used
to explain the losses observed in cyclic peptides, where the: a. radical is migrating along
the peptide backbone bond to other α−carbon causing loss of a small molecule; b. the
radical is propagated by αH-atom abstraction from other amino acids. Figures adapted
with permission from Leymarie, N. and Costello, C. E. and O’Connor, P. B.[192] copyright
(2003) American Chemical Society
Neutral side chain losses of water and ammonium are also explained using the radical
migration model,[192] which are shown in figure 2.11. Subsequent H−atom abstractions
are possible, but would depend on energetic barriers, H−atom affinity, and the ability
of the site to stabilise the radical.[142] Experiments on the deuterium exchange showed
that the radical moves to the lowest energy site, which is the α-carbon of glycine.[142]
The radical on the α-carbon of glycine is stabilised due to the planarity of the Cα − CO
region, caused by the lack of side chain steric interactions.[146]
The free radical reaction cascade mechanism has also been motive of additional studies.
For instance, other research groups explained that the radical at the α-carbon can also
cause elimination of an odd-electron side chain species when the αH−atom, from the
α-carbon, is abstracted. The αH−atom abstraction generates cleavage of the βcarbon-
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γcarbon bond as shown in figure 2.12a.[202]
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Figure 2.11: Schematic illustration of the radical mediated fragmentation pathway used
to explain the neutral losses of: a. water and; b. ammonium. Figures adapted with
permission from Leymarie, N. and Costello, C. E. and O’Connor, P. B.[192] copyright
(2003) American Chemical Society.
Additionally, the radical can cause γ-hydrogen atom abstraction at amino acids with a
γ-carbon in the side chain, γ-hydrogen abstraction can occur generating a stable radical
at the α-carbon of the peptide backbone (figure 2.12b) and eliminating an even-electron
side chain.[173,251] This γ-hydrogen atom abstraction is also observed in z· radical
fragment ions, which generates w-type fragment ions.[142]
The radical attached to the Cα can also migrate to other pi∗ orbitals, which has also
been reported in the helix structures of proteins, but only by overcoming an energetic
barrier.[143] However, the radical migration path in helical structures depends of the
initial structure of the OCN group after electron capture (see figure 2.5). In other words,
it depends on whether the oxygen attached to the α-carbon is forming an O−H bond or
is a radical anion centre O–, as shown in figure 2.13.
Some unusual side chain fragmentations, such as the one observed at the N−terminal
side of proline are illustrated in figure 2.14a and are based on the αH−atom abstraction
from the α-carbon of proline.[173] H−atom abstractions from the β-carbon are observed
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in serine and threonine containing peptides, where the radical located at the β-carbon
can be resonantly stabilised by the hydroxyl group. This intermediate decomposes
causing cleavage at the N − Cα and generating a c· and a non radical z fragment ion
one hydrogen lighter. This is illustrated in figure 2.14b.
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used to explain: a. Proline N−terminus cleavage by α-hydrogen atom abstraction; b.
βH-atom abstractions at the β-carbon. Figures adapted with permission from Fung and
Chan.[173]
Thus, after the initial electron capture and cleavage of the N − Cα backbone bond,
further dissociation of both the charge-reduced radical species and from the z· radical
fragment ion is dominated by radical chemistry.[251] In a radical-directed process the
radical is an active and/or dominant participant in the chemistry. These radical directed
processes generate additional fragmentation products, such as side chain losses, losses
from the z· radical fragment ions, H·-radical loss, and other types of fragments such
as those observed in cyclic peptides and discussed above.[87,173,192] Moreover, radical-
directed fragmentation would not occur indefinitely in the peptide/protein. The radical
will move until one out of three possible conditions is satisfied: either the radical is
stabilised at a low reactivity position (e.g. resonant stabilisation);[192] or, the radical
moves too slow to be detected in the mass spectrometer;2 or loss of H·-radical occurs.
2The time scale of the measurement in a mass spectrometer is usually of the order of seconds.
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It is noteworthy that in the radical migration model H-atom abstraction competes with
H·-radical loss.[192] So, if the H·-radical is lost, a radical-directed fragmentation would
not occur. However, in arginine containing peptides the charge is sequestered at the
guanidino moiety and becomes a fixed-charge. Fixed-charges in peptides increase
the abundance of side chain losses and the number of backbone cleavages decreases
as the number of fixed-charges increases.[252] In peptides with two arginine residues
the neutral side chain loss of arginine occurs first from the charge-reduced radical
species. Subsequently, other side chain losses can be observed.[173] Similar fragmentation
behaviour is observed for tryptophan and histidine containing residues. This behaviour
was explained by fast fragmentation at the recombination site.3
2.6 Non-Ergodicity
When ECD was introduces as an analysis technique in polypeptides, it was hypothesized
that the fragmentation involved non-ergodic behaviour because the capture of one
electron can only releases ∼ 6 eV of energy, which is barely enough to break one N −Cα
bond.[8] A process is referred to as non-ergodic if the fragmentation rate is fast compared
to the rate of the energy redistribution among the many vibrational degrees of freedom
of the polypeptide.[253] This implies that the energy is not redistributed among the
internal vibrational modes of the polypeptide and the excess energy would reside in the
N −Cα bond causing N −Cα bond cleavage[254] A detailed discussion about ergodicity
of gas-phase ions has been presented elsewhere.[255]
In order to address the discussion about non-ergodicity/ergodicity, it is necessary to
consider ECD rate and energies associated with ECD fragmentation. As it was previously
discussed in section 2.5.2, the Coulomb stabilisation at the pi∗ orbital is sufficient
3The recombination site is considered to be the protonation site and the electron capture site.
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to decrease the energy of the orbital allowing exothermical capture of an electron
(∼ 4− 6 eV taken from the electron affinity of protonated nitrogen in an amine or amide
moiety).[8,254] The polypeptide is then in an excited state where the non-fixed energy is
free to move around the molecule, e.g. vibrational and rotational energy, (excluding the
zero-point energy). This intramolecular energy transfer, also referred to as recombination
energy, is suggested to occur in a time scale of 10−11 to 10−12 s,[256] and is believed to
induce fragmentation in the excited electronic state rather than inducing vibration in the
electronic ground state.[53] However, the debate has been focused on finding out whether
the energy is redistributed faster than 10−11 to 10−12 s. Hence, the following discussion
is focused on the electron migration rates using the Utah mechanism discussed in section
2.5.2.
The electron migration considered by the Utah mechanism can follow two pathways.[242,246]
First, the electron is captured at an excited n−Rydberg orbital, with n > 10 and with the
orbital centred at a positive site. Subsequently, electron migration towards a Coulomb
stabilised pi∗ orbital could occur, but only before the Rydberg electron has time to com-
pletely relax to the ground Rydberg state. If the ground state is reached and the electron
has not migrated, prompt (∼ 10 − 9 s) H-atom and NH3 loss is observed in the ECD
spectrum.[254] So, low-energy Rydberg states (n < 20) are suggested to be involved in
electron migration to other Coulomb stabilised pi∗ orbitals. Additionally, the Rydberg
orbital relaxation, from the excited state to the ground state, occurs at a rate of approxi-
mately 106 s−1 while electron migration occurs at a rate of 1010 s−1 per transition.[254]
Therefore, electron migration to a Coulomb stabilised pi∗ orbital is faster than Rydberg
orbital relaxation.
The second pathway of electron migration considers the electron captured at a Rydberg
orbital centred at a positive site and that the electron could migrate to another positive
site. Transfer to this new location from a lower or equal energy Rydberg orbital has been
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considered to be possible.[254] The mathematical treatment of this case suggests that
a faster rate is expected to be obtained from an electron migrating between Rydberg
orbitals with the same quantum number. Moreover, the migration rates decrease as the
quantum number grows.[254] However, conclusive experimental evidence to support this
pathway of electron migration has not been found[254] Indirect experimental evidence,
which supports this second pathway has been reported using electron traps, which have
high electron affinity and can intercept the electron, causing inhibition of the backbone
fragmentation.[257–259]
Additionally, the electron migration from an excited Rydberg orbital to a Coulomb sta-
bilised pi∗ orbital proceeds via a vertical transition (Frank-Condon transition), where the
electron binding energy is very similar to the vertical binding energy of the pi∗ attached
state (figure 2.15).
Finally, high-level ab initio calculations of dissociation rates of the aminoketyl radical
intermediate have shown an ergodic behaviour of peptides.[193,260] However, it is not
possible to extrapolate these results to longer systems (proteins) due to the complexity
of the multiple charged peptide/protein ions simulations and/or calculations.[193,254] It
seems clear, then, that to date the debate about the non-ergodic character of ECD is still
open.
2.7 Concluding remarks
ECD in a FT-ICR-MS has become a preferred ion activation technique for structural
identification of protein/peptides. In this chapter the nomenclature and some of the
concepts used in ECD experiments were presented. In particular, a discussion about
ECD efficiency was addressed on the many different ways to calculate it, which makes
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Figure 2.15: Qualitative depiction of the potential energy hypersurfaces of species
containing N − Cα bond subjected to electron capture at the Rydberg orbital centred at
a positive site and vertical migration of the electron to the Coulomb stabilised pi∗ orbital.
Figure adapted with permission from Neff, D. and Sobczyk, M. and Simons, J.[242]
comparisons in the literature difficult. Additionally, a summary of the side chain losses,
from the charge-reduced radical species, as well as from the z· radical fragment ion,
as reported in ECD literature, was presented. Similarly, a brief summary of other ECD
related methods was done in order to show how particular limitations of ECD have been
circumvented. Moreover, based on the seemingly reached general consensus, the ECD
mechanism for the dissociation of the N − Cα backbone bond was explained. Another
mechanism presented was the free radical reaction cascade mechanism, which occurs
after N − Cα backbone cleavage. Such a mechanism allows to explain additional side
chain losses from the charge-reduced radical species and from the z· radical fragment
ion. Finally, a few comments about non-ergodicity were discussed, but the debate still
continues.
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3
Assignment of binding sites glyoxal-derived advanced
glycation end-products for substance P
3.1 Introduction
In this study, the dicarbonyl glycation reaction is studied through glyoxal binding to
the neuropeptide Substance P using Fourier transform ion cyclotron resonance mass
spectrometry (FT-ICR-MS). Substance P has the amino acid sequence RPKPQQFFGLM,
and normally contains an amidated C−terminus. Thus, the guanidino group of arginine,
the amino group of lysine, the N−terminus and the amidated C−terminus are the
potential glyoxal glycation sites for Substance P. The glyoxal-derived glycation products
(AGE) were fragmented by ECD, double resonance-ECD and CAD and glyoxal binding
site was assigned within 1 ppm error (accurate mass assignments are available in the
Appendix A).
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3.2 Materials and methods
Substance P and Substance P acetate salt, ammonium acetate (∼ 99.6 %), triethylamine,
ammonium phosphate monobasic, and acetic acid (≥ 99 % pure) were purchased from
Sigma-Aldrich (St. Louis, MO, U.S.A). Methanol (LC-MS grade), ethanol (HPLC grade),
and isopropyl alcohol (IPA, GLC-pesticide grade) were purchased from Fisher-Scientific
(Loughborough, Leicestershire, U.K.), and were used without further purification. All
aqueous solutions were prepared using water from a Milli-Q water system (Millipore Inc.,
Durham, U.K.). Micro-dialysis cassettes (GeBa flex-tube, 1 kDa cut-off), were obtained
from Chembio Diagnostic Systems, Inc. (Hertfordshire, U.K.). Glyoxal solution (∼ 39%
in water) was purchased from TCI Europe (Zwijndrecht, Belgium). High purity glyoxal
solution was difficult to obtain because higher concentration favours the formation of
glyoxal dimers and trimers through dioxolane rings.[261] Nuclear magnetic resonance
analysis of glyoxal solution showed hydrolysis and dimer species, as previously reported
by Whipple, E. B.[262]
3.2.1 Substance P glycation
In-vitro glycation with glyoxal at a concentration of 800µmol/L was performed with
Substance P (1mg/mL), or amidated Substance P (1mg/mL). The reaction was carried
at 37 ◦C in MeOH:H2O (50:50), 100 % water, and phosphate buffer [30mM ammonium
phosphate monobasic (NH4H2PO4) and 30µL triethylamine (N(CH2CH3)3) pH 7.5], for
21 and 12 hours, respectively. The samples reacted in phosphate buffer were dialysed
against water and 10mM CH3COONH4, over a period of 24 h, dried, and redissolved
in MeOH/H2O (50:50). Prior to injection in the FTICR-MS, samples were prepared to
a concentration of ∼1 to 5 pmol/µL using electrospray solution (composed either of
MeOH or EtOH/IPA/Acetic acid/H2O; 50:10:1:39). Methanol was used as an inhibitor of
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glyoxal polymerisation instead of acetonitrile, which promotes glyoxal dimerisation.[263]
3.2.2 Mass spectrometry
The experiments were performed in a 12 T solariX FTICR-MS (described in chapter 1).
The sample was electrosprayed in positive ion mode with a capillary voltage of 4.5 kV . To
perform ECD, the precursor ion was isolated in the quadrupole (Q1), and accumulated
in the collision cell (15 s). After being transferred and trapped in the infinity cell[264] the
ions were irradiated with low-energy electrons (∼ 1 eV ) for 150 and 250 ms. Double
resonance ECD (DR-ECD),[227,228] was performed in the cell varying the ejection pulse
between 120 to 220 ms. The laser pulse for the infrared multiphoton dissociation
(IRMPD),[39,265] experiment was kept at 90 ms followed by electron injection. CAD
experiments were performed in the hexapole or collision cell prior to selection of the
precursor ion in the quadrupole with collision energies around 10− 30 eV . The data was
processed with Data Analysis software 4.0 SP 3, and internally calibrated.
3.3 Results and discussion
Experiments were carried out in phosphate buffer, because of its biological relevance,
and in MeOH/H2O (50:50) in order to develop the method aiming to assign the types of
glyoxal-derived glycation products (AGE) and its binding site for amidated Substance
P. Figure 3.1a, shows doubly [M + 2 H]2+ and triply charged [M + 3 H]3+ ions from
unmodified amidated Substance P. The spectrum also shows four more doubly charged
ions, [M + C2O + 2 H]
2+, [M + C2H2O2 + 2 H]
2+, and A and B species. The mass of the
peptide was increased by both 39.9949Da in the case of C2O addition and 58.0055Da
assigned as C2H2O2. Species A and B showed a mass difference of 14.0156Da (CH2),
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with respect to both modified ions, which were identified as ion/molecule reaction ions
with methanol. These A and B ions were eliminated when the reaction was carried out
in 100 % water, and ethanol was used in the electrospray solution, figure 3.1b.
The reaction in phosphate buffer, sprayed in methanol-containing solution, showed
the same ions discussed above for figure 3.1a. The glyoxal-derived AGE observed
ions [M + C2O + 2 H]
2+ (m/z 694.3688), and [M + C2H2O2 + 2 H]
2+ (m/z 703.3741),
are formed following the proposed reaction pathway showed in Scheme 3.1, for both
reaction solutions (MeOH/H2O and phosphate buffer). Scheme 3.1 shows the possible
structures that may be formed by glyoxal; in particular structures 3.1e and scheme 3.1f
were identified by De Haan, D. O. and Corrigan, A. L. and Smith, K. W. and Stroiik, D.
R., D. R. and Turley, J. J. and Lee, F. E. and Tolbert, M. A. and and Cordova, K. E. and
Ferrell, G. R.[266] to coexist in a 3:1 ratio. Thus, the glyoxal-derived AGEs formed by the
net addition of C2O and C2H2O2 were fragmented by ECD and CAD in order to identify
the glyoxal binding site.
3.3.1 Substance P modified by C2O
Figure 3.2a shows the ECD spectra of the precursor ion [M + C2O + 2 H]
2+ reacted in
MeOH/H2O (50:50), with two kind of c fragment ions: unmodified c4 - c10, and modified
c†4 - c
†
10. A dagger symbol was added to the standard Roepstorff nomenclature
[47] (c/z·),
to differentiate the ions with the glyoxal modification. The radical z9·fragment ion,
loss of water from the modified c†n, y9, and side chain losses from the charge-reduced
species were also observed. The pair c1/z10·, c3/z8·, c†1/z10·, and c†3/z8·, together c2
and c†2 were absent in the spectrum. Figure 3.2a additionally shows the unmodified
doubly charged [M + 2 H]2+ ion, which is unusual during ECD experiments, because the
capture of low-energy electrons by the molecule generates the charge-reduced radical
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Figure 3.1: Direct infusion spectrum of: a. glyoxal-derived glycation products (AGEs)
reacted in MeOH/H2O (50:50) and ionized with a solution containing MeOH, IPA, H2O,
and acetic acid; b. glyoxal-derived glycation products (AGEs) reacted in 100 % H2O and
ionized with a solution containing EtOH, MeOH, IPA, H2O, and acetic acid.
species ([M + C2O + 2 H]
2+ + e– becomes [M + C2O + 2 H]
1+· ), and not the loss of the
modification. Thus, isolation spectrum of the precursor ion [M + C2O + 2H]
2+ was
acquired in order to determine if the [M + 2 H]2+ ion originated during quadrupole
isolation. The isolation spectrum of the precursor ion [M + C2O + 2 H]
2+ shows low
abundance of the molecular ion [M + 2 H]2+ indicating that loss of C2O is a low-energy,
facile process. The presence of the [M + 2 H]2+ ion indicates that during isolation some
small, unknown, amount of energy was given to the precursor ion [M + C2O + 2 H]
2+,
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Scheme 3.1: Glyoxal-derived glycation products (AGEs) based in the presence of mono-
hydrate and dihydrate species in glyoxal reagent (∼ 39 %) in water. Structures: a.
Schiff base at the N−terminus or amine group of lysine; b. Schiff base at the guani-
dine group of arginine; c. 3-hydroxyimidazole; d. 2-imino-5-hydroxyimidazoline; e.
2-imino-imidazolidinone (also known as a creatinine side chain); f. crosslinking be-
tween amino group of lysine with the N−terminus; g. 3,4-dihydroxyimidazoline; and h.
2-imino-imidazolidine.
which activates it causing loss of the modification and generating the [M + 2 H]2+ ion.
The [M + 2 H]2+ ion may therefore be responsible for the secondary fragmentation (c4 -
c10) observed during the ECD experiment.
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Figure 3.2: MS/MS spectra of the precursor ion [M + C2O + 2 H]
2+ of glycated ami-
dated substance P reacted in MeOH/H2O (50:50): a. ECD spectrum; b. DR(674.37)-
ECD(694.37) spectrum with ejection of [M + 2 H]2+ species. The symbol ? indicates
unassigned peaks by the current understanding of the fragmentation mechanism, and *
indicates background peaks where no isotopologues were observed. Peak assignments
are presented in Tables A-1 and A-2 Appendix A.
Additionally, because the [M + 2 H]2+ ion and the c4 -c10 ions were formed during
ECD, preisolation yielded no new information about their provenance. So, in order
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to test if they were secondary fragments formed from the [M + 2 H]2+ ion, double
resonance-ECD[229] was used to eject the ion [M + 2 H]2+ during the ECD experiment of
the precursor ion [M + C2O + 2 H]
2+. The notation adopted for the double resonance
experiments is represented as DR(X)-ECD(Y), where X is the m/z value of the ejected
fragment and Y corresponded to the m/z value of the precursor ion. The DR(674.37)-
ECD(694.36) spectrum of glycated, amidated Substance P for the precursor ion [M +
C2O + 2 H]
2+ (Figure 3.2b), exhibited similar features as those described above for the
ECD spectrum, but the difference lies in the absence of c8, c9, c10, z7·, and z5·. The
observed relative intensities of the cn and c
†
n fragment ions (n= 2-10) were normalized to
check their lineage. The normalized relative intensity (Ii) was calculated by application
of the equation 3.1.
Ii =
I(kI)
n=10∑
n=2
I(cn) +
n=10∑
n=2
I(c†n)
(3.1)
Where, Ii takes the values of the relative abundance of the ions of every individual
cn and c
†
n fragment ions. These values are plotted in Figure 3.3 where it is observed
that Ii of the c fragment ions decreased and Ii of c
†
n and z9·fragment ions increased
during the DR-ECD experiment. Thus, based on those results, it is inferred that all c
fragment ions observed in the DR-ECD and ECD spectrum are secondary fragments of
the unmodified [M + 2 H]2+ ion and are derived from a long-lived radical intermediate
species (milliseconds to microsecond time frame).[229] Additionally, from Figure 3.3, the
radical fragment z9·is considered a long-lived species[229] and is a fragment from the
doubly-charged modified species.
The c†n fragment ions locate the C2O modification within four residues of theN−terminus
and the presence of z9·and y9 in Figure 3.2b, indicate an unmodified lysine. Thus,
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Figure 3.3: Comparison of the relative intensity of the cn and c
†
n (n = 2-10) fragment ions
of the precursor ion [M+C2O+2 H]
2+ observed in the ECD and DR(674.37)-ECD(694.36)
spectra of glycated amidated Substance P (reacted in MeOH/H2O (50:50)). The relative
intensity of each cn and c
†
n fragment ion was calculated by application of the equation
3.1 where Ii is the relative intensity of the ion.
the glyoxal-derived AGE for Substance P is located at the arginine residue and more
specifically at the guanidine group. The guanidine group at the arginine residue reacts
with glyoxal causing the loss of water and resulting in the net addition of C2O (39.9949
Da), which can form structure b and/or structure c (hydroxyimidazole) shown in Scheme
3.1.
3.3.2 Substance P modified by C2H2O2
Figure 3.4 shows the DR(674.37)-ECD(703.37) spectrum of the precursor ion [M +
C2H2O2 + 2 H]
2+ with unmodified cn, and modified c‡n (n = 4-10) fragment ions. The
double dagger (‡) symbol is added to the standard Roepstorff nomenclature to identify
the modified fragments. z9·radical fragment ion, side chain losses from the charge-
reduced species, and up to two losses of water from the c‡ fragment ions are observed
in Figure 3.4, with absence of c2, c
‡
2, c
†
1 z10·and c†3 z8·fragment ions. Thus, according
with those results the modified c‡n (n = 4-10) fragment ions locate the modification
C2H2O2 toward the N−terminus and the presence of z9· indicate that the lysine residue
100
is unmodified. The C2H2O2 moiety is located also at the arginine residue as shown in
Scheme 3.1. The proposed structures e and f in Scheme 3.1, are formed at the guanidine
group forming the proposed dihydroxyimidazoline group by the loss of two molecules of
water.
Figure 3.4: DR(674.37)-ECD(703.37) spectrum of the precursor ion [M + C2H2O2 +
2 H]2+ with ejection of [M + 2 H]2+ species of the glycated amidated Substance P
reacted in MeOH:H2O (50:50). The symbol ? indicates unassigned peaks by the current
understanding of the fragmentation mechanism and * indicates background peaks where
no isotopologues were observed. Peak assignments are presented in Table A-3 Appendix
A.
All the results of the ECD and DR-ECD spectra for the precursor ions [M + C2O + 2 H]
2+
(Figure 3.2), and [M + C2H2O2 + 2 H]
2+ (Figure 3.4), shared three features. First, the
absence of the complementary pair c†1 / z10·, c†3 / z8·, c‡1 z10·and c‡3 / z8·that is due to
proline, which requires cleavage of two bonds in order to observe the fragments.[171]
Second, c2 was absent in the ECD spectrum (figure 3.2a), but appeared in the DR-ECD
spectrum (figure 3.2b), whereas c†2, and c
‡
2 were completely absent. The c2 fragment ion
from unmodified Substance P is rarely observed in the ECD spectrum.[171,267] Third, the
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loss of water from every c† and c‡ fragment ion, is attributed to the glyoxal modification.
So, it was hypothesized that hydrogen bond interactions may be involved for both glyoxal
modifications, which may be broken during the ECD event causing the loss of water.
Thus, IRMPD was applied to amidated Substance P, prior to the ECD experiment, in
order to facilitate disruption of the non-covalent interactions (figure 3.5). The obtained
relative intensity of the c†n and c
†
n - H2O (n = 4-10) fragment ions was normalised using
equation 3.1 and plotted in figure 3.6. It is observed that Ii of c
†
n - H2O (n = 4-10)
during the IRMPD-ECD experiment increased in all observed fragments. Thus, use of
infrared heating to disrupt the hydrogen bonding network induced water loss from the
glyoxal-derived AGEs.
Figure 3.5: IRMPD-ECD spectrum of the precursor ion [M + C2O + 2 H]
2+ of the glyoxal-
derived glycation product formed at amidated Substance P in MeOH:H2O (50:50). The
symbol ? indicates unassigned peaks by the current understanding of the fragmentation
mechanism and * indicates background peaks where no isotopologues were observed.
Peak assignments are presented in Table A-4 Appendix A.
On the basis of the previous results it is possible to propose an ECD mechanism for the
loss of water of the glyoxal-derived AGEs for Substance P. Therefore, after the electron is
captured in the peptide, it is suggested that the modified guanidine group at the arginine
residue loses water forming the imidazole radical moiety, as shown in Scheme 3.2a.
Moreover, for the dihydroxyimidazoline group, it is proposed that the capture of the
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Figure 3.6: Comparison of relative intensity of the c†n and c
†
n - H2O fragment ions for the
DR(674.37)-ECD(694.37) and IRMPD-ECD spectra of glycated amidated Substance P
reacted in MeOH/H2O (50:50). The relative intensity was calculated using equation 3.1,
only considering the relative intensity of the c†n and c
†
n - H2O fragment ions.
electron initially generates the loss of one molecule of water forming an intermediate
structure. The imidazole ring (structure II in Scheme 3.2b) is believed to be formed by
an extra loss of water that is not driven by the radical, although the energy deposited
during electron capture, as well as the additional stabilisation energy from conjugation
of the pi system with the radical, would promote this additional loss.
Fragmentation with CAD, for both glyoxal-derived AGEs (modifications with net addition
of C2O and C2H2O2), for amidated Substance P agrees with the ECD and DR-ECD spectra
are shown in the (figure 3.7). Moreover, similar results were obtained about the types
(net addition of C2O and C2H2O2), and binding sites of glyoxal-derived AGEs formed at
the free acid form of Substance P. (see Figure 3.8 for [M + C2O + 2 H]
2+ modification
and Tables A-9 and A-10 in appendix A or the [M + C2H2O2 + 2 H]
2+ modification).
Additionally, as was mentioned before, similar glyoxal-derived AGEs formed for amidated
Substance P were observed under biological conditions (modifications with net addition
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Scheme 3.2: Proposed reaction mechanism of the loss of water after electron capture
dissociation from the glyoxal-derived glycation products (AGE) formed at the guani-
dine group. a. The AGE product formed at the guanidine group (open ring) loses
one molecule of water after electron capture generating the radical imidazole moiety
structure I; bThe 3,4-dihydroxyimidazole (structure II) loses one molecule of water after
electron capture generating the intermediate structure, but the extra loss of water that
originates the radical imidazole moiety structure III is believed not to be driven by the
capture of another electron.
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Figure 3.7: MS/MS spectra of the glyoxal-derived glycation product formed at amidated
Substance P; a. CAD fragmentation pattern for the precursor ion [M + C2O + 2 H]
2+
of ; b. CAD fragmentation pattern for the precursor ion [M + C2H2O
+
2 2H]
2+. The
symbol ? indicates unassigned peaks by the current understanding of the fragmentation
mechanism. Peak assignments are presented in appendix A, Tables A-5 and A-6. A.
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Figure 3.8: MS/MS spectra of the free acid form of Substance P reacted with glyoxal
in MeOH:H2O (50:50): a. DR(674.86)-ECD(694.86) spectrum of the precursor ion
[M + C2O + 2 H]
2+; b. CAD spectrum of the precursor ion [M + C2O + 2 H]
2+. The
symbol ? indicates unassigned peaks by the current understanding of the fragmentation
mechanism and * indicates background peaks where no isotopologues were observed.
Peak assignments are presented in Tables A-7 and A-8 Appendix A.
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of C2O and C2H2O2. Thus, further analysis of the DR-ECD and CAD spectrum of both
precursor ions [M + C2O + 2 H]
2+ and [M + C2H2O2 + 2 H]
2+ showed that glyoxal-
derived AGES and dihydrated glyoxal-derived AGEs are modified at the guanidine
group in the arginine moiety (refer to figure 3.9 and Tables A-11-14 appendix A). This
preferred glycation site, that does not change at physiological conditions (pH 7.5), can
be explained from the high pKa of arginine compared with lysine or the N−terminus
amino group (pKa 12.48, 10.53 and 9.0 respectively).[267]
Figure 3.9: DR(674)-ECD(694) of the precursor ion [M + C2O + 2 H]
2+ amidated
Substance P reacted with glyoxal at pseudo-physiological conditions (pH 7.5). Peak
assignments are presented in Table A-11 appendix A.
Moreover, studies of glyoxal with only arginine found that protonation of one of the
three nitrogen atoms at the side chain did not limit the reactivity of the guanidine group,
and products at the N−terminus (α-amino group) rarely happen.[114] Glycation at the
amide group of glutamine residues was not observed that can be attributed to the lowest
nucleophilicity (low basicity) of the lone pair of the nitrogen atom. It can be concluded
that different species may be present as a result of glycation by glyoxal, particularly
the creatinine compound generated at the guanidine group of arginine, which is used
as a bio-marker in renal failure. Although in this work no evidence was found for
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intramolecular or intermolecular cross-linking, the formation of imidazolone (a common
product found in methylglyoxal-derived glycation products)[268] or diglycation[121] at
longer reaction times may show otherwise.
3.4 Conclusions
The glyoxal-derived glycation products (AGEs) obtained from the reaction of glyoxal
with amidated and free acid form of Substance P, at pseudo-physiological conditions
(pH 7.5) and MeOH:H2O, were analysed by CAD, ECD, and double-resonance ECD
experiments. Tandem mass spectrometry allowed assignment of the binding site to
either the guanidine group at the side chain of the arginine residue of the N−terminus.
Some structures were proposed at the guanidine moiety, such as the hydroxyimidazoline
and dihydroxyimidazoline compounds formed with the guanidine group of the arginine
residue. In the ECD, DR-ECD, and IRMPD-ECD experiments, a characteristic loss of
water from every modified c†n and c
‡
n fragment ion was observed. Thus, it is proposed
that the electron is captured at the modification site and subsequently a water loss is
generated in addition to the typical fragmentation pattern of the peptide at the backbone
N-Cα bond.
It seems, then, that a better understanding of the glycation reaction by the α-dicarbonyl
compound glyoxal can be obtained from analysing the results in small peptides, as
discussed above. However, it is clear that care must be taken when this reaction
is executed in methanol, due to the appearance of ion molecule reactions. In any
case, for the reaction times employed in the experiments outlined in this chapter (see
section 3.2.1), it was not observed any involvement of amino groups from the lysine
residues and the amidated C−terminus. Nevertheless, N−terminus involvement in the
glycation reaction was considered to be a possibility due to the location of the arginine
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residue in the peptide chain. In order to further shed light on the likelihood of such an
involvement of the N−terminus, it was considered necessary to perform the reaction of
glyoxal in other model peptides varying the position of the arginine residue. Further
experimentation by MS aiming to address the potential glycation of the N−terminus is
presented and discussed in chapter 4.
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4
Tandem mass spectrometry for the study of glyoxal-
derived advanced glycation end-products (AGEs) in
peptides
4.1 Introduction
In the present chapter the experiments of model peptides reacted with glyoxal in
MeOH/H2O, intended to reproduce the conditions used for Substance P in chapter 3,
are presented and discussed. Additionally, in order to assess the robustness of the
glycation reaction by glyoxal to the reaction conditions, as well as to sample purification,
two variations to the methodology adopted before were introduced: phosphate saline
buffer (PBS) was used during the glycation reaction; and, the reaction was followed by
precipitation with methanol/chloroform, as a clean up step, prior to direct infusion into
the mass spectrometer.
The modified species were fragmented by collisionally activated dissociation (CAD) and
electron capture dissociation (ECD) to determine glyoxal binding site in the peptides
presented in table 4.1. All the ,peptides with some biological relevance, were chosen
without an N−terminal arginine residue in order to distinguish side chain arginine
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glycation from N−terminal glycation. Glyoxal-derived AGEs were ionized using an
electrospray source (ESI) in positive mode and accumulated in the quadruple mass
filter prior to CAD and ECD. Likewise for Substance P, ejection of unmodified ions was
performed during the ECD experiments, by using double resonance ECD, which allowed
determination of (c/z·) fragment ions lineage.[229] The glyoxal-derived AGEs were
confidently assigned with a mass error < 1 ppm (peak assignment tables are presented
in the Appendix B)
Table 4.1: Model peptides sequences and glyoxal modified ions reacted in MeOH/H2O
and phosphate buffered saline (PBS).
Peptide Sequence Unmodified ion
(m/z)
Modified precursor
ion fragmented
KM-11
KPRPQQFFGLM−NH2
(1436.7387Da)
[M + 2 H]2+
(m/z = 674.37134)
[M + C2O + 2 H]
2+
(m/z = 694.33688)
[M + C2H2O2 + 2 H]
2+
(m/z = 703.37408)
AcKM-11
Ac−KPRPQQFFGLM−NH2
(1388.73869Da)
[M + 2 H]2+
(m/z = 695.37663)
[M + C2O + 2 H]
2+
(m/z = 715.37408)
[M + C2H2O2 + 2 H]
2+
(m/z = 724.37937)
EK-15
ERQIKKQTALVELVK
(1782.0727Da)
[M + 3 H]3+
(m/z = 595.0315)
[M + C2O + 3 H]
3+
(m/z = 608.36315)
[M + C2H2O2 + 3 H]
3+
(m/z = 614.36667)
FR-25
FQNALLVRYTKKVPQV
STPLVEVSR
(2871.6334Da)
[M + 4 H]4+
(m/z = 718.91566)
[M + C2O + 4 H]
4+
(m/z = 728.9144)
[M + C2H2O2 + 4 H]
4+
(m/z = 733.341700)
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4.2 Materials and methods
4.2.1 Materials
The model peptides were custom synthesized by GeneCust Europe (Dudelange, Luxem-
burg). Acetic acid (≥ 99 % pure), sodium phosphate monobasic (Na2HPO4), sodium
chloride (NaCl), and potassium phosphate dibasic KH2PO4 were purchased from Sigma-
Aldrich (St. Louis, Missouri, U.S.A). All aqueous solutions were prepared using water
from a Milli-Q water system (Millipore Inc., Durham, U.K.). A P-97 Flaming/Brown
micropipette puller tip manufactured from Sutter Instrument Company (Novato, C.A.
U.S.A.) was used to obtain glass capillaries employed for nano-ESI. Methanol (LC-MS
grade), isopropanol (GLC-pesticide grade), and chloroform (HPLC grade) were obtained
from Fisher-Scientific (Loughborough, Leicestershire, U.K.). Glyoxal solution (∼ 39% in
water) was purchased from TCI Europe (Zwijndrecht, Belgium).[261]
4.2.2 Model peptide purification
1mg of model peptides was dissolved with 1mL of MeOH/H2O (50:50). A precipitation
was performed with MeOH/chloroform and left at −20 ◦C for 20 minutes. Centrifugation
at 5000 rpm in a Technico-MAXI centrifuge (Fisher Scientific, Leicestershire, U.K.), was
performed during 6 min to deposit the protein pellet at the bottom of the Eppendorf tube.
The supernatant was then carefully extracted with pipette tips allowing metal salts and
polar compounds to dissolve into the MeOH upper layer and thus being removed. The
pellet was then dried in a SpeedVac system (Savant SPD121P, Thermo Fisher Scientific
Inc. Waltham, MA, U.S.A.) at 35 ◦C and stored at −80 ◦C.
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4.2.3 Glycation of model peptides in MeOH/H2O
The dried, purified peptides were re-dissolved in MeOH:H2O (50:50). Three aliquots
were taken from the purified peptides and reacted with glyoxal (800µmol/L). The
reaction was carried out at 37 ◦C for 21 hours at a starting pH of 7.5. The three
reacted peptides were diluted with ionization solution, which contains methanol, water,
isopropanol, and acetic acid (50:39:10:1), to a final concentration of∼ 0.1µM . Methanol
was employed to reproduce the conditions reported in chapter 3.[73]
4.2.4 Glycation of model peptides in PBS
In order to simulate pseudo-physiological conditions, the purified peptides were re-
dissolved in phosphate buffered saline (PBS) solution, prepared using 144mg of sodium
phosphate monobasic (Na2HPO4), 818mg sodium chloride (NaCl), 24mg potassium
phosphate dibasic KH2PO4 in 100mL of water to obtain a pH 7.2 ± 0.2. Three aliquots
of the dissolved peptide were taken to react with glyoxal (400nM) over 6 hours. After
reaction, the three aliquots of each glycated peptides were cleaned from the buffer
solution by the same purification procedure described above. The dried pellet was
re-dissolved in 100 % water and then diluted with ionization solution (ethanol, water,
isopropanol, and acetic acid (50:39:10:1)), to a final concentration of ∼ 0.1µM prior to
direct injection into the mass spectrometer.
4.2.5 Mass spectrometry
The 12 Tesla FTICR mass spectrometer was employed only in positive mode. The positive
ions were generated using ESI and nESI. The capillary voltages were held at 4.5 kV and
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0.8 kV for ESI and nESI, respectively. In the MS/MS experiments the ions were isolated
in the quadrupole (Q1) and accumulated for 1− 30 s, as required by the precursor ion.
Equally, CAD experiments were also performed with argon gas at collision voltages
ranging between 15 to 20V . The fragment ions were then transported to the ICR cell[264]
for excitation and detection. As in the previous tests, a dispenser cathode[163] was used
to perform the ECD experiments at 1.3V and 1.5A. During this set of tests using ECD,
the pulse length was varied between 120 and 200ms as necessary. Double resonance ECD
experiments (DR-ECD)[228] were performed varying the ejection pulse between 100 and
220ms. The results, as in the section 3.2.2, were analysed using the DataAnalysis 4.0 SP
3 software, from Bruker Daltonics, with internal calibration. The masses employed to
perform the internal calibration are summarised in tables presented in Appendix B, and
indicated with a * symbol.
4.3 Results and discussion
In figure 4.1a is shown the direct infusion spectrum of the reacted KM-11 peptide in
MeOH/H2O. In this spectrum is possible to identify: singly, doubly, and triply-charged
unmodified ions; glyoxal modified ions; and the species labeled as A and B, which
correspond to an ion/molecule reaction product generated with methanol (§ 3.3).
The glyoxal modified species showed a net increase of 39.9949Da (C2O) and a net
increase of 58.0055Da (C2H2O2) to the mass of the peptide. These modified species,
[M + C2O + 2 H]
2+ and [M + C2H2O2 + 2 H]
2+, are also observed in PBS as well as in the
direct infusion spectrum of the acetylated KM-11 peptide reacted in both MeOH/H2O
and PBS as is shown in figure 4.1b, (see appendix B table B-2 to B-4).
The direct infusion spectrum of the reacted peptides in PBS showed more species, at
a lower signal to noise ratio, than the direct infusion spectrum of the reacted peptide
114
in MeOH/H2O, which was attributed to the chemical interferences added by the PBS
solution. This chapter is focused on the doubly-charged modified ions [M+C2O+2 H]
2+
and [M + C2H2O2 + 2 H]
2+, which were isolated and fragmented using DR-ECD and
CAD. The notation adopted for the DR-ECD experiment is DR(X)-ECD(Y), where X is the
m/z of the ejected ion and Y is the m/z of the precursor ion as mentioned in (section
3.3).
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Figure 4.1: a. Direct infusion spectrum of glyoxal-derived glycation AGE for the KM-11
peptide in MeOH/H2O (50:50), (A = [M + C2O + 3 H]
3+); b. Direct infusion spectrum
of glyoxal-derived glycation AGE for the KM-11 peptide in PBS; c. Direct infusion
spectrum of glyoxal-derived glycation AGE for the AcKM-11 peptide in MeOH:H2O
(50:50), (B = [M + C2H2O2 + CH2 + 2 H]
2+). Detailed peak assignments are available
in Table B-1 and B-2 of the appendix B.
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4.3.1 Undecapeptides KM-11 and Ac-KM-11
Peptides modified by net increase of 39.9949Da (C2O)
In figure 4.2a is presented the DR(674)-ECD(703) spectrum of the precursor ion [M +
C2O + 2 H]
2+ for the KM-11 peptide in MeOH/H2O. As it can be observed in such a
spectrum, two types of c fragment ions were identified: unmodified and modified. The
modification corresponds to the addition of 39.9949Da to the mass of every observed
fragment. These modified species have been identified by the addition of the dagger
symbol (†) to the Roepstorff and Biemman’s nomenclature (c/z·).[47,48] In particular,
analysing the figure 4.2a it is possible to see the modified c†4 to c
†
10 fragment ions and
the modified z†9·radical fragment.
Unmodified c, y fragment ions, the z9·radical fragment ion, side chain losses from the
charge-reduced species and loss of water from every modified c† fragment ion, were
also observed in figure 4.2. Proline in position 4 inhibits cleavage in position 3 from
the N−terminus and therefore formation of unmodified c3 and/or modified c†3 was not
observed or expected.[171] Thus, the presence of modified c†4 to c
†
10 fragment ions indicate
that the glyoxal-derived AGE formed by the net mass addition of C2O is located towards
the N−terminus. In particular, the presence of the z†9· radical fragment ion locates the
glyoxal modification at the arginine residue in position 3.
The CAD data of the precursor ion [M + C2O + 2 H]
2+ in MeOH/H2O, is presented in
figure 4.2b and Table B-6 of the appendix B. The spectrum shows modified b†3, b
†
5 to b
†
10,
a†10, y
†
9, y
†
10 fragment ions, unmodified b, y fragment ions, and water loss from every
modified fragment ion. CAD result agrees with the DR-ECD results in MeOH/H2O for
the precursor ion [M + C2O + 2 H]
2+, locating the glyoxal-derived AGE at the side chain
of the arginine residue. Similar results for the KM-11 peptide in PBS are obtained from
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Figure 4.2: MS/MS spectrum of the glyoxal modified KM-11 peptide a. DR(674)-
ECD(694) spectrum of the precursor ion [M + C2O + 2 H]
2+ with ejection of [M + 2 H]2+
(peptide reacted in MeOH/H2O); b. CAD spectrum of the precursor ion [M
+C2O
+2H]2+
(peptide reacted in MeOH/H2O); c. DR(674)-ECD(694) spectrum of the precursor
ion [M + C2O + 2 H]
2+ with ejection of [M + 2 H]2+ (peptide reacted in PBS) . The
symbol ? indicates unassigned peaks by the current understanding of the fragmentation
mechanism. Highlighted modified ions in the spectrum and detailed peak assignments
are available in Tables B-5 to B-7 of the Appendix B.
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the DR(674)-ECD(694) spectrum of the [M + C2O + 2 H]
2+ species, which is shown in
figure 4.2c.
As mentioned before the direct infusion spectrum of the reaction with glyoxal of the
N−terminal acetylated KM-11 peptide in MeOH/H2O (figure 4.1c) also showed the
modified [M+C2O + 2 H]
2+ species discussed above, which were further fragmented by
DR-ECD and CAD. The DR(695)-ECD(715) spectrum of the precursor ion [M + C2O +
2 H]2+ in MeOH/H2O is shown in figure 4.3a. Modified c
†
4 to c
†
10 fragment ions, and the
modified z†9·radical fragment ion are present in the spectrum. In addition, modified b†3,
b†5 to b
†
10, and y
†
10 fragment ions were observed in the CAD spectrum of the precursor ion
[M + C2O + 2 H]
2+ in MeOH/H2O, as shown in figure 4.3b. Equally, a
†
3, b
†
5 to b
†
10, y
†
9 and
y†10 fragment ions are present the CAD spectrum of the precursor ion [M + C2O + 2 H]
2+
in PBS (figure 4.3c). These results indicate that the addition of C2O occurs at the
arginine residue in position 3 in MeOH/H2O and in PBS.
Scheme 4.1 shows the proposed reaction for the formation of the glyoxal-derived AGE
at the guanidine group of arginine, where protonation at the carbonyl oxygen generates
an appreciable polarisation of the carbonyl carbon, which made it susceptible to attack
by nucleophiles. The nitrogen atom, of the amino and/or guanidino groups in pro-
tein/peptides, acts as a nucleophile forming a carbon-nitrogen bond. The intermediate
steps of the reaction and the possible glyoxal-derived AGE structures are described in
scheme 3.1 and Lopez-Clavijo, A. F. and Barrow, M. P. and Rabbani, N. and Thornalley,
P. J. and O’Connor, P. B.[73]
Peptides modified by net increase of 58.0055Da (C2H2O2)
Fragmentation of the precursor ion [M + C2H2O2 + 2 H]
2+ in MeOH/H2O and in PBS
solution also shows unmodified and modified c/z·fragment ions. The modified products
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Figure 4.3: MS/MS spectra of the AcKM-11 peptide: a. DR(695)-ECD(715) spectrum
of the precursor ion [M + C2O + 2 H]
2+ with ejection of [M + 2 H]2+ (peptide reacted
MeOH/H2O); b. CAD spectrum of the precursor ion [M + C2O + 2 H]
2+ (peptide reacted
MeOH/H2O); c. CAD spectrum of the precursor ion [M+C2O+2 H]
2+ (peptide reacted in
PBS). Detailed peak assignments are presented in Tables B-8 to B-10 of the Appendix B.
showed a net addition of 58.0055Da to every fragment ion c/z·observed. Modified
c/z·fragment ions are distinguished from the unmodified ones by addition of the double
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Scheme 4.1: a. Proposed reaction for the net addition of 39.9949Da forming the
proposed Schiff base structure at the guanidino group of arginine b. Proposed reaction
for the net addition of 58.0055Da forming the proposed structure dihydroimidzolidine.
One possible structure of the reaction products is presented here, although other possible
structures may be present scheme 3.1.
dagger symbol (‡) to the Roepstorff and Biemman’s nomenclature.
The DR(674)-ECD(703) spectrum of the precursor ion [M + C2H2O2 + 2 H]
2+ for the
KM-11 peptide in MeOH/H2O is shown in figure 4.4a. Modified c
‡
n (n = 4 . . . 10), the
modified z‡9·radical fragment ion, unmodified c4 to c10 fragment ions, loss of water from
every modified c‡ fragment ion, and side chain losses from the charge-reduced species
were observed. Thus, the presence of the modified z‡9·radical fragment ion assigns the
net addition of C2H2O2 as taking place at the arginine residue. The CAD data for the
KM-11 peptide of the precursor ion [M + C2H2O2 + 2 H]
2+, presented in figure 4.4b
and figure 4.4c in MeOH/H2O and in PBS, respectively, agrees with the result obtained
by DR(674)-ECD(703). Moreover, the results obtained for the N−terminus acetylated
KM-11 peptide (figure 4.5) also locate the glyoxal-derived AGE as being formed at the
guanidino group of the arginine residue in both reaction solutions (MeOH/H2O and
PBS Appendix B). The proposed reaction for the formation of the glyoxal-derived AGE is
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shown in scheme 4.1b.
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Figure 4.4: MS/MS spectrum of the KM-11 peptide: a. DR(674)-ECD(703) spectrum of
the precursor ion [M + C2H2O + 2 H]
2+ with ejection of [M + 2 H]2+ (peptide reacted
in MeOH/H2O); b. CAD spectrum of the precursor ion [M + C2H2O + 2 H]
2+ (peptide
reacted in MeOH/H2O); c. Peptide map of the CAD spectrum of the precursor ion [M +
C2H2O + 2 H]
2+ (peptide reacted in PBS). The symbol ? indicates unassigned peaks by
the current understanding of the fragmentation mechanism and * indicates background
peaks where no isotopologues were observed. Peak assignments are presented in Table
B-11 to B-13 of Appendix B.
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Figure 4.5: MS/MS spectra of the AcKM-11 peptide a. DR(695)-ECD(724) spectrum for
the precursor ion [M + C2H2O2 + 2 H]
2+ with ejection of [M + 2 H]2+ (peptide reacted
in MeOH/H2O); b. CAD spectrum of the precursor ion [M + C2H2O2 + 2 H]
2+ (peptide
reacted in MeOH:H2O); c. Peptide map of the CAD spectrum of the precursor ion
[M + C2H2O2 + 2 H]
2+ (peptide reacted in PBS). The symbol ? indicates unassigned
peaks by the current understanding of the fragmentation mechanism. Detailed peak
assignments are available in Table B-14 to B-16 of Appendix B.
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All DR-ECD spectra, the loss of water from every modified c† and c‡ fragment ion
and from the z‡9·radical fragment ion is observed. This water loss further supports the
hypothesis proposed in chapter 3 that the capture of the electron triggers water loss at the
modified guanidine moiety forming an stable imidazole radical species (see scheme 3.2).
Thus, losses of one or two molecules of water loss from every modified c, z·, b, and y
fragment ions are generated in addition to the typical backbone fragmentation pattern
of the peptide and could help to indicate the presence of glyoxal-derived AGEs.
In addition, in all CAD spectra shown so far, it is clear that the presence of unmodified y
fragments ions in positions 2-8 indicates that neither the C−terminus nor other amino
acid residues were modified by addition of C2H2O2 or C2O.
4.3.2 EK-15 and FR-25 peptides
The type of mass addition of C2O and C2H2O2 moieties was also observed in direct
infusion spectra of the peptides EK-15 and FR-25 . Further fragmentation, of both
modified precursor ions and for both peptides, by DR-ECD and CAD revealed again
binding site at the arginine moiety. The modified species were located at the arginine in
position 2 from the N−terminus for the EK-15 peptide. Whereas, in the FR-25 peptide
these modified species were formed at the arginine residue in position 8 from the
N − terminus. (See figures 4.6 and 4.7 and tables B-17 to B-23 in the Appendix B).
It is noteworthy that a couple of unusual mass to charge ratios (m/z = 602.35963 and
m/z = 724.4117), were observed in the direct infusion spectra of these two peptides
(EK-15 and FR-25), when reacted in both MeOH/H2O and PBS. These particular values
of m/z were assigned to the presence of a new modified glyoxal-derived AGE and labeled
in this work as [M + (C2−H2) + nH]nH, with n = 3, 4; this modified AGE features a mass
addition of m = 21.9843Da. Interestingly enough, such as an observation had been not
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obtained in any of the results previously discussed in this work, neither in the literature.
Although this mass addition could also correspond to a sodium adduct, such a possibility
was discarded thanks to the ultra-high resolution offered by the FT-ICR-MS employed in
this work, which enabled us to assign in a confident manner this [M + (C2−H2) + nH]nH
species as a new modified glyoxal-derived AGE. This is further discussed in more detail
in chapter 5.
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Figure 4.6: a. DR(595.03)-ECD(608.37) spectrum of the precursor ion [M+C2O+3 H]
3+
with ejection of [M+3 H]3+ for the peptide EK-15 reacted in MeOH:H2O; b. DR(718.92)-
ECD(728.91) spectrum of the precursor ion [M + C2O + 4 H]
4+ with ejection of [M +
4 H]4+ for the peptide FR-25 reacted in MeOH:H2O. The symbol ? indicates unassigned
peaks by the current understanding of the fragmentation mechanism. Detailed peak
assignments are available in Table B-14 to B-16 of Appendix B.
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Figure 4.7: a. DR(595.03)-ECD(614.36) spectrum of the precursor ion [M + C2H2O +
3 H]3+ with ejection of [M + 3 H]3+ of the EK-15 peptide reacted in MeOH:H2O; b.
DR(718.91)-ECD(733.42) spectrum of the precursor ion [M + C2H2O + 4 H]
4+ with
ejection of [M + 4 H]4+ of the FR-25 peptide reacted in MeOH:H2O. The symbol ? indi-
cates unassigned peaks by the current understanding of the fragmentation mechanism.
Detailed peak assignments are available in Table B-20 and B-22 of Appendix B.
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4.4 Conclusions
C−terminus amidated and N−terminus acetylated undecapeptides (KM-11) were re-
acted with glyoxal under pseudo-physiological and non-physiological conditions, i.e. pH
∼ 7.4 and 4 >pH> 7.5, respectively. Two net mass additions were assigned as C2O and
C2H2O2 by using an FT-ICR mass spectrometer. These two glyoxal-derived AGEs survive
ECD and CAD fragmentation showing a typical backbone fragmentation pattern.
DR-ECD results allowed to clearly identify the binding site of C2O and C2H2O2 modifi-
cations, by exhibiting modified c/z·fragment ion series in the fragmentation pattern.
Accordingly, the fragmentation pattern obtained by using CAD showed modified b/y
fragment ion for both modifications.
Using the results of the fragmentation pattern both mass additions of C2O and C2H2O2
were located at the arginine side chain. Interestingly, this location site for both modifica-
tions remained unaffected regardless of the reaction solution or purification procedures
employed. For instance, whereas in the tests defined in chapter 3 dialysis was used
as purification method, in the tests target of the present chapter the purification was
performed by precipitation with MeOH/chloroform. This factor did not affect the final
outcome, in terms of binding site assignment, indicating that the presence and location
of the modifications were not sensible to this particular change.
It is important to highlight that the water loss from the modified c† and c‡ fragment
ions was a permanent characteristic in all DR-ECD spectra. In fact, such a result turned
out to be fully consistent with the hypothesis proposed in § 3.3.2, and illustrated in the
proposed reaction mechanism of the scheme 3.2.
The experiments outlined and discussed in the present chapter were performed using KM-
11, AcKM-11, EK-15 and FR-25. All of these peptides are characterised by the absence of
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an arginine residue at the first position, taken from the N−terminus to the C−terminus,
within the peptide chain. The use of such peptides lacking of the arginine residue proved
to be an adequate selection in order to differentiate N−terminus glycation from arginine
glycation. In fact, the fragmentation patterns obtained by DR-ECD and CAD, for all
the target peptides, showed that there was not involvement of the N−terminus in the
glycation reaction by glyoxal.
It seems clear, again, that for the reaction times employed in the experiments outlined
in this chapter, there was no involvement of amino groups from the lysine residues
and the amidated C−terminus. Based on these results, and in order to establish lysine
involvement, it was deemed necessary to perform the reaction of glyoxal at longer
reaction times. This is precisely addressed and discussed in chapter 6. Equally, the
observation of an unusual m/z ratio, which was assigned to the presence of [M +
(C2−H2) + nH]nH species, was noteworthy. Given the novelty of such an observation, a
further and more detailed exploration was performed, and those results are presented
and discussed in chapter 5. The experiments regarding this new-identified species were
carried out using the same conditions outlined in the present chapter.
It is worth mention that the [M + (C2−H2) + nH]nH species were not observed for both
undecapeptides (KM-11 and AcKM-11), at the conditions of the experiment used in this
work. It can be hypothesized that the presence of this modification is dependant on
the size of the peptide and the number of basic residues. This would require changing
systematically the number of basic amino acids and the length of the peptide chain,
which is outside of the scope of the present work.
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5
Tandem mass spectrometry for the study of an unusual
glyoxal- derived advanced glycation end-product
5.1 Introduction
In chapter 3 and chapter 4 the detection by mass spectrometry of two species of glyoxal-
derived AGEs was discussed and their binding site was identified at the arginine residue.
Additionally, as mentioned in chapter 4, model peptides EK-15 and FR-25 (table 4.1),
were reacted with glyoxal using the conditions described in section 4.2 (phosphate
buffer saline and MeOH/H2O solution). The direct infusion spectra of both peptides
(EK-15 and FR-25) showed an unusual m/z peak. The direct infusion spectra revealed
a mass addition of 21.9843Da to the mass of the peptide. Thus, it seems necessary
to establish whether this mass addition (21.9843Da) corresponded to a new type of
glyoxal-derived AGE. Therefore, similar reaction, mass spectrometry, and CAD and DR-
ECD[228,229] conditions were used as is indicated in section 4.2
Interestingly enough, the EK-15 and FR-25 peptides are tryptic digest fragments of
human serum albumin (HSA), with positions within the protein equal to 520-534 and
403-421, respectively.[269] The EK-15(520-534) peptide has one arginine residue in
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position 521 and two lysine residues in positions 524 and 525, which are the possible
reaction sites for glycation by glyoxal. In contrast, FR-25(403-421) peptide have amino
acid residues in positions R410, K413, and K414, which in turn could also be modified by
glyoxal. R410 is one previously reported hotspot for methylglyoxal glycation in human
serum albumin.[108] So, ultra-high mass resolution mass spectrometry of both EK-15 and
FR-25 peptides reacted with glyoxal revealed an unusual glyoxal-derived AGE formed at
the arginine side chain (R521 and R410). This species were confidently assigned with a
mass error ≤ 1 ppm. (Peak assignment tables C-1 to C-19 are presented in appendix C).
5.2 Materials and methods
As mentioned before, the materials employed in the experiments outlined in this chapter
are similar to those used in the tests described in chapter 4 (see section 4.2). Therefore,
only new materials and methods used in this work are briefly described below.
5.2.1 Mass spectrometry
An inductively coupled plasma (ICP)-MS 7400cx (Agilent Technologies, Berkshire, U.K.)
was employed to analyse the sodium content of glyoxal and model peptides prior to
reaction with glyoxal. The model peptides were also subjected to the purification step
described in section 4.2 prior to sodium analysis. Plasma gas was introduced at a flow
of 15L/min, whereas the plasma power was held at 1550 W. The auxiliary gas was
constantly held at a flow of 0.8mL/min. Single element standard calibration from QMX
(Essex, U.K.) was performed to quantify the sodium content in both glyoxal and the
purified peptides.
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5.3 Results and discussion
5.3.1 Peptides reacted with glyoxal in MeOH/H2O
The direct infusion spectrum for the peptide EK-15 reacted with glyoxal in MeOH/H2O
shows the presence of modified and unmodified double, triply and quadruply- charged
species figure 5.1. Two modified species denoted by the mass addition of C2O and
C2H2O2 were described in chapter 4 (see table 4.1). In this chapter the discussion
focuses on the results regarding the presence of the reaction product assigned as
[M + C2−H2 + 3 H]3+.
This previously unreported modification, appeared as a triply-charged ion in figure 5.1e
the [M + C2−H2 + 3 H]3+ species. The species shows a mass corresponding to the
net addition of 21.98436Da to the mass of the unmodified peptide. This modification
was also observed for the FR-25 peptide. However, three possible mass additions for
21.98436Da can be hypothesised, the mass addition of a Mg adduct [M + Mg + H]3+, the
mass addition of a Na adduct [M + Na + 2 H]3+, or the net mass addition of two carbon
atoms from glyoxal minus the loss of H2 from the peptide, as summarised in table 5.1.
The presence of the magnesium adduct is rejected due to the high mass error. The
sodiated hypothesis was also discounted for four reasons: first, the calculated mass error
for this assignment, in both peptides (table 5.1), is high compared to the mass errors for
all other assigned species in the spectra (appendix C table C- 1, C-2). Thus, the error
values for the sodiated species are well outside the 95 % confidence interval. Second,
ICP-MS analysis of the purified and unglycated EK-15 and FR-25 peptides did not show
any significant content of sodium, and the sodium concentration of the glyoxal reagent
prior to dilution was < 100 ppb. Additionally, the direct infusion FTICR spectra of the
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Figure 5.1: Direct infusion spectrum of the EK-15 peptide showing the monoisotopic
ion with the net addition of 21.98436Da. a. Simulated pattern of the sodium adduct;
b. Simulated pattern with the addition of C2−H2; c. The monoisotopic ion from the
experimental data; d. Direct infusion spectrum of the EK-15 peptide; e. Enhance of
the direct infusion spectrum showing the triply-charged modified ions. X= glyoxal
modifications and α, β, γ, and δ are peaks showing the ion/molecule reaction with
MeOH. The symbol ? indicates unassigned peaks and * indicates background noise
peaks where no isotopologues were present. A detailed peak assignment is available as
table C-1 in the appendix C.
Table 5.1: Comparison of the masses of possible magnesium or sodium adducts and
glyoxal-derived AGEs for the EK-15 and FR-25 peptides reacted in MeOH/H2O.
Peptide Modified ion Theoretical
(m/z)
Experimental
value (m/z)
Error
(ppm)
Error
Std. Dev. (ppm)
EK-15
[M + Mg + H]3+ 602.35503 602.35974 7.8193 0.275a
[M + Na + 2 H]3+ 602.35882 1.524
[M + C2−H2 + 3 H]3+ 602.35963 0.183
FR-25
[M + Mg + 2 H]4+ 724.40827 724.41171 4.749 0.342a
[M + Na + 3 H]4+ 724.41111 0.819
[M + C2−H2 + 4 H]4+ 724.41172 −0.026
a Standard Deviation (Std. Dev.) of the error for the internally calibrated direct infusion spectra of the
EK-15 and FR-25 peptide. Details can be found in appendix C, table C-1 and table C-2.
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non-reacted peptides (EK-15 and FR-25) did not show evidence of sodiated species,
which suggest that precipitation with MeOH/chloroform, employed to desalt the model
peptides, was sufficient to eliminate significant sodium interference. Third, sodiated
fragment ions are absent in the MS/MS spectra as is shown below (section 5.3.1 and
5.3.1).
Fourth, no evidence was found of other sodiated ions such as [M + 2 Na + H]3+ or
[M + 3 Na]3+ species in the glycated and unglycated spectrum of EK-15 peptide, or
[M + 2 Na + 2 H]4+, [M + 3 Na + H]4+, or [M + 4 Na]4+ species in the glycated and
unglycated spectrum of FR-25 peptide. Furthermore, both peptides (EK-15 and FR-
25) were analysed by nESI from solutions contained 3.4µmol of sodium chloride, in
order to induce the formation of sodiated ions and no glyoxal was used to this set of
samples (see figure 5.2). The theoretical value of the sodiated ions were compared
to the experimental value in table 5.2. The mass to charge of the observed ions and
mass error of the sodiated ions peaks, in the resultant mass spectra, provided additional
confidence to the assignments of the original glycated peptide ion as described above.
Table 5.2: Comparison of the sodiated species induced by addition of sodium chloride to
the EK-15 and FR-25 peptides.
Peptide Modified ion Theoretical
(m/z)
Experimental
value (m/z)
Error
(ppm)
Error
Std. Dev. (ppm)
EK-15
[M + Na + 2 H]3+ 602.35882 602.35910 0.158 0.127a
[M + 2 Na + H]3+ 609.68614 609.68649 −0.019
[M + 3 Na]3+ 617.01345 617.01381 −0.305
FR-25
[M + Na + 3 H]4+ 724.41111 724.41145 0.461 0.399a
[M + 2 Na + 2 H]4+ 729.90660 729.90655 −0.070
[M + 3 Na + H]4+ 735.40209 735.40209 0.005
[M + 4 Na]4+ 740.89757 740.89770 0.173
a Standard Deviation (Std. Dev.) of the error for the internally calibrated direct infusion spectra of the
EK-15 and FR-25 peptide infused with sodium chloride. Details can be found in appendix C, table C-3
and table C-4.
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Figure 5.2: Direct infusion spectra of the sodiated a. EK-15 and b. FR-25 peptide.
Sodiation was induced by addition of 3.4µmol/L of sodium chloride to the model
peptides and no glyoxal was added. The symbol * indicates sodium adduct peaks.
Highlighted sodiated species of particular interest, for detailed peak assignments see the
appendix C, table C-4 and C-5.
The addition of 21.98436Da, thus, likely corresponds to a type of glyoxal-derived AGE
(net mass addition of C2 from glyoxal minus the mass of H2 from the peptide, C2−H2, are
shown in scheme 5.1. The [M + C2−H2 + 3 H]3+ species was fragmented using DR-ECD
and CAD of the triply and quadruply-charged precursor ion of modified EK-15 and FR-25
peptides, respectively. Again, as shown in chapter 3 and chapter 4, during quadrupole
isolation of the modified species (table 4.1) a low abundance ion is observed. This low
abundance ion corresponds to the unmodified species [M + 3 H]3+ and [M + 4 H]4+,
respectively for the EK-15 and FR-25 peptides (see table 4.1). The unmodified ion is
then ejected in the ICR cell, during ECD, using a DR-ECD experiment.[228,229]
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Scheme 5.1: Proposed possible structures for the glyoxal-derived AGE with addition
of 21.98436Da (C2−H2). a. crosslinking between amino group of lysine with the N-
terminus; a. 2-imine imidazole species formed at the guanidine group of arginine. These
structures are proposed only with the purpose of illustration where no structural isomers
are considered.
In this work the fragment ions generated by DR-ECD and CAD dissociation techniques
are identified by the addition of the star symbol (*) to the Roepstorff and Biemman’s
nomenclature (c/z·). The unmodified fragment ions do not have any superscript added
to the c/z nomenclature,[47,48] equally, as considered in previous chapters (chapter 3
and chapter 4).
EK-15 peptide
Figure 5.3 shows the DR(595.03)-ECD(602.36) spectrum for the EK-15 peptide. Modified
c∗ (n = 2− 12, 14) fragment ions show addition of 21.98436Da. Unmodified z·radical
fragment ions as well as unmodified c, y, a, and w fragment ions were also observed.
Loss of water from the charge-reduced species is also present in the spectrum. The
modified c∗ fragment ions locate the modification at the arginine in position 2. To
further support the rejection of the sodiated hypothesis, as an example, a comparison
of the experimental mass obtained for the c∗3 fragment ion (453.22041Da), with the
theoretical mass value of the glyoxal modification and with a possible sodium adduct is
made in table 5.3 and figure 5.4. The mass difference between the theoretical mass of
the putative sodium adduct [c3 + Na]
+ and the measured mass, is 5.2 ppm, while the
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same mass difference for the glyoxal modification, is only -0.09 ppm. Since the standard
deviations of the error in the calibration is 0.362 ppm, 5.2 ppm is approximately 14
standard deviations away. For the FR-25 peptide the corresponding [c8 + Na]
+ ion is ∼ 4
standard deviations away, and at 4 standard deviations, assuming normally distributed
errors, there is less than 0.01 % probability that fragments with sodiated species are a
correct assignment.
Figure 5.3: DR(595.03)-ECD(602.36) spectrum of the precursor ion [M + C2−H2 +
3 H]3+ with ejection of [M + 3 H]3+ of the EK-15 peptide in MeOH/H2O solution. The
symbol ? indicates unassigned peaks by the current understanding of the fragmentation
mechanism. Highlighted modified c∗ in the spectrum, for detailed peak assignments see
the table C-5 of the supporting information appendix C.
The CAD spectrum (figure 5.5) shows modified b∗n (n = 2 − 14) and a modified y∗14
fragment ions. Unmodified y, b, a fragment ions, losses of NH3 from the glutamine, and
H2O from the glutamic acid are present at some b, b
∗, and y fragment ions (see table C-10
appendix C). The modified b∗ and y∗ fragment ions locate the modification at the arginine
in position 2. A CAD spectrum of sodiated species with mobile protons should present
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Table 5.3: Comparison of the c∗ and b∗ fragment ion masses of sodium adducts and
glyoxal- derived AGEs.
Peptide
Modified
ion
Theoretical
(m/z)
Experimental
value (m/z)
Error
(ppm)
Error
Std. Dev.
(ppm)
EK-15
MeOH/H2O
[c3 + Na]
+ 453.21804
453.22041
5.229
0.362
c∗3 453.22045 −0.088
EK-15
PBS
[b3 + Na]
+ 436.19150
436.19391
5.523
0.428
b∗3 436.19390 −0.002
FR25
MeOH/H2O
[c8 + Na]
+ 981.56099
981.56298
2.027
0.279
b∗3 981.56284 0.143
FR25
PBS
[b8 + Na]
+ 964.53389
964.53606
2.249
0.594
b∗8 964.536295 0.347
[b+ Na]+, [a+ Na]+ and [y + Na]+ fragment ion species.[270,271] However, the sodium,
if present, is more likely to bind at the C-terminus, so abundant [y + Na]+ should also
be present in the spectrum.[271] However, [b+ Na]+, [a+ Na]+ and [y + Na]+ fragment
ions are absent in the CAD spectrum of the EK-15 peptide reacted in MeOH/H2O and
shown in figure 5.5. Thus, the absence of the sodiated fragment ions, together with
the modified c∗ fragment ion series, indicate that the addition of 21.9844Da is far more
likely to correspond to the glyoxal modification (C2−H2) than to sodiation.
FR-25 peptide
The DR(718.91)-ECD(724.41) spectrum of the FR-25 peptide (figure 5.6, table C-11
appendix C) shows modified c∗ fragment ions in positions 8 to 25. Modified z∗18· , z∗23·and
unmodified zn·radical, fragment ions, a∗ , x9 , unmodified y fragment ions, losses of
water, and NH3 are present in the spectrum. Thus, the presence of c
∗ fragment ions
and z∗·indicate that the modification is located at the arginine residue in position 8.
Moreover, the results showed so far, for both peptides, indicate that the glyoxal-derived
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Figure 5.4: Comparison of the c3 fragment ion for the EK-15 peptide in MeOH/H2O
solution: a. elemental composition of the unmodified c3 fragment ion; b. simulated
pattern of the c3 fragment ion modified with possible addition of a sodium adduct; c.
experimental spectrum highlighting the c∗3 fragment ion; d. simulated pattern of the c
∗
3
fragment ion modified with the addition of C2 minus H2. Spectrum internally calibrated
with unmodified ions (see table C-6) appendix C.
AGE compound is formed with the guanidine group at the arginine residue (proposed
possible structure b, scheme 5.1, although other structural isomers may be present).
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Figure 5.5: CAD spectrum of the precursor ion [M + C2−H2 + 3 H]3+ of the EK-15
peptide in MeOH/H2O solution. The symbol ? indicates unassigned peaks by the current
understanding of the fragmentation mechanism. Detailed peak assignments are available
in the Tables C-10 of the appendix C.
5.3.2 Peptides reacted with glyoxal in PBS
In order to test under pseudo-physiological conditions, the peptides were reacted with
glyoxal at pH 7.2±0.2 maintained by a phosphate buffer saline solution. This experiment
was also repeated three times. The direct infusion spectra of desalted EK-15 and
FR-25, reacted with glyoxal, showed similar modified species as C2O (39.9943Da),
C2H2O2 (58.0055Da), discussed in chapter 4 and the unusual modification C2−H2
(21.98436Da)).
EK-15 peptide
The DR(595.03)-ECD(602.36) data for the EK-15 peptide with the addition of 21.98436Da
shows the complementary pairs c∗n/z
∗
n· , (with n = 3− 12), c∗2/z13·, and fragment ions
c∗13, c
∗
14 , and the radical fragment ion z
∗
14·(table C-16). No evidence of fragment ions
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Figure 5.6: DR(718.91)-ECD(724.41) spectrum of the precursor ion [M+C2−H2+4 H]4+
with ejection of [M + 4 H]4+ of the FR-25 peptide in MeOH/H2O. The symbol ? indi-
cates unassigned peaks by the current understanding of the fragmentation mechanism.
Detailed peak assignments are available in the tables C-17 of the appendix C.
with the addition of sodium were observed in the spectrum (e.g. [c+Na]+). Additionally,
the CAD spectrum shows modified b∗ fragment ions, unmodified y, b, a fragment ions,
side chain losses of H2O, and NH3 (figure 5.7, table C-16). Losses of Na, [b + Na]
+,
and [a + Na]+ fragment ions are absent in the spectra, but low abundance [y + Na]+
fragment ions in positions 3, and 6 to 9 were observed.
The presence of the [y + Na]+ fragment ions agrees with previous findings that the
sodium binds to the C- terminal carboxylic acid.[270] However, for instance, the m/z
of the b∗ fragment ions (table 5.3), with the glyoxal modification C2−H2 has a low
error compared with a potential [bn + Na]
+ fragment ion series. Thus, the presence
of highly abundant modified c∗, b∗ , z∗14 and y
∗
14 fragment ions, together with a low
abundance of [y+ Na]+ species, indicates the presence of two ion species with the same
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mass in the samples reacted in PBS. The highly abundant one, that corresponds to the
glyoxal modification (C2−H2) and the low abundant, second one, that corresponds to
the formation of [M + Na + 2 H]3+. The low abundance of the [M + Na + 2 H]3+ species
and consequently of the [y + Na]+ fragment ions are attributed to the residual presence
of NaCl from the PBS buffer after the desalting procedure described above. CAD and
DR-ECD results localize the glyoxal modification (C2−H2) site to the arginine residue in
position 2, for the EK-15 peptide.
Figure 5.7: CAD spectrum of the precursor ion [M + C2−H2 + 3 H]3+ of the EK-15
peptide in PBS buffer with enhance of the b3 fragment ion: a. elemental composition
of the unmodified b3 fragment ion b. simulated pattern of the b3 fragment ion with
addition of the sodium adduct; c. experimental spectrum highlighting the b∗3 fragment
ion; d. simulated pattern of the b3 fragment ion with the addition of C2 minus H2; e.
peptide map of the CAD spectrum. Spectrum internally calibrated with unmodified ions
(see table C-7) to compare the monoisotopic modified b3 fragment ions. Detailed peak
assignments of the spectrum are available in the Tables C-19 appendix C.
Addition of 21.98436Dawas also observed for the FR-25 peptide under pseudo-physiological
conditions. Further analysis of the CAD spectrum showed that a glyoxal-derived species
is formed at the guanidine group in the arginine moiety in position 8 (refer to table
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C-20, appendix C).
Additionally, sodium chloride, up to a concentration of 3.4µM , was directly added to
the glycated EK-15 peptide diluted in the electrospray solution. The sodiated-glycated
peptides were then ionized by nano-ESI and fragmented by CAD. The CAD spectrum
revealed an increase in the abundance of the [y + Na]+ fragment ions observed in the
pseudo-physiological conditions. The glycated EK-15 peptide, in MeOH/H2O, was also
fragmented by CAD. The data (table C-21) showed the presence of [y + Na]+ fragment
ions in positions 3, 6, 7, 9, and [a10 + Na]
+ fragment ions. The main difference with the
CAD data presented in figure 5.5 and table C-8 (appendix C) is precisely, the presence of
the sodiated fragment ions. These results further support the presence of two ion species
with the same mass, [M + Na + 2 H]3+ and [M + (C2−H2) + 3 H]3+, due to residual NaCl
in the glycated peptides using PBS solution.
The results presented here suggest that the addition of 21.98436Da to the peptide
mass, at both pseudo-physiological and non-physiological conditions, corresponds to
an unusual type of glyoxal-derived AGE. This compound is formed at the guanidino
moiety at the arginine residue and the proposed reaction in shown in scheme 5.2. The
addition of 21.98436Da to the peptide mass could also be formed by dehydration during
the electrospray process. However, as this modification disappeared after 21 hours of
reaction in MeOH/H2O and after 12 hours of reaction in PBS buffer, it is most likely
that they are formed in solution. A reasonably likely interpretation of these results
is that this unusual modification with glyoxal is a kinetic product (a rapidly formed
intermediate product, which is not the final most stable product), due to the formation
of a five member ring moiety. Moreover, this modification disappears over time to allow
the formation the formation of the thermodynamic product (a dihydrated five member
ring), which shows the addition of C2H2O2 at the guanidino group of arginine and it
was proposed to be the 4,5 dihydroxyimidazoline.[73] Nonetheless, thermodynamics
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and kinetic studies as well as further research for the formation of this compound in
biological systems needs to be addressed before any biological conclusions can be drawn
from these results.
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Scheme 5.2: Schematic of the proposed reaction for the mass addition of 21.98436Da
forming the glyoxal-derived AGE. Although, the reaction is depicted forming a possible
chemical structure, other structural isomers may be present. The hypothesized reaction
is illustrated with glyoxal dehydrate, however, unhydrated and monohydrated species
also coexist in the glyoxal reagent (39%).[262]
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5.4 Conclusions
Glyoxal was reacted, under non-physiological and pseudo-physiological conditions,
with model peptides EK-15 and FR-25, both fragments of human serum albumin. The
reaction products were analysed using ECD and CAD in a Fourier transform ion cyclotron
resonance mass spectrometer (FT-ICR-MS). The glyoxal bound to the guanidino group
of the arginine residue forming an unusual glyoxal-derived AGE in both peptides used in
this study. This glyoxal modification increased the mass of the peptide by 21.98436Da
and was assigned as C2−H2. A general structure was proposed as the 2-imino-imidazole.
It is noteworthy that although a structure is being proposed, no structural conformation
has been considered. It is clear then that a further study on the possible isomers is
required, in order to asses the validity of the proposed structure.
Examining the results for the FR-25 peptide it is important to note that, surprisingly,
the arginine in position 25, i.e. 25Arg from the N−terminus, was not found to be
susceptible to glycation by glyoxal, neither under MeOH/H2O or PBS reaction solutions.
Nevertheless, as it could be expected for this case, the arginine in position 8, i.e. 8Arg,
was modified by the glyoxal reagent, forming the unusual compound previously indicated
(scheme 5.2). Considering this finding, it is herein argued that the conformation of the
peptide in the reaction solutions used in this work, might be allowing the exposure of
the arginine in position 8, and at the same time be protecting the arginine in position 25.
In summary, we argue that the absence of the modification in 25Arg could be explained
by the inaccessibility of the arginine at the C−terminus in the peptide chain. However,
the validity of this argument shall be assessed by additional experimentation, varying
systematically the position of the arginine in any polypeptide chain. Thus, although
additional experimentation is deemed necessary to prove this hypothesis, such additional
experimentation was considered beyond the scope of the present work. More research
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activity is then required, but we hope that the arguments outlined above can be a
potential motivation for such an extended research.
The results also showed that two compounds with the same mass were formed when
sodium was present during the glycation reaction with glyoxal. In the experiments
carried out in this work the source of sodium was provided by the PBS reaction solution.
Thanks to the use of the ultrahigh resolution of the FT-ICR-MS, an accurate detection of
such species was possible, with mass assignments exhibiting errors ≤ 1ppm in every case.
It is worth to mention that the detection of mass differences below 2.4mDa is either not
possible or extremely difficult to achieve with low resolution mass spectrometers. This
may explain why this type of modification (2-imino-imidazole) has not been reported
before.
Finally, given the reaction times employed in the experiments outlined in the present
chapter, and as equally mentioned in § 4.4, it was deemed necessary to glycate the
peptides at longer reaction times in order to assess the involvement of the lysine and/or
other basic residues within the peptide. This is addressed in the following chapter.
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6
Study of an unexpected crosslinking and diglycation as
advanced glycation end-products by tandem mass
spectrometry
6.1 Introduction
The experimental evidence presented and discussed in chapters 3 to 5 showed that
glyoxal is an arginine glycating agent that reacts at 21 hours in MeOH/H2O, and at 6
hours when used with PBS. In the analyses discussed previously three modifications to
the peptides were detected at the guanidino group of the arginine residue. These modi-
fications were assigned as: a C2O addition (39.99Da); a C2H2O2 addition (58.055Da);
and, finally, a modification including a two-atom addition of carbon, i.e. C2 (provided
by the glyoxal), and a two-atom loss of hydrogen, i.e. H2 (lost by each peptide), which
accounts for a net mass increase of 21.9843Da to the peptide mass after the reaction
with glyoxal, and represented as C2−H2. It is appropriate to clarify that although the
C2O and C2H2O2 modifications were detected for all tested peptides employed in this
study, the C2−H2 modification was only detected in the FR-25 and EK-15 peptides, as
mentioned before (see chapter 5).
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In spite of the satisfactory results obtained so far regarding the determination of a
number of modifications by glyoxal at the arginine residue, there still remains to clarify
the possibility of involvement, if any, of the lysine residue and/or other basic sites within
any of the peptides selected for this work.
Arguably, it could be hypothesized that the lack of evidence regarding the involvement
of the lysine residue, or of any other basic site, is due to the extension of the range
of reaction times selected for the performed tests. Therefore, in order to explore this
hypothesis, a set of experiments at longer reaction times was carried out using model
peptides KM-11 and AcKM-11. In keeping with the previous experiments, MeOH/H2O
and PBS are used too as reaction solutions for the experiments discussed in this chapter.
6.2 Materials and methods
Acetylated and non-acetylated undecapeptides, with one arginine and one lysine residue
available for glycation, were used to react with glyoxal for up to 29 days with analysis
by MS/MS at 4, 7, 11, and 29 days in MeOH/H2O, and for 12 hours in PBS. Mass
spectrometry results from a Fourier transform ion cyclotron resonance mass spectrometer
are used to show the presence of glycated compounds. A more detailed description of
the methods and materials is presented below.
6.2.1 Materials
The peptides used for the experiments target of this section are the acetylated and
non-acetylated undecapeptides, as described and summarised in table 6.1. Additionally,
due to the similar nature of the target experiments of this part of the present work, the
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materials employed here were consistent with those described in chapter 4 (see section
4.2).
Table 6.1: Common modified ions for the model peptides reacted with glyoxal in
MeOH/H2O and PBS.
Peptide Sequence
Unmodified
ion (m/z)
Observed modified
ions in MeOH/H2O
a
Observed modified
ions in PBSa
KM-11
KPRPQQFFGLM−NH2
(1346.72813Da)
[M+ 2 H]2+
(674.37134)
[M+ 2 (C2H2O2)+ 2 H]
2+
(m/z 732.37680)
Error −0.027 ppm
[M+ 2 (C2H2O2)+ 2 H]
2+
(m/z 732.37654)
Error 0.384 ppm
AcKM-11
AcKPRPQQFFGLM−NH2
(1388.73869Da)
[M+ 2 H]2+
(695.37663)
[M+ 2 (C2H2O2)+ 2 H]
2+
(m/z 753.38140)
Error 0.149 ppm
[M+ 2 (C2H2O2)+ 2 H]
2+
(m/z 753.38140)
Error −0.942 ppm
a Detailed peak assignment is showed in Table D-1 to D-4 appendix D, respectively.
6.2.2 Glycation of model peptides in MeOH/H2O
The peptides were purified using the procedure described in section 4.2. Subsequently,
the peptides were re-dissolved in MeOH/H2O (50:50). Three aliquots from this peptide-
containing solution were put to react with glyoxal (800µmol/L). The reaction was
carried out at 37 ◦C for up to 29 days at a starting pH of 7.5, monitoring by MS/MS
analysis at 4, 7, 11, and 29 days. The reacted peptides were diluted with an ionization
solution containing methanol, water, isopropanol, and acetic acid (50:39:10:1), up to a
final concentration of ∼ 0.1µM .
6.2.3 Glycation of model peptides in PBS
For the reaction in PBS, peptides were purified in exactly same manner as described
above. However, for this case, the purified peptides were dissolved in PBS (pH = 7.2±0.2)
and three aliquots were taken to react with glyoxal (400nM) over a 10-hour incubation.
After the reaction the three glycated peptides were cleaned from the buffer solution
147
using a purification procedure alike to that described in section 4.2. Interestingly, the
reaction in PBS at longer reaction times and higher concentration caused insolubility of
the pellet after desalting. Consequently different glyoxal concentrations and reaction
times were employed until solubility of the sample was achieved.
The dried pellet was re-dissolved in 100% water and then diluted with ionization solution
to a final concentration of ∼ 0.1µM prior to injection into the mass spectrometer.
6.2.4 Mass spectrometry
Similar set of conditions as those used in section 4.2 for mass spectrometry were used
for the analysis of the reacted peptides. In this case nano electrospray (n-ESI) was used
to ionise the reacted peptides. Double resonance ECD experiments[228] were performed
by varying the ejection pulse between 70 and 120ms. Internal calibration was performed
with DataAnalysis software 4.0 SP 3 (Bruker Daltonics). The masses used for calibration
are indicated with a symbol * in the tables contained within the appendix D.
Ion mobility spectra were acquired with a Synapt G2 (Waters, Manchester, U.K.) traveling
wave mass spectrometer (TWIMS). The sample, diluted with ionization solution (as
above), was loaded into a grounded metallic coated glass capillary. To generate the ions
the spray shield voltage was kept at 1.3 kV , the cone voltage was 20 − 180V , and the
ion source temperature was maintained at 90 ◦C. The ion of interest was isolated in
the quadrupole prior to ion mobility separation. The T-wave velocity and peak height
voltages were 500m/s and 40V , respectively. The T-wave mobility cell was operated at a
pressure of 0.55 mbar and nitrogen was employed as separation gas. External calibration
was performed using sodium iodide standard (1mg/mL) from (Waters Corporation,
Manchester, UK). Data processing was carried out by use of the Waters Driftscope 2.1
software and MassLynx 4.1 (Waters Corporation, Manchester, UK).
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6.3 Results and discussion
The direct infusion spectra of the glycated peptide KM-11 (KPRPQQFFGLM−NH2),
reacted in MeOH/H2O and in PBS solutions, are shown in figure 6.1. Similar reaction
products were obtained when this peptide was reacted with glyoxal in MeOH/H2O (as
shown in figure 6.1a) and in PBS (as shown in figure 6.1b), and common ions included
a [M + 2 (C2H2O2) + 2 H]
2+ (m/z 732.3768) species. Equally, as mentioned above, the
acetylated version of the KM-11 peptide was reacted with glyoxal in MeOH/H2O and
in PBS. Similar species to those observed in the reaction of the non-acetylated peptide
were obtained, also including the [M + 2 (C2H2O2) + 2 H]
2+ ion (a summary of these
findings is presented in Tables D-3 and D-4 of the appendix D).
In table 6.1 the mass error of the [M + 2 (C2H2O2) + 2 H]
2+ species, for both peptides
(KM-11 and AcKM-11), is presented for both reaction solutions (MeOH/H2O and PBS)
with standard deviations of the errors between 0.315 and 0.519 ppm (see tables D-1 to
D-4 in appendix D). Thus, it is hypothesized that the net addition of two molecules
of C2H2O2 to the peptide corresponds to diglycation at the arginine and at the lysine
residues, respectively, as shown in scheme 6.1. In order to test this hypothesis, ECD and
CAD fragmentation techniques were employed to accurately assign glyoxal binding sites
using a FT-ICR-MS.
K P R P Q
C2H2O2 C2H2O2
Scheme 6.1: Illustration of diglycation at the lysine and at the arginine residue by the
addition of one molecule of C2H2O2 from glyoxal. These diglycation is represented by
the formation of [M + 2 (C2H2O2) + 2 H]
2+ species.
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Figure 6.1: Direct infusion spectrum of the KM-11 reacted with glyoxal: a. in
MeOH/H2O; b. in PBS. A−[M + C4H2O3 + 2 H]2+]. The symbol ? indicates unas-
signed peaks and an * indicates chemical noise, probably from the PBS buffer. Labeled
peaks are assigned in the detailed peak assignment tables D-1 and D-2 of the appendix D.
6.3.1 Fragmentation of KM-11 peptide
The spectrum of the quadrupole isolation of the diglycated [M + 2 (C2H2O2) + 2 H]
2+
(m/z 732.37680) species, revealed low abundance of a monoglycated [M + C2H2O2 +
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2 H]2+ (m/z 703.37391) ion. The presence of the monoglycated [M + C2H2O2 + 2 H]
2+
ion is attributed to activation of the diglycated precursor ion [M + 2 (C2H2O2) + 2 H]
2+
during quadrupole isolation, which causes loss of one molecule of C2H2O2. Consequently,
the quadrupole isolated precursor ion ([M + 2 (C2H2O2) + 2 H]
2+) was further separated
from the monoglycated species in the ICR cell by application of the double resonance
(DR) experiment during ECD. This experiment allows ejection of the monoglycated
[M + C2H2O2 + 2 H]
2+ species while performing ECD.
The DR-ECD spectrum of the diglycated species showed three types of fragment ions
(c/z·): unmodified, with single modification (addition of one molecule of C2H2O2, and
with double modification (addition of two molecules of C2H2O2. In the present chapter
these fragment ions are distinguished using a prescribed nomenclature, as follows.
Singly-modified fragment ions are identified by adding a double dagger symbol (‡) to
the Roepstorff and Biemann’s nomenclature (c/z·),[47,48] this single modification was as-
sociated with the addition of one molecule of C2H2O2 (i.e., a net addition of 58.00546Da
to the fragment ion mass). Doubly-modified fragment ions are identified by adding the
hash symbol (#) to the normalized (c/z·) nomenclature; this modification was linked
to the addition of two molecules of C2H2O2 (i.e., a net addition of 116.01092Da to the
fragment ion mass). Finally, for clarity, the unmodified fragment ions are indicated by
using the standard c/z·nomenclature, with no superscript added.[47,48]
The DR(703)-ECD(732) spectrum of the diglycated modified ion [M + 2 (C2H2O2) +
2 H]2+, in MeOH/H2O solution is shown in figure 6.2. c
#
n modified fragment ions in
position 4 to 10 are observed in the spectrum. The monoglycated modified c fragment
ion in position 2 shows addition of one molecule of C2H2O2 and is represented as c
‡
2
in figure 6.2. Diglycated z#9 ·radical fragment ion, unmodified c, y, fragment ions, and
z·radical fragment ions are also present in the spectrum. The modified c fragment ion
in position 3 were not detected due to the presence of proline.[171,272]
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Figure 6.2: DR(703)-ECD(732) spectrum of the KM-11 peptide of the precursor ion
[M + 2 (C2H2O2) + 2 H]
2+ with ejection of [M + C2H2O2 + 2 H]
2+ in MeOH/H2O so-
lution. The symbol ? indicates unassigned peak by the current understanding of the
fragmentation mechanism. Highlighted modified c#, c‡2, and z
#
9 ·fragment ions in the
spectrum and unlabelled peaks are assigned in the detailed peak assignment Table D-5
of the appendix D.
The presence of the monoglycated modified c‡2 fragment ion could be attributed to frag-
mentation of the monoglycated species, which although ejected by the double resonance
experiment, could also be formed during ECD. In order to test the provenance of mono-
glycated modify c‡2, c
‡
4 to c
‡
10 fragment ions, z
‡
9· radical fragment ions, along with the
diglycated z#9 ·radical fragment ion their relative intensities were normalized (see equa-
tion (3.1)) and plotted in figure 6.3. Furthermore, ECD experiments were performed
without double resonance, and the intensities of the c‡n fragment ions (n = 2, 4, . . . , 10),
were also normalized and plotted in figure 6.3. Comparison of the normalized relative
intensity of the modified c‡n fragment ion, z
#
9 ·and z‡9·radical fragment ions, from the
ECD(703) and DR(703)-ECD(732) spectra, revealed that the intensity of the mono-
glycated c‡2, z
‡
9·radical fragment ion, and diglycated z#9 ·radical fragment ion did not
decrease during the DR-ECD experiment. Normally, in a DR-ECD experiment, the de-
crease in the normalized relative intensity of a particular fragment ion indicates the
parentage of the ejected ion.[228] Thus, as the intensity of the monoglycated c‡2 fragment
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ion and z‡9·radical fragment ion did not decrease, it is though that these species are
likely to be derived from the diglycated species ([M + 2 (C2H2O2) + 2 H]
2+), and not
from the ejected monoglycated species.
Figure 6.3: Comparison of the relative intensity of the c‡n fragment ions and z
#
9 · , and z‡9
radical fragment ions for the ECD(732) and DR(703)-ECD(732) spectra for the KM-11
peptide.
The CAD spectrum presented in figure 6.4, for the diglycated ion ([M + 2 (C2H2O2) +
2 H]2+) in MeOH/H2O, shows modified b
#
n (n = 3−10) with addition of two molecules of
C2H2O2, and b
‡
2 fragment ions with the addition of one molecule of C2H2O2. Unmodified
y, b, a fragment ions, losses of NH3, loss of the modification, and up to three losses of
H2O from the charge reduced-species were also observed in the spectrum. The results
showed so far indicate that both the lysine, in position 1, and the arginine, in position 3
are modified by glyoxal in the MeOH/H2O solution, with c
‡
2 and b
‡
2 fragment ions likely
associated to the diglycated species [M + 2 (C2H2O2)
+2 H]2+.
The KM-11 peptide was also reacted with glyoxal in PBS and the modified diglycated ion
[M + 2 (C2H2O2) + 2 H]
2+ species was also present. The DR(703)-ECD(732) spectrum
of the [M + 2 (C2H2O2) + 2 H]
2+ species, showed in figure 6.5, agrees with the previous
results. In summary, addition of two molecules of C2H2O2 is observed in c
#
4 to c
#
10 , b
#
3
to b#10, z
#
9 ·, y#9 , y#10 fragment ions, and addition of one molecule of C2H2O2 is shown in
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Figure 6.4: CAD spectrum of the precursor ion [M + 2 (C2H2O2) + 2 H]
2+ for the KM-11
peptide in MeOH/H2O solution. The symbol ? indicates unassigned peaks by the current
understanding of the fragmentation mechanism. Highlighted modified b# fragment ions
in the spectrum and unlabelled peaks are assigned in the detailed peak assignment table
D-7 of the appendix D.
c‡2 , b
‡
2 , and y
‡
9 fragment ions. It seems clear then that the lysine residue (position 1) is
modified by one molecule of C2H2O2 and the arginine residue (position 3) is modified
either by one or two molecules of C2H2O2.
Figure 6.5: DR(703)-ECD(732) spectrum of the precursor ion [M + 2 (C2H2O2) + 2 H]
2+
with ejection of [M + C2H2O2 + 2 H]
2+ of the KM-11 peptide in PBS solution. The
symbol ? indicates unassigned peaks by the current understanding of the fragmentation
mechanism. Highlighted modified c#, c‡2, and x
#
9 ·fragment ions and unlabelled peaks are
assigned in the detailed peak assignment Table D-8 of the supplementary information.
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Based on these findings, two possible compounds with the same mass could be formed
in the KM-11 peptide in both MeOH/H2O and PBS solution. The first compound that
represents diglycation was shown in scheme 6.1, which has an elemental composition of
C67H103N18O17S and is represented as [M + 2 (C2H2O2) + 2 H]
2+ with a theoretical m/z
of 732.37683. This compound correlates well with the observed c‡2, b
‡
2 fragment ions, and
z‡9·radical fragment ion. These fragments as discussed above, are likely to be derived
from the diglycated [M + 2 (C2H2O2) + 2 H]
2+ species.
A second compound shows the addition of two molecules of C2H2O2 at the arginine
residue, as in illustrated in scheme 6.2. Interestingly, this compound has similar elemen-
tal composition and theoretical m/z as described above (see scheme 6.2) and herein is
represented by [M + C4H4O4 + 2 H]
2+. This second compound accounts for the presence
of z#9 ·radical fragment ion, y#9 , and y#10 fragment ions. Thus, due to the mixed presence
of the c‡2, b
‡
2, and z
‡
9·along with the presence of z#9 ·, y#9 , and y#10 fragment ions is likely
that glyoxal is forming with the KM-11 peptide two isomeric compounds with the same
mass, which are detected in the mass spectrometer as m/z 732.37682.
Scheme 6.2: Illustration of the addition of two molecules of C2H2O2 at the arginine
residue. These diglycation is represented by the formation of [M + C4H4O4) + 2 H]
2+
species.
The [M + C4H4O4) + 2 H]
2+ species could have the chemical structures proposed in
scheme 6.3. The structure proposed in scheme 6.3a represents the formation of Nδ-[2-
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(dihydroxymethyl)-2H,3aH,4H,6aH-[1,3]dioxolo[5,6-d]imidazolin-5-yl]-L-ornithine, herein
referred to as glyoxal dimer at the arginine residue. A second structure could be the
formation of Schiff base at the arginine residue, as is illustrated in scheme 6.3. It is note-
worthy that the proposed formation of the glyoxal dimer (scheme 6.3a) is energetically
favored over the Schiff base species (scheme 6.3), because of the formation of the stable
dioxolane ring.[261]
Scheme 6.3: Representation of the proposed species for the KM-11 peptide reacted with
glyoxal in MeOH/H2O and in PBS solutions showing addtion of C4H4O4 at the arginine
residue: a. proposed glyoxal dimer structure formed at the arginine residue (Nδ-[2-
(dihydroxymethyl)-2H,3aH,4H,6aH-[1,3]dioxolo[5,6-d]imidazolin-5-yl]-L-ornithine); b.
proposed Schiff base structure.
In contrast the diglycated [M + 2 (C2H2O2) + 2 H]
2+species (scheme 6.1) could have
the lysine residue modified by glyoxal crosslinking with the N-terminus as shown
scheme 6.4a, but also other chemical structures are possible as proposed in scheme 6.4b
and scheme 6.4c. It seems clear then that acetylation at the N-terminus could block the
formation of the possible glyoxal crosslinked species. Moreover, if the species proposed
in scheme 6.1b and scheme 6.4c are formed, acetylation at the N-terminus should not
affect the fragmentation pattern and in particular c‡2, and b
‡
2 fragment ions should be
present in the MS/MS experiments. Thus, further experiments were carried out in order
to differentiate the proposed intramolecular crosslinking (scheme 6.4a) from the Schiff
base formation (scheme 6.4b) or formation of other species (scheme 6.4c) at the lysine
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residue, using an acetylated version of the KM-11 peptide (AcKM-11).
Scheme 6.4: Illustration of the possible structures formed at the lysine residue for the
KM-11 peptide reacted with glyoxal in MeOH/H2O and in PBS solutions a. Lysine
residue crosslinked with glyoxal and the N−terminus ; b. Schiff base formed at the
lysine residue; b. heterocyclic amine.
6.3.2 Fragmentation of AcKM-11 peptide.
The direct infusion spectrum of the AcKM-11 peptide showed the addition of two
molecules of C2H2O2 (m/z 753.38211) , which were formed in MeOH/H2O and in PBS
solution (figure 6.6). Isolation of the [M + 2 (C2H2O2) + 2 H]
2+ species again revealed
monoglycated ions, which were ejected during the DR-ECD experiment.
Figure 6.7a shows the DR(724)-ECD(753) spectrum of the precursor ion [M+2 (C2H2O2)+
2 H]2+ in MeOH/H2O solution. Modified c
#
n and c
‡
n fragment ions in position 4 to 10,
modified z#9 · , z‡9·radical fragment ions and unmodified c, and y, fragment ions are also
observed in such a spectrum. No evidence was found of the modified c fragment ion in
position 2 in the DR(724)-ECD(753) spectrum at 4, 7, 11, and 29 days. Equally, com-
parison of the normalized relative intensity of the modified c‡n, c
#
n fragment ions, z
#
9 ·,
and z‡9·radical fragment ions obtained by ECD(753) and DR(724)-ECD(753) suggest
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Figure 6.6: Direct infusion spectra of the AcKM-11peptide: a. reacted in MeOH/H2O; b.
reacted in PBS solution.
that the c‡4, c
‡
6, c
‡
7, c
‡
9, c
‡
10, and z
‡
9·species are formed from the precursor ion diglycated
[M + 2 (C2H2O2) + 2 H]
2+ species (see figure 6.8).
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Figure 6.7: Spectra of the Ac-KM-11 peptide: a. DR(724)-ECD(753) spectrum of the pre-
cursor ion [M+2 (C2H2O2)+2 H]
2+ with ejection of [M+C2H2O2+2 H]
2+ in MeOH/H2O;
b. CAD spectrum of the precursor ion [M + 2 (C2H2O2) + 2 H]
2+ in MeOH/H2O solution;
c. CAD fragmentation pattern of the precursor ion [M + 2 (C2H2O2) + 2 H]
2+ in PBS
solution. The symbol ? indicates unassigned peaks by the current understanding of the
fragmentation mechanism. Highlighted modified c#, b#, y#10, and z
#
9 ·fragment ions in
the spectrum and unlabelled peaks are assigned in the detailed peak assignment Tables
D-9, D-10 and D-11 presented in appendix D.
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Figure 6.8: Comparison of the relative intensity of the c‡ and c# fragment ions for the
ECD(753) and DR(724)-ECD(753) spectra of the AcKM-11 peptide.
Inhibition of the fragmentation towards the N−terminus is also observed in the CAD
spectrum of the precursor ion [M + 2 (C2H2O2) + 2 H]
2+ in MeOH/H2O solution (fig-
ure 6.7b), where the modified b‡2 fragment ion and its complementary pair y
‡
9 are absent,
together with y#9 . Similar results are also observed in the fragmentation pattern obtained
from the CAD spectrum of the precursor ion [M + 2 (C2H2O2) + 2 H]
2+ in PBS solution
(figure 6.7c). Therefore, the presence of modified c#4 to c
#
10, b
#
3 , b
#
5 to b
#
10, y
#
10 fragment
ions, and the modified z#9 ·radical fragment ion indicate that the arginine residue in
position 3 is modified by the addition of two molecules of C2H2O2 in MeOH/H2O and in
PBS solution, which could have the previously proposed structures shown in scheme 6.3.
Comparing the fragmentation pattern of the KM-11 and AcKM-11 peptides obtained
by CAD and DR-ECD experiments is noticeable the change of the peptide map of the
acetylated peptide. Moreover, the absence of b‡2 / y
‡
9, and y
#
9 fragment ions suggest that
Schiff base formation (scheme 6.4b) and/or heterocyclic amines (scheme 6.4c) could
not be formed at the amino group of the lysine residue in neither the acetylated nor the
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non-acetylated KM-11 peptide. These data strongly suggest that the lysine residue in the
non-acetylated KM-11 peptide is crosslinked by glyoxal with the N-terminus, and the
reaction mechanism is shown in scheme 6.5. However, a systematic study varying the
position of the lysine residue relative to the N-terminus is required in order to assess the
extent of the glyoxal crosslinking ability between the lysine and the N-terminus.
Scheme 6.5: Proposed reaction mechanism for the formation crosslinked species formed
with glyoxal at the lysine residue and the N−terminus.
Additionally, in the acetylated peptide is difficult difficult to establish whether the lysine
residue is involved in the glycation. Nonetheless, the consistent presence of the modified
b#5 to b
#
10 and c
#
5 to c
#
10 fragment ions, together with inhibition of the fragmentation in
position 2 from the N−terminus and 9 from the C−terminus (b‡2 / y‡9, and y#9 ) suggest
that intramolecular cyclization between the lysine amino group and the side chain of
glutamine in position 4 could occur. The presence of different isomers in the AcKM-11
peptide was checked with ion mobility mass spectrometry. The DriftScope displays of
selected ion mobility spectra are presented in figure 6.9. Quadrupole isolation, prior to
separation by their drift time, shows isomeric species, which correlate with the observed
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spectra in figure 6.7. However, further research varying the relative position between
lysine and glutamine is necessary before any definitive conclusion can be drawn about
glutamine side chain involvement during the glycation reaction.
Finally, what is important to note is that the results indicate the presence of two prod-
ucts formed during the reaction of glyoxal with the non-acetylated KM-11 peptide in
MeOH/H2O and in PBS solution. These two species have the same net mass addition of
116.01092Da forming the diglycated ion [M + 2 (C2H2O2) + 2 H]
2+. Fragmentation of
the diglycated ion suggest the formation of the glyoxal dimer (N5-[2-(dihydroxymethyl)-
2H,3aH,4H,6aH-[1,3]dioxolo[5,6-d]imidazolin-5-yl]-L-ornithine). The proposed struc-
ture does not show any stereochemistry, and other structural compounds at the arginine
residue that can potentially be formed. Intramolecular crosslinking of the lysine residue
and the N−terminus is also consistent with the results. However, a deep understanding
of the formation of these compounds in biological systems is needed in order to address
the extent of the glycation reaction. Equally, it is clear that the determination of the
crosslinked glutamine-glyoxal-lysine residues requires conformational calculations. In
any case, given the scope of the current project, those calculations were omitted in the
present study.
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(a) DriftScope display of the ion mobility spectra obtained for acetylated peptide KM-11
(b) DriftScope display of the ion mobility spectra obtained for the AcKM-11 peptide
Figure 6.9: Results of ion mobility mass spectrometry of the AcKM-11 peptide in
MeOH/H2O. a DriftScope display of the ion mobility spectra for acetylated peptide
KM-11; b DriftScope display of the ion mobility spectra obtained for the isolated ion
[M + 2 (C2H2O2) + 2 H]
2+ (m/z 753.381) in MeOH/H2O of the AcKM-11 peptide.
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6.4 Conclusions
Glyoxal was reacted with acetylated and non-acetylated undecapeptides in MeOH/H2O
(50:50) and PBS solution (four representative cases in total), and studied using an
FTICR-MS. Reaction products for both peptides, showing the addition of two molecules
of C2H2O2, were subjected to DR-ECD and CAD fragmentation.
Unexpectedly, the fragmentation pattern obtained for the acetylated peptide showed the
presence of two compounds with the same mass addition of 116.01092Da, i.e. (C2H2O2)2.
The results strongly indicated that one compound was formed by crosslink of one
molecule of glyoxal, the N−terminus and the lysine side chain. Additionally, the second
compound was assigned as N5-[2-(dihydroxymethyl)-2H, 3aH,4H,6aH-[1,3]dioxolo[5,6-
d] imidazolin-5-yl]-L-ornithine formed at the guanidine group of arginine.
For the acetylated peptide it is clear that crosslinking with theN−terminus is not possible.
However, the results suggest that crosslinked species might be formed between the lysine
side chain, the glyoxal reagent and the glutamine residue. Nevertheless, a systematic
study is required in order to determine with greater confidence the participation of the
glutamine residue in the formation of crosslinked species with glyoxal, although this
was deemed to be beyond the scope of the present work.
The N5-[2-(dihydroxymethyl)-2H,3aH,4H,6aH-[1,3]dioxolo[5,6-d] imidazolin-5-yl]-L-
ornithine was also formed at the guanidine group of arginine in the acetylated peptide.
It seems necessary to clarify that although a structure is being proposed, no structural
conformation of the compounds has been considered. Therefore, further studies are
required in order to assess the validity of the proposed structure. In any case, these
findings were true for the experiments using both type of reaction solutions, regardless
of the peptide employed
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It is hypothesised that the compound assigned asN5-[2-(dihydroxymethyl) -2H,3aH,4H,6aH-
[1,3]dioxolo[5,6-d] imidazolin-5-yl]-L-ornithine, formed at longer reaction times, might
be the first, product of one molecule of glyoxal dimer reacted with the model peptide.
On the other hand, it could be obtained by the reaction of one molecule of glyoxal with
the modified peptide that contains the dihydroxyimidazoline moiety at the arginine
residue. It is suggested that the second pathway is more likely to occur due to the fact
that the aforementioned compound was not observed at early stages of the glycation
reaction. However, further studies are needed to prove the validity of such a hypothesis.
165
7
Summary of results and ongoing projects
7.1 Summary of results
The glycation reaction of glyoxal with model peptides was studied in this work using
a Fourier transform ion cyclotron resonance mass spectrometer. The model peptides
were reacted with glyoxal under pseudo-physiological (phosphate buffer) and non-
physiological (MeOH/H2O) conditions at two different reaction times as is shown in
table 7.1. The reacted peptides were analysed by mass spectrometry using an FT-ICR-
MS. Interestingly, a variety of products were found in the reaction of glyoxal with
the model peptides. These reaction products were characterised by measuring how
much the mass of the peptide changed compared to its initial mass before reaction
with glyoxal. The increase in mass was, then, assigned as different types of reaction
products 39.9949Da (C2O), 58.0055Da (C2H2O2), 21.9843Da (C2−H2), 116.01092Da
((C2H2O2)2, and crosslinked species (see table 7.1).
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Table 7.1: Summary of the assigned species found in model Peptides reacted with glyoxal
in MeOH/H2O and phosphate buffer.
Peptides Reaction Times Aminoacid residues Type of mass change
MeOH
Phosphate
buffer
N−
terminus
K R C2O C2H2O2 C2−H2 (C2H2O2)2 Cross-linking
Substance
P
21h 6h X X X X X X X X
KM-11 21h 6h X X X X X X X X
AcKM-11 21h 6h X X X X X X X X
EK-15 21h 6h X X X X X X X X
FR-25 21h 6h X X X X X X X X
KM-11 29 days 12h X X X X X X X X
AcKM-11 29 days 12h X X X X X X X X
7.2 Ongoing projects
The glycation reaction with glyoxal was performed in human serum albumin (HSA)
aiming to extend the results found in model peptides. The reaction was carried out in
PBS using the reaction conditions and dialysis, as the purification step, prior to mass
spectrometry analysis. These set of conditions were described in section 3.2.1. However,
the purification procedure caused loss of the glycated HSA. It was thought that this
loss could be caused due to glycated HSA bound to the dialysis membrane. Therefore,
purification by precipitation was also employed as described in section § 4.2.2, but this
caused insolubility of the glycated HSA. Many variations to the glyoxal concentration
and reaction times were employed until it was obtained the direct infusion, top-down,
spectra of glyoxal glycated HSA at a glyoxal concentration of 100nM using precipitation
by MeOH/chloroform prior to MS analysis. The reaction was monitored at 1 hour
(figure 7.1) and ionized with 10mM of ammonium acetate in order to minimise the
complexity of the spectra caused by interference with methanol. 1
It is observed from the spectra at 5 hours of reaction that additional low abundance
1ion/molecule reactions with methanol were reported in section 3.3.
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Native HSA 
reacted 1 hour with glyoxal
[M + 15H]15+
Top-down spectra 
Mass ~ 66,965 Da
Native HSA 
reacted 5 hour with glyoxal
Top-down spectra 
4300 4400 4500 4600 4700 4800 m/z
4700 m/z4900 5100 5300 55004300 4500
Figure 7.1: Top-down direct infusion spectrum of glyoxal glycated HSA.
glycated products are formed (see figure 7.1). It is noteworthy that the complexity of
the spectra of the glycated HSA at longer reaction times likely depends on the number
of lysine and arginine residues available for glycation and the number of possible
modifications that can be formed with glyoxal. In a simplistic assumption and only
considering that the location of the elements does matter and that any combination can
be possible, even allowing repetition, the total number of possible permutations can be
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calculated as in equation (7.1),
T =
kmax∑
k=1
nk (7.1)
where n is the number of possible modifications observed with glyoxal, k is the number
of residues to glycate, and kmax is the maximum number of residues to glycate. For
instance, assuming that the maximum number of possible residues to glycate in a protein
is four, and that the total number of possible modifications is five, then the total number
of possible permutations is
T =
4∑
k=1
(5)k = 780 (7.2)
The application of fragmentation by ECD and CAD did not yield any useful structural
information. Thus, it was decided to use the bottom-up approach presented in § 1.6,
but, so far, it was not possible to identify any glycated peptide in the spectrum because
of the probable low abundance of the glycated species in the direct infusion spectrum.
Other approaches prior mass spectrometry analysis were considered, such as fraction
collection using a high performance liquid chromatography (HPLC).
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8
Conclusions and future work
8.1 Conclusions
An ultra-high performance Fourier transform ion cyclotron resonance mass spectrometer
was used to characterize glyoxal modifications on model peptides. High confidence in
the assignments was obtained due to the high resolution and mass accuracy achieved
with the mass spectrometer. The experimental methods were established in chapter 3
using substance P as a model.
Reproducibility of the results was tested with other model peptides and was shown
in chapter 4, and the appearance of a new type of modification was analysed and
discussed in chapter 5. Finally, a variation on the experimental method was introduced
by changing the reaction time and the results were discussed in chapter 6. Chapter 7
summarised the results and addresses the challenges of glyoxal modifications in proteins.
The glyoxal reaction products that showed a mass change of 39.9949Da (C2O), 58.0055Da
(C2H2O2), 21.9843Da (C2−H2), and 116.01092Da ((C2H2O2)2) were subjected to DR-
ECD and CAD fragmentation in order to identify the location of the modification. As is
observed in table 7.1 only arginine residues were modified at 21 hours of reaction in
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MeOH/H2O and 6 hours of reaction in PBS. At longer reaction times other basic residues
are modified by glyoxal, producing crosslinked species.
Some chemical structures were proposed, such as the hydroxyimidazoline, dihydrox-
yimidazoline were previously reported in the literature. However, a new glyoxal-
derived species referred here to as 2-imino-imidazole was formed at the guanidine
group of the arginine residue. Interestingly, the compound N5-[2-(dihydroxymethyl)
-2H,3aH,4H,6aH -[1,3]dioxolo[5,6-d] imidazolin-5-yl]-L-ornithine is also formed at the
guanidino group of arginine at longer reaction times. It is noteworthy that although
a structure is being proposed, no structural conformation has been considered. It is
clear, then, that a further study on the possible isomers is required, in order to asses the
validity of the proposed structures.
A characteristic loss of water from every modified c†n c
‡
n, and c
∗
n fragment ion was
observed. Thus, it is proposed that the electron is captured at the modification site and
subsequently a water loss is generated in addition to the typical fragmentation pattern of
the peptide at the backbone N-Cα bond. It is important to highlight that the water loss
from the modified fragment ions was a permanent characteristic in all DR-ECD spectra.
In fact, such a result turned out to be fully consistent with the hypothesis proposed in
§ 3.3.2, and illustrated in the proposed reaction mechanism of the scheme 3.2.
From the results presented in chapter 3 it is clear that care must be taken when this
reaction is executed in methanol, due to the appearance of ion molecule reactions with
the solvent. Also, care must be taken when sodium is present in the reaction solution
due to the formation of two species with the same that can overshadow the presence of
the glyoxal modification (C2−H2) if the mass spectrometer used for detection can not
achieve the resolution to separate mass differences below 2.4mDa.
The location and type of mass additions, such as C2O, C2H2O2, (C2−H2), and (C2H2O2)2
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remained unaffected regardless of the reaction solution employed (MeOH/H2O or PBS).
Equally, the type of mass addition and the modification site was not altered C2O, C2H2O2
by changes in the purification procedures. For instance, whereas in the tests defined in
chapter 3 dialysis was used as purification method, in the tests target of the chapter 4 the
purification was performed by precipitation with MeOH/Chloroform. This factor did not
affect the final outcome, in terms of binding site assignment and types of mass additions,
indicating that the presence and location of the modifications were not sensitive to this
particular change.
It seems clear from the results of the C−terminus amidated model peptides presented
in chapters 3 to 5 that there was no involvement of the C-terminus amide group in the
reaction with glyoxal at any reaction condition employed in this work.
The results presented in chapter 6 strongly suggest that the N-terminus and the lysine
residue form a crosslinked species with glyoxal. This species is formed at longer reaction
times where arginine glycation was also observed. Blockage of the N−terminus strongly
indicate that lysine residue is crosslinked with other amino acid residues (glutamine)
within the peptide. However, studies varying systematically the relative position of the
lysine and the glutamine need to be carried out in the future in order to extent these
results to another samples.
The current research has defined some of the fundamental chemistry involved in glyoxal
binding to peptides. Nevertheless, it seems, then, that a better understanding of the
glycation reaction by the α-dicarbonyl compound glyoxal can be obtained from analysing
the results in small peptides, as discussed in previous chapters. This study represents a
step in understanding the different glyoxal-derived AGEs formed at different reaction
conditions and sample preparation procedures. In order to extend this research into
analysis of clinical samples, additional understanding of competitive binding between
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the amino acid residues and between peptides in complex biological samples will be
needed. Moreover, understanding the implication of changes in sample purification of
complex biological samples in the glycation results is also needed, thus protein glycation
in the medical sphere can be fully understood.
8.2 Future work
An interesting observation from chapter 3 was the presence of the species with the
mass addition of C2−H2 (21.98436Da). This species was present in peptides containing
15 and 25 amino acids and at least four amino acid residues available for glycation.
However, this mass addition (C2−H2), was absent in the undecapeptides substance P,
KM-11 and AcKM-11, which contained two residues available for glyoxal glycation. It is
suggested here that the presence of this modification might be dependant on both the
size of the peptide and the number of basic residues present in the peptide. In order
to further prove this hypothesis, studies where the size and the number of lysine and
arginine residues are systematically varied within the peptide are necessary.
It would be interesting to check the binding site of the modified species observed
in figure 5.1 and figure 6.1, such as the C4O2, C4H2O3, (figure 5.1) and C4H2O3,
2 (C2H2O2) + H2O, 3 (C2H2O2) + H2O, and 4 (C2H2O2) + H2O (figure 6.1).
The compound assigned asN5-[2-(dihydroxymethyl) -2H,3aH,4H,6aH -[1,3]dioxolo[5,6-
d] imidazolin-5-yl] -L-ornithine chapter 6, observed at longer reaction times, might
be formed by either the direct reaction of one molecule of glyoxal dimer or by the
reaction of one molecule of glyoxal with the modified peptide that contains the dihy-
droxyimidazoline moiety at the arginine residue. It is believed that the compound N5-
[2-(dihydroxymethyl)-2H,3aH,4H,6aH -[1,3]dioxolo[5,6-d] imidazolin-5-yl]-L-ornithine
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is not derived from the direct addition of the glyoxal dimer species. This hypothesis is
based in the fact that direct addition of glyoxal was not observed at early stages of the
glycation reaction. However, further studies are needed to prove the validity of such a
hypothesis.
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Mass Error tables with assignments used to interpret
the data of Chapter 3
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 A-2 
Table A-1.  ECD mass error analysis for the parent ion [M+C2O+2H]2+ of the glyoxal-derived glycation 
product formed at amidated Substance P in MeOH:H2O (50:50). * indicates mass to charge used for 
calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
496.33541  *  496.33516 c4 -0.494 
517.31194  517.31171 c†4•-H2O -0.435 
523.27891  523.27876 z5•-C3H6S -0.285 
535.32250  535.32235 c†4• -0.280 
536.33033    536.33021 c†4 -0.214 
547.79441  547.79402 y92+ -0.703 
552.30906  *  552.30894 c92+ -0.222 
580.27139  580.27142 z7•-NH3 0.060 
 592.30739 ?  
608.85110  608.85170 [c10+H]2+ 0.994 
624.39399  *  624.39398 c5 -0.008 
645.37051  645.37048 c†5•-H2O -0.046 
646.37834  646.37840 c†5 - H2O 0.101 
663.38108  663.38113 c†5• 0.083 
664.38890    664.38899 c†5 0.135 
666.36225  666.36208 [c11 -NH3]2+ -0.255 
674.37134  674.37147 [M+2H]2+ 0.200 
694.36879  694.36895 [M† +2H]2+ 0.227 
751.44529  751.44476 c6• -0.699 
752.45257  *  752.45277 c6 0.272 
774.43692  774.43710 c†6 - H2O 0.239 
791.43966  791.43980 c†6• 0.183 
792.44748  792.44768 c†6 0.252 
895.50172  895.50140 a†7 -0.352 
898.51315  898.51426 c7• 1.235 
899.52098  899.52122 c7 0.272 
921.50533  921.50541 c†7-H2O 0.092 
938.50807  938.50794 c†7• -0.133 
939.51589  939.51609 c† 7 0.213 
1004.54379  1004.54407 z9•  - C3H6S 0.279 
1042.57013  1042.57076 a†8 0.609 
1046.58939  *  1046.58938 c8 -0.005 
1068.57374  1068.57364 c†8- H2O -0.089 
1078.56281  1078.56266 z9• -0.139 
1086.58430  1086.58434 c†8 0.037 
 A-3 
THEORICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
1103.61085  1103.61070 c9 -0.131 
1125.59520  1125.59490 c†9 - H2O -0.262 
1143.60576  1143.60568 c†9 -0.070 
1216.69491  *  1216.69447 c10 -0.358 
  1220.63633 ?   
1238.67926  1238.67898 c†10 - H2O -0.222 
1256.68982  1256.68935 c†10 -0.374 
1314.71856  1314.71841 [M†-C3H6S + 2H]1+· -0.117 
  1317.66500 ?   
 1330.70640 ?  
1343.71723  1343.71585 [M† -•CONH2+H]1+ -1.023 
1370.72757  *  1370.72705 [M† -H2O+2H]1+• -0.095 
1387.73031  *  1387.72973 [M† +H]1+ -0.418 
mean -0.159  
St. Dv. 0.376 
 
TableA-2.  DR(674)-ECD(694) mass error analysis for the parent ion [M+C2O+2H]2+of the glyoxal-
derived glycation product formed at amidated Substance P in MeOH:H2O (50:50). * indicates mass to 
charge used for calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL      
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
271.18769  *  271.18766 c2 -0.092 
  415.21121 ?   
  437.19323 ?   
496.33541  *  496.33524 c4 -0.332 
517.31194  517.31186 c†4•-H2O -0.145 
518.31976  518.31966 c†4-H2O -0.193 
535.32250  535.32242 c†4• -0.149 
536.33033  *  536.33025 c†4 -0.140 
547.79441  547.79428 y92+ -0.228 
552.30906  552.30904 c92+ -0.041 
 581.31180 ?  
 592.30762 ?   
608.85110  608.85114 [c10+H]2+ 0.074 
620.37473  620.37519 a†5 0.750 
624.39399  *  624.39408 c5 0.152 
645.37051  645.37047 c†5•-H2O -0.062 
 A-4 
THEORICAL 
(m/z) 
EXPERIMENTAL      
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
646.37834  646.37827 c†5 - H2O -0.101 
663.38108  663.38102 c†5• -0.083 
664.38890    664.38883 c†5 -0.105 
666.36225  666.36202 [c11 –NH3]2+ -0.345 
694.36879    694.36868 [M†+2H]2+ -0.162 
752.45257  *  752.45297 c6 0.538 
773.42909  773.42938 c†6•-H2O 0.375 
774.43692  774.43706 c†6 - H2O 0.187 
791.43966  791.43992 c†6• 0.335 
792.44748    792.44779 c†6 0.391 
895.50172  895.50257 a†7 0.955 
 899.52125 ?   
921.50533  921.50548 c†7-H2O 0.168 
  937.73782 ?   
938.50807  938.50838 c†7• 0.336 
939.51589    939.51617 c†7 0.298 
  965.76939 ?   
1004.54379  1004.54393 z9•  -C3H6S 0.139 
  1007.52553 ?   
1042.57013  1042.57037 a†8 0.235 
1068.57374  1068.57383 c†8- H2O 0.089 
1078.56281  *  1078.56286 z9• 0.046 
1086.58430    1086.58443 c†8 0.120 
1125.59520  1125.59538 c†9 - H2O 0.164 
1143.60576    1143.60570 c†9 -0.052 
 1220.63681 ?  
1238.67926  1238.67902 c†10 - H2O -0.190 
1256.68982    1256.68941 c†10 -0.326 
1296.70855  1296.70848 [M†- C3H6S - H2O + 2H]1+• -0.053 
1314.71856  1314.71881 [M†- C3H6S + 2H]1+• 0.187 
  1317.66460 ?   
1330.70885  1330.70905 [M-NH3 + H]1+ 0.150 
1343.71723  1343.71645 [M†-•CONH2+H]1+ 0.577 
1353.70158  1353.70171 [M†- H2O - NH3 +2H]1+• 0.100 
1370.72702  *  1370.72689 [M†-H2O+2H]1+• -0.095 
1387.73031  *  1387.72956 [M†+H]1+ -0.540 
 mean -0.101 
 A-5 
THEORICAL 
(m/z) 
EXPERIMENTAL      
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
St. Dv. 0.291 
 
Table A-3.  DR(674)-ECD(703) mass error analysis for the parent ion [M+C2H2O2+2H]2+of the 
glyoxal-derived glycation product formed at amidated Substance P MeOH:H2O (50:50). * indicates 
mass to charge used for calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
 332.11950 *  
 341.30578 *  
 344.13180 ?  
 345.11579 *  
 360.15078 ?  
 365.10062 *  
 373.11070 *  
 381.29765 *  
 390.12496 *  
496.33541 *  496.33537 c4 -0.071 
517.31193  517.31201 c‡4•-2H2O 0.155 
518.31976  518.31967 c‡4-2H2O -0.164 
535.32250 535.32250 c‡4•−Η2Ο 0.000 
553.33306 553.33309 c‡4• 0.054 
554.34089 554.34071 c‡4 -0.316 
624.39399 *  624.39413 c5 0.232 
646.37834  646.37814 c‡5-2H2O -0.302 
663.38108 663.38135 c‡5·−Η2Ο 0.415 
681.39164 681.39129 c‡5• -0.514 
682.39947 682.39946 c‡5 -0.007 
703.37408 703.37370 [M‡ +2H]2+ -0.540 
752.45257 752.45272 c6 0.206 
774.43692  774.43684 c‡6-2H2O -0.097 
791.43966 791.43965 c‡6•−Η2Ο -0.006 
792.44748 792.44775 c‡6−Η2Ο 0.341 
809.45022 809.45032 c‡6• 0.124 
810.45805 810.45794 c‡6 -0.130 
899.52098 *  899.52069 c7 -0.317 
913.51228 913.51332 a‡7 1.138 
921.50533  921.50509 c‡7-2H2O -0.255 
939.51589 939.51554 c‡7−Η2Ο -0.373 
 A-6 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
957.52646 957.52654 c‡7 0.089 
1004.54379 1004.54366 z9•  - C3H6S -0.129 
 1007.52567 ?  
1046.58939 *  1046.58936 c8 -0.024 
1060.58069  1060.58078 a‡8 0.085 
1078.56281 1078.56252 z9• -0.269 
1086.58430 1086.58425 c‡8−Η2Ο -0.046 
1104.59487 1104.59477 c‡8 -0.086 
1103.61085 *  1103.61052 c9 -0.294 
1125.59519 1125.59518 c‡9-2H2O -0.013 
1143.60576 1143.60539 c‡9 - H2O -0.324 
1161.61633 1161.61603 c‡9 -0.254 
1216.69491 *  1216.69447 c10 -0.358 
1238.67926  1238.68000 c‡10 - 2H2O 0.601 
1256.68982 1256.68903 c‡10 - H2O -0.629 
1274.70039   1274.70014 c‡10 -0.192 
1331.71668 1331.71657 [M-NH3+2H] 1+• -0.079 
1343.71668 1343.71707 [M‡ -•CONH2-H2O+H]1+ 0.294 
1347.73540 1347.73507 [M+H]1+ -0.241 
1348.74377 1348.74359 [M+2H]1+• -0.133 
1361.72724 1361.72718 [M‡ -•CONH2+H]1+ -0.044 
1370.72757 1370.72699 [M‡ -2H2O+2H]1+• -0.423 
1371.71214 1371.71144 [M‡ -H2O-NH3+2H]1+• -0.510 
1388.73814 *  1388.73808 [M‡ -H2O+2H]1+• -0.997 
1405.74088 *  1405.74033 [M‡ +H]1+ -0.388 
Mean -0.342  
St.Dv. 0.044 
 
Table A-4.  IRMPD-ECD mass error analysis for the parent ion [M+C2O+2H]2+ of the glyoxal-derived 
glycation product formed at amidated Substance P in MeOH:H2O (50:50). * indicates mass to charge 
used for calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL 
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
496.33541  *  496.33519 c4 0.433 
517.31194  517.31171 c†4•-H2O 0.435 
518.31976    518.31955 c†4-H2O 0.405 
535.32250  535.32234 c†4• 0.299 
536.33033  536.33019 c†4 0.252 
 A-7 
THEORICAL 
(m/z) 
EXPERIMENTAL 
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
547.79441  547.79422 y92+ 0.338 
552.30906  552.30895 [c9+H]2+ 0.204 
 581.31180 *   
 592.30762 *   
 593.31090 *   
600.33809  600.33767 [b10+H]2+ -0.704 
608.85110  608.85110 [c10+H]2+ -0.008 
624.39399  *  624.39402 c5 -0.056 
645.37051    645.37048 c†5•-H2O 0.046 
646.37834  646.37835 c†5 - H2O -0.023 
663.38108  663.38114 c†5• -0.098 
664.38890  664.38898 c†5 -0.120 
674.37134  *  674.37140 [M + 2H]2+ -0.096 
694.36879   694.36886 [M† + 2H]2+ -0.097 
752.45257  *  752.45297 c6 -0.538 
773.42909  773.42938 c†6•-H2O -0.375 
774.43692    774.43706 c†6 - H2O -0.187 
791.43966  791.43992 c†6• -0.335 
792.44748  792.44779 c†6 -0.391 
895.50172  895.50257 a†7 -0.955 
 899.52125 ?   
921.50533    921.50548 c†7-H2O -0.168 
  937.73782 ?   
938.50807  938.50838 c†7• -0.336 
939.51589  939.51617 c†7 -0.298 
  965.76939 ?   
1004.54379  1004.54393 z9•  - C3H6S -0.139 
  1007.52553 ?   
1042.57013  1042.57037 a†8 -0.235 
1068.57374    1068.57383 c†8- H2O -0.089 
1078.56281  1078.56286 z9• -0.046 
1086.58430  1086.58443 c†8 -0.120 
1103.61085  *  1103.61126 c9 -0.376 
1125.59520    1125.59538 c†9 - H2O -0.164 
1143.60576  1143.60570 c†9 0.052 
 1220.63681 ?   
1238.67926    1238.67902 c†10 - H2O 0.190 
1256.68982  1256.68941 c†10 0.326 
 A-8 
THEORICAL 
(m/z) 
EXPERIMENTAL 
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
1296.70800  1296.70758 [M† - C3H6S- H2O + 2H]1+• 0.323 
  1309.71461 ?   
  1312.69702 ?   
1314.71911  1314.71916 [M† -C3H6S + 2H]1+• -0.035 
  1317.66527 ?   
1330.70885  1330.70824 [M-C2O-NH3 + H]1+ -0.458 
1343.71668  1343.71599 [M† -•CONH2+H]1+ -0.510 
1353.70103  1353.70029 [M† -H2O - NH3 +2H]1+• -0.543 
1369.71975  *  1369.71826 [M† -H2O +H]1+ -1.084 
1370.72702  1370.72679 [M† -H2O +2H]1+• -0.569 
1387.73031  *  1387.72936 [M† + H]1+ 0.685 
mean -0.063  
St. Dv. 0.318 
 
Table A-5.  CAD mass error analysis for the parent ion [M+C2O+2H]2+ of the glyoxal-derived glycation 
product formed at amidated Substance P in MeOH:H2O (50:50). * indicates mass to charge used for 
calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
254.16114  *  254.16114 b2 0.000 
262.15837  262.15836 y2 0.038 
 267.14918 *   
276.14549    276.14549 b†2  -H2O 0.000 
294.15606  294.15606 b†2 -0.017 
  295.14410 *   
302.15329  302.15328 y3-NH3 0.083 
 307.14409 *   
 313.27371 *   
  318.18122 *   
319.17983  *  319.17984 y3 -0.031 
 335.09487 *   
 350.25776 ?   
  352.16557 ?   
  354.17720 *   
 363.08979 *   
 364.27341 ?   
379.20883    379.20883 [b†6-H2O+H]2+ -0.013 
404.24045  404.24048 b†3  -H2O -0.074 
 420.22819 ?   
422.25102  422.25108 b†3 -0.154 
 A-9 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
449.22170  449.22171 y4-NH3 -0.033 
452.74303    452.74306 [b†7-H2O+H]2+ -0.066 
 457.75353 ?   
 463.19762 ?   
 464.26161 ?   
466.24824  *  466.24828 y4 -0.086 
 471.75089 ?   
  478.76038 ?   
  486.77435 ?   
  490.26110 *   
  495.99993 *   
501.29321  501.29329 b†4 -H2O -0.160 
503.76651  503.76657 [a†8-H2O-NH3+H]2+ -0.129 
509.25096  509.25076 [b†8-H2O-2NH3+H]2+ 0.398 
512.28005  512.27980 [a†8-H2O+H]2+ 0.488 
515.28533  *  515.28511 [b8+H]2+ 0.432 
517.27223  517.27200 [b†8-2H2O+H]2+ 0.435 
526.27751  526.27728 [b9-H2O-NH3+H]2+ 0.432 
528.79078  528.79054 [a9+H]2+ 0.454 
  532.27741 ?   
540.79078  540.79066 [a†9-H2O+H]2+ -0.222 
543.79606  *  543.79585 [b9+H]2+ 0.391 
545.78296    545.78272 [b†9-2H2O+H]2+ 0.431 
  548.28678 ?  
  552.29463 *   
554.78824  554.78802 [b†9-H2O+H]2+ 0.392 
563.79325  563.79323 [b†9+H]2+ 0.031 
  565.28260 ?   
  573.79584 ?   
  574.29751 ?   
  576.28170 ?   
  581.80894 ?   
582.81954  582.81937 [b10-H2O-NH3+H]2+ 0.287 
586.34064 586.34061 [a10+H]2+ 0.043 
  591.79757 ?   
593.31970   593.31944 [b†10-3H2O+H]2+ 0.442 
596.29011  596.29016 y5-NH3 -0.092 
  597.33260 ?   
600.33809  600.33789 [b10+H]2+ 0.337 
601.35688 601.35697 a†5  -H2O   
602.32499  602.32477 [b†10-2H2O+H]2+ 0.357 
613.31665  *  613.31669  y5 -0.065 
 A-10 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
611.33000    611.33004 [b†10-H2O+H]2+ -0.074 
620.33528  620.33530 [b†10+H]2+ -0.036 
629.35179  629.35185 b†5  -H2O -0.095 
  638.85116 ?   
645.33423    645.33428 [M† -2H2O-2NH3-CO+2H]2+ -0.085 
  647.37838 ?   
647.36236 647.36246 b†5 -0.162 
  650.81852 ?   
  652.84863 ?   
659.33168 659.33175 [M† -2H2O-2NH3+2H]2+ -0.102 
662.85278 662.85286 [M† -H2O-NH3-CO+2H]2+ -0.121 
667.84496 667.84502 [M† -2H2O-NH3+2H]2+ -0.097 
674.37134 *  674.37141 [M+2H]2+ -0.111 
676.85024 676.85028 [M† -H2O-NH3+2H]2+ -0.063 
685.36351   685.36352 [M† -H2O+2H]2+ -0.015 
694.36879 694.36879 [M† +2H]2+ 0.004 
724.34869  724.34877 y6-NH3 -0.117 
729.41546  729.41542 a†6 -H2O   
735.42602  735.42606 b6 -0.054 
740.38383  740.38385 b†6 -H2O-NH3 -0.034 
741.37523  *  741.37526 y6 -0.040 
757.41037    757.41042 b†6 -H2O -0.066 
775.42094  775.42103 b†6 -0.123 
  783.38257 ?   
  790.42468 ?   
  809.40945 ?   
  816.48387 ?   
  823.46141 ?   
  852.45496 ?   
876.48387  876.48394 a†7 -H2O -0.080 
904.47878    904.47886 b†7 -H2O -0.088 
922.48935  922.48932 b†7 0.027 
932.43348  932.43352  y8-2NH3 -0.043 
  946.52577  ?   
949.46003  949.46007 y8-NH3 -0.047 
  956.51364 ?   
966.48657  966.48662 y8 -0.052 
  979.51495 ?   
  1023.55283 ?   
 1024.56011  a†8  -H2O   
 A-11 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
1029.56284  *  1029.56300 b8 -0.155 
 1048.57284  ?   
1051.54719    1051.54727 b†8  -H2O -0.076 
  1058.55631 ?   
1069.55776  1069.55816 b†8 -0.379 
  1091.54236 ?   
1108.56865    1108.56874 b†9  -H2O -0.081 
  1110.55330 ?   
1126.57922  1126.57954 b†9 -0.288 
  1146.58441 ?   
 1160.60403 ?   
 1179.61365 ?  
1193.65780  1193.65816 a†10  -H2O 0.306 
1203.64215  *  1203.64255 b†10  -2H2O -0.336 
  1205.62483 ?   
1221.65271  1221.65276 b†10  -H2O -0.041 
1239.66328  *  1239.66335 b†10 -0.061 
Mean 0.016  
St.Dv. 0.0263 
 
Table A-6.  CAD mass error analysis for the parent ion [M+C2H2O2+2H]2+ of the glyoxal-derived 
glycation product formed at amidated Substance P in MeOH:H2O (50:50). * indicates mass to charge 
used for calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
 200.77000 *  
 203.77743 *  
 226.11859 *  
 228.45627 *  
254.16114 *  254.16115 b2 0.039 
294.15606   294.15607 b‡2 0.051 
 341.30505 *  
 350.25776 ?  
 352.16557 *  
 354.17720 *  
 363.08979 *  
 364.27341 ?  
 371.20376 *  
 373.22342 *  
379.20883 379.20883 [b‡6-H2O+H]2+ 0.013 
382.25610 *  382.25610 b3 0.000 
404.24045 404.24035 b‡3  -H2O -0.247 
449.22170 449.22167 y4-NH3 -0.056 
 501.24555 ∗  
 A-12 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
515.28533 515.28503 [b8+H]2+ -0.587 
543.79606 543.79585 [b9+H]2+ -0.391 
563.79325 563.79322 [b‡9+H]2+ -0.049 
582.81954 582.81937 [b10-H2O-NH3+H]2+ -0.287 
586.34037 586.34035 [a10+H]2+ -0.026 
591.33281 591.33251 [b10-H2O+2H]2+ -0.507 
600.33809 *  600.33780 [b10+H]2+ -0.487 
607.36744 607.36742 b5 -0.033 
 609.31598 *  
611.33000   611.32990 [b‡10-H2O+H]2+ -0.155 
 614.83660 *  
 619.34566 *  
620.33528 620.33525 [b‡10+H]2+ -0.044 
 627.85892 *  
647.36236   647.36242 b‡5 0.100 
643.34733 643.34726 [M-2NH3-CO+2H]2+ -0.113 
648.33951 648.33946 [M-2NH3-H2O+2H]2+ -0.073 
651.86061 651.86060 [M-NH3-CO+2H]2+ -0.008 
656.85278 656.85278 [M-NH3-H2O+2H]2+ 0.000 
665.85806 *  665.85805 [M-NH3+2H]2+ -0.019 
674.37134 674.37141 [M+2H]2+ 0.111 
735.42602 735.42599 b6 -0.041 
775.42094 775.42108 b‡6 -0.187 
882.49443 *  882.49440 b7 0.034 
922.48935 922.48882 b‡7 -0.567 
932.43348 932.43406 y8-2NH3 0.622 
 946.51477 ?  
949.46003 949.46007 y8-NH3 0.047 
966.48657 966.48633 y8 -0.248 
1029.56284 1029.56298 b8 0.136 
 1036.57201 ?  
1051.54719   1051.54727 b‡8  -H2O 0.076 
 1058.55631 *  
1069.55776 1069.55794 b‡8 0.173 
1077.55499 1077.55504 y9-NH3 -0.051 
1086.58430 *  1086.58440 b9 -0.092 
1094.58153 1094.58162 y9 0.082 
 1103.58215 ?  
 1105.59774 ?  
1126.57922   1126.57896 b‡9 -0.226 
1171.67345 1171.67346 a10 -0.013 
 A-13 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
1191.63429 1191.63551 y10 -1.024 
1199.66836 1199.66854 b10 -0.150 
 1205.62483 ?  
1221.65271 *  1221.65332 b‡10  -H2O 0.499 
1239.66328 *  1239.66351 b‡10 0.190 
Mean -0.086 
 St.Dv. 0.036 
 
Table A-7.  DR(674.86)-ECD(694.86) mass error analysis of the parent ion [M + C2O + 2H]2+ of 
glyoxal-derived glycation product formed at free acid form of Substance P in MeOH:H2O (50:50).          
* indicates mass to charge used for calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL      
(m/z) ASSIGNMENTS 
ERROR 
(pppm) 
496.33541  *  496.33536 c4 -0.091 
517.31194  517.31208 c†4•-H2O 0.280 
518.31976  518.31990 c†4-H2O 0.270 
535.32250  535.32242 c†4• -0.149 
536.33033    536.33025 c†4 -0.140 
  592.30759 *   
  593.31113 *   
  602.64730 *   
  603.37268 *   
624.39399  *  624.39408 c5 0.152 
645.37051  645.37047 c†5•-H2O -0.062 
646.37834  646.37827 c†5 - H2O -0.101 
663.38108  663.38102 c†5• -0.083 
664.38890    664.38883 c†5 -0.105 
  682.39944 ?   
694.86081  694.86069 [M† +2H]2+ -0.169 
  727.53949 ?   
748.43385  748.43363 a†6 -0.294 
773.42909  773.42901 c†6•-H2O -0.103 
774.43692  774.43684 c†6 - H2O -0.097 
791.43966  791.43945 c†6• -0.259 
792.44748    792.44733 c†6 -0.189 
895.50226  895.50203 a†7 -0.257 
921.50533  921.50519 c†7-H2O -0.146 
  937.73767 ?   
938.50807    938.50808 c†7• 0.016 
 A-14 
THEORICAL 
(m/z) 
EXPERIMENTAL      
(m/z) ASSIGNMENTS 
ERROR 
(pppm) 
939.51589  939.51570 c†7 -0.202 
  965.76895 ?   
  1008.50933 ?   
1042.57013  1042.57077 a†8 0.619 
1068.57374  1068.57369 c†8- H2O -0.042 
1079.54683  *  1079.54661 z9• -0.204 
1086.58430    1086.58419 c†8 -0.101 
  1117.49388 ?   
1125.59520  1125.59525 c†9 - H2O 0.049 
1143.60577    1143.60564 c†9 -0.109 
  1212.67607 ?   
 1221.62094 ?   
1238.67926  1238.67917 c†10 - H2O -0.073 
1256.68983    1256.68985 c†10 0.020 
1297.69257  1297.69335 [M† -C3H6S - H2O + 2H]1+• 0.602 
 1300.67469 ?   
1315.70313  1315.70315 [M† -C3H6S + 2H]1+• 0.012 
 1318.64933 ?   
1326.69013  1326.68999 [M† - H2O -•CONH2+H]1+ -0.106 
1331.69342  1331.69369 [M-C2O-NH3 + H]1+ 0.203 
1343.71613  1343.71648 [M† -•COOH + H]1+ 0.264 
1344.70125 1344.70070 [M† -•CONH2+2H]1+ 0.405 
1354.68505  1354.68501 [M† -H2O-NH3 +2H]1+• -0.026 
1361.72724  1361.72774 [M† -CO+2H]1+• 0.367 
1371.71159  *  1371.71173 [M† -H2O+2H]1+• 0.102 
  1387.67436 ?   
1388.71488  *  1388.71470 [M† +H]1+ -0.130 
1389.72161  1389.72151 [M† +2H]1+• -0.068 
mean -0.048  
St. Dv. 0.260 
 
Table A-8  DR(674)-ECD(703) mass error analysis of amidated, glycated Substance P MeOH:H2O 
(50:50), for the parent ion [M + C2H2O2 + 2H]2+. * indicates mass to charge used for calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
 332.11950 *  
 341.30578 *  
 344.13180 ?  
 A-15 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
 345.11579 *  
 360.15078 ?  
 365.10062 *  
 373.11070 *  
 381.29765 *  
 390.12496 *  
496.33541 *  496.33537 c4 -0.071 
517.31193    517.31201 c‡4•-2H2O 0.155 
518.31976  518.31967 c‡4-2H2O -0.164 
535.32250   535.32250 c‡4•−Η2Ο 0.000 
553.33306 553.33309 c‡4• 0.054 
554.34089   554.34071 c‡4 -0.316 
624.39399 *  624.39413 c5 0.232 
646.37834  646.37814 c‡5-2H2O -0.302 
663.38108 663.38135 c‡5•−Η2Ο 0.415 
681.39164 681.39129 c‡5• -0.514 
682.39947   682.39946 c‡5 -0.007 
703.37408 703.37370 [M‡ + 2H]2+ -0.540 
752.45257 *  752.45272 c6 0.206 
774.43692  774.43684 c‡6-2H2O -0.097 
791.43966 791.43965 c‡6·−Η2Ο -0.006 
792.44748 792.44775 c‡6−Η2Ο 0.341 
809.45022 809.45032 c‡6· 0.124 
810.45805 *  810.45794 c‡6 -0.130 
899.52098 *  899.52069 c7 -0.317 
913.51228 913.51332 a‡7 1.138 
921.50533    921.50509 c‡7-2H2O -0.255 
939.51589 939.51554 c‡7−Η2Ο -0.373 
957.52646   957.52654 c‡7 0.089 
1004.54379 1004.54366 z9•  - C3H6S -0.129 
 1007.52567 ?  
1046.58939 1046.58936 c8 -0.024 
1060.58069  1060.58078 a‡8 0.085 
1078.56281 1078.56252 z9• -0.269 
1086.58430   1086.58425 c‡8−Η2Ο -0.046 
1104.59487   1104.59477 c‡8 -0.086 
1103.61085 *  1103.61052 c9 -0.294 
 A-16 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
1125.59519  1125.59518 c‡9-2H2O -0.013 
1143.60576   1143.60539 c‡9 - H2O -0.324 
1161.61633   1161.61603 c‡9 -0.254 
1216.69491 *  1216.69447 c10 -0.358 
1238.67926  1238.68000 c‡10 - 2H2O 0.601 
1256.68982   1256.68903 c‡10 - H2O -0.629 
1274.70039   1274.70014 c‡10 -0.192 
1331.71668 1331.71657 [M-NH3+2H]1+• -0.079 
1343.71668 1343.71707 [M‡ -•CONH2-H2O+H]1+ 0.294 
1347.73540 1347.73507 [M+H]1+ -0.241 
1348.74377 1348.74359 [M+2H]1+• -0.133 
1361.72724 1361.72718 [M‡ -•CONH2+H]1+ -0.044 
1370.72757 1370.72699 [M‡ -2H2O+2H]1+• -0.423 
1371.71214 1371.71144 [M‡ -H2O-NH3+2H]1+• -0.510 
1388.73814 *  1388.73808 [M‡ -H2O+2H]1+• -0.997 
1405.74088 *  1405.74033 [M‡ +H]1+ -0.388 
Mean -0.342  
St.Dv. 0.044 
 
Table A-9.  CAD mass error analysis for the parent ion [M+C2O+2H]2+of glyoxal-derived glycation 
product formed at free acid form of Substance P in MeOH:H2O (50:50). * indicates mass to charge used 
for calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
254.16114  *  254.16112 b2 -0.079 
276.14549  *  276.14548 b†2  -H2O -0.036 
294.15606  *  294.15605 b†2 -0.017 
 307.14409 *   
 313.27372 *   
 318.18121 *   
320.1644 *  320.16387 y3 -1.655 
 338.34175 *   
 341.30505 *   
 354.17722 ?   
 363.08981 ?   
379.20883 379.20887 [b6-H2O+H]2+ 0.119 
404.24045 404.24051 b†3  -H2O 0.148 
422.25102    422.25109 b†3 0.178 
452.74303  452.74311 [b†6-H2O+H]2+ 0.177 
 463.19768 ?   
 A-17 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
467.23281 *  467.23235 y4 -0.985 
 486.77435 ?   
 490.26117 ?   
  495.99993 ?   
501.29321    501.29333 b†4 -H2O 0.239 
503.76651  503.76660 [a†8-H2O-NH3+H]2+ 0.189 
 506.77184 ?   
509.25096  509.25077 [b†8-H2O-2NH3+H]2+ -0.378 
512.28005  512.27987 [a†8-H2O+H]2+ -0.351 
515.28533  515.28511 [b8+H]2+ -0.432 
517.27223  *  517.27205 [b†8-2H2O+H]2+ -0.338 
 524.79013 ?   
526.27751  526.27734 [b9-H2O-NH3+H]2+ -0.318 
 533.30332 ?   
535.28252 535.28280  [b†8+H]2+ 0.528 
 537.79591 ?   
540.79078  540.79059 [a†9-H2O+H]2+ -0.351 
543.79606  543.79588 [b9+H]2+ -0.336 
545.78296  545.78281 [b†9-2H2O+H]2+ -0.266 
548.28669 *  548.28686 [y8+H]2+ 0.310 
 548.28678 ?   
554.78824    554.78809 [b†9-H2O+H]2+ -0.266 
 560.30865 ?   
563.79325  563.79336 [b†9+H]2+ 0.200 
 574.34614 ?   
577.82736  577.82699 [a10-NH3+H]2+ -0.645 
582.81954  582.81936 [b10-H2O-NH3+H]2+ -0.305 
586.34064 586.34045 [a10+H]2+ -0.316 
593.31970   593.31946 [b†10-3H2O+H]2+ -0.409 
596.29066 596.29011 y5-H2O -0.914 
 597.33267 ?   
600.33809  *  600.33796 [b10+H]2+ -0.221 
601.35688  601.35706 a†5  -H2O 0.308 
602.32499  602.32484 [b†10-2H2O+H]2+ -0.241 
611.33000    611.33014 [b†10-H2O+H]2+ 0.232 
614.30122 614.30081 y5 -0.667 
620.33528  620.33541 [b†10+H]2+ 0.214 
629.35179  629.35193 b†5  -H2O 0.222 
647.36236 647.36255 b†5 0.301 
663.34480 663.34436 [M† -H2O-NH3-CO+2H]2+ -0.656 
668.33697 668.33697 [M† -2H2O-NH3+2H]2+ 0.000 
 A-18 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
674.86390 *  674.86348 [M+2H]2+ -0.615 
677.34225 677.34239 [M† -H2O-NH3+2H]2+ 0.203 
685.85553 *  685.85566 [M† -H2O+2H]2+ 0.197 
694.86081 694.86095 [M† +2H]2+ 0.205 
724.34869  724.34881 y6-NH3 0.173 
729.41546  729.41551 a†6 -H2O 0.075 
735.42602  *  735.42633 b6   
740.38383  740.38399 b†6 -H2O-NH3 0.223 
742.35980 742.35944 y6 -0.485 
757.41037 757.41051 b†6 -H2O 0.185 
775.42094  775.42105 b†6 0.148 
 783.38247 ?   
 790.42472 ?   
 809.40948 ?   
 816.48404 ?   
 823.46141 ?   
  868.48295 ?   
904.47878  904.47890 b†7 -H2O 0.133 
922.48935 922.48944 b†7 0.103 
950.44460 950.44411 y8-NH3 -0.510 
967.47114 *  967.47068 y8 -0.475 
  974.52133 ?   
  996.54142 ?   
  1023.55220 ?   
1029.56284  1029.56303 b8 0.185 
1051.547   1051.54722 b†8  -H2O 0.029 
  1057.55829 ?   
1069.55776 1069.55771 b†8 -0.042 
  1074.58437 ?   
1095.5661 *  1095.56542 y9 -0.621 
1108.56865   1108.56861 b†9  -H2O -0.036 
1126.57922 1126.57927 b†9 0.049 
1192.61886 1192.61781 y10 -0.880 
1193.65780  1193.65749 a†10  -H2O -0.256 
1203.64215 1203.64163 b†10  -2H2O -0.430 
1221.65271 *  1221.65287 b†10  -H2O 0.133 
1239.66328 *  1239.66319 b†10 -0.068 
Mean -0.122  
St.Dv. 0.049 
 
 A-19 
Table A-10.  CAD mass error analysis for the parent ion [M+C2H2O2+2H]2+ of glyoxal-derived 
glycation product formed at free acid form of Substance P in MeOH:H2O (50:50). * indicates mass to 
charge used for calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
254.16114  *  254.16112 b2 -0.079 
263.14294 263.14236 y2   
276.14549  276.14548 b‡2  -H2O -0.036 
294.15606  294.15605 b‡2 -0.017 
  295.14410 ?   
 307.14409 *   
 313.27372 *   
 318.18121 ?   
 335.09488 ?   
 338.34175 *   
 341.30505 *   
 350.25780 ?   
 352.16559    
 354.17722 *   
 363.08981 *   
 364.27342 ?   
 371.20376 *   
 373.22351 *   
 378.28910 ?   
379.20883 379.20887 [b6-H2O+H]2+ 0.119 
404.24045 404.24051 b‡3  -H2O 0.148 
 406.17955 ?   
 420.22821 *   
422.25102  422.25109 b‡3 0.178 
452.74303  452.74311 [b‡6-H2O+H]2+ 0.177 
 463.19768 ?   
 464.26161 *   
467.23281 *  467.23235 y4 -0.985 
 486.77435 *   
 490.26117 *   
  495.99993 *   
 501.24570 *   
501.29321  501.29333 b‡4 -H2O 0.239 
503.76651  503.76660 [a‡8-H2O-NH3+H]2+ 0.189 
509.25096  509.25077 [b‡8-H2O-2NH3+H]2+ -0.378 
512.28005  512.27987 [a‡8-H2O+H]2+ -0.351 
515.28533  515.28511 [b8+H]2+ -0.432 
517.27223  517.27205 [b‡8-2H2O+H]2+ -0.338 
 517.76406 ?   
 518.26575 *   
 524.79013 ?   
 A-20 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
526.27751  526.27734 [b9-H2O-NH3+H]2+ -0.318 
 533.30332 ?   
535.28252 535.28280  [b‡8+H]2+ 0.528 
 537.79591 ?   
 538.79935 *   
540.79078  540.79059 [a‡9-H2O+H]2+ -0.351 
543.79606  543.79588 [b9+H]2+ -0.336 
545.78296  545.78281 [b‡9-2H2O+H]2+ -0.266 
 546.27482 ?   
 540.80250 *   
548.28669 *  548.28686 [y8+H]2+ 0.310 
554.78824  554.78809 [b‡9-H2O+H]2+ -0.266 
 555.81409 ?   
 560.30865 *   
563.79325  563.79336 [b‡9+H]2+ 0.200 
 574.34614 ?   
 576.28178 *   
577.82736  577.82699 [b10-CO-NH3+H]2+ -0.645 
 580.80581 ?   
582.81954  582.81936 [b10-H2O-NH3+H]2+ -0.305 
586.34064 586.34045 [a10+H]2+ -0.316 
593.31970 593.31946 [b‡10-3H2O+H]2+ -0.409 
596.29066 596.29011 y5-H2O -0.914 
 597.33267 ?   
600.33809  600.33796 [b10+H]2+ -0.221 
601.35688  601.35706 a‡5  -H2O 0.308 
602.32499  602.32484 [b‡10-2H2O+H]2+ -0.241 
611.33000  611.33014 [b‡10-H2O+H]2+ 0.232 
614.30122 *  614.30081 y5 -0.667 
620.33528  620.33541 [b‡10+H]2+ 0.214 
629.35179  629.35193 b‡5  -H2O 0.222 
647.36236 647.36255 b‡5 0.301 
663.34480 663.34436 [M‡ -H2O-NH3-CO+2H]2+ -0.656 
668.33697 668.33697 [M‡ -2H2O-NH3+2H]2+ 0.000 
674.86390 674.86348 [M+2H]2+ -0.615 
677.34225 677.34239 [M‡ -H2O-NH3+2H]2+ 0.203 
685.85553 685.85566 [M‡ -H2O+2H]2+ 0.197 
694.86081 694.86095 [M‡ +2H]2+ 0.205 
  721.41447 ?   
724.34869  724.34881 y6-NH3 0.173 
729.41546  729.41551 a‡6 -H2O 0.075 
 A-21 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
735.42602  735.42633 b6   
740.38383  740.38399 b‡6 -H2O-NH3 0.223 
742.35980 *  742.35944 y6 -0.485 
  742.43601 ?   
757.41037 757.41051 b‡6 -H2O 0.185 
775.42094  775.42105 b‡6 0.148 
904.47878  904.47890 b‡7 -H2O 0.133 
922.48935 922.48944 b†7 0.103 
950.44460 950.44411 y8-NH3 -0.510 
967.47114 *  967.47068 y8 -0.475 
  974.52133 ?   
  996.54142 *   
  1023.55220 ?   
1029.56284  1029.56303 b8 0.185 
  1051.54722 b‡8  -H2O   
  1057.55829 ?   
1069.55776 1069.55771 b†8 -0.042 
  1074.58437 ?   
1091.534255 1091.54217 ?   
  1093.59391 *   
1095.56610 * 1095.56542 y9 -0.621 
1108.56865 1108.56861 b‡9  -H2O -0.036 
1126.57922 1126.57927 b‡9 0.049 
1192.61886 * 1192.61781 y10 -0.880 
1193.65780  1193.65749 a‡10  -H2O -0.256 
1203.64215 1203.64163 b‡10  -2H2O -0.430 
1221.65271 1221.65287 b‡10  -H2O 0.133 
1239.66328 * 1239.66319 b‡10   -0.068 
mean -0.138   
St. Dv. 0.049 
 
Table A-11.  DR(674)-ECD(694) mass error analysis for the parent ion [M+C2O+2H]2+ of glyoxal-
derived glycation product formed at amidated Substance P at biological conditions (pH 7.5). * indicates 
mass to charge used for calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
271.18769  *  271.18766 c2 -0.092 
  381.29684 *   
  415.21095 *   
  438.19362 *   
 A-22 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
496.33541  *  496.33517 c4 -0.473 
 515.39601 ?   
517.31194  517.31174 c†4•-H2O -0.377 
518.31976  518.31953 c†4-H2O -0.444 
535.32250  535.32233 c†4• -0.318 
536.33033  *  536.33014 c†4 -0.345 
  592.30749 ?   
645.37051  645.37066 c†5•-H2O 0.232 
646.37834  646.37842 c†5 - H2O 0.132 
663.38108  663.38124 c†5• 0.249 
664.38890  *  664.38906 c†5 0.241 
  682.39944 ?   
694.36879  694.36904 [M† +2H]2+ 0.356 
774.43692  774.43706 c†6 - H2O 0.187 
791.43966  791.43981 c†6• 0.196 
792.44748    792.44733 c†6 -0.189 
921.50533  921.50564 c†7-H2O 0.342 
  937.73807 ?   
938.50807  938.50760 c†7• -0.495 
939.51589    939.51611 c†7 0.234 
  993.80067 ?   
1004.54379  1004.54364 z9• - C3H6S -0.149 
1042.57013  1042.57063 a†8 0.484 
1068.57374  1068.57355 c†8- H2O -0.173 
1078.56281  *  1078.56280 z9• -0.009 
1086.58430    1086.58428 c†8 -0.018 
1125.59520  1125.59526 c†9 - H2O 0.058 
1143.60576    1143.60557 c†9 -0.166 
 1220.63744 ?   
1238.67926  1238.67905 c†10 - H2O -0.165 
1256.68982    1256.68926 c†10 -0.446 
1314.71856  1314.71860 [M† -C3H6S + 2H]1+• 0.027 
1343.71668  1343.71621 [M† -•CONH2+H]1+ -0.346 
1370.72757  *  1370.72658 [M† -H2O+2H]1+• -0.722 
1387.73031  *  1387.72948 [M† +H]1+ -0.598 
mean -0.090  
St. Dv. 0.3123 
 A-23 
 
Table A-12.  DR(674)-ECD(703) mass error analysis for the parent ion [M+C2H2O2+2H]2+ of glyoxal-
derived glycation product formed at amidated Substance P at biological conditions (pH 7.5). * indicates 
mass to charge used for calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
 331.28460 *  
 341.30532 *  
 344.01439 *  
 345.01281 *  
 357.00860 ?  
 359.31586 ?  
 373.23520 *  
 381.29778 *  
 422.28790 *  
 437.19365 *  
496.335405  *  496.33553 c4 0.252 
517.311935  517.31193 c‡4•-2H2O -0.010 
 524.33451 ?  
535.322500  535.32253 c‡4•-H2O 0.056 
536.330325  536.33039 c‡4-H2O 0.121 
553.333060  553.33313 c‡4• 0.127 
554.340885    554.34092 c‡4 0.063 
 610.31815 *  
623.38616  623.38618 c5• 0.032 
624.39399  *  624.39402 c5 0.056 
645.37051  645.37056 c‡5•-2H2O 0.077 
646.37834  646.37840 c‡5 - 2H2O 0.101 
663.38108  663.38106 c‡5•-H2O -0.023 
664.38890  664.38892 c‡5 - H2O 0.030 
674.37134  674.37151 [M+2H]2+ 0.260 
681.39164  681.39165 c‡5• 0.015 
682.39947    682.39947 c‡5 0.007 
703.37408  703.37403 [M‡ +2H]2+ -0.071 
 715.31659 *  
 728.54292 *  
752.45257  *  752.45297 c6 0.538 
 755.57084 *  
791.43966  791.43965 c‡6•- H2O -0.006 
792.44748  792.44748 c‡6 - H2O 0.000 
 A-24 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
809.45022  809.45006 c‡6• -0.198 
810.45805    810.45800 c‡6 -0.056 
895.50172  895.50249 a‡7 - H2O 0.865 
899.52098  *  899.52101 c7 0.039 
913.51228  913.51278 a‡7 0.547 
938.50807  938.50731 c‡7•- H2O -0.804 
939.51589  939.51598 c‡7 - H2O 0.096 
 952.75699 ?  
957.52646    957.52649 c‡7 0.037 
 966.77274 ?  
 980.78841 ?  
1004.54379  1004.54407 z9• - C3H6S 0.279 
 1007.52572 ?  
1042.57013  1042.57076 a‡8- H2O 0.609 
1046.58939  1046.58958 c8 0.186 
1060.58069  1060.58045 a‡8 -0.226 
1078.56281  * 1078.56299 z9• 0.167 
1086.58430  1086.58425 c‡8- H2O -0.046 
1104.59487    1104.59457 c‡8 -0.267 
1103.61085  * 1103.61111 c9 0.240 
1143.60576  1143.60606 c‡10 - H2O 0.262 
1161.61633  1161.61666 c‡9 0.288 
1216.69491  1216.69537 c10 0.382 
1256.68982  1256.69020  c‡10 - H2O 0.302 
1274.70039  1274.70088 c‡10 0.388 
1331.71668 1331.71738 [M‡ -NH3+2H]1+• 0.529 
1343.71668 1343.71689 [M‡ -•CONH2-H2O+H]1+ 0.160 
1347.73540 1347.73612 [M+H]1+ 0.538 
1348.74377 1348.74325 [M+2H]1+• -0.386 
1361.72724 1361.72824 [M‡ -•CONH2+H]1+ 0.734 
1370.72757 1370.72843 [M‡ -2H2O+2H]1+• 0.627 
1371.71214 1371.71144 [M‡ -H2O-NH3+2H]1+• -0.510 
 1387.72764 ?  
1388.73814 *  1388.73897 [M‡ -H2O+2H]1+• 0.601 
1405.74088 *  1405.74139 [M‡ +H]1+ 0.366 
Mean 0.151  
St. Dv. 0.065 
 A-25 
 
Table A-13.  CAD error analysis for the parent ion [M+C2O+2H]2+ of glyoxal-derived glycation product 
formed at amidated Substance P at biological conditions (pH 7.5). * indicates mass to charge used for 
calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
254.16114  *  254.16115 b2 0.039 
294.15606  294.15607 b†2 0.051 
379.20883  378.28909 ?   
382.25610  *  382.25610 b3 0.000 
404.24045    404.24035 b†3  -H2O -0.247 
449.22170  449.22167 y4-NH3 -0.056 
515.28533  515.28503 [b8+H]2+ -0.587 
543.79606  *  543.79585 [b9+H]2+ -0.391 
545.78296   [b†9-2H2O+H]2+   
563.79325  563.79322 [b†9+H]2+ -0.049 
582.81954  582.81937 [b10-H2O-NH3+H]2+ -0.287 
586.34037 586.34035 [a10+H]2+ -0.026 
591.33281  591.33251 [b10-H2O+2H]2+ -0.507 
600.33809  *  600.33780 [b10+H]2+ -0.487 
607.36744  607.36742 b5 -0.033 
611.33000  611.32990 [b†10-H2O+H]2+ -0.155 
  614.83660  *   
  619.34566 *   
620.33528  620.33525 [b†10+H]2+ -0.044 
647.36236  647.36242 b†5 0.100 
643.347333 643.34726 [M-2NH3-CO+2H]2+ -0.113 
648.339508 648.33946 [M-2NH3-H2O+2H]2+ -0.073 
651.860605 651.86060 [M-NH3-CO+2H]2+ -0.008 
656.852780 656.85278 [M-NH3-H2O+2H]2+ 0.000 
665.85806 665.85805 [M-NH3+2H]2+ -0.019 
674.37134 674.37141 [M+2H]2+ 0.111 
735.42602  735.42599 b6 -0.041 
775.42094   775.42108 b†6 -0.187 
882.49443  *  882.49440 b7 0.034 
922.48935    922.48882 b†7 -0.567 
932.43348  932.43406  y8-2NH3 0.622 
949.46003  949.46007 y8-NH3 0.047 
966.48657  966.48633 y8 -0.248 
1029.56284  1029.56298 b8 0.136 
1051.54719    1051.54727 b†8  -H2O 0.076 
1069.55776    1069.55794 b†8 0.173 
1077.55499  1077.55504  y9-NH3 -0.051 
 A-26 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
1086.58430  1086.58440 b9 -0.092 
1094.58153  1094.58162 y9 0.082 
1126.57922    1126.57896 b†9 -0.226 
1171.67345  1171.67346 a10 -0.013 
1191.63429  1191.63551 y10 -1.024 
1199.66836  *  1199.66854 b10   -0.150 
1221.65271  *  1221.65332 b†10  -H2O 0.499 
1239.66328  *  1239.66351 b†10 0.190 
Mean -0.086  
St. Dv.  
 
Table A-14.  CAD mass for the parent ion [M+C2H2O2+2H]2+of glyoxal-derived glycation product 
formed at amidated Substance P at biological conditions (pH 7.5). * indicates mass to charge used for 
calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
254.16114  *  254.16115 b2 0.039 
294.15606  294.15607 b‡2   0.051 
  341.30505 ?   
 350.25776 ?   
  352.16557 *   
  354.17720 ?   
 363.08979 ?   
 371.20376 ?   
 378.28909 ?   
382.25610  *  382.25610 b3 0.000 
404.24045  404.24035 b‡3  -H2O -0.247 
449.22170  449.22167 y4-NH3 -0.056 
466.24824  466.24944 y4   
 501.24555    
515.28533  515.28503 [b8+H]2+ -0.587 
543.79606  543.79585 [b9+H]2+ -0.391 
563.79325  563.79322 [b‡9+H]2+ -0.049 
582.81954  582.81937 [b10-H2O-NH3+H]2+ -0.287 
586.34037 586.34035 [a10+H]2+ -0.026 
591.33281  591.33251 [b10-H2O+2H]2+ -0.507 
600.33809  600.33780 [b10+H]2+ -0.487 
607.36744  *  607.36742 b5 -0.033 
  609.31598 ?   
611.33000  611.32990 [b‡10-H2O+H]2+ -0.155 
  614.83660  *   
 A-27 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
  619.34566 *   
620.33528  620.33525 [b‡10+H]2+ -0.044 
  627.85892 ?   
647.36236 647.36242 b‡5 0.100 
643.34733 643.34726 [M-2NH3-CO+2H]2+ -0.113 
648.33951 648.33946 [M-2NH3-H2O+2H]2+ -0.073 
651.86061 651.86060 [M-NH3-CO+2H]2+ -0.008 
656.85278 656.85278 [M-NH3-H2O+2H]2+ 0.000 
665.85806 665.85805 [M-NH3+2H]2+ -0.019 
674.37134 674.37141 [M+2H]2+ 0.111 
735.42602  735.42599 b6 -0.041 
775.42094  775.42108 b‡6 -0.187 
882.49443  *  882.49440 b7 0.034 
922.48935  922.48882 b†7 -0.567 
  929.48822  ?   
932.43348  932.43406  y8-2NH3 0.622 
  946.51477  ?   
949.46003  949.46007 y8-NH3 0.047 
966.48657  966.48633 y8 -0.248 
  974.52046 ?   
1029.56284  *  1029.56298 b8 0.136 
 1036.57201  ?   
1051.54719  1051.54727 b‡8  -H2O 0.076 
  1058.55631 ?   
1069.55776  1069.55794 b‡8 0.173 
1077.55499  1077.55504  y9-NH3 -0.051 
1086.58430  1086.58440 b9 -0.092 
1094.58153  1094.58162 y9 0.082 
  1103.58215 ?   
  1105.59774 ?   
1126.57922  1126.57896 b‡9 -0.226 
1171.67345  1171.67346 a10 -0.013 
1191.63429  1191.63551 y10 -1.024 
1199.66836  *  1199.66854 b10   -0.150 
  1205.62483 ?   
1221.65271  1221.65332 b‡10  -H2O 0.499 
1239.66328  *  1239.66351 b‡10   0.190 
Mean -0.086  
St. Dv. 0.043 
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Table B-1.  Mass error analysis of the direct infusion spectrum of the KM-11 peptide reacted in 
MeOH/H2O (50:50). * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENT 
ERROR 
(ppm) 
*  449.91665 449.91663 [M+3H]3+ -0.043 
463.24829 463.24831 [M+C2O+3H]3+ 0.036 
469.25182 469.25183 [M+C2H2O2+3H]3+ 0.028 
488.58698 488.58699 [M+2(C2H2O2)+3H]3+ 0.021 
600.33782 600.33819 b102+ 0.616 
*  674.37134 674.37156 [M+2H]2+ 0.320 
694.36880 694.36871 [M+C2O+2H]2+ -0.129 
703.37408 703.37432 [M+C2H2O2+2H]2+ -0.251 
710.38191 710.38207 [M+C2H2O2+CH2+2H]2+ 0.225 
723.37154 723.37123 [M+C2H2O2+2H]2+ -0.433 
*  732.37682 732.37674 [M+2(C2H2O2) +2H]2+ -0.116 
*  1347.73542 1347.73545 [M+H]1+ 0.019 
Mean 0.024 
 St. Dv. 0.272 
 
 
 
 B-3 
Table B-2.  Mass error of the direct infusion spectra of the KM-11 peptide reacted in PBS. * indicates 
the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENT  
ERROR 
(ppm) 
*  469.25182 469.25180 [M+C2H2O2+3H]3+ 0.042 
488.58698 488.58699 [M+2(C2H2O2)+3H]3+ -0.020 
600.33782 600.33760 b102+ 0.366 
*  674.37134 674.37202 [M+2H]2+ 0.997 
*  685.36352 685.36366 [M+(C2-H2)+2H]2+ 0.204 
694.36880 694.36872 [M+C2O+2H]2+ -0.115 
703.37408 703.37359 [M+C2H2O2+2H]2+ -0.697 
*  723.37154 723.37109 [M+C4H2O3+C2O+2H]2+ -0.622 
Mean 0.019 
 St. Dv. 0.542 
 
Table B-3.  Mass error of the direct infusion spectra of the AcKM-11 peptide reacted in MeOH/H2O. * 
indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENT 
ERROR 
(ppm) 
*  463.92018 463.92019 [M+3H]3+ -0.194 
483.25534 483.25543 [M+C2H2O2+3H]3+ 0.186 
*  621.34311  621.34298 b102+ -0.209 
695.37663 695.37620 [M+2H]2+ -0.618 
715.37408 715.37410 [M+C2O+2H]2+ 0.028 
724.37937 724.37934 [M+C2H2O2+2H]2+ -0.041 
*  753.38211 753.38218 [M+2(C2H2O2)+2H]2+ 0.092 
*  1389.74597 1389.74494 [M+H]1+ -0.742 
mean -0.187 
 
St. Dv. 0.334 
 
 
 
 
 
 B-4 
Table B-4.  Mass error of the direct infusion spectra of the reacted AcKM-11 peptide reacted in PBS. * 
indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENT 
ERROR 
(ppm) 
463.92018 463.92030 [M+3H]3+ 0.254 
483.25534 483.25545 [M+C2H2O2+3H]3+ 0.234 
695.37663 695.37683 [M+2H]2+ 0.291 
706.36880 706.36866 [M+(C2-H2)+2H]2+ -0.198 
715.37408 715.37370 [M+C2O+2H]2+ -0.536 
724.88104 724.88119 [M+C2H2O2+C2O+2H]2+ 0.203 
753.38211 753.38140 [M+2(C2H2O2)+2H]2+ -0.942 
1389.74597 1389.74599 [M+H]1+ 0.017 
Mean 
-0.085 
 St. Dv. 0.448 
 
Table B-5.  DR(674)-ECD(694) error analysis of the KM-11 peptide reacted in MeOH/H2O (50:50) for 
the precursor ion [M+C2O+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
* 243.18154     243.18154   c2     0.205 
   319.17983     319.17976   y3    -0.219 
   365.22956     365.22951   b3-NH3   -0.137 
   376.72992     376.73006   c62+     0.358 
   382.25610     382.25614   b3     0.092 
   449.76022     449.76019   c7•2+    -0.062 
   450.26413     450.26410   c72+    -0.067 
   466.24824     466.24823   y4    -0.021 
   479.30887     479.30894   b4     0.156 
   483.74693     483.74655   y82+    -0.786 
   495.32758     495.32756   c4•    -0.050 
   496.33541     496.33540   c4    -0.020 
   517.31193     517.31194   c†4•-H2O    0.010 
   523.29442     523.29442   c8•2+    -0.006 
   523.79833     523.79836   c82+     0.048 
   535.32250     535.32249   c†4•    -0.019 
   536.33033     536.33027   c†4    -0.103 
   552.30907     552.30907   c92+     0.009 
   561.79748     561.79748   y92+     0.000 
   572.30652     572.30654   c†92+     0.031 
   580.38036     580.38065   a5     0.500 
   581.79494     581.79505   y†92+     0.189 
   591.82455     591.82460   (b10-NH3)2+    0.084 
 B-5 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   600.33782     600.33787   b102+     0.078 
   607.36744     607.36747   b5     0.041 
   608.85109     608.85109   c102+    -0.008 
   610.32386     610.32391   y102+     0.082 
   613.31665     613.31663   y5    -0.033 
   623.38617     623.38615   c5•    -0.024 
   624.39399     624.39398   c5    -0.016 
   628.34464     628.34412   c†10•2+    -0.828 
   628.84855     628.84861   c†102+     0.091 
   645.37051     645.37050   c†5•-H2O   -0.023 
   646.37834     646.37848   c†5-H2O    0.217 
   657.34479     657.34486   [M-2NH3+H] 2+   0.099 
   663.38108     663.38099   c†5•    -0.136 
   664.38891     664.38888   c†5    -0.038 
   665.85807     665.85807   [M-2NH3+2H] 2+   0.000 
   685.85553     685.85516   [M-NH3+2H] 2+  -0.539 
   694.36880     694.36877   [M†+2H] 2+   -0.040 
   696.37020     696.37045   a†5-2NH3-H2O    0.359 
   707.32214     707.32205   y6-2NH3   -0.127 
   724.34869     724.34858   y6-NH3   -0.152 
   735.42602     735.42599   b6    -0.048 
   741.37523     741.37522   y6    -0.013 
   751.44475     751.44469   c6•    -0.073 
   752.45257     752.45256   c6    -0.013 
   767.42256     767.42182   a7-2NH3-2H2O  -0.971 
   773.42909     773.42969   c†6•-H2O    0.769 
   774.43692     774.43731   c†6-H2O    0.504 
   775.42094     775.42087   b†6    -0.090 
   791.43966     791.43960   c†6•    -0.076 
   792.44749     792.44746   c†6    -0.032 
   852.40727     852.40702   y7-NH3   -0.293 
   882.49443     882.49442   b7    -0.017 
   898.51315     898.51313   c7•    -0.028 
   899.52098     899.52100   c7     0.022 
   921.50533     921.50594   c†7•-H2O    0.662 
   922.48935     922.48885   b†7    -0.542 
   938.50807     938.50829   c†7•     0.234 
   939.51590     939.51598   c†7     0.090 
   966.48657     966.48651   y8    -0.062 
  1012.53630    1012.53626   b8-NH3   -0.040 
  1032.54994    1032.55002   z9•-C3H6S    0.077 
  1042.57067    1042.57046   a†8    -0.206 
  1045.58156    1045.58197   c8•     0.387 
  1046.58939    1046.58951   c8     0.115 
  1069.55776    1069.55731   b†8    -0.421 
  1072.54485    1072.54472   z†9•-C3H6S   -0.121 
  1086.58431    1086.58434   c†8     0.032 
  1103.61085    1103.61089   c9     0.036 
 B-6 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
  1106.56896    1106.56903   z9•     0.063 
  1122.58768    1122.58751   y9    -0.151 
  1125.59520    1125.59409   c†9-H2O   -0.986 
  1143.60577    1143.60577   c†9     0.004 
  1146.56388    1146.56377   z†9•    -0.096 
  1162.58260    1162.58229   y†9    -0.267 
1216.69491    1216.69490   c10    -0.008 
  1239.66328    1239.66366   b†10     0.307 
  1256.68982    1256.68990   c†10     0.060 
  1286.69631    1286.69550   [M-•CONH2-NH3+H]1+ -0.630 
  1303.72177    1303.72221   [M†-HCONH2-H2O+2H] 1+•  0.337 
1314.71857    1314.71864   [M†-C3H6S+2H] 1+•  -0.368 
  1330.70886    1330.70897   [M-NH3+H]1+    0.496 
  1331.71724    1331.71698   [M-NH3+2H] 1+•  -0.195 
1335.66667    1335.66557   [M-H2O-2NH3+H]1+  -0.816 
  1347.73540    1347.73532   [M +H] 1+   -0.067 
  1353.70104    1353.70082   [M†-H2O-NH3+2H] 1+• -0.159 
  1370.72785    1370.72783   [M†-H2O +2H] 1+•  -0.015 
  1388.73815    1388.73809   [M† +2H] 1+•   -0.072 
Mean 
-0.011 
 St. Dv. 0.351 
 
Table B-6.  CAD(694) error analysis of the KM-11 peptide reacted in MeOH/H2O (50:50) for the 
precursor ion [M+C2O+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   226.15500     226.15505   b2     0.243 
   262.15837     262.15846   y2     0.343 
   302.15329     302.15336   y3-NH3    0.232 
   319.17983     319.17993   y3     0.313 
   364.24554     364.24562   b3-H2O    0.220 
   382.25610     382.25610   b3    -0.013 
   404.24045     404.24059   b†3-H2O    0.334 
   422.25102     422.25101   b†3    -0.024 
   441.75086     441.75075   b72+    -0.244 
   449.22170     449.22182   y4-NH3    0.267 
   453.23504     453.23489   (b†7-NH3) 2+   -0.336 
   466.24824     466.24825   y4     0.021 
   479.30887     479.30890   b4     0.073 
   492.77461     492.77435   (a8-NH3) 2+   -0.517 
   501.28761     501.28765   a8 2+     0.084 
   506.27978     506.27972   (b8-H2O) 2+   -0.119 
   506.77179     506.77189   (b8-NH3) 2+    0.197 
   515.28506     515.28510   b8 2+     0.072 
   526.27724     526.27699   (b†8-H2O) 2+   -0.470 
 B-7 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   526.76925     526.76896   (b†8-NH3) 2+   -0.546 
   534.79051     534.79082   (b9-H2O) 2+    0.580 
   535.28252     535.28259   b†8 2+     0.131 
   543.79579     543.79593   b9 2+     0.252 
   549.79579     549.79523   a†9 2+    -1.023 
   554.78797     554.78803   (b†9-H2O) 2+    0.113 
   555.27998     555.28007   (b†9-NH3) 2+    0.167 
   563.79325     563.79332   b†9 2+     0.124 
   577.82736     577.82728   (a10-NH3) 2+   -0.147 
   582.81927     582.81930   (b10-H2O-NH3) 2+   0.055 
   586.34037     586.34053   (a10+H]2+    0.276 
   591.33254     591.33272   (b10-H2O) 2+    0.304 
   591.82455     591.82477   (b10-NH3) 2+    0.372 
   596.29011     596.29026   y5-NH3    0.252 
   597.33254     597.33273   (a†10-H2O) 2+    0.318 
   600.33782     600.33801   b10 2+     0.311 
   602.81673     602.81698   (b†10-H2O-NH3) 2+   0.423 
   606.33782     606.33792   a†10 2+     0.157 
   607.36744     607.36764   b5     0.321 
   610.32386     610.32389   y10 2+     0.049 
   611.33000     611.33017   (b†10-H2O) 2+    0.282 
   611.82201     611.82209   (b†10-NH3) 2+    0.135 
   613.31665     613.31672   y5     0.114 
   620.33528     620.33543   b†10 2+     0.242 
   630.32132     630.32165   y†10 2+     0.528 
   643.34761     643.34767   [M-HCONH2-NH3+2H] 2+  0.093 
   647.36236     647.36242   b†5     0.093 
   654.33951     654.33943  [M†- HCONH2-H2O-NH3+2H] 2+ -0.126 
   656.85279     656.85326   [M-H2O-NH3+2H] 2+   0.723 
   657.34479     657.34543   [M-2NH3+2H] 2+   0.966 
   662.85279     662.85316  [M†- HCONH2-H2O +2H] 2+   0.566 
   665.36606     665.36644   [M-H2O+2H]2+   0.571 
   665.85807     665.85868   [M-NH3+2H] 2+   0.919 
   671.85807     671.85866   [M†- HCONH2+2H] 2+  0.878 
   674.37134     674.37188   [M+2H] 2+    0.801 
   676.85025     676.85008   [M†-H2O-NH3+2H] 2  -0.251 
   677.34226     677.34238   [M†-2NH3+2H]2+   0.177 
   685.36352     685.36310   [M†-H2O+2H]2+  -0.613 
   685.85553     685.85526   [M†-NH3+2H]2+  -0.394 
   694.36880     694.36841   [M†+2H]2+   -0.562 
   696.37020     696.36980   a†6-2NH3-H2O   -0.574 
   707.32214     707.32173   y6-2NH3   -0.580 
   735.42602     735.42591   b6    -0.156 
   741.37523     741.37536   y6     0.175 
   757.41038     757.40975   b†6-H2O   -0.825 
   854.49952     854.49885   a7    -0.784 
   865.46789     865.46775   b7-NH3    -0.162 
   882.49443     882.49427   b7    -0.187 
 B-8 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   905.46281     905.46212   b†7-NH3   -0.757 
   922.48935     922.48971   b†7     0.390 
   932.43348     932.43378   y8-2NH3    0.322 
   949.46003     949.45980   y8-NH3    -0.242 
   966.48657     966.48643   y8    -0.145 
  1001.56793    1001.56691   a8    -1.018 
  1012.53630    1012.53625   b8-NH3    -0.049 
  1041.56284    1041.56240   a†8    -0.427 
  1051.54720    1051.54691   b†8-H2O   -0.271 
  1052.53121    1052.53128   b†8-NH3    0.062 
  1105.56114    1105.56121   y9-NH3     0.063 
  1108.56866    1108.56807   b†9-H2O   -0.528 
1109.55267    1109.55269   b†9-NH3    0.014 
  1122.58768    1122.58715   y9    -0.472 
  1126.57922    1126.57849   b†9    -0.648 
  1144.57203    1144.57243   y†9-H2O    0.349 
  1145.55605    1145.55610   y†9-NH3    0.044 
  1162.58260    1162.58303   y†9     0.370 
  1171.67345    1171.67323   a10    -0.188 
  1182.64182    1182.64203   b†10-NH3    0.173 
  1185.58735    1185.58679   y10-2NH3   -0.472 
  1199.66836    1199.66756   b10    -0.671 
  1202.61390    1202.61360   y10-NH3   -0.249 
  1211.66836    1211.66782   a†10†10    -0.450 
  1219.64044    1219.64013   y10    -0.254 
1222.63674    1222.63630   b†10-NH3   -0.356 
1239.66328    1239.66306   b†10    -0.177 
1347.73541    1347.73655   [M+H]1+    0.849 
Mean -0.024 
 
St. Dv. 0.428 
 
 
 
Table B-7.  DR(674)-ECD(694) error analysis of the KM-11 peptide reacted in PBS for the precursor 
ion [M+C2O+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  243.18154     243.18159   c2     0.001 
   450.26413     450.26419   c72+     0.133 
   517.31193     517.31189   c†4•-H2O   -0.087 
   535.32250     535.32251   c†4•     0.001 
   536.33033     536.33033   c†4     0.018 
   579.26356     579.26345   y5-2NH3   -0.190 
 B-9 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   620.33528     620.33498   b†102+    -0.484 
   624.39399     624.39404   c5     0.080 
   628.34464     628.34402   c†102+•    -0.986 
   645.37051     645.37052   c†5•-H2O    0.008 
   646.37834     646.37798   c†5-H2O   -0.557 
   663.38108     663.38107   c†5•    -0.015 
   664.38891     664.38893   c†5     0.038 
   685.36352     685.36330   [M†-H2O+2H] 2+  -0.321 
   694.36880     694.36873   [M†+2H] 2+   -0.101 
   696.37020     696.36995   a†5-2NH3-H2O   -0.359 
   707.32214     707.32266   y6-2NH3    0.735 
   752.45257     752.45253   c6    -0.053 
   773.42909     773.42918   c†6•-H2O    0.110 
   774.43692     774.43692   c†6-H2O    0.000 
   791.43966     791.43970   c†6•     0.051 
   792.44749     792.44749   c†6     0.006 
   921.50533     921.50529   c†7-H2O   -0.043 
   938.50807     938.50756   c†7•    -0.543 
   939.51590     939.51595   c†7     0.059 
  1042.57067    1042.57050   a†8    -0.168 
  1072.54485    1072.54482   z†9•-C3H6S   -0.028 
  1086.58431    1086.58423   b9    -0.069 
  1125.59520    1125.59540   c†9-H2O    0.178 
  1143.60577    1143.60586   c†9     0.083 
  1146.56388    1146.56357   z†9•    -0.270 
  1162.58260    1162.58262   y†9     0.017 
  1238.67926    1238.67922   c†10-H2O   -0.032 
  1256.68982    1256.68990   c†10     0.060 
  1296.70856    1296.70890   [M†-H2O-C3H6S+2H]1+•  0.262 
1325.70557    1325.70595   [M†-H2O-•CONH2+H] 1+  0.287 
1325.70611    1325.70595   [M†-•CONH2-H2O+H] 1+ -0.124 
  1330.70886    1330.70957   [M-NH3+H]1+    0.537 
1331.71668    1331.71829   [M-NH3+2H]1+•   0.788 
1343.71613    1343.71645   [M†-•CONH2 +H] 1+   0.238 
1370.72758    1370.72768   [M†-2H2O-NH3 +H] 1+  0.073 
1387.73032    1387.73086   [M† +H] 1+    0.389 
1388.73870    1388.73846   [M† +2H] 1+•   -0.173 
mean -0.003  
St. Dv. 0.458 
 
 
 
 
 B-10 
Table B-8.  DR(695)-ECD(715) error analysis of the AcKM-11 peptide reacted in MeOH/H2O (50:50) 
for the precursor ion [M+C2O+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   285.19211     285.19211   c2     0.018 
   319.17983     319.17982   y3    -0.031 
   466.24824     466.24825   y4     0.021 
   537.33815     537.33823   c4•     0.149 
   538.34597     538.34599   c4     0.028 
   544.80362     544.80371   c82+     0.169 
   561.79748     561.79747   y92+    -0.018 
   573.31435     573.31431   c92+    -0.066 
   577.33307     577.33304   c†4•    -0.043 
   578.34089     578.34084   c†4    -0.086 
   613.31665     613.31661   y5    -0.065 
   641.34056     641.34056   b†102+    -0.004 
   665.39673     665.39670   c5•    -0.045 
   665.85779     665.85812   [M- CH3CONH2+2H]2+  0.491 
   666.40455     666.40456   c5     0.008 
   686.86335     686.86391   [M†- HCONH2+2H]2+   0.815 
   695.37662     695.37665   [M†+2H]2+    0.039 
   705.39165     705.39163   c†5•    -0.021 
   706.39947     706.39946   c†5    -0.014 
   706.86081     706.86082   [M†-NH3+2H]2+   0.014 
   715.37408     715.37404   [M†+2H]2+   -0.056 
   716.39642     716.39576   a6-2NH3   -0.914 
   777.43659     777.43718   b6     0.759 
   793.45531     793.45574   c6•     0.542 
   794.46313     794.46320   c6     0.082 
   833.45023     833.45041   c†6•     0.222 
   834.45805     834.45812   c†6     0.084 
   941.53155     941.53150   c7    -0.048 
   964.49991     964.49960   b†7    -0.327 
   966.48657     966.48644   y8    -0.135 
   981.52646     981.52648   c†7     0.020 
  1032.54994    1032.54984   z9•-C3H6S   -0.097 
  1084.58124    1084.58164   a†8     0.369 
  1088.59995    1088.59999   c8     0.032 
  1106.56896    1106.56890   z9•    -0.054 
  1111.56832    1111.56769   b†8    -0.571 
  1122.58768    1122.58714   y9    -0.481 
  1128.59487    1128.59512   b9     0.222 
1145.62142    1145.62146   c9     0.039 
1146.56388    1146.56306   z†9•    -0.715 
  1185.61633    1185.61615   c†9    -0.152 
  1220.63367    1220.63375   a†10-2NH3    0.066 
  1241.67893    1241.67895   b10     0.016 
  1254.68620    1254.68530   c†10-•CONH2   -0.721 
  1257.69765    1257.69746   c10•    -0.151 
  1258.70547    1258.70583   c10     0.282 
 B-11 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
  1281.67385    1281.67344   b†10    -0.316 
  1298.70039    1298.70020   c†10    -0.146 
  1331.71668    1331.71769   [M-CH3CONH2+2H] 1+•  0.758 
1356.72969    1356.72862   [M†-C3H6S+2H] 1+•  -0.789 
1385.72719    1385.72746   [M†-HCONH2 +2H] 1+•  0.195 
1389.74597    1389.74559   [M +H] 1+   -0.273 
      1402.75360   ? 
1413.72272    1413.72194   [M†-NH3+2H] 1+•  -0.548 
1430.749260    1430.74855   [M†+2H] 1+•   -0.496 
mean -0.038  
St. Dv. 0.369 
 
Table B-9.  CAD(715) error analysis of the AcKM-11 peptide reacted in MeOH/H2O (50:50) for the 
precursor ion [M+C2O+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   302.15329     302.15323   y3-NH3   -0.199 
   319.17983     319.17980   y3    -0.094 
   407.24012     407.24009   b3-NH3   -0.086 
   424.26667     424.26667   b3     0.000 
   436.26667     436.26657   a†3    -0.229 
   449.22170     449.22169   y4-NH3   -0.022 
   451.23759     451.23756   (a†7-H2O-NH3)2+   -0.055 
   454.24287     454.24291   (b7-NH3)2+    0.092 
   462.75614     462.75604   b7 2+    -0.216 
   464.26159     464.26165   b†3     0.129 
   466.24824     466.24823   y4    -0.021 
   468.75614     468.75633   a†7 2+     0.400 
   482.75360     482.75359   b†7 2+    -0.016 
   513.77989     513.77938   (a8-NH3)2+   -0.989 
   521.31943     521.31942   b4    -0.019 
   522.29289     522.29287   a82+    -0.034 
   527.77707     527.77706   (b8-NH3)2+   -0.025 
   536.29035     536.29039   b82+     0.084 
   542.29035     542.29042   a†8 2+     0.134 
   547.28252     547.28246   (b†8-H2O)2+   -0.110 
   547.77453     547.77467   (b†8-NH3)2+    0.256 
   556.28780     556.28787   (b9-NH3)2+    0.120 
   561.79748     561.79781   y92+     0.587 
   564.80107     564.80115   b92+     0.133 
   570.80108     570.80109   a†9 2+     0.022 
   575.79325     575.79334   (b†9-H2O)2+    0.156 
   576.28526     576.28529   (b†9-NH3)2+    0.052 
   584.79853     584.79854   b†92+     0.013 
   596.29011     596.29017   y5-NH3    0.101 
 B-12 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   598.83265     598.83216   (a10-NH3)2+   -0.815 
   601.81059     601.81062   (y10-NH3)2+    0.050 
   603.82455     603.82464   (b10-H2O-NH3)2+   0.149 
   607.34565     607.34561   a102+    -0.063 
   609.82455     609.82426   (a†10-H2O-NH3)2+  -0.476 
   610.32386     610.32397   y102+     0.180 
   612.82983     612.82995   (b10-NH3)2+    0.191 
   613.31665     613.31675   y5     0.163 
   618.33782     618.33793   (a†10-H2O)2+    0.174 
   621.34311     621.34309   b102+    -0.024 
   627.34311     627.34324   a†10 2+     0.211 
   630.32132     630.32139   y†102+    0.115 
   632.33528     632.33525   (b†10-H2O)2+   -0.047 
   632.82729     632.82740   (b†10-NH3)2+    0.174 
   641.34056     641.34066   b†102+     0.152 
   649.37801     649.37810   b5     0.139 
   661.37801     661.37817   a†5     0.242 
   664.35289     664.35265   [M-HCONH2-NH3+2H]2+ -0.366 
   674.37134     674.37144   [M-CH2CO+2H]2+   0.148 
   678.35008     678.35013   [M-2NH3+2H]2+   0.077 
   683.85807     683.85827   [M†-CH3CONH2+2H]2+  0.296 
   686.86335     686.86346   [M†-HCONH2+2H]2+   0.160 
   689.34225     689.34223   [M†-H2O-2NH3+2H]2+ -0.033 
   689.37293     689.37300   b†5     0.109 
   692.86335     692.86347   [M†-HCONH2+2H]2+   0.170 
   694.36880     694.36929   [M†-CH2CO+2H]2+   0.709 
   697.85553     697.85524   [M†-H2O-NH3+2H]2+  -0.416 
   698.34754     698.34778   [M†-2NH3+2H]2+   0.344 
   699.36987     699.36982   a6-3NH3   -0.071 
   706.36880     706.36825   [M†-H2O+2H] 2+  -0.779 
   706.86081     706.86072   [M†-NH3+2H] 2+  -0.127 
   707.32214     707.32212   y6-2NH3   -0.028 
   724.34869     724.34862   y6    -0.097 
   741.37523     741.37468   y6    -0.742 
   771.42602     771.42573   a†6-H2O   -0.382 
   777.43659     777.43653   b6    -0.077 
   789.43659     789.43634   a†6    -0.317 
   799.42094     799.42087   b†6-H2O   -0.088 
   817.43151     817.43136   b†6    -0.177 
   918.49443     918.49481   a†7-H2O    0.408 
   924.50500     924.50506   b7     0.065 
   932.43348     932.43380   y8-2NH3    0.343 
   936.50500     936.50499   a†7    -0.011 
   946.48935     946.48984   b†7-H2O    0.518 
   947.47337     947.47343   b†7-NH3    0.063 
   949.46003     949.46028   y8-NH3    0.263 
   964.49991     964.50001   b†7     0.098 
   966.48657     966.48684   y8     0.279 
 B-13 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
  1043.57849    1043.57834   a8    -0.149 
  1054.54687    1054.54668   b8-NH3   -0.175 
  1066.54687    1066.54724   a9-2NH3    0.352 
  1071.57341    1071.57316   b8    -0.233 
  1083.57341    1083.57311   a†8    -0.277 
  1093.55776    1093.55784   b†8-H2O    0.073 
  1094.54178    1094.54156   b†8-NH3   -0.201 
  1105.56114    1105.56091   y9-NH3   -0.208 
  1122.58768    1122.58769   y9     0.009 
  1128.59487    1128.59508   b9     0.186 
  1133.55267    1133.55287   b†9-H2O-NH3    0.172 
  1140.59487    1140.59486   a†9    -0.009 
  1150.57922    1150.57929   b†9-H2O    0.061 
  1151.56324    1151.56369   b†9-NH3    0.391 
  1168.58978    1168.59012   b†9     0.287 
  1185.58735    1185.58728   y10-2NH3   -0.059 
  1219.64044    1219.64055   y10     0.090 
  1224.65239    1224.65191   b†10-NH3   -0.388 
  1225.58227    1225.58163   y†10-2NH3   -0.518 
  1241.67893    1241.67909   b10     0.129 
  1242.60881    1242.60847   y†10-NH3   -0.274 
  1253.67893    1253.67852   a†10    -0.327 
  1259.63535    1259.63471   y†10    -0.512 
  1263.66328    1263.66258   b†10-H2O   -0.554 
1264.64730    1264.64779   b†10-NH3    0.387 
1281.67385    1281.67343   b†10    -0.324 
1389.74597    1389.74584   [M+H]1+   -0.094 
mean -0.011  
St. Dv. 0.358 
 
Table B-10.  CAD(715) error analysis of the AcKM-11 peptide reacted in PBS for the precursor ion 
[M+C2O+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   268.16556     268.16556   b2     0.000 
   319.17983     319.17951   y3    -1.003 
   466.24824     466.24871   y4     1.008 
   403.22141     403.22111   a†3-2NH3   -0.744 
   460.24977     460.24985   (a†7-H2O)2+    0.168 
   482.75360     482.75312   b92+    -0.994 
   607.34565     607.34554   a102+    -0.178 
   612.82983     612.82941   (b10-NH3)2+   -0.690 
   613.31665     613.31610   y5    -0.897 
   618.33782     618.33717   (a†10-H2O)2+   -1.055 
   621.34311     621.34287   b102+    -0.378 
   621.80804     621.80737   (y†10-NH3)2+   -1.086 
 B-14 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   623.82201     623.82134   (b†10-H2O-NH3)2+  -1.070 
   627.34311     627.34251   a†102+    -0.948 
   630.32132     630.32074   y†102+    -0.916 
   632.33528     632.33469   (b†10-H2O)2+   -0.933 
   632.82729     632.82675   (b†10-NH3)2+   -0.853 
   641.34056     641.34019   b†102+    -0.581 
   649.37801     649.37814   b5     0.200 
   661.37801     661.37779   a†5    -0.333 
   664.35289     664.35230   [M-2NH3+2H] 2+  -0.893 
   671.36236     671.36197   b†5-H2O   -0.581 
   683.85807     683.85773   [M†-H2O-NH3+2H] 2+  -0.494 
   686.86335     686.86345   [M-NH3+2H] 2+   0.146 
   689.34225     689.34245   [M†-H2O-2NH3+2H] 2+  0.287 
   689.37293     689.37289   b†5    -0.051 
   692.86335     692.86360   [M†- NH3+2H] 2+   0.357 
   697.85552     697.85583   [M†- NH3-H2O+2H] 2+  0.437 
   697.85553     697.85583   [M††-H2O-NH3+2H] 2+  0.430 
   698.34754     698.34745   [M†-2NH3+2H] 2+  -0.129 
   706.36880     706.36900   [M†-H2O+2H] 2+   0.283 
   706.86081     706.86102   [M†-NH3+2H] 2+   0.297 
   707.32214     707.32226   y6-2NH3    0.170 
   724.34869     724.34861   y6-NH3   -0.110 
   741.37523     741.37539   y6     0.216 
   771.42602     771.42677   a†6-H2O    0.966 
   777.43659     777.43675   b6     0.206 
   800.40496     800.40526   b†6-NH3    0.375 
   817.43151     817.43210   b†6     0.728 
   918.49443     918.49516   a†7-H2O    0.789 
   929.46281     929.46342   b†7-H2O-NH3    0.662 
   964.49991     964.50080   b†7     0.923 
   966.48657     966.48731   y8     0.766 
  1066.57067    1066.57071   a†8-H2O    0.033 
1094.54178    1094.54279   b†8-NH3    0.923 
1111.56833    1111.56847   b†8     0.126 
  1128.59487    1128.59486   b9    -0.009 
  1145.55605    1145.55544   y†9-NH3   -0.532 
  1150.57922    1150.57997   b†9-H2O    0.652 
1166.60198    1166.60296   a†10-2NH3-2H2O   0.844 
1168.58978    1168.59012   b†9     0.291 
  1202.61390    1202.61385   y10-NH3   -0.042 
  1213.68402    1213.68319   a10    -0.680 
  1219.64044    1219.64003   y10    -0.336 
  1224.59824    1224.59791   y†10-H2O-NH3   -0.274 
1225.58227    1225.58215   y†10-2NH3   -0.094 
1259.63535    1259.63567   y†10     0.254 
1281.67385    1281.67259   b†10    -0.983 
1389.745970    1389.74587   [M+H]1+   -0.072 
 B-15 
mean -0.046  
St. Dv. 0.586 
 
Table B-11.  DR(674)-ECD(703) error analysis of the KM-11 peptide reacted in MeOH/H2O (50:50) for 
the precursor ion [M+C2H2O2+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
* 495.32758     495.32758    c4•   -0.010 
   496.33541     496.33541    c4    0.000 
   535.32250     535.32252    c‡4•-H2O   0.037 
   536.33033     536.33033    c‡4-H2O   0.009 
   553.33307     553.33305    c‡4•   -0.027 
   554.34089     554.34092    c‡4    0.054 
   561.79748     561.79759    y92+    0.196 
   623.38617     623.38616    c5•   -0.008 
* 624.39399     624.39400    c5    0.016 
   663.38108     663.38107    c‡5•-H2O  -0.015 
   664.38891     664.38893    c‡5-H2O   0.038 
   681.39165     681.39161    c‡5•   -0.051 
   682.39947     682.39948    c‡5    0.015 
   694.36880     694.36883    [M†-H2O+2H] 2+  0.043 
   703.37408     703.37410    [M‡+2H] 2+   0.028 
   705.35410     705.35398    y6-2H2O  -0.170 
   751.44475     751.44479    c6•    0.060 
* 752.45257     752.45258    c6    0.013 
   791.43966     791.43963    c‡6•-H2O  -0.038 
   792.44749     792.44760    c‡6-H2O   0.145 
   809.45023     809.45032    c‡6•    0.117 
   810.45805     810.45808    c‡6    0.037 
   898.51315     898.51267    c7•   -0.540 
* 899.52098     899.52103    c7    0.056 
   939.51590     939.51581    c‡7-H2O  -0.090 
   956.51864     956.51863    c‡7•   -0.005 
   957.52646     957.52649    c‡7    0.031 
*1046.58939    1046.58950    c8    0.105 
  1060.58124    1060.58119    a‡8-H20  -0.047 
  1072.54485    1072.54467    z‡9•-C3H6S  -0.168 
  1086.58431    1086.58412    b9   -0.170 
*1103.61085    1103.61091    c9    0.054 
  1104.59487    1104.59496    c‡8-    0.081 
  1106.56896    1106.56985    z9•    0.804 
  1143.60577    1143.60598    c‡9-H2O   0.188 
  1146.56388    1146.56382    z‡9•-H2O  -0.048 
  1161.61633    1161.61633    c‡9    0.000 
  1164.57444    1164.57449    z‡9•    0.043 
*1216.69491    1216.69483    c10   -0.066 
  1256.68982    1256.68974    c‡10-H2O  -0.068 
 B-16 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
  1274.70039    1274.70030    c‡10   -0.071 
  1303.72177    1303.72055   [M-HCONH2+2H] 1+•  -0.510 
  1331.71668    1331.71673        [M-NH3+2H] 1+•   0.038 
  1343.71614    1343.71626   [M‡-H2O-•CONH2+1H] 1+  0.089 
*1347.73540    1347.73557        [M +H] 1+    0.126 
1370.72785    1370.72773        [M‡-2H2O+H] 1+   0.088 
1388.73815    1388.73812       [M‡-H2O+2H] 1+•   0.022 
*1405.74089    1405.74103       [M‡ +H] 1+    0.103 
mean -0.011  
St. Dv. 0.265 
 
Table B-12.  CAD (703) error analysis of the KM-11 peptide reacted in MeOH/H2O (50:50) for the 
precursor ion [M+C2H2O2+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
* 226.15500     226.15506    b2    0.287 
   245.13183     245.13186    y2-NH3   0.122 
   262.15837     262.15841    y2    0.153 
   302.15329     302.15333    y3-NH3   0.132 
   319.17983     319.17999    y3    0.501 
   365.22956     365.22954    b3-NH3  -0.055 
* 382.25610     382.25614    b3    0.092 
   404.24045     404.24045    b‡3-2H2O  -0.012 
   422.25102     422.25102    b‡3-H2O   0.000 
   441.75086     441.75086    b72+    0.005 
   449.22170     449.22174    y4-NH3   0.089 
   453.23504     453.23508    (b‡7-H2O-NH3) 2+  0.083 
   461.74831     461.74834    (b‡7-H2O) 2+   0.054 
* 466.24824     466.24833    y4    0.193 
   479.30887     479.30876    b4   -0.219 
   501.28761     501.28761    a82+    0.004 
   506.27978     506.27968    (b8-H2O) 2+  -0.198 
   506.77179     506.77178    (b8-NH3) 2+  -0.020 
   512.77179     512.77174    (a‡8-H2O-NH3) 2+ -0.098 
   515.28506     515.28513    b82+    0.130 
   521.28506     521.28516    (a‡8-H2O) 2+   0.187 
   526.27724     526.27751    (b9-H2O-NH3) 2++  0.517 
   534.79051     534.79052    (b9-H2O) 2+   0.019 
   535.28252     535.28266    (b‡8-H2O) 2+   0.262 
   543.79579     543.79582    b9 2+    0.050 
   544.28780     544.28794    b‡8 2+    0.253 
   554.78797     554.78786    (b‡9-2H2O) 2+  -0.194 
   555.27998     555.27996    (b‡9-H2O-NH3) 2+ -0.032 
   556.28781     556.28765    b5-3NH3  -0.288 
   563.79325     563.79331    (b‡9-H2O) 2+   0.106 
 B-17 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   564.28526     564.28546    (b‡9-NH3) 2+   0.354 
   572.79853     572.79868    b‡9 2+    0.258 
   573.81399     573.81414    (b10-2H2O-NH3) 2+   0.270 
   577.33508     577.33522    (a10-H2O) 2+   0.237 
   577.82736     577.82725    (a10-NH3) 2+  -0.199 
   582.81927     582.81942    (b10-H2O-NH3) 2+  0.261 
   586.34037     586.34054    a102+    0.293 
   590.34090     590.34121    b5-NH3   0.525 
   591.33254     591.33272    (b10-H2O) 2+   0.304 
   591.82455     591.82472    (b10-NH3) 2+   0.287 
* 596.29011     596.29028    y5-NH3   0.285 
   597.33254     597.33272    (a‡10-2H2O) 2+   0.301 
   597.82455     597.82467    (a‡10-H2O-NH3) 2+   0.201 
   600.33782     600.33795    b10 2+    0.212 
   602.81673     602.81697    (b‡10-2H2O-NH3) 2+   0.406 
   606.33782     606.33792    (a‡10-H2O) 2+   0.161 
   607.36744     607.36750    b5    0.091 
   610.32386     610.32389    y102+    0.049 
   611.33000     611.33006    (b‡10-2H2O) 2+   0.102 
   611.82201     611.82214    (b‡10-H2O-NH3) 2+  0.217 
* 613.31665     613.31678    y5    0.212 
   615.34311     615.34320    a‡10 2+    0.150 
   620.33528     620.33534    (b‡10-H2O) 2+   0.097 
   629.34056     629.34060    b‡102+    0.060 
   647.36236     647.36254    b‡5-H2O   0.278 
   648.33951     648.33967   [M-H2O-2NH3+H] 2+   0.242 
   656.85279     656.85295   [M-H2O-NH3+2H] 2+   0.251 
   657.34479     657.34492   [M-2NH3+2H] 2+   0.190 
   665.85807     665.85824   [M-NH3+2H] 2+   0.258 
   668.33697     668.33737   [M‡-H2O-2NH3+2H] 2+  0.599 
   671.85807     671.85838   [M‡-H2O-HCONH2+2H] 2+  0.465 
   674.37134     674.37134   [M+H] 2+    0.000 
   676.85025     676.85000   [M‡-2H2O-NH3+2H] 2+ -0.369 
   677.34225     677.34207   [M‡-H2O-2NH3+H] 2+  -0.269 
   685.36352     685.36319   [M‡-2H2O+H] 2+  -0.474 
   685.85553     685.85529   [M‡-H2O-NH3+2H] 2+  -0.350 
   694.36880     694.36860   [M‡-H2O+2H] 2+  -0.288 
   694.86081     694.86030   [M‡-NH3+2H] 2+  -0.734 
   707.32214     707.32217    y6-2NH3   0.042 
   707.43111     707.43105    a6   -0.085 
   718.39948     718.39939    b6-NH3  -0.125 
* 724.34869     724.34863    y6-NH3  -0.083 
   735.42602     735.42599    b6   -0.048 
   757.41038     757.41057    b‡6-2H2O   0.257 
   758.39440     758.39463    b‡6-H2O-NH3   0.310 
   775.42094     775.42092    b‡6-H2O  -0.026 
   793.43151     793.43188    b‡6    0.473 
   854.49952     854.49961    a7    0.105 
 B-18 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   865.46789     865.46813    b7-NH3   0.277 
* 882.49443     882.49466    b7    0.255 
   894.49443     894.49450    a‡7-H2O   0.073 
   904.47879     904.47932    b‡7-2H2O   0.592 
   905.46281     905.46306    b‡7-H2O-NH3   0.282 
   922.48935     922.48953    b‡7-H2O   0.195 
   932.43348     932.43378    y8-2NH3   0.322 
   940.49991     940.50006    b‡7    0.154 
* 966.48657     966.48688    y8    0.321 
  1001.56793    1001.56833    a8    0.399 
  1012.53630    1012.53680    b8-NH3   0.494 
  1051.54720    1051.54734    b‡8-2H2O   0.138 
  1052.53121    1052.53117    b‡8-H2O-NH3  -0.043 
  1069.55776    1069.55781    b‡8-H2O   0.047 
*1086.58431    1086.58458    b9    0.253 
  1108.56866    1108.56877    b‡9-2H2O   0.104 
  1109.55267    1109.55367    b‡9-H2O-NH3   0.897 
  1110.55669    1110.55591    b‡9-2NH3  -0.707 
*1122.58768    1122.58805    y9    0.330 
  1126.57922    1126.57958    b‡9-H2O   0.320 
  1144.58978    1144.58909    b‡9   -0.607 
  1162.58260    1162.58313    y‡9-H2O   0.456 
  1171.67345    1171.67380    a10    0.299 
  1182.64182    1182.64211    b10-NH3   0.245 
  1185.58735    1185.58624    y10-2NH3  -0.936 
  1199.66836    1199.66843    b10    0.054 
  1202.61390    1202.61393    y10-NH3   0.025 
  1211.66836    1211.66747    a‡10-H2O  -0.739 
*1219.64044    1219.63995    y10   -0.402 
  1221.65271    1221.65253    b‡10-2H2O  -0.151 
1222.63674    1222.63693    b‡10-H2O-NH3   0.159 
1239.66328    1239.66286    b‡10-H2O  -0.339 
*1257.67385    1257.67300    b‡10   -0.672 
mean 0.051  
St. Dv. 0.369 
 
Table B-13.  CAD (703) error analysis of the KM-11 peptide reacted in PBS for the precursor ion 
[M+C2H2O2+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
* 226.15500     226.15501    b2    0.066 
   319.17983     319.17967    y3   -0.501 
   365.22956     365.22923    b3-NH3  -0.904 
   382.25610     382.25591    b3   -0.510 
   404.24045     404.24041    b‡3-2H2O  -0.111 
 B-19 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   405.22447     405.22414    b‡3-H2O-NH3  -0.827 
   422.25102     422.25085    b‡3-H2O  -0.403 
   440.26159     440.26185    b‡3    0.602 
   449.22170     449.22164    y4-NH3  -0.134 
* 466.24824     466.24816    y4   -0.172 
   501.28760     501.28733    a8 2+   -0.549 
   515.28506     515.28507    b8 2+    0.014 
   535.28252     535.28230    (b‡8-H2O) 2+  -0.411 
   543.79579     543.79587    b9 2+    0.142 
   544.28780     544.28732    b‡8 2+   -0.886 
   553.28421     553.28371    (y9-NH3) 2+  -0.904 
   554.78797     554.78761    (b‡9-2H2O) 2+  -0.644 
   555.27998     555.27998    (b‡9-H2O-NH3) 2+  0.005 
   556.28781     556.28751    b5-3NH3  -0.539 
   563.79325     563.79328    (b‡9-H2O) 2+   0.053 
   572.79853     572.79864    b‡9 2+    0.188 
   577.82736     577.82738    (a10-NH3) 2+   0.026 
   586.34037     586.34056    a10 2+    0.327 
* 590.34090     590.34076    b5-NH3  -0.237 
   591.82455     591.82477    (b10-NH3) 2+   0.372 
   596.29011     596.28993    y5-NH3  -0.302 
   597.33254     597.33248    (a‡10-2H2O) 2+  -0.100 
   597.82455     597.82430    (a‡10-H2O-NH3) 2+ -0.418 
   600.33782     600.33793    b10 2+    0.178 
   602.81673     602.81718    (b‡10-2H2O-NH3) 2+   0.755 
   606.33782     606.33800    (a‡10-H2O) 2+   0.293 
   607.36744     607.36733    b5   -0.189 
   610.32386     610.32415    y102+    0.475 
   611.33000     611.33017    (b‡10-2H2O)2+   0.282 
   611.82201     611.82210    (b‡10-H2O-NH3) 2+  0.151 
   613.31665     613.31672    y5    0.114 
   615.34311     615.34310    a‡10 2+   -0.008 
   620.33528     620.33542    (b‡10-H2O) 2+   0.226 
   621.80804     621.80806    (y‡10-NH3) 2+   0.024 
   629.34056     629.34062    b‡10 2+    0.091 
   630.32132     630.32168    y‡10 2+    0.575 
   643.34761     643.34767   [M-CO-2NH3+2H] 2+   0.093 
   647.36236     647.36242    b‡5-H2O   0.093 
   648.33951     648.33961   [M-H2O-2NH3+ 2+H] 2+  0.150 
   656.85279     656.85312   [M-H2O-NH3+2H] 2+   0.510 
   657.34479     657.34511   [M-2NH3+2H] 2+   0.479 
   665.85807     665.85839    [M-NH3+2H] 2+  0.484 
   668.33697     668.33723   [M‡-2H2O-2NH3+2H] 2+  0.389 
   671.85807     671.85847   [M‡-H2O-HCONH2+2H] 2+  0.599 
   674.37134     674.37171    [M+2H] 2+   0.549 
   676.85025     676.84989   [M‡-2H2O-NH3+2H] 2+  -0.532 
   685.36352     685.36279   [M‡-2H2O+2H] 2+  -1.058 
   685.85553     685.85596   [M‡-H2O-NH3+2H] 2+   0.627 
 B-20 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   694.36880     694.36868   [M‡-H2O+2H] 2+  -0.173 
   694.86081     694.86073   [M‡-NH3+2H] 2+  -0.115 
   707.43111     707.43161    a6    0.707 
* 735.42602     735.42655    b6    0.714 
   741.37523     741.37457    y6   -0.890 
   758.39440     758.39444    b‡6-H2O-NH3   0.059 
   775.42094     775.42085    b‡6-H2O  -0.116 
   882.49443     882.49425    b7   -0.210 
   922.48935     922.48912    b‡7-H2O  -0.249 
   940.49991     940.50021    b‡7    0.314 
   949.46003     949.45983    y8-NH3  -0.211 
   966.48657     966.48587    y8   -0.724 
  1029.56284    1029.56278    b8   -0.063 
  1069.55776    1069.55822    b‡8-H2O   0.430 
  1086.58431    1086.58328    b9   -0.943 
  1109.55267    1109.55262    b‡9-H2O-NH3  -0.050 
*1122.58768    1122.58837    y9    0.615 
  1126.57922    1126.57876    b‡9-H2O  -0.408 
  1162.58260    1162.58237    y‡9-H2O  -0.194 
  1199.66836    1199.66835    b10   -0.013 
  1219.64044    1219.64167    y10    1.008 
  1221.65271    1221.65296    b‡10-2H2O   0.201 
*1239.66328    1239.66427    b‡10-H2O  0.799 
mean   
St. Dv.  
 
Table B-14.  DR(695)-ECD(724) error analysis of the AcKM-11 peptide reacted in MeOH/H2O (50:50) 
for the precursor ion [M+C2H2O2+2H]2+.  * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
* 466.24824     466.24821    y4   -0.064 
   537.33815     537.33815    c4•    0.000 
   538.34597     538.34597    c4   -0.009 
   577.33307     577.33304    c‡4•-H2O  -0.043 
   578.34089     578.34093    c‡4-H2O   0.069 
   595.34363     595.34362    c‡4•   -0.017 
   596.35145     596.35144    c‡4   -0.025 
   665.39673     665.39673    c5•    0.000 
* 666.40455     666.40453    c5   -0.038 
   705.39165     705.39163    c‡5●-H2O  -0.021 
   706.39947     706.39949    c‡5-H2O   0.028 
   707.32214     707.32211    y6-2NH3  -0.042 
   715.37408     715.37411    [M‡-H2O+2H] 2+  0.042 
   723.40221     723.40218    c‡5•   -0.041 
   724.34869     724.34872    y-NH3    0.041 
 B-21 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   724.37937     724.37935    [M‡+2H] 2+  -0.028 
   724.41003     724.40994    c‡5   -0.131 
   793.45531     793.45538    c6•    0.088 
* 794.46313     794.46313    c6   -0.006 
   833.45023     833.45027    c‡6•-H2O   0.054 
   834.45805     834.45808    c‡6-H2O   0.036 
   851.46079     851.46077    c‡6•   -0.023 
   852.46861     852.46858    c‡6   -0.041 
   940.52372     940.52371    c7•   -0.011 
   941.53155     941.53153    c7   -0.016 
   980.51864     980.51854    c‡7•-H2O  -0.097 
   981.52646     981.52653    c‡7-H2O   0.071 
   998.52920     998.52932    c‡7•    0.120 
   999.53702     999.53706    c‡7    0.035 
  1072.54485    1072.54456    z‡9•-C3H6S-H2O -0.270 
  1088.59995    1088.60009    c8    0.124 
  1090.55542    1090.55611    z‡9•-C3H6S   0.633 
  1102.59181    1102.59178    a‡8   -0.023 
  1106.56896    1106.56822    z9•   -0.669 
  1128.59487    1128.59427    c‡8-H2O  -0.532 
* 1145.62142    1145.62136    c9   -0.048 
  1146.56388    1146.56376    z‡9•-H2O  -0.105 
  1146.60543    1146.60548    c‡9    0.039 
  1164.57444    1164.57441    z‡9●   -0.026 
  1185.61633    1185.61642    c‡9-H2O   0.076 
  1203.62690    1203.62689    c‡9   -0.004 
  1257.69765    1257.69821    c10•    0.445 
  1258.70547    1258.70562    c10    0.115 
  1298.70039    1298.70020    c‡10-H2O  -0.146 
  1315.70313    1315.70351    c‡10•    0.289 
  1316.71096    1316.71107    c‡10    0.087 
  1330.70879    1330.70871   [M-CH3CONH2+H] 1+  -0.465 
  1331.71662    1331.71689   [M-CH3CONH2+2H] 1+•  0.613 
1347.73541    1347.73557   [M-CH2CO+H] 1+  -0.383 
1348.74323    1348.74359   [M-CH2CO+2H] 1+•  -0.073 
  1356.72969    1356.72917   [M‡-H2O-C3H6S+2H] 1+• -0.386 
      1371.71170    ? 
  1385.72719    1385.72715   [M‡-HCONH2.-H2O+2H] 1+• -0.028 
      1388.73815   ? 
* 1405.74089    1405.74103   [M‡-CH2CO+H] 1+   0.099 
mean   
St. Dv.  
 
 
 B-22 
Table B-15.  CAD (724) error analysis of the Ac-KM-11 peptide reacted in MeOH/H2O (50:50) for the 
precursor ion [M+C2H2O2+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
* 245.13183     245.13181    y2-NH3  -0.082 
   262.15837     262.15838    y2    0.038 
   268.16556     268.16558    b2    0.075 
   272.15553     272.15532    (b‡6-2H2O) 2+  -0.772 
   302.15329     302.15329    y3-NH3   0.000 
   319.17983     319.17983    y3    0.000 
   424.26667     424.26666    b3   -0.024 
   436.26667     436.26664    a‡3-H2O       0.183 
   446.25102     446.25111    b‡3-2H2O   0.202 
   447.23504     447.23525    b‡3-H2O-NH3   0.470 
   449.22170     449.22169    y4-NH3  -0.022 
   451.23759     451.23746    (a‡7-2H2O-NH3) 2+ -0.277 
   464.26159     464.26157    b‡3-H2O  -0.032 
* 466.24824     466.24820    y4   -0.086 
   468.75614     468.75606   (a‡7-H2O) 2+   -0.171 
   473.74831     473.74828   (b‡7-2H2O) 2+   -0.074 
   474.24032     474.24038   (b‡7-H2O-NH3) 2+  0.116 
   482.27215     482.27209   b‡3    -0.124 
   482.75360     482.75359   (b‡7-H2O) 2+   -0.016 
   491.75888     491.75882   b‡7 2+    -0.122 
   522.29289     522.29271   a8 2+    -0.341 
   527.77707     527.77682   (b8-NH3) 2+   -0.479 
   533.28506     533.28496   (a‡8-2H2O) 2+   -0.192 
   533.77707     533.77689   (a‡8-H2O-NH3) 2+  -0.342 
   536.29035     536.29012   b8 2+    -0.420 
   538.76925     538.76878   (b9-H2O-2NH3) 2+  -0.868 
   539.26126     539.26097   (b‡8-H2O-2NH3) 2+  -0.533 
   542.29035     542.29012   (a‡8-H2O) 2+   -0.415 
   547.77453     547.77430   (b‡8-H2O-NH3) 2+  -0.420 
   551.29563     551.29553   a‡8 2+    -0.177 
   556.77981     556.77957   (b‡8-NH3) 2+   -0.436 
   561.31435     561.31392   b‡4-H2O   -0.757 
   562.28780     562.28731   (a‡9-H2O-NH3) 2+  -0.876 
   564.80107     564.80077   b9 2+    -0.540 
   565.29309     565.29284   b‡8 2+    -0.433 
   567.27998     567.27981   (b‡9-2H2O-NH3) 2+  -0.295 
   570.80107     570.80071   (a‡9-H2O) 2+   -0.639 
   575.79325     575.79292   (b‡9-2H2O) 2+   -0.573 
   576.28526     576.28506   (b‡9-H2O-NH3) 2+  -0.347 
   584.79853     584.79822   (b‡9-H2O) 2+   -0.534 
   585.29054     585.29026   (b‡9-NH3) 2+   -0.483 
   593.80381     593.80351   b‡9 2+    -0.514 
* 596.29011     596.28977   y5-NH3   -0.570 
   601.81059     601.81023   (y10-NH3) 2+   -0.598 
  603.82455     603.82413   (b10-H2O-NH3) 2+  -0.696 
 B-23 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   607.34565     607.34530   a10 2+    -0.573 
   610.32386     610.32347   y10 2+    -0.639 
   612.82983     612.82945   (b10-NH3) 2+   -0.625 
   613.31665     613.31630   y5    -0.571 
   618.33782     618.33757   (a‡10-2H2O) 2+   -0.408 
   618.82983     618.82943   (a‡10-H2O-NH3) 2+   0.650 
   621.31604     621.31564   (y‡10-2H2O) 2+   -0.636 
   621.34311     621.34273   b10 2++    -0.604 
   623.82201     623.82162   (b‡10-2H2O-NH3) 2+  -0.621 
   624.31402     624.31359   (b‡10-H2O-2NH3) 2+  -0.685 
   627.34311     627.34271   (a‡10-H2O) 2+   -0.630 
   630.32132     630.32091   (y‡10-H2O) 2+   -0.646 
   630.81333     630.81291   (y‡10-NH3) 2+   -0.662 
   632.33528     632.33489   (b‡10-2H2O) 2+   -0.617 
   632.82729     632.82689   (b‡10-H2O-NH3) 2+  -0.632 
   636.34839     636.34793   a‡10 2++    -0.719 
   639.32660     639.32617   y‡10 2+    -0.673 
   641.34056     641.34016   (b‡10-H2O) 2+   -0.628 
   641.83257     641.83201   (b‡10-NH3) 2+   -0.876 
* 649.37801     649.37757   b5    -0.678 
   650.34585     650.34538   b‡10 2+    -0.715 
   669.34479     669.34421   [M-H2O-2NH3+2H] 2+ -0.874 
   672.86589     672.86549   [M-HCONH2+2H] 2+  -0.599 
   678.35008     678.34956   [M-2NH3+2H] 2+  -0.764 
   683.85807     683.85750  [M‡-2H2O-HCONH2+2H] 2+  -0.830 
   684.35008     684.34968  [M‡-H2O-HCONH2-NH3+2H] 2+ -0.581 
   686.86335     686.86287   [M-NH3+2H] 2+  -0.699 
   689.34225     689.34168  [M‡-2H2O-2NH3+2H] 2+  -0.831 
   689.37293     689.37242   b‡5-H2O   -0.733 
   692.86335     692.86291  [M‡-H2O-HCONH2+2H] 2+  -0.635 
   694.36880     694.36810  [M‡-CH2CO-H2O+2H] 2+  -1.005 
   697.85553     697.85501   [M‡-2H2O-NH3+2H] 2+ -0.745 
   698.34753     698.34702   [M‡-H2O-2NH3+2H] 2+ -0.737 
   701.86863     701.86791   [M‡-HCONH2+2H] 2+  -1.029 
   706.86081     706.86031   [M‡-H2O-NH3+2H] 2+  -0.707 
* 707.32214     707.32167   y6-2NH3   -0.664 
   715.37408     715.37355   [M‡-H2O+2H] 2+  -0.741 
   715.38859     715.38807   a6-2NH3   -0.720 
   715.86609     715.86551   [M-NH3+2H] 2+  -0.810 
   724.34869     724.34829   y6-NH3   -0.552 
   724.37937     724.37889   [M‡+2H] 2+   -0.663 
   741.37523     741.37467   y6    -0.755 
   749.44168     749.44158   a6    -0.127 
   754.39948     754.39897   a‡6-2H2O-NH3   -0.676 
   771.42602     771.42544   a‡6-2H2O   -0.758 
   774.40189     774.40163   a‡6-2NH3   -0.342 
   777.43659     777.43607   b6    -0.669 
   789.43659     789.43656   a‡6-H2O   -0.038 
 B-24 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   799.42094     799.42034   b‡6-2H2O   -0.751 
   800.40496     800.40416   b‡6-H2O-NH3   -0.999 
   817.43151     817.43102   b‡6-H2O   -0.593 
   827.44370     827.44377   a7-2NH3-2H2O   0.091 
   835.38072     835.38108   y7-2NH3    0.431 
   835.44207     835.44178   b‡6    -0.347 
   896.51009     896.50945   a7    -0.708 
   901.46789     901.46743   a‡7-2H2O-NH3   -0.510 
   907.47846     907.47768   b7-NH3   -0.854 
* 924.50500     924.50461   b7    -0.422 
   932.43348     932.43305   y8-2NH3   -0.461 
   936.50500     936.50489   a‡7-H2O   -0.117 
   946.48935     946.48871   b‡7-2H2O   -0.676 
   947.47337     947.47309   b‡7-H2O-NH3   -0.296 
   948.47739     948.47741   b‡7-2NH3    0.021 
   949.46003     949.45971   y8-NH3   -0.337 
   964.49991     964.49948   b‡7-H2O   -0.451 
   966.48657     966.48616   y8    -0.424 
   982.51048     982.50948   b‡7    -1.018 
  1043.57849    1043.57856   a8     0.062 
  1054.54687    1054.54694   b8-NH3    0.071 
  1083.57341    1083.57345   a‡8-H2O    0.037 
  1093.55776    1093.55784   b‡8-2H2O    0.073 
  1094.54178    1094.54184   b‡8-H2O-NH3    0.055 
  1095.54580    1095.54562   b‡8-2NH3   -0.164 
  1111.56832    1111.56860   b‡8-H2O    0.247 
  1128.59487    1128.59498   b9     0.097 
  1145.55605    1145.55618   y‡9-H2O-NH3    0.113 
  1150.57922    1150.57922   b‡9-2H2O    0.000 
  1151.56324    1151.56350   b‡9-H2O-NH3    0.226 
  1152.56726    1152.56691   b‡9-2NH3   -0.304 
  1162.58260    1162.58358   y‡9-H2O    0.847 
  1168.58978    1168.59043   b‡9-H2O    0.552 
  1213.68402    1213.68430   a10     0.235 
*1219.64044    1219.64096   y10     0.426 
  1241.62479    1241.62548   y‡10-2H2O    0.556 
  1241.67893    1241.67964   b10     0.572 
  1242.60881    1242.60940   y‡10-H2O-NH3    0.475 
  1253.67893    1253.67925   a‡10-H2O    0.255 
  1259.63536    1259.63548   y‡10-H2O    0.095 
*1281.67385    1281.67448   b‡10-H2O    0.498 
mean   
 St. Dv.  
 
 B-25 
Table B-16.  CAD (724) error analysis of the AcKM-11 peptide reacted in PBS for the precursor ion 
[M+C2H2O2+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
* 245.13183     245.13180    y2-NH3  -0.122 
   262.15837     262.15838    y2    0.038 
   268.16556     268.16561    b2    0.186 
   302.15329     302.15337    y3-NH3   0.265 
   319.17983     319.17993    y3    0.313 
   409.21939     409.21948    (b‡6-H2O)2+   0.214 
   418.22467     418.22465    b‡6 2+   -0.060 
   424.26667     424.26667    b3    0.000 
   436.26667     436.26637    a‡3-H2O  -0.688 
   446.25102     446.25125    b‡3-2H2O   0.515 
   448.75869     448.75877    a72+    0.189 
   449.22170     449.22176    y4-NH3   0.134 
   460.24287     460.24315    (a‡7-H2O-NH3)2+   0.614 
   462.75614     462.75605    b7 2+   -0.194 
   464.26159     464.26166    b‡3-H2O   0.162 
* 466.24824     466.24820    y4   -0.086 
   468.75614     468.75591    (a‡7-H2O)2+  -0.491 
   473.74831     473.74851    (b‡7-2H2O)2+   0.412 
   474.24032     474.24031    (b‡7-H2O-NH3)2+ -0.032 
   482.27215     482.27207    b‡3   -0.166 
   482.75360     482.75353    (b‡7-H2O)2+  -0.140 
   491.75888     491.75901    b‡72+    0.264 
   513.77989     513.77941    (a8-NH3)2+  -0.930 
   521.31943     521.31948    b4    0.096 
   522.29289     522.29279    a82+   -0.188 
   527.28506     527.28507    (b8-H2O)2+   0.013 
   527.77707     527.77702    (b8-NH3)2+  -0.100 
   533.28506     533.28475    (a‡8-2H2O)2+  -0.586 
   533.77707     533.77697    (a‡8-H2O-NH3)2+  -0.192 
   536.29035     536.29040    b82+    0.103 
   538.76925     538.76963    (b9-H2O-2NH3)2+   0.709 
   539.26126     539.26151    (b‡8-H2O-2NH3)2+  0.468 
   542.29035     542.29044    (a‡8-H2O)2+   0.175 
   547.77453     547.77455    (b‡8-H2O-NH3)2++  0.037 
   551.29563     551.29588    a‡82+    0.453 
   556.28780     556.28785    (b9-NH3)2+   0.084 
   561.31435     561.31494    b‡4-H2O   1.060 
   562.28780     562.28776    (a‡9-H2O-NH3)2+ -0.076 
   564.80107     564.80099    b92+   -0.150 
   565.29309     565.29290    b‡82+   -0.327 
   567.27998     567.27958    (b‡9-2H2O-NH3)2+ -0.701 
   570.80107     570.80103    (a‡9-H2O)2+  -0.079 
   575.79325     575.79316    (b‡9-2H2O)2++  -0.156 
   576.28526     576.28587    (b‡9-H2O-NH3)2+  1.059 
   584.79853     584.79850    (b‡9-H2O)2+  -0.056 
 B-26 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   585.29054     585.29047    (b‡9-NH3)2+  -0.124 
   593.80381     593.80390    b2++    0.143 
* 596.29011     596.29017    y5-NH3    0.101 
   601.81059     601.81067    (y10-NH3)2+   0.133 
   607.34565     607.34569    a102+    0.066 
   610.32386     610.32392    y102+    0.098 
   612.82983     612.82982    (b10-NH3)2+  -0.021 
   613.31665     613.31679    y5    0.228 
   618.82983     618.82974    (a‡10-H2O-NH3)2+ -0.149 
   621.31604     621.31604    (y‡10-2H2O)2+   0.008 
   621.34311     621.34326    b102+    0.249 
   623.82201     623.82229    (b‡10-2H2O-NH3)2+  0.453 
   624.31402     624.31429    (b‡10-H2O-2NH3)2+  0.436 
   627.34311     627.34320    (a‡10-H2O)2+   0.151 
   630.32132     630.32138    (y‡10-H2O)2+   0.099 
   630.81333     630.81319    (y‡10-NH3)2+  -0.218 
   632.33528     632.33522    (b‡10-2H2O)2+  -0.095 
   632.82729     632.82729    (b‡10-H2O-NH3)2+  0.000 
   636.34839     636.34836    a‡102+   -0.043 
   639.32660     639.32663    y‡102+    0.047 
   641.34056     641.34066    (b‡10-H2O)2+   0.152 
* 649.37801     649.37814    b5    0.200 
   650.34585     650.34602    b‡102+    0.269 
   663.86061     663.86012   [M-H2O-HCONH2+2H]2+ -0.738 
   664.35289     664.35265   [M-NH3-HCONH2+2H] 2+ -0.366 
   669.34479     669.34444   [M-H2O-2NH3+2H]2++ -0.530 
   671.36236     671.36214    b‡5-2H2O  -0.328 
   672.86589     672.86578   [M-HCONH2+2H]2+  -0.168 
   674.37134     674.37147   [M-CH2CO+2H]2+   0.193 
   677.85807     677.85810   [M-H2O-NH3+2H]2++   0.047 
   678.35008     678.35000   [M-2NH3+2H] 2+  -0.115 
   683.85807     683.85799  [M‡-2H2O- HCONH2+2H]2+  -0.113 
   684.35008     684.35011   [M‡-H2O-2NH3+2H]2+  0.047 
   686.37134     686.37133    [M-H2O+2H]2+ -0.015 
   686.86335     686.86348    [M-NH3+2H]2+  0.189 
   689.34225     689.34227   [M‡-2H2O-2NH3+2H]2+  0.025 
   689.37293     689.37303    b‡5-H2O   0.152 
   689.83426     689.83429   [M‡-H2O-3NH3+2H] 2+  0.040 
   692.86335     692.86348   [M‡-H2O-HCONH2+2H] 2+  0.188 
   694.36880     694.36823   [M-H2O-CH2CO+2] 2+ -0.817 
   695.37663     695.37662    [M+2H] 2+]  -0.014 
   697.85553     697.85577   [M-2H2O-NH3+2H] 2+  0.344 
   698.34753     698.34777   [M‡-H2O-2NH3+2H] 2+  0.337 
   701.86864     701.86896   [M‡-HCONH2+2H] 2+   0.463 
   706.36880     706.36810   [M‡-2H2O+2H] 2+  -0.991 
   706.86081     706.86150   [M‡-H2O-NH3+2H] 2+   0.976 
   707.32214     707.32282    y6-2NH3   0.961 
   799.42094     799.42094    b‡6-2H2O   0.000 
 B-27 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   817.43151     817.43091    b‡6-H2O  -0.728 
   835.38072     835.38096    y7-2NH3   0.287 
   835.44207     835.44123    b‡6   -1.005 
   901.46789     901.46825    a‡7-2H2O-NH3   0.399 
* 924.50500     924.50467    b7   -0.357 
   932.43348     932.43340    y8-2NH3  -0.086 
   936.50500     936.50470    a‡7-H2O  -0.320 
   946.48935     946.48905    b‡7-2H2O  -0.317 
   947.47337     947.47368    b‡7-H2O-NH3   0.327 
   948.47739     948.47777    b‡7-2NH3   0.401 
   964.49991     964.49949    b‡7-H2O  -0.441 
   966.48657     966.48593    y8   -0.662 
   982.51048     982.50975    b‡7   -0.743 
   990.53082     990.53175    a8-2H2O-NH3   0.939 
  1043.57849    1043.57809    a8   -0.388 
  1054.54687    1054.54710    b8-NH3   0.223 
  1066.54687    1066.54678    a9 -2NH3  -0.080 
  1071.52848    1071.52932    a‡9-2NH3-2H2O  0.784 
  1083.57341    1083.57337    a‡8-H2O  -0.037 
  1093.55776    1093.55717    b‡8-2H2O  -0.540 
  1094.54178    1094.54151    b‡8-H2O-NH3  -0.247 
  1095.54580    1095.54509    b‡8-2NH3  -0.648 
  1111.56832    1111.56911    b‡8-H2O   0.706 
  1150.57922    1150.57844    b‡9-2H2O  -0.678 
  1162.58260    1162.58155    y‡9-H2O  -0.903 
  1168.58978    1168.58999    b‡9-H2O   0.175 
  1185.58735    1185.58818    y10-2NH3   0.700 
  1202.61389    1202.61311    y10-NH3  -0.653 
  1213.68402    1213.68290    a10   -0.919 
*1219.64044    1219.64002    y10   -0.344 
  1236.67620    1236.67614    a‡10-2H2O  -0.044 
  1241.62479    1241.62375    y‡10-2H2O  -0.838 
  1241.67893    1241.67869    b10   -0.193 
*1242.60881    1242.60803    y‡10-H2O-NH3  -0.628 
mean   
St. Dv.  
 
Table B-17.  DR(595.03)-ECD(608.36) mass error analysis of the EK-15 peptide reacted in MeOH/H2O 
solution for the precursor ion [M+C2O+3H]3+. * indicates the masses used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  303.17752  303.17752 c2 0.000 
325.16187  325.16189 c†2 - H2O 0.062 
  334.17210 ?   
343.17244  343.17243 c†2 -0.015 
 B-28 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  343.24655  343.24655 z3• 0.000 
344.25438  344.25437 
 z3 -0.015 
  348.15138 ?  
359.26527  359.26529 y3 0.056 
387.22247  387.22247 a3 0.000 
400.75868  400.75866 c6 2+ -0.050 
  411.75076 ?   
413.22554  413.22552 c3- H2O -0.036 
413.27584  413.27584 w4 0.012 
427.21739  427.21738 a†3 -0.012 
431.23610  431.23610 c3 0.000 
453.22045  453.22046 c†3-H2O 0.022 
464.78797  464.78796 c7 2+  -0.022 
*  471.23102  471.23101 c†3 -0.011 
472.28914  472.28914 z4• 0.000 
473.29697  473.29699 z4 0.053 
  473.31942 ?   
488.30786  488.30785 y4 -0.020 
500.30653  500.30653 a4 0.000 
500.80549  500.80544 y9 2+ -0.100 
515.31181  515.31180 c8 2+ -0.019 
526.30959 526.30959 c4- H2O -0.010 
540.30145 540.30145 a†4 0.009 
544.32016  544.32016 c4 0.000 
550.83037  550.83031 c9 2+ -0.100 
556.84361  556.84363 z10• 2+ 0.036 
561.82254  561.82231 (c†9-H2O) 2+ -0.409 
566.30451  566.30450 c†4 - H2O -0.018 
571.35755  571.35755 z5• 0.000 
  582.29941 ?   
*  584.31508  584.31507 c†4 -0.009 
587.37627  587.37628 y5 0.017 
589.02799  589.02801 [M -H2O+3H]3+ 0.040 
602.35963  602.35964 [M†-H2O+3H]3+ 0.025 
608.36315  608.36310 [M†+3H]3+ -0.077 
620.89109  620.89103 z11• 2+  -0.096 
628.40149  628.40142 a5 -0.111 
641.38629  641.38683 z6•-C3H7 0.850 
650.38584  650.38576 a†5 – H2O -0.123  
654.40456  654.40453 c5- H2O -0.038 
656.90660  656.90656 c11 2+ -0.061 
 B-29 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
668.39641  668.39632 a†5 -0.127 
672.41512  672.41512 c5 0.000 
677.43312  677.43316 z12• 2+ 0.059 
684.44161  684.44160 z6• -0.015 
*  694.39947  694.39946 c†5- H2O -0.014 
  699.41610 ?   
700.46033  700.46030 y6 -0.043 
  705.93754 ?   
712.41004  712.40999 c†5 -0.063 
721.42790  721.42790 c12 2+ 0.007 
  726.42567 ?   
*  732.42007 732.42008 (c†12-H2O) 2+ 0.014 
 738.42032 ?   
741.42535 741.42532 c†12 2+ -0.044 
741.46241 741.46246 z13• 2+ 0.067 
749.47177 749.47175 y13 2+ -0.027 
755.47872  755.47873 z7• 0.013 
768.96464  768.96479 (c13-H2O)2+ 0.192 
771.49744  771.49740 y7 -0.052 
777.96993  777.97015 c13 2+ 0.289 
782.49952  782.49953 c6- H2O 0.019 
788.96210  788.96207 (c†13-2 H2O)2+ -0.038 
796.49136  796.49194 a†6 0.728 
799.50226  799.50229 c6• 0.044 
  800.46373 ?   
800.51008  800.51009 c6 0.012 
  804.48386 ?   
818.49885  818.49881 (c14- H2O)2+ -0.046 
819.51297  819.51289 z14• 2+ -0.092 
822.49443  822.49445 c†6- H2O 0.024 
825.49477  825.49469 a†14 2+ -0.100 
827.50413  827.50447 c14 2+ 0.411 
827.52233  827.52283 y14 2+ 0.610 
829.49102  829.49088 (c†14-2 H2O) 2+ -0.172 
  833.51004 ?   
838.49631  838.49628 (c†14-H2O) 2+ -0.030 
839.51042  839.51077 z†14• 2+ 0.414 
*  840.50500  840.50494 c†6 -0.065 
847.50159  847.50157 c†14 2+ -0.021 
  854.51065 ?   
 B-30 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
856.52640  856.52662 z8• 0.257 
872.54512  872.54516 y8 0.046 
883.03834  883.03825 [M -H2O+2H]2+ -0.102 
894.03052  894.03059 [M†-2H2O+2H]2+ 0.084 
903.03580  903.03580 [M†-H2O+2H]2+ 0.003 
910.55810  910.55835 c6- H2O 0.280 
912.04108  912.04102 [M†+2H]2+ -0.066 
912.54499  912.54417 [M†+3H]2+• -0.899 
924.54995  924.54975 a†7 -0.211 
  928.52210 ?   
928.56866  928.56895 c7 0.312 
  932.54245 ?   
950.55301  950.55296 c†7- H2O -0.053 
966.57442 966.57427 z9•-H2O -0.150 
*  968.56358  968.56340 c†7 -0.181 
984.58498  984.58488 z9• -0.102 
1000.60370  1000.60347 y9 -0.230 
1007.58706  1007.58704 a†8 - H2O -0.020 
1011.60578  1011.60570 c8- H2O -0.074 
  1022.53180 ?   
1025.59763  1025.59729 a†8 -0.327 
  1028.58453 *   
1029.61634  1029.61606 c8 -0.272 
  1033.59009 ?   
  1040.65889 ?   
1051.60069  1051.60055 c†8- H2O -0.133 
  1056.61728 ?   
1065.61634  1065.61635 b9-H2O 0.009 
*  1069.61126  1069.61105 c†8 -0.192 
1082.64289  1082.64277 c9- H2O -0.106 
  1084.66117 ?   
1094.64557  1094.64572 y10-2NH3 0.137 
1096.63474  1096.63406 a†9 -0.616 
1100.65345  1100.65300 c9 -0.409 
1112.67994  1112.67976 z10•   
1122.63780  1122.63766 c†9- H2O -0.125 
1128.69866  1128.69841 y10 -0.221 
*  1140.64837  1140.64811 c†9 -0.224 
1166.64613  1166.64559 QIKKQTALVEL-H2O-4NH3 -0.463 
 B-31 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
1195.72695  1195.72664 c10- H2O -0.255 
1213.73751  1213.73871 c10 0.989 
1222.74053  1222.74035 y11 - 2NH3 -0.147 
  1225.76381 ?   
1235.72186  1235.72148 c†10 - H2O -0.308 
1240.77490  1240.77461 z11• -0.234 
*  1253.73243  1253.73217 c†10 -0.203 
1256.79362  1256.79336 y11 -0.207 
1294.79536  1294.79511 c11 - H2O -0.189 
1312.80592  1312.80505 c11 -0.663 
  1316.78006 ?   
1334.79027  1334.78997 c†11 - H2O -0.225 
1349.74501  1349.74452 a†12 -3H2O-2NH3 -0.363 
1352.80084  1352.80044 c†11 -0.292 
1353.85896  1353.85871 z12• -0.185 
1369.87768  1369.87658 y12 -0.803 
1423.837945 1423.83769 c12- H2O -0.179 
  1445.82216 ?   
*  1463.83286  1463.83252 c†12- H2O -0.232 
1481.84343  1481.84315 c†12 -0.186 
1481.91754  1481.91714 z13• -0.270 
 1495.93347 ?  
1497.93626  1497.93669 y13 0.287 
1536.92201  1536.92143 c13- H2O -0.374 
*  1576.91692  1576.91833 c†13- H2O 0.894 
1635.99042  1635.99012 c14- H2O -0.180 
*  1639.02648  1639.02559 z14 -0.540 
1806.07214  1806.07273 [M†-H2O+2H]1+• 0.329 
*  1824.08270  1824.08089 [M†+2H]1+• -0.992 
Mean -0.342  
St.Dv. 0.044 
 
Table B-18.  CAD mass error analysis of the EK-15 peptide reacted in MeOH/H2O solution for the 
precursor ion [M+C2O+3H]3+.  * indicates the masses used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  246.18121  246.18123 y2 0.081 
268.14041  268.14041 b2  -H2O 0.000 
308.13533  308.13533 b†2  -H2O 0.016 
*  326.14589  326.14593 b†2 0.123 
359.26527  359.26526 y3 -0.028 
 B-32 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
367.23398  367.23396 TALV-H2O -0.041 
374.23484  374.23484 (b6-2H2O) 2+ -0.007 
374.72685  374.72672 (b6-H2O-NH3) 2+ -0.354 
379.17245  379.17241 b3  -H2O-NH3 -0.092 
379.19760  379.19759 QTAL-H2O-NH3 -0.026 
383.24013  383.24009 b62+ -0.091 
385.24454  385.24451 TALV -0.078 
394.23230  394.23224 (b†6-2H2O) 2+ -0.152 
395.22889  395.22885 ALVE-H2O -0.089 
396.19899  396.19895 b3  -H2O -0.101 
397.20817  397.20813 QTAL-NH3 -0.088 
403.23758  403.23757 (b†6-H2O)2+ -0.031 
411.23505 411.23498 KQTA-H2O -0.158 
*  412.24287 412.24283 b†6 2+ -0.085 
413.23945 413.23946 ALVE 0.024 
413.27584 413.27579 VELV-CO -0.109 
427.29149  427.29143 LVEL-CO -0.129 
429.24561  429.24555 KQTA -0.140 
429.75086  429.75075 (b7-2H2O-NH3)2+ -0.256 
436.19391  436.19390 b†3  -H2O -0.011 
437.27584  437.27568 LVEL-CO -0.354 
438.26413  438.26408 (b7-2H2O) 2+ -0.120 
438.75614  438.75612 (b7-H2O-NH3) 2+ -0.051 
441.27075  441.27073 VELV-CO -0.045 
447.26942  447.26939 (b7-H2O) 2+ -0.056 
  447.77104 ?   
*  454.20447  454.20441 b†3 -0.132 
455.28640  455.28634 LVEL -0.132 
458.26159  458.26158 (b†7-2H2O) 2+ -0.022 
  464.26162 ?   
467.26687  467.26684 (b†7-H2O) 2+ -0.070 
  468.28163 ?   
470.29730  470.29727 y4-H2O -0.053 
476.27216  476.27214 b†7 2+ -0.031 
 477.28186 ?  
 477.79585 ?  
481.28814  481.28812 a4 -H2O -0.031 
482.79493  482.79482 (y9-2H2O) 2+ -0.217 
486.30346  486.30346 KKQT 0.000 
488.30786  488.30783 y4 -0.061 
491.80021  491.80022 (y9-H2O) 2+ 0.025 
495.29256  495.29254 QTALV-H2O -0.030 
496.27657  496.27653 TALVE-H2O -0.071 
 B-33 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
497.79326  497.79324 (b8-H2O) 2+ -0.030 
  498.32849 ?   
508.31295  508.31299 ALVEL-H2O 0.089 
508.78543  508.78547 (b†8-2H2O) 2+ 0.079 
509.28305  509.28300 b4 -H2O -0.098 
510.26707  510.26710 b4 -NH3 0.059 
514.28713  514.28711 TALVE-H2O -0.041 
515.79326  515.79317 (b9-2H2O-NH3) 2+ -0.165 
*  517.79071  517.79065 (b†8-H2O) 2+ -0.121 
521.28305  521.28300 a†4 -H2O -0.096 
522.30346  522.30356 KKQTA-H2O-NH3 0.191 
524.30653  524.30632 (b9-2H2O) 2+ -0.396 
524.31911  524.31906 KQTAL-H2O -0.086 
524.79854  524.79843 (b9-H2O-NH3) 2+ -0.205 
526.32351  526.32352 ALVEL 0.019 
526.34599  526.34596 RQIK -0.057 
527.29362  527.29358 b4 -0.066 
531.26740  531.26726 b†4 -2H2O -0.264 
533.31181  533.31179 (b9-H2O) 2+ -0.038 
  536.99418 ?   
539.29362  539.29351 a†4 -0.195 
539.33001  539.32996 KKQTA-H2O -0.083 
542.31709  542.31716 b9 2+ 0.124 
542.32967  542.32970  KQTAL 0.055 
549.27797  549.27791 b†4 -H2O -0.100 
  550.30670 ?   
552.01731  552.01714 y14 3+ -0.308 
553.30927  553.30923 (b†9-H2O) 2+ -0.068 
554.35481  554.35476 LVELV -0.090 
555.84769  555.84772 (y10-H2O) 2+ 0.058 
556.33970  556.33973 (y10-NH3) 2+ 0.058 
557.34057  557.34053 KKQTA -0.072 
562.31455  562.31459 b†9 2+ 0.071 
  563.29352 ?   
564.85297  564.85288 y10 2+ -0.159 
*  567.28853  567.28850 b†4 -0.053 
569.36571  569.36558 y5-H2O -0.220 
 577.34884 ?   
580.84856  580.84854 (b10-2H2O) 2+ -0.030 
587.37627  587.37626 y5 -0.017 
589.02799  589.02797 [M-C2O-H2O+3H]3+ -0.028 
589.85384  589.85383 (b10-H2O) 2+ -0.017 
 B-34 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
595.03151  595.03153 [M+C2O+3H]3+ 0.036 
596.35610  596.35603  [M+C2O-2H2O+3H]3+ -0.123 
597.39701  597.39720  ALVELV-CO 0.326 
598.85912  598.85901 b10 2+ -0.188 
600.84602  600.84602  (b†10-2H2O) 2+ 0.008 
602.35963  602.35960  [M+C2O-H2O+3H]3+ -0.042 
606.32458  606.32468  QTALVE-2H2O 0.165 
 607.03155  ?   
608.36315  608.36308  [M+C2O+3H]3+ -0.110 
609.36063  609.36062  TALVEL-H2O -0.008 
609.85157  609.85126  (b†10-H2O) 2+ -0.508 
*  618.85658  618.85651  b†10 2+ -0.113 
620.35147  620.35164  b5  -H2O-NH3 0.282 
623.38752  623.38758  KQTALV-H2O 0.104 
624.33515  624.33527  QTALVE-H2O 0.200 
 625.31912  ?  
628.90045  628.90041  y11 2+ -0.064 
637.37801  637.37801 b5  -H2O 0.000 
648.39333  648.39315 b11 2+ -0.274 
655.38858  655.38862 b5 0.069 
659.38550  659.38542 (b†11-H2O) 2+ -0.125 
668.39079  668.39086  b†112+ 0.112 
677.37293  677.37293 b†5  -H2O 0.007 
682.44977  682.44980 y6-H2O 0.051 
685.44248  685.44229 y12 2+ -0.277 
694.90406  694.90426 (b12-2H2O) 2+ 0.291 
*  695.38349 695.38352 b†5 0.043 
700.46033  700.46037 y6 0.057 
703.90934  703.90937  (b12-H2O) 2+ 0.043 
712.91462  712.91471 b12 2+ 0.123 
732.91208  732.91210 b†12 2+ 0.027 
760.45137  760.45141 (b13-H2O) 2+ 0.053 
765.47297  765.47310 b6 -H2O 0.170 
771.49744  771.49750 y7 0.078 
783.48354  783.48373 b6 0.249 
787.47485  787.47504 (a13-H2O-NH3) 2+ 0.248 
  618.30909 ?   
795.98812  795.98858 (a9-H2O) 2+ 0.581 
800.98029  800.98043 (b14-2H2O) 2+ 0.172 
805.46789  805.46796 b†6 -H2O -0.093 
809.98558  809.98559 (b14-H2O) 2+ -0.019 
 B-35 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
818.99086  818.99089 (b14-H2O)2+ -0.040 
*  823.47845  823.47863 b†6 -0.219 
 829.98302 ?  
838.98832  838.98853 [b†14-H2O+H]2+ -0.256 
854.53456  854.53462 y8-H2O -0.076 
872.54512  872.54528 y8 0.183 
880.52507 880.52506 [M+C2O-H2O-NH3-CO+2H]2+ -0.009 
893.53155  893.53191 b7 -H2O 0.403 
*   915.51590 915.51607 b‡7-2H2O 0.186 
964.58257  964.58252 y9  - 2H2O -0.052 
965.56659  965.56693 y9  - H2O-NH3 0.352 
982.59314 982.59341  y9  - H2O 0.280 
983.57716 983.57746  y9-NH3 0.310 
994.57923 994.579040 b8  -H2O -0.191 
*  1000.60370 1000.60408 y9 0.380 
1034.57415  1034.57424  b†8  -H2O 0.092 
1092.67753 1092.67747 y10  - H2O -0.055 
1105.61126  1105.61214 b†9  -H2O  0.800 
*  1123.62182  1123.62251 b†9 0.614 
1128.69866  1128.69907 y10 0.363 
1178.70040  1178.70085 b10  -H2O 0.382 
1218.69532  1218.69568 b†10  -H2O 0.300 
*  1277.76881  1277.76989 b11  -H2O 0.845 
Mean -0.342  
St.Dv. 0.044 
 
Table B-19.  DR(718.91)-ECD(728.91) mass error analysis of the FR-25 peptide reacted in MeOH/H2O 
solution for the precursor ion [M+C2O+4H]4+. * indicates the masses used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  246.13226  246.13233 z2• 0.284 
247.14009 247.14019 z2 0.405   
293.16081  293.16099 c2 0.614 
345.20067  345.20079 z3• 0.348 
346.20850 346.20864 z3 0.404 
  403.20623 ?  
*  407.20374  407.20390 c3 0.393 
415.22996  415.23012 w4 0.385 
473.23598 473.23565 z4−Η• -0.697 
474.24326  474.24342 z4• 0.337 
475.25109  475.25126 z4 0.368 
 B-36 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
478.24085  478.24100 c4 0.314 
*  490.26198  490.26213 y4 0.306 
  499.21758 ?   
514.29837  514.29860 z5•-CH3COOH 0.457 
572.30385  572.30422 y5 - NH3 0.655 
573.31167  573.31187 z5• 0.349 
*  574.31950 574.31992 z5 0.731 
  582.29941 ?   
589.33039  589.33049 y5 0.170 
591.32491  591.32506 c5 0.254 
686.39573  686.39596 z6• 0.335 
*  687.40356 687.40413 z6 0.829 
696.39333  696.39359 c†112+ 0.377 
 697.24148 ?  
698.39573 698.39631 z13 2+  0.830 
  698.16238 ?   
702.41445  702.41485 y6 0.569 
*  704.40897  704.40945 c6 0.681 
 711.44696 ?   
728.91436 728.91479 [M†+4H]4+ 0.590 
738.43399 738.43392 a†122+ -0.095 
740.44335 740.44353 c12 2+ 0.243 
 743.39626 ?   
760.44080 751.43622 (c†12-H2O) 2+ 0.918 
753.43793 753.43839 (z14-H2O)2+ 0.611 
*  751.43553 760.44105 c†12 2+ 0.319 
761.93930  761.93955 z14• 2+ 0.328 
769.94866  769.94923 y14 2+ 0.740 
799.46721  799.46747 y7 0.325 
802.46956 802.46966 c7• 0.125 
*  803.47738  803.47771 c7 0.411 
825.48259  825.48338 (z•15−Η•) 2+ 0.954 
833.99614  833.99609 y15 2+ -0.060 
849.49611  849.49677 (c†14-H2O) 2+ 0.777 
*  858.50139  858.50166 c†14 2+ 0.312 
861.16984  861.17025 z23• 3+ 0.472 
865.47778 865.47808 y8 -H2O-NH3 0.347 
867.49343 867.49392 z8•- Η2Ο 0.565 
 869.47294 ?   
876.00698  876.00679 (z•16−Η•) 2+ 0.408 
876.51062  876.51093 z16• 2+ 0.354 
 B-37 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
883.48780  883.48822 z•8−Η• 0.481 
884.49617  884.49697 z8• 0.904 
  885.02191 ?   
*  900.51489  900.51483 y8 -0.067 
900.52387 900.52446 a15 2+ 0.655 
903.85604  903.85664 z24• 3+ 0.668 
913.52540  913.52517 (c†15-H2O) 2+ -0.252 
  916.54914 ?   
922.53068  922.53097 c†15 2+ 0.312 
950.05807 950.05834 a†16 2+ 0.284 
952.06743 952.06724 c16 2+ -0.200 
 955.51004 ?   
955.55978  955.56037 a†8 0.623 
958.04229  958.04256 z17• 2+ 0.287 
959.57849  959.57906 c8 0.594 
965.54653  965.54565 [M†-H2O+3H]3+ -0.913 
965.88247 965.88276 [M†-H2O+4H]3+• 0.300 
966.05165 966.05209 y17 2+ 0.455 
971.52820  971.52871 z9• 0.525 
971.55005  971.55051 [M†+3H]3+ 0.470 
972.06489  972.06526 c†16 2+ 0.383 
980.55502  980.55546 c†8• - H2O 0.454 
*  981.56284  981.56383 c†8- H2O 1.009 
987.54692  987.54703 y9 0.111 
993.57409  993.57393 a†17 2+ -0.159 
998.56558 998.56604 c†8• 0.461 
999.57341  999.57392 c†8 0.515 
1006.57562  1006.57541 (c†17- H2O)2+ -0.209 
1015.07699 1015.58124 c†17• 2+ -0.158 
1015.58090  1015.07683 c†17 2+ 0.332 
1027.08756  1027.08735 (z18•-H2O) 2+ -0.202 
1035.58920 1035.58923 (z18•-H•) 2+ 0.029 
1036.09284  1036.09311 z18• 2+ 0.261 
*  1036.59675 1036.59683 z18 2+ 0.077 
1047.58893    1047.58963                    (z†18-H2O) 2+            0.668 
1052.58605    1052.58621               z10.- H2O             0.152 
1056.09030    1056.09050                       z†18• 2+              0.189 
1069.58933    1069.58911             z10-H•            -0.206 
1070.59661    1070.59707   z10•                 0.430 
 B-38 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
 1085.62705    1085.62736              z19• 2+                0.286 
1086.13096    1086.13117               z19 2+                 0.193 
1086.61533    1086.61555   y10                 0.202 
1106.12842    1106.12742              z†19• 2+                 -0.904 
1114.63112    1114.63132   c†19 2+                  0.179 
1118.62311    1118.62316   a†9                0.045 
1122.64182    1122.64228   c9             0.410 
1142.16908    1142.16978   z20•2+             0.613 
1142.67299    1142.67326   z20 2+             0.236 
* 1143.61835    1143.61932   c†9•- H2O            0.848 
1161.62891    1161.62928   c†9•              0.319 
1162.16787    1162.16860   (c†20- H2O)2+             0.628 
1162.63674    1162.63723   c†9               0.421 
1171.17315    1171.17341   c†20 2+              0.222 
1189.70582    1189.70592   (z21•- H2O) 2+             0.084 
1197.64791    1197.64777   z11-H•              -0.117 
1198.65519    1198.65556   z11•              0.309 
1199.21502    1199.21542   z21 2+              0.334 
1210.20719    1210.20834   (z†21- H2O) 2+             0.950 
1211.70208    1211.70199   (c†21- H2O) 2+              -0.074 
1214.67391    1214.67420   y11             0.239 
1218.70856    1218.70903   z†21• 2+             0.386 
1219.21248    1219.21319   z†21 2+             0.582 
1219.67079    1219.67096   a†10                              0.139 
1220.70736    1220.70768   c†21 2+             0.262 
1223.68950    1223.68905   c10            -0.368 
1226.22030    1226.22014   (z22•-NH3) 2+           -0.130 
1234.22966    1234.23035   z22• 2+             0.559 
1234.73357    1234.73396   z22 2+             0.316 
1245.67385    1245.67352   c†10- H2O           -0.265 
1245.72575    1245.72621   (z†22- H2O) 2+            0.369 
1254.73103    1254.73138   z22 2+             0.279 
* 1262.67659    1262.67660   c†10•             0.008 
1263.68442    1263.68486   c†10            0.348 
1264.72728    1264.72763   c22• 2+               0.277 
1276.22337    1276.22232   (c†22- H2O) 2+          -0.823 
1282.74976    1282.75038   (z23- H2O) 2+           0.483 
1285.22865    1285.22898   c†22 2+            0.257 
1291.25113    1291.25135   z23• 2+            0.170 
* 1291.75504    1291.75538   z23 2+             0.263 
1302.74721    1302.74713   (z†23- H2O) 2+          -0.061 
1311.72667    1311.72686   y12            0.145 
1325.75758    1325.75856   (c†23- H2O) 2+           0.739 
1334.76286    1334.76329   c†23 2+           0.322  
1351.78446    1351.78560   c11               0.843 
 B-39 
THEORETICAL 
(m/z) 
EXPERIMENTAL  
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
 1355.78433    1355.78471   z24 2+             0.280 
1356.27206    1356.27142   a†24 2+               -0.472 
1369.27359    1369.27427   (c†24- H2O) 2+           0.497 
1372.76099    1372.76043   c†11•- H2O          -0.408 
1375.27787    1375.27774   z†24• 2+               -0.095 
1378.27887    1378.27930   c†24 2+            0.312 
* 1390.77155    1390.77158   c†11•            0.022 
1391.77938    1391.77976   c†11•            0.273 
1394.77636    1394.77643   z13•            0.050 
1410.79508    1410.79546   y13            0.269 
1430.81342    1430.81335   [M†- 3H2O +4H]2+••         -0.051 
1447.81616    1447.81732   [M†- H2O +2H] 2+          0.801 
1448.82398    1448.82444   [M†- H2O +4H]2+••          0.317 
1456.82144    1456.82002   [M†+2H] 2+          -0.975 
1457.82927    1457.82947   [M†+4H] 2+••           0.137 
1501.86377    1501.86420   c†12- H2O           0.286 
1504.83695    1504.83657   y14-2NH3          -0.253 
* 1519.87434    1519.87450   c†12            0.105 
1521.86404    1521.86302   z14-H•           -0.670 
1522.87132    1522.87115   z14•           -0.112 
1523.87915    1523.87809   z14           -0.696 
1538.89004    1538.89053   y14            0.318 
1632.93191    1632.93194   y15-2NH3           0.018 
1633.96354    1633.96475   z15•- H2O           0.741 
1649.95900    1649.95911   z15-H•            0.067 
1650.96628    1650.96564   z15•           -0.388 
1651.97411    1651.97480   z15            0.418 
1666.98500    1666.98621   y15            0.726 
1697.98494    1697.98415   c†14- H2O          -0.465 
* 1714.98768    1714.98731   c†14•           -0.216 
1715.99551    1715.99542   c†14           -0.052 
1732.99557    1732.99579   y16- H2O -NH3           0.127 
1735.01122    1735.00942   z16- H2O          -1.037 
1751.00668    1751.00702   z16-H•           0.194 
1752.01396    1752.01251   z16•          -0.828 
1753.02179    1753.02249   z16           0.399 
1826.04352    1826.04452   c†15- H2O          0.548 
* 1844.05409    1844.05461   c†15           0.282 
1898.07455    1898.07366   z17• - H2O         -0.469 
1914.07001    1914.06918   z17-H•          -0.434 
1915.07729    1915.07534   z17•          -1.018 
1916.08512    1916.08426   z17          -0.449 
1925.11193    1925.11073   c†16- H2O         -0.623 
1931.09601    1931.09494   y17          -0.554 
* 1942.11467    1942.11520   c†16•           0.273 
 B-40 
1943.12250    1943.12255   c†16           0.026 
2012.14396    2012.14189   c†17 - H2O         -1.029 
2029.14670    2029.14798   c†17•           0.631 
* 2030.15453    2030.15394   c†17          -0.291 
2054.17566    2054.17653   z†18•- H2O          0.424 
2072.18623    2072.18745   z18           0.589 
* 2111.17332    2111.17144   z†18•          -0.891 
2112.18382    2112.18329   c†18- H2O         -0.251 
* 2228.25497    2228.25719   c†19           0.996 
* 2897.64853    2897.64915   [M†- H2O +4H]1+•••         0.216 
Mean -0.133  
St.Dv. 0.537 
 
Table B-20  DR(595.03)-ECD(614 37) mass error analysis for the precursor ion [M+C2H2O2+3H]3+ of 
the glyoxal-derived glycation product formed at EK-15 peptide in MeOH/H2O solution.  * indicates the 
masses used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  303.17752  303.17751 c2 -0.033 
325.16187  325.16184 c‡2 - 2H2O -0.092 
343.17244  343.17243 c‡2 - H2O -0.015 
343.24655  343.24655 z3• 0.000 
344.25438  344.25436 z3 -0.044 
*  361.18300 361.18300 c‡2 0.000 
359.26527  359.26529 y3 0.056 
 372.27175 ?   
387.22247 387.22241 a3 -0.155 
400.75868  400.75863 c6 2+ -0.125 
413.27584  413.27584 w4 0.012 
431.23610  431.23609 c3 -0.023 
445.22795  445.22796 a‡3 0.034 
453.22045  453.22046 c‡3- 2H2O 0.022 
464.78797  464.78792 c7 2+ -0.108 
471.23102  471.23102 c‡3- H2O 0.011 
*  472.28914  472.28914 z4• 0.000 
489.24158 489.24158 c‡3 0.000 
488.30786  488.30787 y4 0.020 
500.30653  500.30646 a4 -0.140 
500.80549  500.80544 
  y9 2+ -0.100 
*  515.31181  515.31174 c8 2+ -0.136 
522.29088  522.29069 a‡4-2H2O -0.354 
526.30959 526.30959 c4- H2O -0.010 
 528.36161 ?   
 B-41 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
540.30145 540.30144 a‡4 - H2O -0.009 
544.32016  544.32016 c4 0.000 
550.83037  550.83023 c9 2+ -0.245 
 554.31710 ?   
556.84361  556.84328 z10• 2+ -0.593 
558.31201  558.31200 a‡4 -0.009 
566.30451  566.30453 c‡4 - 2H2O 0.035 
571.35755  571.35755 z5• 0.000 
584.31508 584.31508 c‡4 - H2O 0.009 
587.37627  587.37631 y5 0.068 
596.35610 596.35612 [M‡-3H2O+3H]3+ 0.028 
602.32564 602.32568 c‡4 0.066 
608.36315 608.36313 [M‡-H2O+3H] 3+ -0.027 
614.36667 614.36669 [M‡+3H]3+ 0.035 
620.89109 620.89100 z11• + -0.145 
628.40149  628.40145 a5 -0.064 
641.38629  641.38685 z6•-C3H7 0.881 
650.38584 650.38601 a‡5 -2H2O 0.269 
654.40456  654.40469 c5- H2O 0.206 
*  656.90660  656.90696 c11 2+ 0.548 
668.39641  668.39641 a‡5 - H2O 0.007 
672.41512  672.41511 c5 -0.015 
677.43312  677.43300 z12• 2+ -0.177 
684.44161  684.44162 z6• 0.015 
686.40697  686.40703 a‡5 0.095 
694.39947  694.39948 c‡5 - 2H2O 0.014 
 699.41613 ?   
700.46033  700.46035 y6 0.029 
712.41004  712.41005 c‡5-H2O 0.021 
 712.49533 ?   
721.42790  721.42794 
 c12 
2+
 
0.062 
*  730.42060  730.42062 c‡5 0.027 
741.46241  741.46253 
 z13
•
 
2+
 
0.162 
749.47177  749.47151 
  y13 2+ -0.347 
755.47872  755.47873 z7• 0.013 
771.49744  771.49747 y7 0.039 
777.96993  777.96998 c13 2+ 0.071 
788.96210  788.96242 (c‡13-3H2O) 2+ 0.406 
796.49136  796.49193 a‡6-H2O 0.716 
800.51008  800.51008 c6 0.000 
 B-42 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
805.49732  805.49732 a14 2+ 0.006 
819.51297  819.51297 z14• 2+ 0.006 
822.49443  822.49442 c‡6 - 2H2O -0.012 
825.49477  825.49472 (a‡14-H2O) 2+ -0.064 
827.50413  827.50415 c14 2+ 0.024 
827.52233  827.52243 y14 2+ 0.127 
829.49102  829.49094 (c‡14-3H2O) 2+ -0.099 
830.50514  830.50520 (z‡14•-2H2O) 2+ 0.072 
834.50005  834.50015 a‡14 2+ 0.117 
*  838.49631  838.49641 (c‡14-2H2O) 2+ 0.125 
839.51042  839.51036 (z‡14•-H2O) 2+ -0.074 
840.50500  840.50500 c‡6 - H2O 0.006 
 845.50408  ?   
847.50159 847.50165 (c‡14-H2O) 2+ 0.074 
856.52640 856.52669 z8• 0.339 
858.51556  858.51544 c‡6 -0.140 
872.54512  872.54516 y8 0.046 
883.03834  883.03835 [M -H2O+2H]2+ 0.011 
884.03399  884.03424 [M-NH3+3H]2+ 0.283 
892.04362  892.04373 [M +2H]2+ 0.121 
894.03052  894.03047 [M‡-3H2O+2H]2+ -0.050 
898.54726  898.54741 [M‡-H2O-CO+2H]2+ 0.164 
903.03580  903.03574 [M‡-2H2O+2H]2+ -0.064 
912.04108  912.04131 [M‡-H2O+2H]2+ 0.252 
913.03700  913.03708 [M‡-NH3+3H]2+• 0.383 
921.04636  921.04649 [M‡+2H]2+ 0.138 
924.54995  924.54969 a‡7-H2O -0.276 
928.56866  928.56860 c7 -0.065 
942.56051  942.56007 a‡7 -0.462 
950.55301  950.55309 c‡7- 2H2O 0.084 
966.57442 966.57443 z9•-H2O 0.016 
*  968.56358  968.56340 c‡7 - H2O -0.181 
984.58498  984.58495 z9• -0.030 
986.57414  986.57398 c‡7 -0.162 
 998.63578 ?   
1000.60370  1000.60367 y9 -0.030 
1007.58706  1007.58692 a†8 - H2O -0.139 
1011.60578  1011.60591 c8- H2O 0.133 
 B-43 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
1025.59763  1025.59716 a†8 -0.453 
1029.61634  1029.61624 c8 -0.097 
1043.60819  1043.60725 a‡8 -0.896 
1051.60069  1051.60072 c‡8- 2H2O 0.029 
1065.61634  1065.61625 b9-H2O -0.084 
*  1069.61126  1069.61116 c‡8 - H2O -0.089 
1083.62691  1083.62677 b9 -0.125 
1085.60617  1085.60593 a‡9•-C2H4 -0.221 
1087.62182  1087.62166 c‡8 -0.147 
1094.64557  1094.64549 y10-2NH3 -0.073 
1096.63473  1096.63457 a‡9-H2O -0.150 
1100.65345  1100.65338 c9 -0.064 
1112.67994  1112.67992 z10• -0.018 
1114.64529 1114.64514 a‡9 -0.139 
*  1122.63780  1122.63786 c‡9- 2H2O 0.053 
1128.69866  1128.69852 y10 -0.124 
1140.64837  1140.64819 c‡9 - H2O -0.153 
1158.65893  1158.65878 c‡9 -0.129 
1213.73751 1213.73738 c10 -0.107 
1222.74053 1222.74033 y11 - 2NH3 -0.164 
1235.72186  1235.72203 c‡10- 2H2O 0.138 
1240.77490 1240.77475 z11• -0.121 
*  1253.73243  1253.73207 c‡10- H2O -0.283 
1256.79362 1256.79351 y11 -0.088 
1267.74808 1267.74790 b11 - C2H4 -0.138 
1271.74299 1271.74302 c‡10 0.024 
1312.80592 1312.80595 c11 0.023 
1334.79027  1334.79009 c‡10- 2H2O -0.135 
*  1352.80084  1352.80075 c‡10- H2O -0.063 
1353.85896 1353.85878 z12• -0.133 
1368.79575 1368.79562 a‡12•-C2H4 -0.095 
1369.87768 1369.87740 y12 -0.204 
1370.81140 1370.81173 c‡11 0.241 
1423.83795 1423.83752 c12- H2O -0.298 
1441.84851 1441.84843 c12 -0.055 
*  1463.83286  1463.83280 c‡12- 2H2O -0.041 
1481.84343  1481.84338 c‡12- H2O -0.030 
1481.91754 1481.91749 z13• -0.034 
*  1499.85399 1499.85436 c‡12 0.247 
 B-44 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
1554.93257  1554.93273 c13 0.103 
1639.02648  1639.02537 z14 -0.674 
*  1654.00098  1654.00020 c14 -0.472 
1678.01357  1678.01448 z‡14•- H2O 0.545 
1679.02139  1679.02147 z‡14 - H2O 0.048 
*  1750.05851  1750.05785 [M -NH3 -H2O+3H]1+•• -0.377 
1766.05342  1766.05178 [M -NH3 +H]1+ -0.926 
1783.07997  1783.08025 [M +H]1+ 0.160 
 1789.06987 ?   
*  1806.07214  1806.07088 [M‡-2H2O+2H]1+• -0.695 
 Mean -0.342 
 St.Dv. 0.044 
 
Table B-21.  CAD mass error analysis of the EK-15 peptide reacted in MeOH/H2O solution for the 
precursor ion [M+C2H2O2+3H]3+.  * indicates the masses used for calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  246.18121  246.18119 y2 -0.081 
268.14041  268.14041 b2  -H2O 0.000 
286.15098  286.15099 b2 0.052 
308.13533  308.13533 b‡2  -2H2O 0.016 
*  326.14589  326.14580 b‡2  -H2O -0.276 
351.20269  351.20266 KKQ -0.085 
358.20850  358.20848 KQT -0.056 
359.26527  359.26528 y3 0.028 
362.14590  362.14590 b3  -H2O-2NH3 0.000 
365.72157  365.72165 (b6-2H2O-NH3)2+ 0.219 
367.23398  367.23396 TALV-H2O -0.041 
370.25612  370.25611 RQI-CO -0.014 
374.23484  374.23483 (b6-2H2O)2+ -0.033 
374.72685  374.72687 (b6-H2O-NH3) 2+ 0.047 
379.17245  379.17244 b3  -H2O-NH3 -0.013 
379.19760  379.19760 QTAL-H2O-NH3 0.000 
380.15647  380.15646 b3  -2NH3 -0.013 
383.24013  383.24015 b6 2+ 0.065 
385.24454  385.24454 TALV 0.000 
386.21464  386.21463 a3 -0.026 
392.24541  392.24541 b6 2+ 0.006 
394.20850  394.20846 KQTA-H2O-NH3 -0.101 
394.23230  394.23229 (b‡6-3H2O) 2+ -0.025 
395.22889  395.22885 ALVE-H2O -0.089 
396.19895  396.19899 b3  -H2O 0.101 
 B-45 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
397.18301 397.18296 b3  -NH3 -0.126 
397.20817  397.20815 QTAL-NH3 -0.038 
398.25103 398.25101  RQI -0.050 
*  403.23758  403.23757 (b†6-2H2O)2+ -0.031 
411.23505 411.23502 KQTA-H2O -0.061 
413.23945 413.23947 ALVE 0.048 
413.27584 413.27583 VELV-CO -0.012 
414.20950  414.20955 b3 -0.121 
424.75869  424.75868 (a7-H2O-NH3) 2+ 0.012 
426.20956  426.20955 a‡3  -H2O 0.012 
427.29149  427.29153 LVEL-CO 0.105 
429.24561  429.24565 KQTA 0.093 
429.75086  429.75085 (b7-2H2O-NH3)2+ -0.023 
430.24287  430.24292 (b7-H2O-2NH3) 2+ 0.116 
  434.76618 ?   
436.19390  436.19390 b‡3  -2H2O 0.000 
437.27584  437.27590 LVEL-CO 0.149 
438.26413  438.26414 (b7-2H2O) 2+ 0.017 
438.75614  438.75612 (b7-H2O-NH3)2+ -0.051 
441.27075  441.27076 VELV-CO 0.023 
447.26942  447.26942 
  (b7-H2O) 2+ 0.011 
447.76143  447.76145 
 (b7-NH3)2+ 0.056 
454.20447  454.20457 b‡3-H2O 0.220 
455.28640  455.28641 LVEL 0.022 
486.26410  486.26419 b7 2+ 0.185 
458.26159  458.26164 (b‡7 -3H2O) 2+ 0.109 
  464.26160 ?   
467.26687  467.26690 (b‡7 -2H2O) 2+ 0.059 
  468.28167 ?   
470.29730  470.29730 y4-H2O 0.011 
476.27216  476.27217 b‡7 2+ 0.021 
481.28814  481.28813 a4 -H2O -0.010 
482.27216  482.27216 a4 -NH3 0.010 
482.79493  482.79494 (y9-2H2O) 2+ 0.031 
486.30346  486.30346 KKQT 0.000 
488.30786  488.30788 y4 0.041 
491.80021  491.80022 (y9-H2O) 2+ 0.025 
495.29256  495.29253 QTALV-H2O -0.050 
496.27657  496.27658 TALVE-H2O 0.030 
497.79326  497.79325 (b8-H2O) 2+ -0.010 
499.29870  499.29871 a4 0.020 
503.27249  503.27243 a‡4-3H2O -0.109 
506.79854  506.79852 b8 2+ -0.035 
 B-46 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
508.31295  508.31295 ALVEL-H2O 0.010 
508.78543  508.78545 (b‡8-3H2O) 2+ 0.039 
509.28305  509.28304 b4 -H2O -0.020 
510.26707  510.26708 b4 -NH3 0.020 
513.30312  513.30311 QTALV -0.019 
514.28713  514.28712 TALVE-H2O -0.019 
515.79326  515.79327 (b9-2H2O-NH3)2+ 0.029 
517.79071  517.79084 (b‡8-2H2O) 2+ 0.246 
521.28305  521.28305 a‡4-2H2O 0.000 
522.30346  522.30343 KKQTA-H2O-NH3 -0.057 
523.28748  523.28747 KKQTA-2NH3 -0.019 
524.30653  524.30633 (b9-2H2O) 2+ -0.377 
524.31911  524.31914 KQTAL-H2O 0.067 
524.79854  524.79851 (b9-H2O-NH3) 2+ -0.052 
526.32351  526.32354 ALVEL 0.057 
526.34599  526.34598 RQIK -0.019 
527.29362  527.29358 b4 -0.066 
531.26740  531.26726 b‡4 -3H2O -0.264 
533.31181  533.31180 (b9-H2O) 2+ -0.019 
  534.33778 ?   
535.29870  535.29866 (b‡9-4H2O) 2+ -0.079 
539.29362  539.29363 a‡4-H2O 0.028 
539.33001  539.32997 KKQTA-H2O -0.065 
*  542.31709  542.31709 b9 2+ -0.005 
542.32967  542.32968  KQTAL 0.018 
544.30399  544.30410 (b‡9-3H2O) 2+ 0.211 
  544.32018 ?   
549.27797  549.27794 b‡4-2H2O -0.046 
550.29838  550.29835 R(C2H2O2)QIK-2NH3 -0.055 
552.01731  552.01731 y14 3+ 0.000 
553.30927  553.30927 (b‡9-2H2O) 2+ 0.005 
554.35481  554.35483 LVELV 0.036 
555.84769  555.84762 (y10-H2O) 2+ -0.121 
556.33970  556.33964 (y10-NH3) 2+ -0.103 
557.34057  557.34052 KKQTA -0.090 
562.31455  562.31462 (b‡9-H2O) 2+ 0.124 
564.85297  564.85288 y10 2+ -0.159 
567.28853  567.28844 b‡4-H2O -0.159 
  568.83732 ?   
569.36571  569.36557 y5-H2O -0.237 
572.33529  572.33542 (b10-2H2O-NH3) 2+ 0.236 
575.85638  575.85640 (a10-H2O) 2+ 0.030 
 B-47 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
 577.34886 ?   
580.84856  580.84853 (b10-2H2O) 2+ -0.047 
 581.30417 ?   
581.34057  581.34054 (b10-H2O-NH3) 2+ -0.047 
584.86167  584.86163 a10 2+ -0.060 
587.37627  587.37629 y5 0.034 
589.02799  589.02798 [M-C2H2O2-H2O+3H]3+ -0.011 
589.85384  589.85386 b10 2+ 0.034 
590.34585  590.34592 (b10-NH3) 2+ 0.119 
595.03151  595.03150 [M+C2O+3H]3+ -0.014 
595.85384  595.85383  (a†10-H2O) 2+ -0.017 
596.35610  596.35603  [M+C2H2O2-3H2O+3H]3+ -0.123 
597.39701  597.39710  ALVELV-CO 0.159 
598.85912  598.85911  b10 2+ -0.021 
600.84602  600.84602  [b‡10-3H2O+H]2+ 0.008 
602.35963  602.35957  [M+C2H2O2-2H2O+3H]3+ -0.091 
604.85912  604.85919 (a‡10-H2O) 2+ 0.112 
606.32458  606.32459  QTALVE-2H2O 0.013 
606.36097  606.36092  KQTALV-H2O-NH3 -0.082 
607.30860  607.30861  QTALVE-H2O-NH3 0.016 
608.36315  608.36308  [M+C2H2O2-H2O+3H]3+ -0.110 
*  609.85157  609.85123 (b‡10-2H2O) 2+ -0.558 
609.38310  609.38300 a5 -0.156 
616.87732  616.87719 (a11-H2O-NH3) 2+ -0.203 
618.85658  618.85630  (b‡10-H2O)  2+ -0.452 
620.35147  620.35145  b5  -H2O-NH3 -0.024 
624.33515  624.33517  QTALVE-H2O 0.040 
628.90045  628.90057  y11 2+ 0.191 
637.37801  637.37803 b5  -H2O 0.031 
648.39333  648.39331 b11 2+ -0.027 
655.38858  655.38858 b5 0.008 
659.38550  659.38541 (b‡11-2H2O) 2+ -0.140 
667.38858  667.38857 a‡5-H2O -0.007 
677.37293  677.37290 b‡5-2H2O -0.037 
682.44977  682.44949 y6-H2O -0.403 
685.44248  685.44249 
   y12 2+ 0.015 
694.90406  694.90401 (b12-2H2O) 2+ -0.068 
695.38349 695.38361 b‡5-H2O 0.173 
*  700.46033  700.46036 y6 0.043 
703.90936  703.90937  (b12-H2O) 2+ 0.014 
712.91462  712.91465 b12 2+ 0.039 
 B-48 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
749.47177 749.47195 (y13) 2+ 0.240 
760.45137  760.45143 (b13-H2O) 2+ 0.079 
765.47297  765.47300 b6 -H2O 0.039 
769.45665  769.45668 b13 2+ 0.036 
771.49744  771.49750 y7 0.078 
777.47297  777.47309 a‡6-2H2O 0.154 
  778.40941 ?   
783.48354  783.48358 b6 0.057 
787.47485  787.47478 (a13-H2O-NH3) 2+ -0.083 
788.44134  788.44180 b‡6 -2H2O-NH3 0.583 
789.45411  789.45425 (b‡13-H2O) 2+ 0.177 
795.48354  795.48355 a‡6-H2O 0.019 
795.98812  795.98839 (a9-H2O) 2+ 0.342 
800.98029 800.98043 (b14-2H2O) 2+ 0.172 
805.46789  805.46786 b‡6-2H2O -0.031 
809.98558  809.98559 (b14-H2O) 2+ -0.019 
818.99086  818.99083 (b14-H2O) 2+ 0.034 
820.97775  820.97776 (b†14-3H2O) 2+ -0.012 
823.47845  823.47863 b‡6-H2O -0.219 
*  841.48902  841.48888  b‡6 0.160 
854.53456  854.53463 y8-H2O -0.088 
 868.52514 ?  
872.54512  872.54528 y8 -0.183 
  891.49348 ?   
893.53155  893.53156 b7 -H2O 0.011 
911.54212  911.54213 b7 0.016 
915.51590 915.51607 b‡7-3H2O 0.186 
923.54212  923.54258 a‡7-H2O 0.503 
933.52647  933.52676 b‡7-2H2O 0.316 
*  951.53703  951.53688 b‡7-H2O -0.158 
964.58252  964.58264 y9  - 2H2O 0.124 
965.56693  965.56672 y9  - H2O-NH3 -0.217 
982.59314 982.59323  y9  - H2O 0.097 
983.57715 983.57725  y9-NH3 0.097 
994.57923  994.57928 b8  -H2O 0.050 
1000.60370  1000.60383 y9 0.130 
1012.58980  1012.58977 b8 -0.025 
*  1034.57415  1034.57371  b‡8  -2H2O -0.420 
1065.61634  1065.61663 b9  -H2O 0.272 
1092.67753 1092.67768 y10  - H2O 0.137 
1083.62691  1083.62701 b9 0.097 
 B-49 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
1105.61126  1105.61142 b‡9-2H2O 0.149 
*  1123.62182  1123.62139 b‡9-H2O -0.383 
1128.69866  1128.69877 y10 0.097 
1141.63239  1141.63284 b‡9 0.399 
1161.67386  1161.67314 b10  -H2O-NH3 -0.615 
1178.70040  1178.70042 b10  -H2O 0.017 
1196.71097  1196.71062 b10 -0.288 
*  1218.69532  1218.69505 b‡10-2H2O -0.217 
1277.76881  1277.76931 b11  -H2O 0.391 
1295.77938  1295.77954 b11 0.127 
1317.76373  1317.76372 b‡11-2H2O -0.004 
*  1335.77429  1335.77403 b‡11-H2O -0.195 
1406.81140  1406.81080 b12  -H2O -0.426 
*  1424.82197  1424.82238 b12 0.291 
Mean -0.122  
St.Dv. 0.049 
 
Table B-22.  DR(718.91)-ECD(733.42) mass error analysis of the FR-25 peptide reacted in MeOH/H2O 
solution for the precursor ion [M + C2H2O2 + 4H]4+.  * indicates the masses used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  246.13226  246.13228 z2• 0.081 
247.14009 247.14015 z2 0.243 
293.16081  293.16081 c2 0.000 
*  345.20067  345.20066 z3• -0.029 
346.20850 346.20846 z3 -0.116 
361.21939  361.21934 y3 -0.138 
407.20374  407.20372 c3 -0.049 
415.22996  415.22995 w4 -0.012 
*  474.24326  474.24322 z4• -0.084 
475.25109  475.25109 z4 0.011 
478.24085  478.24083 c4 -0.042 
490.26198  490.26197 y4 -0.020 
572.30385  572.30389 y5 - NH3 0.079 
*  573.31167  573.31165 z5• -0.035 
574.31950  57431980 z5 0.522 
589.33039  589.33058 y5 0.322 
591.32491  591.32489 c5 -0.034 
676.39587  676.39591 c11 2+ 0.059 
685.38791  685.38781 y6 - NH3 -0.139 
685.38736  685.38781 z•6−Η•  0.664 
*  686.39573  686.39570 z6• -0.044 
 B-50 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
702.41445  702.41465 y6 0.285 
704.40897  704.40891 c6 -0.085 
733.41700  733.41724 [M‡+4H]4+ 0.326 
761.93930  761.93955 z14• 2+ 0.328 
*  769.44609  769.44609 c†12 2+ 0.000 
769.94866  769.94801 y14 2+ -0.844 
799.46721  799.46727 y7 0.075 
803.47738  803.47739 c7 0.012 
825.48259  825.48312 (z•15−Η•)2+ 0.639 
833.99614  833.99609 y15 2+ -0.060 
858.50139 858.50148 (c‡14-H2O)2+ 0.102 
861.16984  861.16973 z23• 3+ -0.132 
865.47778 865.47792 y8 -H2O-NH3 0.162 
867.50668 867.50677 c‡14 2+ 0.110 
876.00643 876.00651 (z•16−Η•)2+ 0.088 
876.51062 876.51067 z16• 2+ 0.057 
*  880.50500 880.50480 z‡23• 3+ -0.231 
  
 
 
883.48780 883.48856 z•8−Η• 0.866 
884.49617 884.49657 z8• 0.452 
900.51489  900.51525 y8 0.400 
902.53323  902.53322 c15 2+ -0.006 
903.85604  903.85601 z24• 3+ -0.030 
915.56486  915.56515 a8 0.317 
922.53068  922.53110 (c‡15-H2O) 2+ 0.453 
*  931.53597  931.53614 c‡15 2+ 0.188 
952.06743  952.06737 c16 2+ -0.063 
955.55978  955.56012 a‡8 - H2O 0.361 
958.04229  958.04224 z17• 2+ -0.047 
958.55436  958.55437 [M+4H]3+• -0.177 
959.57849  959.57874 c8 0.261 
962.55454  962.55453 [M‡-H2O-CO+4H]3+• -0.010 
965.88247 965.88266 [M‡-2H2O+4H]3+• 0.197 
970.51983  970.52061 z•9−Η• 0.809 
971.52820  971.52840 z9• 0.206 
971.88599 971.88599 [M‡-H2O+4H]3+• 0.000 
981.07017 981.07029 c‡16 2+ 0.122 
987.54692  987.54687 y9 -0.051 
995.58345  995.58333 c17 2+ -0.116 
1002.57937  1002.57915 a‡17 2+ -0.217 
 B-51 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  1015.58090  1015.58118 (c‡17- H2O) 2+ 0.273 
1017.58397  1017.58411 c‡8 0.138 
1024.58619  1024.58633 c‡17 2+ 0.142 
1027.08756  1027.08733 (z18•-H2O) 2+ -0.222 
1036.09284  1036.09290 z18• 2+ 0.058 
1065.09558  1065.09555 z‡18•2+ -0.028 
1069.58824  1069.58875          z10•+H•     -0.037 
1070.59661  1070.59671   z10•      0.093 
1078.62819  1078.62865   a9                  0.426 
1085.62705  1085.62712   z14• 2+       0.064 
1086.13096  1086.13050   z14 2+     -0.424 
1086.61533  1086.61525   y10     -0.074 
1094.63367  1094.63342   c19 2+     -0.228 
1105.62450  1105.62472       (z‡19•- H2O) 2+      0.199 
1114.62979  1114.63031   z‡19• 2+      0.467 
*  1114.63112  1114.63031       (c‡19- H2O) 2+      0.199 
1121.63400  1121.63408   c9•      0.071 
1122.64182  1122.64199   c9      0.151 
1124.65052  1124.65016   (z20•- H2O - NH3) 2+     -0.320 
1136.63367  1136.63363   a‡9     -0.035 
1140.62591  1140.62522   w11                -0.605 
1142.16908  1142.16915   z20• 2+                 0.061 
1142.67299  1142.67248   z20 2+                -0.446 
1150.17844  1150.17943   y20 2+                 0.861 
1151.17570  1151.17554   c20 2+                -0.139 
1162.16653  1162.16653        (z‡20•- H2O) 2+                0.000 
1162.63674  1162.63603          c‡9- H2O                -0.611 
1171.17182  1171.17214   z‡20• 2+                 0.273 
1171.17315  1171.17214          (c‡20- H2O) 2+               -0.862 
1178.63166  1178.63180           b20-C2H4                 0.119 
1178.70309  1178.70425   a21 2+                 0.984 
1181.68456  1181.68340        (z21•-2NH3) 2+               -0.982 
1189.70582  1189.70531        (z21•- H2O) 2+               -0.429 
1190.20974  1190.20947         (z21- H2O) 2+               -0.227 
1197.64737  1197.64721           z11•-H2•                -0.134 
1198.20719  1198.20683          (z21•-H•) 2+                -0.300 
1198.65519  1198.65529   z11•                 0.083 
1198.71111  1198.71088   z21• 2+                -0.192 
*   1199.21502  1199.21420   z21 2+                -0.684 
1206.72047  1206.72042   y21 2+                -0.041 
1209.70328  1209.70294      (z‡21•-2H2O) 2+               -0.281 
     1210.20719  210.20673       (z‡21-2H2O) 2+               -0.380 
1214.67391  1214.67446   y11                 0.453 
1218.70856  1218.70844        (z‡21•-H2O) 2+               -0.098 
 B-52 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
 1220.70736  1220.70627        (c‡21-H2O) 2+    -0.893 
1222.68168  1222.68108   c10•                -0.491 
1223.68950  1223.68961   c10      0.090 
1227.71385  1227.71374   z‡21• 2+     -0.090 
1234.22966  1234.22921   z22 2+     -0.365 
1234.73357  1234.73243   z22 2+     -0.923 
1237.68135  1237.68158   a‡10       0.186 
1242.23902  1242.23876   y22 2+     -0.209 
1245.72575  1245.72465        (z‡22-2H2O) 2+    -0.883 
1254.22712  1254.22677         (z‡22•-H2O) 2+    -0.279 
1263.23240  1263.23253   z‡22• 2+      0.103 
1263.68442  1263.68429   c‡10 -H2O    -0.103 
1263.73631  1263.73513   z‡22 2+     -0.934 
1265.23120  1265.23028   c22 2+     -0.727 
*  1285.22865  1285.22745   (c‡22 -H2O) 2+    -0.934 
1291.25113  1291.25104   z23• 2+     -0.070 
1291.75504  1291.75454   z23 2+     -0.387 
1307.77083  1307.77147   a11       0.489 
1311.24858  1311.24839        (z23•-H2O) 2+     -0.145 
1311.72667  1311.72634   y12     -0.252 
1314.76540  1314.76531   c23 2+     -0.068 
1320.25387  1320.25379   z‡23•2+     -0.061 
1327.26432  1327.26560           (a24- H2O) 2+     0.964 
1334.76286  1334.76234           (c‡23- H2O) 2+   -0.390 
1336.27460  1336.27447   a24 2+    -0.097 
1346.77905  1346.77961           (z24- H2O) 2+     0.416 
1350.77664  1350.77681   c11•      0.126 
1351.78446  1351.78445   c11     -0.007 
1355.28042  1355.28015   z24• 2+     -0.199 
1355.78433  1355.78405   z24 2+     -0.207 
1358.28142  1358.28113   c24 2+     -0.214 
1365.27734  1365.27714   a‡24 2+       0.344 
1369.27359  1369.27355        (c‡24- 2H2O) 2+    -0.029 
1375.78179  1375.78166   z‡242+       -0.094 
     1378.27887  1378.27841            (c‡24- H2O) 2+    -0.334 
 1391.77938  1391.77859             c‡11- H2O    -0.568 
1393.76854  1393.76790              z13•- H•     -0.459 
1394.77636  1394.77644   z13•       0.057 
1410.79508  1410.79467   y13      -0.291 
1429.81884  1429.81984          c12- H2O - NH3      0.699 
1448.82398  1448.82389          [M‡- 2H2O +4H] 2+••    -0.442 
1456.82144  1456.82104          [M‡- H2O +2H] 2+     -0.275 
*  1465.82672  1465.82691   [M‡+2H] 2+      0.130 
1478.87160  1478.87069   c12•      -0.615 
1479.87942  1479.87974   c12       0.216 
 B-53 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
 1504.83695  1504.83747          y14-2NH3       0.346 
1505.86858  1505.86813          z14•- H2O      -0.299 
1521.86404  1521.86380            z14-H•      -0.158 
*  1522.87132  1522.87086   z14•      -0.302 
1538.89004  1538.88971   y14      -0.214 
1632.93191  1632.93127          y15-2NH3      -0.392 
1649.95900  1649.95860            z15•- H•       0.085 
*  1650.96628  1650.96555   z15•      -0.442 
1651.97411  1651.97447   z15       0.218 
1666.98500  1666.98531   y15       0.186 
1674.99277  1674.99304   c14•       0.161 
*   1676.00059  1676.00088   c14       0.173 
     1715.99551  1715.99523          c‡14- H2O      -0.163 
1732.99557  1732.99533        y16- H2O - NH3     -0.138 
1734.00340  1734.00258           z16•- H2O      -0.473 
1735.01122  1735.01090            z16•- H2O      -0.184 
1751.00668  1751.00592            z16•- H•      -0434 
1753.02179  1753.02222   z16       0.245 
1803.05135  1803.05103   c15•      -0.177 
1804.05917  1804.05965   c15       0.266 
*  1898.07455  1898.07415          z17•- H2O      -0.211 
1902.11976  1902.12108   c16•       0.694 
1903.12758  1903.12834   c16       0.399 
1916.08512  1916.08454               z17      -0.303 
*  1990.15961  1990.15989   c17       0.141 
2054.17566  2054.17545           z18•- H2O      -0.102 
2070.17112  2070.17238            z18-H•       0.609 
*  2072.18623  2072.18717   z18       0.454 
2094.17058  2094.17017          z‡18•- 2H2O     -0.196 
2111.17332  2111.17270           z‡18•- H2O      -0.294 
     2112.18114  2112.18085           z‡18- H2O        -0.137 
2171.25464  2171.25526   z19       0.286 
2188.26005  2188.26019   c19       0.064 
2211.24955  2211.24892            z‡19•- H2O     -0.285 
2284.33870  2284.33923   z20       0.232 
 2301.34411  2301.34553   c20       0.617 
     2342.34418  2342.34369   z‡20      -0.209 
2397.42276  2397.42389   z21       0.471 
2468.45987  2468.45995   z22       0.032 
2508.45478  2508.45626            z22- H2O        0.590 
2528.44729  2528.44709   c22•      -0.079 
2529.45511  2529.45503   c22      -0.032 
*  2582.50280  2582.50513   z23       0.902 
 mean -0.051  
 B-54 
St. Dv. 0.462 
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[M+C2 - H2+4H]4+ of the reacted EK-15 peptide in PBS buffer.  Every chosen ion did not 
contain the added mass of the modification.  
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Table C-8.  Mass error of the internal calibration of the DR(718.91)-ECD(724.41) spectrum 
of the parent ion [M+C2-H2+4H]4+ with ejection of [M+4H]4+ of the FR-25 peptide in 
MeOH/H2O solution.  Every chosen ion did not contain the added mass of the modification. 
C-7 
Table C-9.  Mass error of the internal calibration of the CAD spectrum of the parent ion 
[M+C2-H2+4H]4+ of the FR-25 peptide in PBS buffer.  Every chosen ion did not contain the 
added mass of the modification.  
C-8 
Table C-10.  CAD mass error analysis for the parent ion [M+C2 – H2+3H]3+ of the glyoxal-
derived glycation product formed at EK-15 peptide in MeOH/H2O solution.   
C-8 
Table C-11.  DR(718.91)-ECD(724.41) mass error analysis for the parent ion [M+C2 - 
H2+4H]4+ of the glyoxal-derived glycation product formed at FR-25 peptide in MeOH/H2O 
solution. 
C-10 
Table C-12.  DR(595.03)-ECD(602.36) mass error analysis for the parent ion [M+C2 - 
H2+3H]3+ of the glyoxal-derived glycation product formed at EK-15 peptide in PBS buffer. C-13 
Table C-13.  CAD mass error analysis for the parent ion [M+C2 - H2+3H]3+ of the glyoxal-
derived glycation product formed at EK-15 peptide in PBS buffer.  
C-14 
 
 C-2 
Table C-14 CAD mass error analysis for the parent ion [M+C2 - H2+3H]3+ of the glyoxal-
derived glycation product formed at EK-15 with addition of sodium chloride. C-22 
 
Table C-1.  Mass error of the internal calibration of the direct infusion spectra of the reacted EK-15 
peptide in MeOH/H2O solution.  Every chosen ion did not contain the added mass of the modification. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) 
INTERNAL CALIBRANT 
CHOSEN ION 
ERROR 
(ppm) 
446.77629 446.77621 [M+4H]4+ -0.186 
446.52545 446.52542 [M+13C+4H]4+ -0.078 
456.52418 456.52428 [M+C2O+4H]4+ 0.209 
461.02682 461.02688 [M+C2H2O2+4H]4+ 0.128 
595.03151 595.03148 [M+3H]3+ -0.042 
595.36596 595.36564 [M+13C+3H]3+ -0.544 
608.36315 608.36332 [M+C2O+3H]3+ 0.287 
614.36667 614.36680 [M+C2H2O2+3H]3+ 0.213 
892.54530 892.54527 [M+2H]2+ -0.032 
892.04362 892.04388 [M+13C+2H]2+ -0.294 
912.04108 912.04101 [M+13C2+2H]2+ -0.082 
921.04636 921.04621 [M+C2H2O2+2H]2+ -0.167 
  
Standard deviation:  0.275 
 
Table C-2.  Mass error of the internal calibration of the direct infusion spectra of the reacted FR-25 
peptide in MeOH/H2O solution.  Every chosen ion did not contain the added mass of the modification. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) 
INTERNAL CALIBRANT 
CHOSEN ION 
ERROR 
(ppm) 
958.21843 958.21847 [M + 3H]3+ 0.049 
    958.55288 958.55307 [M + 13C + 3H]3+ 0.205 
958.88733 958.88754 [M + 13C2 + 3H]3+ 0.223 
977.55358 977.55405 [M + C2H2O2 + 3H]3+ 0.490 
971.55005 971.54913 [M + C2O + 3H]3+ -0.955 
718.91564 718.91560 [M+4H]4+ -0.052 
719.16648 719.16656 [M+13C+4H]4+ 0.113 
719.41732 719.41732 [M+13C2+4H]4+ 0.004 
719.66815 719.66816 [M+13C3+4H]4+ 0.003 
 C-3 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) 
INTERNAL CALIBRANT 
CHOSEN ION 
ERROR 
(ppm) 
728.91436 728.91426 [M + C2O + 4H]4+ -0.142 
733.41700 733.41704 [M + C2H2O2 + 4H]4+ 0.060 
575.33397 575.33399 [M+5H]5+ 0.038 
575.53464 575.53472 [M+13C+5H]5+ 0.153 
575.73531 575.73586 [M+13C2+5H]5+ -0.205 
575.93598 575.93586 [M+13C3+5H]5+ -0.205 
  Standard deviation 0.342 
 
Table C-3  Mass error of the internal calibration of the direct infusion spectra of the sodiated EK-15 
peptide. Every chosen ion did not contain the added mass of the sodiation. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) 
INTERNAL CALIBRANT 
CHOSEN ION 
ERROR 
(ppm) 
446.52545 446.52550 [M + 4H]4+  0.106 
446.77629 446.77624 [M + 13C + 4H]4+ -0.107 
595.03151 595.03154 [M + 3H]3+  0.055 
595.36596 595.36593 [M + 13C+ 3H]3+ -0.054 
892.04362 892.04362 [M + 2H]2+ -0.000 
  Standard deviation 0.127 
 
Table C-4  Mass error of the internal calibration of the direct infusion spectra of the sodiated FR-25 
peptide. Every chosen ion did not contain the added mass of the sodiation. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) 
INTERNAL CALIBRANT 
CHOSEN ION 
ERROR 
(ppm) 
575.33397 575.33398 [M + 5H]5+ 0.030 
575.53464 575.53480 [M + 13C + 5H]5+ 0.278 
718.91564 718.91548 [M + 4H]4+ -0.226 
719.16648 719.16630 [M + 13C + 4H]4+ -0.241 
958.21843 958.21917 [M + 3H]3+ 0.781 
958.88733 958.88732 [M + 13C+ 3H]3+ -0.014 
  Standard deviation 0.399 
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Table C-5.  DR(595.03)-ECD(602.36) mass error analysis for the parent ion [M+C2 - H2+3H]3+ of the 
glyoxal-derived glycation product formed at EK-15 peptide in MeOH/H2O solution.  * indicates the 
masses used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  230.16249   230.16250   z2•     0.043 
246.18121   246.18123   y2     0.081 
285.16695   285.16696   c2- H2O     0.018 
302.16969   302.16973   c2•     0.116 
303.17752   303.17750   c2    -0.066 
*  325.16187   325.16184   c*2    -0.092 
343.24655   343.24652   z3•    -0.087 
344.25438   344.25435   z3     -0.087 
359.26527   359.26529   y3     0.056 
387.22247   387.22245   a3     -0.052 
400.75868   400.75868   c6 2+     0.000 
411.75086   411.75093   c*6 2+     0.170 
413.22553   413.22554   c3-H20     0.012 
413.27584   413.27582   w4    -0.048 
431.23610   431.23612   c3     0.046 
436.77620   436.77627   y8 2+     0.160 
*  453.22045   453.22046   c*3     0.022 
464.78797   464.78801   c7 2+     0.086 
472.28914   472.28914   z4•     0.000 
473.29697   473.29699   z4     0.042 
475.78015   475.78022   c*72+     0.147 
488.30786   488.30794   y4     0.164 
500.30653   500.30678   a4      0.500 
515.31181   515.31190   c82+     0.175 
517.30499   517.30500         (a*9 -•CONH2) 2+    0.019 
522.29088   522.29083   a9      -0.096 
526.30399   526.30383   c*8 2+    -0.304 
526.30959   526.30956   c
 4- H2O   -0.067 
544.32016   544.32022   c4     0.110 
550.83037   550.83087   c9 2+     0.908 
556.84361   556.84351   z10• 2+    -0.180 
561.82254   561.82281   c*9 2+     0.481 
564.85297   564.85352   y10 2+     0.974 
*  566.30451   566.30444   c*4    -0.124 
570.35027   570.35039   z5-H•     0.210 
571.35755   571.35763   z5•     0.140 
587.37627   587.37629   y5     0.034 
596.35610   596.35589  [M+C2-H2- H2O +3H] 3+   -0.352 
602.35963   602.35946        [M+C2-H2+3H] 3+   -0.282 
620.89109   620.89103   z11• 2+    -0.097 
621.39500   621.39503   z11 2+     0.048 
    641.38689   ? 
 C-5 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
654.40455   654.40448   c5- H2O    -0.115 
656.90660   656.90657   c11 2+    -0.046 
672.41512   672.41505   c5    -0.104 
677.37293   677.37340   b5     0.694 
677.43312   677.43348   z12• 2+     0.219 
684.44161   684.44176   z6•     0.219 
*  694.39947   694.39962   c*5     0.216 
700.46033   700.46032   y6    -0.014 
    712.42387   ? 
721.42790   721.42827   c12 2+    -0.500 
741.46241   741.46221   z13• 2+    -0.270 
741.96632   741.96642   z13 2+      0.135 
749.47177   749.47240   y13 2+      0.841 
*  755.47872   755.47875   z7•      0.040 
771.49744   771.49711   y7     -0.428 
777.96993   777.96940   c13 2+     -0.681 
782.49951   782.49995   c6- H2O      0.556 
    813.47179   ? 
819.51297   819.51305   z14• 2+      0.098 
*  822.49443   822.49417   c*6     -0.316 
827.50413   827.50453   c14 2+      0.483 
838.49631   838.49577   c*14 2+     -0.644 
855.51912   855.51904   z8•-H•     -0.094 
872.54512   872.54523   y8      0.126 
903.03580   903.03661       [M+C2-H2+2H] 2+     0.897 
903.53971   903.53932            [M+3H] 2+•    -0.432 
910.55809   910.55750   c7- H2O     -0.653 
926.55570   926.55619   w9      0.529 
928.56866   928.56904   c7      0.409 
*  950.55301   950.55319   c*7      0.189 
984.58498   984.58480   z9•     -0.183 
*  1000.60370  1000.60455   y9      0.849 
1011.60577  1011.60588   c8- H2O      0.104 
1029.61634  1029.61645   c8      0.107 
1051.60069  1051.60072   c*8      0.029 
1082.64288  1082.64334   c9- H2O      0.420 
1112.67994  1112.68058   z10•      0.575 
*  1122.63780  1122.63750   c*9     -0.267 
1128.69866  1128.69869   y10      0.027 
*  1235.72186  1235.72167   c*10     -0.154 
1240.77490  1240.77500   z11•      0.081 
1294.79535  1294.79484   c11- H2O    -0.398 
*  1334.79027  1334.79007   c*11     -0.150 
1353.85896  1353.85873   z12•     -0.170 
*  1463.83286  1463.83254   c*12     -0.157 
 C-6 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
1481.91754  1481.91766   z14      0.081 
1789.06941  1789.06759  [M+(C2-H2)- H2O +3H] 1+••   -1.017 
*  1807.07997  1807.07946       [M+(C2-H2)+3H] 1+••    -0.282 
mean -0.059  
St. Dv. 0.463 
 
Table C-6.  Mass error of the internal calibration of the DR(595.03)-ECD(602.36) spectra for the parent 
ion m/z 602.36 of the reacted EK-15 peptide in MeOH/H2O solution. Every chosen ion did not contain 
the added mass of the modification. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) 
INTERNAL CALIBRANT 
CHOSEN ION 
ERROR 
(ppm) 
230.16249 230.16250 z●2 0.024 
343.24655 343.24652 z●3 -0.101 
431.23610 431.23610 c3 0.011 
544.32020 544.32018 c4 -0.031 
672.41510 672.41499 c5 -0.170 
755.47872 755.47866 z●7 -0.083 
856.52640 856.52716 z●8 0.886 
928.56870 928.56888 c7 0.195 
1029.61640 1029.61624 c8 0.159 
1112.67994 1112.68033 z●10 0.346 
1240.77490 1240.77466 z●11 -0.194 
1353.85896 1353.85832 z●12 -0.474 
1441.84851 1441.84823 c12 -0.192 
1481.91754 1481.91714 z●13 -0.267 
  Standard deviation 0.362 
 
Table C-7.  Mass error of the internal calibration of the CAD spectra for the parent ion [M+C2 - 
H2+4H]4+ of the reacted EK-15 peptide in PBS buffer. Every chosen ion did not contain the added mass 
of the modification. 
THEORETICAL 
(m/z) 
EXPERIMENT
AL   (m/z) 
INTERNAL CALIBRANT 
CHOSEN ION 
ERROR 
(ppm) 
359.26527 359.26534 y3 0.195 
396.19899 396.19872 b3- H2O -0.681 
414.20956 414.20962 b3 0.144 
527.29362 527.29354 b4 -0.146 
 C-7 
THEORETICAL 
(m/z) 
EXPERIMENT
AL   (m/z) 
INTERNAL CALIBRANT 
CHOSEN ION 
ERROR 
(ppm) 
655.38858 655.38857 b5 -0.015 
765.47297 765.47335 b6- H2O 0.496 
872.54120 872.54155 y8 0.401 
1000.60370 1000.60304 y9 0.009 
1128.69866 1128.69945 y10 -0.699 
  Standard deviation 0.428 
 
Table C-8.  Mass error of the internal calibration of the DR(718.91)-ECD(724.41) spectrum of the 
parent ion [M+C2-H2+4H]4+ with ejection of [M+4H]4+ of the FR-25 peptide in MeOH/H2O solution.  
Every chosen ion did not contain the added mass of the modification.  
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) 
INTERNAL CALIBRANT 
CHOSEN ION 
ERROR 
(ppm) 
246.13226 246.13226 z●2 0.020 
345.20067 345.20066 z●3 -0.035 
474.24326 474.24322 z●4 -0.079 
573.31167 573.31164 z●5 -0.057 
686.39573 686.39572 z●6 -0.015 
704.40843 704.40886 c6 -0.150 
761.93930 761.93939 z●142+ 0.116 
803.47684 803.47742 c7 0.044 
825.98678 825.98678 z●172+ 0.003 
876.51062 876.51064 z●172+ 0.019 
958.04229 958.04232 z●17 2+ 0.032 
971.52820 971.52846 z●9 0.271 
1070.59661 1070.59680 z●10 0.176 
1122.64182 1122.64227 c9 0.398 
1223.68950 1223.68996 c10 0.380 
1394.77636 1394.77641 z●13 0.035 
1522.87132 1522.87046 z●14 -0.562 
1650.96628 1650.96582 z●15 -0.281 
1752.01396 1752.01292 z●16 -0.596 
  Standard deviation 0.475 
 
 C-8 
Table C-9.    Mass error of the internal calibration of the CAD spectrum of the parent ion [M+C2-
H2+4H]4+ of the FR-25 peptide in PBS buffer.  Every chosen ion did not contain the added mass of the 
modification. 
THEORETICAL 
(m/z) 
EXPERIMENT
AL   (m/z) 
INTERNAL CALIBRANT 
CHOSEN ION 
ERROR 
(ppm) 
262.15098 262.15094 y2 -0.163 
361.21939 361.21958 y3 0.538 
461.21431 461.21429 b4 -0.023 
574.29836 574.29819 b5 -0.311 
603.83512 603.83498 b102+ -0.238 
702.41445 702.41478 y6 0.467 
799.46721 799.46671 y7 -0.622 
900.51489 900.51425 y8 -0.706 
1086.61533 1086.61471 y10     -0.571 
1214.67391 1214.67491 y11 0.824 
1311.72667 1311.72795 y12 0.975 
  Standard deviation 0.594 
 
Table C-10.  CAD mass error analysis for the parent ion [M+C2 – H2+3H]3+ of the glyoxal-derived 
glycation product formed at EK-15 peptide in MeOH/H2O solution.  * indicates the masses used for 
calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  308.13533   308.13531   b*2     -0.049 
350.73381   350.73369   y6 2+     -0.342 
359.26527   359.26534   y3      0.195 
394.23230   394.23205   (b*6- H2O) 2+    -0.634 
396.19899   396.19872   b3- H2O     -0.681 
403.23758   403.23740   b*6 2+     -0.446 
413.27584   413.27579   w4     -0.121 
*  436.19390   436.19386   b*3     -0.103 
456.27470   456.27446   b7 2+     -0.526 
458.26159   458.26144   (b*7- H2O)2+    -0.327 
458.75360   458.75355   (b*7- NH3)2+    -0.109 
467.26687   467.26649   b*72+     -0.813 
470.29730   470.29736   y4- H2O      0.128 
488.30786   488.30781   y4     -0.102 
491.80021   491.80004   (y9- H2O) 2+    -0.346 
498.28527   498.28562   (b8- NH3)2+     0.702 
506.79854   506.79833   b8 2+     -0.414 
509.28305   509.28281   b4- H2O     -0.471 
517.79071   517.79067   b*82+      0.384 
 C-9 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
521.28305   521.28259   a*4     -0.882 
524.79854   524.79834   (b9- H2O - NH3)2+   -0.381 
527.29362   527.29322   b4     -0.749 
533.31181   533.31142   (b9- H2O) 2+    -0.731 
542.31709   542.31698   b92+     -0.203 
544.30399   544.30376   (b*9- H2O)2+    -0.423 
*  549.27796   549.27768   b*4     -0.519 
559.34500   559.34514   y14 3+     -0.518 
564.85297   564.85279   y10 2+     -0.319 
569.36571   569.36618   y5- H2O      0.825 
581.34057   581.34047   (b10- H2O - NH3) 2+    0.172 
587.37627   587.37653   y5      0.443 
589.85384   589.85337   (b10- H2O)2+    -0.797 
590.68059   590.68064  [M+C2-H2- H2O - NH3+3H] 3+    0.085 
590.68059   590.68064  [M+C2-H2- H2O - NH3+3H] 3+    0.688 
595.35610   595.35651  [M+C2-H2 - H2O +3H] 3+    -0.585 
596.68411   596.68374  [M+C2-H2 - NH3+3H] 3+    -0.620 
598.85912   598.85944   b10 2+     -0.969 
602.35963   602.35948   [M+C2-H2 +3H]3+   -0.249 
*  609.85130   609.85127   b*10 2+     -0.667 
628.90045   628.89986   y11 2+     -0.938 
637.37801   637.37741   b5- H2O     -0.941 
655.38857   655.38803   b5     -0.832 
677.37293   677.37273   b*5     -0.288 
682.44977   682.44936   y6- H2O     -0.601 
700.46033   700.46093   y6      0.857 
703.90934   703.90977   (b12- H2O) 2+     0.611 
712.91462   712.91427   b122+     -0.491 
714.90152   714.90180   (b*12- H2O)2+     0.392 
765.47297   765.47335   b6- H2O      0.496 
712.91462   712.91427   b13 2+       0.611 
*  769.45665   769.45618   (b*13- H2O)2+     0.881 
771.49744   771.49741   y7     -0.039 
780.44883   780.44820   (b*13- H2O)2+    -0.807 
787.45732   787.45720   b*6- H2O    -0.152 
*  829.98306   829.98357   b*142+      0.614 
872.54120   872.54140   y8     -0.321 
915.51590   915.51532   b*7- H2O    -0.634 
*  933.52647   933.52574   b*7     -0.777 
982.59314   982.59384   y9- H2O      0.717 
*  1000.60370  1000.60304   y9     -0.660 
Mean -0.019  
St. Dv. 0.524 
 
 C-10 
Table C-11.  DR(718.91)-ECD(724.41) mass error analysis for the parent ion [M+C2 – H2+4H]4+ of the 
glyoxal-derived glycation product formed at FR-25 peptide in MeOH/H2O solution.  * indicates the 
masses used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  246.13226  246.13212 z2• -0.569 
293.16081  293.16065 c2 -0.546 
*  345.20067  345.20045 z3• -0.637 
 351.08983 ?   
361.21939  361.21934 y3 -0.138 
407.20374  407.20343 c3 -0.761 
415.22996  415.22971 w4 -0.590 
*  474.24326  474.24296 z4• -0.633 
475.25109  475.25081 z4 -0.579 
478.24085  478.24060 c4 -0.523 
490.26198  490.26167 y4 -0.632 
572.30385  572.30336 y5 – NH3 -0.847 
572.30330  572.30336 z•5−Η• 0.114 
*  573.31167  573.31134 z5• -0.576 
589.33039  589.32980 y5 -1.001 
591.32491  591.32446 c5 -0.761 
643.34041  643.34035 z6•-C3H7 -0.085 
685.38791  685.38774 y6 – NH3 -0.241 
685.38736  685.38774 z•6−Η• 0.562 
*  686.39573  686.39540 z6• -0.481 
702.41445  702.41418 y6 -0.384 
704.40897  704.40855 c6 -0.596 
724.41172 724.41172 [M-H2+(C2 -H2)+4H]4+ 0.000 
751.43553  751.43518 c∗122+ -0.459 
761.93930  761.93955 z14•2+ 0.328 
*  769.94866  769.94817 y142+ -0.636 
799.46721  799.46689 y7 -0.400 
803.47738  803.47710 c7 -0.348 
825.48259  825.48243 (z•15−Η•)2+ -0.197 
833.99614  833.99609 y152+ -0.060 
849.49611  849.49579 c*142+ -0.377 
865.47778 865.47771 y8 –H2O-NH3 -0.081 
867.49343 867.49306 z8•- Η2Ο -0.427 
*  876.51062 876.51069 z16•2+ 0.080 
882.47997 882.48028 z•8−Η2• 0.351 
883.48780 883.48822 z•8−Η• 0.481 
884.49617 884.49644 z8• 0.305 
900.51489  900.51470 y8 -0.211 
903.85604  903.85632 z24• 3+ 0.313 
 C-11 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
912.51490  912.51468 wa9 -0.236 
913.52540  913.52507 c*15 2+ -0.361 
958.04229  958.04202 z17•2+ -0.277 
*  959.57849  959.57839 c8 -0.104 
960.20696  960.20633 [M+(C2-H2)-NH3+4H]3+• -0.656 
965.54653  965.54565 [M+(C2-H2)+3H]3+ -0.913 
969.51200  969.51283 z•9−Η2• 0.856 
970.51983  970.52038 z•9−Η• 0.572 
971.52820  971.52816 z9• -0.041 
980.55502  980.55535 c*8•  0.342 
981.56284  981.56268 c*8 -0.163 
987.54692  987.54693 y9 0.010 
1006.57562  1006.57537 c*172+ -0.248 
1027.08756  1027.08835 (z18•-H2O)2+ 0.772 
 1031.59953 ?   
1035.58865  1035.58814 (z18 –H•)2+ -0.495 
*  1036.09284  1036.09228 z18•2+ -0.540 
1036.59675  1036.59667            z182+     -0.077 
1044.10220  1044.10256             y18 2+      0.345 
1052.58605  1052.58665          z10•- H2O      0.570 
1069.58934  1069.58852           z10•- H•     -0.762 
1070.59661  1070.59653   z10•     -0.075 
1086.13096  1086.13127              z192+      0.285 
1086.61533  1086.61511   y10     -0.202 
    1105.62584  1105.62572              c*19 2+     -0.109 
1122.64182  1122.64201   c9      0.169 
1142.67299  1142.67317              z202+      0.158 
1143.61835  1143.61862   c*9•      0.236 
1144.62617  1144.62610   c*9     -0.061 
1162.16787  1162.16776             c*202+     -0.095 
1181.65245  1181.65171          z11•-H20     -0.626 
1189.70592  1189.70550         (z21•-H2O)2+    -0.269 
1197.64737  1197.64741            z11•- H•      0.422 
1198.65519  1198.65509   z11•     -0.083 
1199.21502  1199.21517              z212+      0.125 
    1211.70208  1211.70212              c*21 2+      0.033 
1214.67391  1214.67380   y11     -0.091 
*  1223.68950  1223.68976   c10      0.212 
1234.73357  1234.73411               z222+      0.437 
1245.67385  1245.67381   c*10     -0.032 
1276.22337  1276.22364              c*222+      0.212 
1284.24531  1284.24488      (b23-•CONH2) 2+    -0.335 
 C-12 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
1284.72475  1284.72481     (z*23•-H2O- NH3) 2+        0.047 
1291.75504  1291.75522   z23 2+      0.139 
1299.26049  1299.26030   y23 2+     -0.146 
1301.73966  1301.73977   (z*23-H•) 2+     0.085 
1311.72667  1311.72646   y12     -0.160 
1325.75758  1325.75796   c*232+      0.287 
1347.26677  1347.26742   a*242+      0.482 
1349.27613  1349.27556   (c24- H2O) 2+    -0.422 
1351.78446  1351.78545   c11      0.732 
1355.28042  1355.28098              z24•2+      0.413 
1355.78433  1355.78472              z242+      0.288 
1369.27359  1369.27420              c*24 2+      0.445 
1372.76099  1372.76053   c∗11•     -0.335 
1393.76909  1393.76797   z13•-H•     -0.795 
1394.77636  1394.77631   z13•     -0.036 
*  1410.79508  1410.79487   y13     -0.149 
1448.32007  1448.32128          [M+C2-H2+3H] 2+•     0.835 
1448.82398  1448.82455         [M+C2-H2+4H] 2+••     0.393 
1501.86377  1501.86403   c*12      0.173 
1504.83695  1504.83723          y14-2 NH3      0.186 
1521.86350  1521.86373           z14•-H•      0.151 
1522.87132  1522.87047   z14•     -0.558 
1523.87915  1523.87960   z14      0.295 
1538.89004  1538.88973   y14     -0.201 
1632.93191  1632.93214           y15-2NH3      0.141 
1633.96354  1633.96383           z15•- H2O      0.177 
1651.97411  1651.97467              z15      0.339 
1666.98500  1666.98641   y15      0.846 
*  1697.98494  1697.98473   c*14     -0.124 
1732.99557  1732.99588         y16- H2O - NH3     0.179 
1735.01122  1735.00983          z16- H2O     -0.801 
1751.00614  1751.00621            z16•-H•      0.040 
1752.01396  1752.01315   z16•     -0.462 
1753.02179  1753.02263              z16      0.479 
1826.04352  1826.04435   c*15      0.455 
1914.07001  1914.07089            z17•-H•      0.460 
1916.08512  1916.08533               z17      0.110 
1925.11193  1925.11257   c*16      0.332 
1931.09601  1931.09604   y17      0.016 
2012.14396  12012.14579   c*17      0.909 
*  2072.18890  2072.18810           c19•- H2O     -0.386 
Mean -0.072  
St. Dv. 0.503 
 
 C-13 
Table C-12.  DR(595.03)-ECD(602.36) mass error analysis for the parent ion [M+C2 - H2+3H]3+ of the 
glyoxal-derived glycation product formed at EK-15 peptide in PBS buffer. 
THEORETICAL (m/z) EXPERIMENTAL   (m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  325.16187        325.16188    c*2    0.031 
343.24655        343.24654    z3•   -0.029 
359.26527        359.26528    y3    0.028 
*  453.22045        453.22031    c*3   -0.309 
472.28914        472.28904    z4•   -0.212 
488.30786        488.30773    y4   -0.266  
*  566.30451        566.30444    c*4   -0.124  
571.35755        571.35751    z5•   -0.070  
587.37627        587.37613    y5   -0.238  
650.38584        650.38583    a*5   -0.015 
684.44161        684.44150    z6•   -0.161 
*  694.39947        694.39934    c*5   -0.187 
700.46033        700.46015    y6   -0.257 
*  755.47872        755.47863    z7•   -0.119 
771.49744        771.49743    y7   -0.013 
788.96210        788.96181    c*132+   -0.368 
816.48949        816.48921    a*142+   -0.343 
822.49443        822.49432    c*6   -0.134 
830.50514        830.50437    z*14•2+    1.019 
*  838.49631        838.49619    c*142+    -0.137 
838.51450        838.51425    y*14   -0.298 
856.52640        856.52639    z8•   -0.012 
872.54512        872.54598    y8    0.986 
885.51724        885.51698   [M-H2O-NH3+2H]2+  -0.294 
895.02644        895.02604   [M-NH3+3H] 2+ •  -0.445 
903.53971        903.53960         [M+3H] 2+ •  -0.122 
*  950.55301        950.55285    c*7   -0.168 
984.58498        984.58478    z9•   -0.203 
1000.60370      1000.60336    y9   -0.340 
1007.58706      1007.58787    a*8    0.804 
*  1051.60069      1051.60075    c*8    0.057 
1112.67994      1112.68007    z10•    0.117 
*  1122.63780      1122.63772    c*9   -0.071 
1128.69866      1128.69936    y10    0.620 
*  1235.72186      1235.72195    c*10    0.073 
1240.77490      1240.77497    z11•    0.056 
1256.79362      1256.79437    y11    0.597 
*  1334.79027      1334.79013    c*11   -0.105 
1353.85896      1353.85786    z12•   -0.812 
1369.87768      1369.87772    y12    0.029 
*  1463.83286      1463.83267    c*12   -0.129 
1481.91754      1481.91668    z13•   -0.580 
1807.07966      1807.07890         [M+3H] 1+ • •  -0.421 
*  1789.06940      1789.06859     [M-H2O+3H] 1+ • •  -0.453 
Mean -0.083  
St. Dv. 0.385 
 C-14 
 
Table C-13.  CAD mass error analysis for the parent ion [M+C2 - H2+3H]3+ of the glyoxal-derived 
glycation product formed at EK-15 peptide in PBS buffer. 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  246.18121       246.18128   y2     0.284 
268.14041       268.14052   b2-H2O    0.410 
273.09821       273.09826              b*2-H2O-NH3    0.165 
286.15098      286.15096   b2    -0.070 
290.12476      290.12483   b*2-H2O    0.241 
291.10878      291.10885   b*2-NH3    0.240 
*  308.13533      308.13534   b*2     0.049 
324.22816      324.22828              y3-H2O-NH3    0.370 
341.25471      341.25480   y3- H2O    0.264 
359.26527      359.26537   y3     0.278 
366.21358      366.21388              b6-H2O-2NH3    0.819 
369.24267      369.24232   (a6- H2O) 2+   -0.948 
371.72157      371.72171   (a*6-H2O-NH3) 2+   0.377 
374.14590      374.14606              a*3-2NH3    0.428 
379.17245      379.17248   b3- H2O-NH3    0.079 
380.23484      380.23496   (a*6- H2O) 2+    0.309 
380.72713      380.72692   (a*6-NH3 ) 2+   -0.538 
381.24722      381.24736   y3+Na-H    0.367 
383.24013      383.24017   (b6- H2O) 2+    0.104 
384.13025      384.13037   b*3-H2O-2NH3    0.312 
385.71903      385.71912   (b*6- H2O - NH3) 2+   0.240 
389.24013      389.24019   a*6 2+     0.161 
390.18842      390.18853   a*3- H2O    0.269 
394.23230      394.23239   (b*6- H2O) 2+    0.228 
394.72431      394.72445   (b*6- NH3) 2+    0.355 
396.19899      396.19901   (b3- H2O) 2+    0.050 
401.15679      401.15685   b*3- H2O - NH3    0.137 
402.14081      402.14090   b*3-2NH3    0.211 
403.23758      403.23764   b*6 2+     0.143 
408.19899      408.19903   a*3     0.098 
413.27583      413.27589   w4     0.133 
414.20956      414.20961   b3     0.121 
418.18334      418.18337   b*3- H2O    0.072 
419.16736      419.16739   b*3- NH3    0.072 
427.23759      427.23752   (a*7- H2O - 2NH3) 2+  -0.158 
427.77092      427.77082   (y8- H2O) 2+   -0.228 
430.24287      430.24259   (b7-H2O - 2NH3) 2+  -0.651 
435.75086      435.75091   (a*7- H2O - NH3) 2+   0.115 
*  436.19390      436.19388   b*3    -0.046 
444.26413      444.26405   (a*7- H2O) 2+   -0.186  
444.75642      444.75609   (a*7 - NH3) 2+   -0.731 
447.26942      447.26947   (b7- H2O) 2+    0.112 
447.76143      447.76151   (b7 - NH3) 2+    0.179 
449.74832      449.74829   (b*7- H2O - NH3) 2+  -0.061 
452.28673      452.28669   y4- 2H2O    -0.088 
 C-15 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
453.26941      453.26919   a*7  2+    -0.496 
453.27075      453.27091   y4- H2O - NH3    0.353 
458.26159      458.26154   (b*7- H2O) 2+   -0.109 
458.75360      458.75352   (b*7 - NH3) 2+   -0.174 
467.26687      467.26682   b*7 2+    -0.112 
470.29730      470.29725   y4- H2O   -0.096 
471.76143      471.76127   (b8-2H2O -2NH3) 2+  -0.339 
477.76143      477.76098   (a*8- H2O -2NH3) 2+  -0.937 
480.27470      480.27451   (b8-2H2O - NH3) 2+  -0.396 
481.28814      481.28807   a4 - H2O   -0.145 
482.79492      482.79485   (y9-2H2O) 2+   -0.155  
482.94029      482.94032   b*12 3+     0.059 
485.78269      485.78284   (a*8-2H2O) 2+    0.309 
486.27470      486.27465   (a*8- H2O - NH3 ) 2+  -0.103 
487.22996      487.22990   a*4- 2NH3   -0.123 
488.30786      488.30780   y4    -0.123 
488.78797      488.78782   (b8-2H2O) 2+   -0.307 
491.26688      491.26679   (b*8-2H2O - NH3) 2+  -0.173 
491.75889      491.75900   (b*8- H2O -2NH3) 2+   0.234 
491.80021      491.80014   (y9- H2O) 2+   -0.138 
492.25651      492.25661   b4- H2O - NH3    0.203 
494.78797      494.78795   (a*8- H2O) 2+   -0.045 
495.28026      495.28004   (a*8-NH3) 2+   -0.434  
497.21431      497.21439   b*4- H2O -2NH3   0.161 
497.79326      497.79331   (b8- H2O) 2+    0.100 
499.29870      499.29863   a4    -0.140 
499.78015      499.78002   (b*8-2H2O) 2+   -0.255 
500.27216      500.27206   (b*8- H2O - NH3) 2+  -0.195 
503.27249      503.27237   a*4- H2O   -0.229 
503.79325      503.79321   a*8 2+    -0.089 
508.78543      508.78535   (b*8- H2O) 2+   -0.157 
509.27744      509.27744   (b*8- NH3) 2+    0.000 
509.28305      509.28295   b4- H2O   -0.196 
513.27998      513.27979   (a*9- H2O -2NH3) 2+  -0.375  
514.24086      514.24080   b*4- H2O - NH3   -0.107  
514.63146      514.63120   (b*13- H2O) 3+   -0.499 
515.22487      515.22484   b*4-2NH3   -0.068 
517.79071      517.79062   b*8 2+    -0.179 
518.27216      518.27241   (b*9-2H2O -2NH3) 2+   0.486 
520.63498      520.63488   b*13 3+    -0.189 
521.28305      521.28297   a*4    -0.153 
521.79326      521.79318   (a*9- H2O - NH3) 2+  -0.144 
526.78543      526.78541   (b*9-2H2O - NH3) 2+  -0.038 
527.29362      527.29354   b4    -0.152 
530.30653      530.30652   (a*9- H2O) 2+   -0.014  
530.79881      530.79848   (a*9- NH3) 2+   -0.622  
531.26740      531.26733   b*4- H2O   -0.132  
532.25142      532.25135   b*4- NH3   -0.132 
533.31181      533.31173   (b9- H2O) 2+   -0.150  
 C-16 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
535.29870      535.29859   (b*9-2H2O) 2+   -0.210  
535.79071      535.79062   (b*9- H2O - NH3) 2+  -0.173 
539.31181      539.31166   a*9 2+    -0.278 
544.30399      544.30388   (b*9- H2O) 2+   -0.193 
544.79599      544.79596   (b*9- NH3) 2+   -0.064 
*  549.27796      549.27790   b*4    -0.118 
551.35514      551.35515   y5-2H2O    0.018 
552.01731      552.01729   y14  3+    -0.036 
552.33916      552.33918   y5- H2O - NH3    0.036 
553.30927      553.30919   b*9 2+    -0.140 
555.84769      555.84765   (y10- H2O) 2+   -0.067 
556.33970      556.33966   (y10- NH3) 2+   -0.067 
559.34543      559.34500   y*14 3+    -0.763 
564.85297      564.85287   y10 2+    -0.177 
569.36571      569.36569   y5- H2O   -0.026 
569.82201      569.82203   (a*10 - H2O -2NH3) 2+   0.031 
572.33529      572.33504   (b10-2H2O - NH3) 2+  -0.437  
572.82730      572.82710   (b10- H2O -2NH3) 2+  -0.349  
574.34599      574.34608   a5-2H2O - NH3    0.157 
577.84327      577.84301   (a*10 -2H2O) 2+   -0.459 
578.33528      578.33519   (a*10 - H2O - NH3) 2+  0.164 
580.84856      580.84808   (b10-2H2O) 2+   -0.826 
581.34057      581.34044   (b10- H2O - NH3 2+)  -0.224 
583.32746      583.32741   (b*10 - H2O - NH3) 2+  -0.086 
583.81947      583.81955   (b*10 - H2O -2NH3) 2+    0.137 
584.67707      584.67683       [M-2H2O -NH3+3H] 3+  -0.410  
586.29838      586.29809   b5-2H2O -2NH3  -0.495 
586.84856      586.84845   (a*10 - H2O) 2+   -0.183 
587.34084      587.34053   (a*10 - NH3) 2+   -0.528  
587.37627      587.37624   y5    -0.051 
589.85384      589.85397   (b10- H2O) 2+    0.220 
590.35258      590.35250   [M-2H2O +3H] 3+  -0.136  
590.68059      590.68048       [M- H2O- NH3+3H] 3+  -0.186  
591.84073      591.84065   (b*10 -2H2O) 2+   -0.139 
592.33274      592.33253   (b*10 - H2O - NH3) 2+  -0.359 
593.02799      593.02756   [M-CO+3H]3+  -0.725 
595.85384      595.85377   a*10 2+    -0.117 
596.35610      596.35602   [M- H2O +3H] 3+  -0.134 
596.68411      596.68409   [M- NH3+3H] 3+  -0.034  
600.84601      600.84596   (b*10 - H2O) 2+   -0.092 
601.33803      601.33807   (b*10 - NH3) 2+    0.075 
603.32492      603.32502   b5- H2O -2NH3  0.166 
609.85130      609.85122   b*10 2+    -0.127 
614.36471      614.36451   a*5 -2H2O   -0.326 
615.32492      615.32491   a*5 -2NH3   -0.016 
619.35622      619.35596   (a*11- H2O -2NH3) 2+  0.416 
619.89517      619.89508   (y11- H2O) 2+   -0.141 
620.35147      620.35146   b5- H2O - NH3   -0.016 
621.33549      621.33550   b5-2NH3    0.016 
 C-17 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
621.86949      621.86943   (b11-2H2O - NH3) 2+  -0.096 
627.86949      627.86937   (a*11- H2O - NH3) 2+  0.191 
*  628.90045      628.90035   y11 2+    -0.159 
630.87477      630.87434   (b11- H2O - NH3) 2+  -0.682 
631.36744      631.36745   a*5 - H2O    0.008 
632.86167      632.86154   (b*11-2H2O - NH3) 2+  -0.198 
636.38276      636.38277   (a*11- H2O) 2+    0.012 
636.87505      636.87471   (a*11- NH3) 2+   -0.526 
637.37801      637.37816   b5- H2O    0.235 
639.38805      639.38772   (b11- H2O) 2+   -0.516 
639.88006      639.87967   (b11- NH3) 2+   -0.609 
641.37494      641.37505   (b*11-2H2O) 2+    0.175 
641.86695      641.86687   (b*11- H2O - NH3) 2+  -0.121 
642.33582      642.33573   b*5 - H2O- NH3   -0.132  
643.31984      643.31981   b*5 -2NH3   -0.039 
645.38805      645.38801   a*11 2+    -0.054 
648.39333      648.39367   b11 2+     0.524 
649.37801      649.37801   a*5     0.000 
650.38022      650.38027   (b*11- H2O) 2+    0.077 
650.87223      650.87216   (b*11- NH3) 2+   -0.108 
655.38858      655.38856   b5    -0.031 
659.36236      659.36233   b*5 - H2O   -0.045  
659.38550      659.38546   b*11 2+    -0.064 
660.34638      660.34638   b*5 - NH3    0.000 
664.43920      664.43924   y6-2H2O    0.060  
665.42322      665.42347   y6- H2O - NH3    0.376 
677.37293      677.37293   b*5     0.007 
682.44976      682.44974   y6- H2O   -0.037 
683.87751      683.87744   (a*12 - H2O -2NH3) 2+  -0.106 
685.44248      685.44257   y12 2+     0.131 
686.39079      686.39048   (b12-2H2O - NH3) 2+  -0.444 
691.89878      691.89872   (a*12 -2H2O) 2+   -0.079 
692.39079      692.39081   (a*12 - H2O - NH3) 2+   0.036 
696.89095      696.89089   (b*12 -3H2O) 2+   -0.086  
697.38296      697.38294   (b*12 -2H2O - NH3) 2+  -0.029  
697.87497      697.87478   (b*12 - H2O -2NH3) 2+  -0.272 
*  700.46033      700.46031   y6    -0.029 
700.90406      700.90406   (a*12 - H2O) 2+    0.004 
701.39634      701.39588   (a*12 - NH3) 2+   -0.656 
703.90934      703.90929   (b12- H2O) 2+   -0.071 
705.89623      705.89619   (b*12 -2 H2O) 2+   -0.060  
706.38824      706.38820   (b*12 - H2O - NH3) 2+  -0.060 
709.43686      709.43672   x6- H2O   -0.190 
709.90934      709.90940   a*12  2+     0.081 
714.90152      714.90148   (b*12 - H2O) 2+   -0.049 
715.39352      715.39358   (b*12 - NH3) 2+    0.077 
722.44227      722.44220   y6+Na-H   -0.104 
*  723.90680      723.90676   b*12  2+    -0.052 
727.44742      727.44750   x6     0.110 
 C-18 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
731.41988      731.42034   b6- H2O -2NH3   0.629 
731.46120  731.46106   (y13-2H2O) 2+   -0.198 
734.41954  734.41947   (b13-2H2O -2NH3) 2+  -0.099 
736.46033  736.46011   y7- H2O - NH3   -0.299 
740.41954  740.41961   (a*13- H2O -2NH3) 2+   0.091 
740.46649  740.46649   (y13- H2O) 2+    0.003 
740.95850  740.95855   (y13- NH3) 2+    0.071 
743.41988  743.41976   a*6 -2NH3   -0.161 
747.46241  747.46305   b6-2H2O    0.856 
748.44643  748.44655   b6- H2O - NH3    0.160 
748.93282  748.93278   (a*13- H2O - NH3) 2+  -0.047 
749.47177  749.47136   y13 2+    -0.547 
751.44609  751.44608   (b13-2H2O) 2+   -0.010 
753.40423  753.40452   b*6 -H2O-2 NH3   0.385 
753.43298  753.43331   (b*13-3H2O) 2+    0.438 
753.48688  753.48679   y7- H2O   -0.113 
753.92499  753.92495   (b*13-2H2O- NH3) 2+  -0.053 
754.41700  754.41717   (b-*13- H2O -2NH3) 2+   0.225 
757.44609  757.44612   (a*13- H2O) 2+    0.043 
757.93837  757.93807   (a*13- NH3) 2+   -0.396  
759.46240  759.46244   a*6 - H2O    0.046 
762.43826  762.43829   (b*13-2H2O) 2+    0.036 
762.93027  762.93030   (b*13- H2O - NH3) 2+   0.036 
765.47297  765.47306   b6- H2O    0.118 
766.45137  766.45130   a*13 2+    -0.091 
769.44676  769.44707   b*6 -2H2O    0.409 
769.45665  769.45656   b132+    -0.120 
770.43078  770.43071   b*6 - H2O - NH3  -0.084 
771.41480  771.41552   b*6 -2NH3    0.940 
771.44354  771.44360   (b*13- H2O) 2+    0.071 
771.49744  771.49743   y7    -0.013 
771.93556  771.93543   (b*13- NH3) 2+   -0.162 
777.47297  777.47280   a*6    -0.219 
780.44883  780.44884   b*13 2+     0.016 
781.45799  781.45724   x7- NH3   -0.953 
783.48354  783.48363   b6     0.115 
787.45732  787.45729   b*6 - H2O   -0.038  
788.44134  788.44129   b*6 - NH3   -0.063  
789.95375  789.95449   (a*14 - H2O -2NH3) 2+   0.940 
793.47938  793.47937   y7+Na-H   -0.019 
797.97501  797.97501   (a*14 2H2O)2+    0.000 
798.46702  798.46696   (a*14 -H2O- NH3) 2+  -0.075 
802.96718  802.96775   (b*14 -3H2O) 2+     0.704 
*  805.46789  805.46789   b*6     0.006 
806.98029  806.98012   (a*14 - H2O) 2+   -0.214 
809.98558  809.98569   (b14- H2O) 2+    0.142 
811.97247  811.97253   (b*14 -2H2O) 2+    0.077 
812.46448  812.46430   (b*14 - H2O - NH3) 2+  -0.218 
815.98558  815.98539   a*14  2+    -0.227 
 C-19 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
820.97775  820.97772   (b*14 - H2O) 2+   -0.037 
821.46976  821.47051   (b*14 - NH3) 2+    0.913 
829.98303  829.98299   b*14 2+    -0.051 
836.52399  836.52363   y8-2H2O   -0.430 
842.45192  842.45107   b7-2H2O -2NH3  -1.009 
854.53455  854.53458   y8- H2O    0.029 
859.47846  859.47840   b7- H2O -2NH3  -0.070 
860.53451  860.53396   [M- H2O+2H] 2+  -0.642 
862.51450  862.51467   [M- H2O - NH3 +2H] 2+  0.197 
871.47846  871.47854   a*7 -2NH3    0.092 
872.54512  872.54509   y8    -0.034 
876.50501  876.50497   b7- H2O - NH3   -0.046 
877.48903  877.48957   b7-2NH3    0.615 
881.46281  881.46325   b*7 - H2O -2NH3   0.499  
887.52098  887.52032   a*7 - H2O   -0.749  
893.53155  893.53141   b7- H2O   -0.157 
894.52706  894.52738   y8+Na-H    0.352 
897.50533  897.50448   b*7 -2H2O   -0.953 
898.48936  898.48961   b*7 - H2O - NH3   0.284 
899.47338  899.47358   b*7 -2NH3    0.228  
915.51590  915.51585   b*7 - H2O   -0.055  
916.49992  916.49987   b*7 - NH3   -0.055 
*  933.52647  933.52645   b*7    -0.016 
956.50743  956.50650   a*8-3NH3   -0.967  
961.51016  961.51014   b8-3NH3   -0.021  
964.58257  964.58266   y9-2H2O    0.093 
965.56659  965.56659   y9- H2O - NH3    0.000 
972.52614  972.52584   a*8-2NH3   -0.308 
977.55269  977.55244   b8- H2O - NH3   -0.256 
982.59313  982.59312   y9- H2O   -0.015 
986.56560  986.56516   a9-2NH3-2H2O   -0.446 
998.55301  998.55291   b*8-2H2O   -0.105 
999.53703  999.53706   b*8- H2O - NH3     0.025 
1000.60370  1000.60366   y9    -0.040 
1004.57617  1004.57520   a9-2NH3- H2O   -0.966 
1005.56019  1005.55931   a9-3NH3   -0.875 
1006.57923  1006.57997   a*8     0.735 
1016.56358  1016.56361   b*8- H2O    0.030 
1017.54760  1017.54772   b*8- NH3    0.118 
1022.58564  1022.58591   y9+Na-H    0.259 
1022.58673  1022.58591   a9-2NH3   -0.802 
1031.56325  1031.56351   b9- H2O -2NH3   0.252 
*  1034.57415  1034.57415   b*8     0.005 
1043.56325  1043.56321   a*9-2NH3   -0.038  
1053.54760  1053.54713   b*9- H2O -2NH3  -0.446 
1059.60577  1059.60644   a*9- H2O    0.628 
1065.61634  1065.61545   b9- H2O   -0.835 
1069.59012  1069.58944   b*9-2H2O   -0.640  
1070.57415  1070.57345   b*9- H2O - NH3   -0.649  
 C-20 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
1077.61634  1077.61625   a*9    -0.084  
1087.60069  1087.60060   b*9- H2O   -0.083  
1088.58471  1088.58477   b*9- NH3     0.055 
1092.67753  1092.67762   y10-2H2O    0.082 
1093.66155  1093.66157   y10- H2O - NH3   0.018 
1105.61126  1105.61120   b*9    -0.050 
1110.68809  1110.68814   y10- H2O    0.041 
1127.62077  1127.62085   b10-2H2O -2NH3   0.071 
*  1128.69866  1128.69881   y10     0.133 
1145.63133  1145.63193   b10-3NH3    0.524 
1157.65514  1157.65511   a*10 -2NH3   -0.026 
1172.68983  1172.68953   a*10 - H2O   -0.260 
1178.70040  1178.70076   b10- H2O    0.305 
1183.65820  1183.65821   b*10 - H2O - NH3   0.004 
1190.70040  1190.70010   a*10    -0.252 
1200.68475  1200.68452   b*10 - H2O   -0.192 
1201.66877  1201.66899   b*10 - NH3    0.183 
*  1218.69531  1218.69542   b*10     0.086 
1220.70242  1220.70236   a*11 -2NH3-2 H2O  -0.049 
1256.79362  1256.79398   y11     0.286 
1271.75824  1271.75827   a*11- H2O    0.020 
1277.76881  1277.76808   b11- H2O   -0.571 
*  1289.76881  1289.76868   a*11    -0.101 
Mean -0.031  
St. Dv. 0.401 
 
Table C-13.  CAD mass error analysis for the parent ion [M+C2 - H2+3H]3+ of the glyoxal-derived 
glycation product formed at FR-25 peptide in PBS buffer. 
THEORETICAL (m/z) EXPERIMENTAL   (m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  262.15098      262.15094   y2    -0.167 
361.21939      361.21958   y3     0.526 
390.17719      390.17726   b3     0.175 
400.23724      400.23735   y7+2     0.262 
433.21939      433.21926   a4    -0.300 
441.75580      441.75582   (y8-H2O)2+    0.040 
444.18776      444.18770   b4-NH3   -0.135 
450.76108      450.76111   y82+     0.055 
461.21431      461.21430   b4    -0.011 
472.25142      472.25154   y4- H2O    0.265 
476.26653      476.26657   (y9- 2H2O)2+    0.073 
482.77179      482.77143   b82+    -0.741 
485.27182      485.27170   (y9- H2O)2+   -0.242 
*  490.26198  490.26194   y4    -0.082  
494.27710  494.27689   y92+    -0.425 
525.80074  525.80073   (y10- 2H2O)2+   -0.019 
539.81774  539.81821   a92+     0.871 
 C-21 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
540.24527  540.24516   b5-2NH3   -0.213 
546.30345  546.30331   a5    -0.256 
557.27182  557.27164   b5-NH3   -0.323 
*  574.29836  574.29821   b*5    -0.270 
589.33039  589.33028   y5    -0.187 
590.01575  590.01581   y163+     0.107 
596.34906  596.34934   b153+     0.467 
598.83531  598.83526   (y11- H2O)2+   -0.088 
603.67718  603.67696   b*153+    -0.362 
603.83512  603.83501   b102+    -0.182 
607.84060  607.83997   y112+    -1.028 
629.37186  629.37184   b163+    -0.040 
636.36659  636.36721   (a11-H2O-NH3) 2+    0.974 
*  636.69998  636.69969   b*163+    -0.458 
638.35641  638.35626   (y12- 2H2O)2+   -0.235 
644.37019  644.36949   y173+    -1.086 
645.37877  645.37916   (a11- H2O)2+    0.604 
656.36698  656.36691   y122+    -0.099 
665.71066  665.71083   b*173+     0.258 
670.35588  670.35564   b6-NH3   -0.358 
680.05806  680.05791   (b18- 2H2O)3+   -0.218 
687.38617  687.38612   (b*18- 2H2O)3+   -0.080 
689.38953  689.38974   a7-2NH3-2H2O   0.305 
692.06510  692.06480   b183+    -0.436 
697.38791  697.38782   (y13- NH3)2+   -0.125 
702.41445  702.41484   y6     0.555 
705.89825  705.89787   (b12-H2O-2NH3)2+  -0.538 
711.40624  711.40623   (a*12- H2O-2NH3) 2+   -0.014 
714.41152  714.41134   (b12-H2O-NH3)2+  -0.255 
715.40644  715.40645   [M-2H2O+4H]4+   0.014 
718.41250  718.41237   (b19-H2O)3+   -0.181 
720.15508  720.15525   [M-HN3+4H]4+   0.236 
762.11071  762.11068   b203+    -0.037 
767.12138  767.12092   y203+    -0.604 
769.94600  769.94654   (a*13-NH3)2+    0.701 
781.46428  781.46382   b132+    -0.592 
783.45118  783.45099   (b*13-H2O)2+   -0.236 
*  792.45646  792.45578   b*132+    -0.855 
795.13351  795.13377   b213+     0.325 
799.46721  799.46680   y7    -0.513 
804.81607  804.81617   y213+     0.124 
828.49511  828.49521   y223+     0.125 
838.14771  838.14847   b223+     0.909 
845.47582  845.47574   b*223+    -0.101 
866.50942  866.50982   y233+     0.465 
876.00671  876.00657   (y16-NH3)2+   -0.157 
882.50167  882.50241   (a15-NH3)2+    0.839 
*  884.51998  884.51979   y162+    -0.215 
894.01995  894.01974   b152+    -0.238 
 C-22 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
898.01352  898.01280   x162+    -0.807 
900.51489  900.51439   y8    -0.555 
*  905.01213  905.01149   b*152+    -0.704 
909.19561  909.19580   y243+     0.209 
943.55416  943.55447   b162+     0.331 
950.56199  950.56108   (a17-C2H3)2+   -0.952 
951.52579  951.52593   y9-2H2O    0.147 
953.53949  953.53996   [M-2H2O+3H]3+   0.493 
954.54633  954.54646   b*162+     0.134 
964.53629  964.53623   b*8    -0.067 
964.55971  964.56017   (a17-NH3)3+    0.472 
966.05165  966.05121   y172+    -0.450 
969.53635  969.53597   y9-H2O   -0.397 
970.54018  970.54022   (x17-H2O)2+    0.041 
987.07017  987.07059   b172+     0.423 
987.54692  987.54694   y9     0.020 
*  998.06235  998.06280   b*172+     0.453 
1034.58873  1034.58803   a*182+    -0.677 
1037.59401  1037.59479   b182+     0.749 
1048.54888  1048.54851   a*9-2NH3-H2O   -0.358 
*  1048.58619  1048.58683   b*182+     0.613 
1086.61533  1086.61495   y10    -0.350 
*  1127.59963  1127.60059   b*9     0.856 
1214.67391  1214.6749   y11     0.824 
1228.64731  1228.66632   b*10    -0.804 
*  1311.72667  1311.72795   y12     0.975 
Mean -0.029  
St. Dv. 0.471 
 
Table C-14. CAD mass error analysis for the parent ion [M+C2 - H2+3H]3+ of the glyoxal-derived 
glycation product formed at EK-15 with addition of sodium chloride. 
THEORETICAL (m/z) EXPERIMENTAL   (m/z) ASSIGNMENTS 
ERROR 
(ppm) 
246.18121  246.18120   y2    -0.041 
291.10878  291.10874   b*2- NH3   -0.137 
308.13533  308.13532   b*2    -0.016 
324.22816  324.22825   y3- H2O - NH3    0.278 
359.26527  359.26522   y3    -0.139 
379.17245  379.17267   b3- H2O - NH3    0.580 
381.24721  381.24699   y3+Na-H   -0.590 
385.71903  385.71890   (b*6- H2O - NH3)2+  -0.331 
394.23230  394.23225   (b*6- H2O)2+   -0.127 
394.72431  394.72438   (b*6- NH3)2+    0.177 
396.19899  396.19898   b3- H2O   -0.025 
401.15679  401.15670   b*3- H2O - NH3  -0.237 
403.23758  403.23761   b*6 2+     0.068 
408.19899  408.19910   a*3     0.269 
 C-23 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
413.27583  413.27592   w4     0.206 
418.18334  418.18332   b*3- H2O   -0.048 
419.16736  419.16740   b*3- NH3    0.095 
436.19390  436.19392   b*3     0.034 
438.75614  438.75617   (b7- H2O - NH3)2+   0.068 
449.74832  449.74830   (b*7- H2O - NH3) 2+  -0.039 
458.26159  458.26159   (b*7- H2O)2+    0.000 
458.75360  458.75350   (b*7- NH3)2+   -0.218 
467.26687  467.26689   b*7 2+     0.037 
470.29730  470.29729   y4- H2O   -0.011 
481.28814  481.28809   a4- H2O   -0.104 
482.79492  482.79511   (y9-2H2O)2+    0.383 
487.22996  487.23021   a*4-2NH3   0.513 
488.30786  488.30788   y4     0.041 
491.80021  491.80022   (y9- H2O)2+    0.025 
497.79326  497.79356   (b8- H2O)2+    0.603 
499.78015  499.78010   (b*8-2H2O)2+   -0.095 
500.27216  500.27217   (b*8- H2O - NH3)2+   0.025 
503.27249  503.27238   a*4- H2O   -0.209 
508.78543  508.78529   (b*8- H2O)2+   -0.275 
509.28305  509.28304   b4- H2O   -0.020 
517.79071  517.79072   b*8 2+     0.014 
521.28305  521.28302   a*4    -0.058 
526.78543  526.78511   (b*9-2H2O - NH3)2+  -0.607 
527.29362  527.29345   b4    -0.322 
531.26740  531.26740   b*4- H2O    0.000 
532.25142  532.25141   b*4- NH3   -0.019 
535.29870  535.29879   (b*9-2H2O)2+    0.163 
535.79071  535.79081   (b*9- H2O - NH3)2+   0.182 
539.31181  539.31160   a*9 2+    -0.389 
544.30399  544.30394   (b*9- H2O)2+   -0.083 
544.79599  544.79619   (b*9- NH3)2+    0.358 
549.27796  549.27795   b*4    -0.027 
551.35514  551.35509   y5-2H2O   -0.091 
552.01731  552.01700   y14 3+    -0.562 
553.30927  553.30921   b*9 2+    -0.104 
555.84769  555.84743   (y10- H2O)2+   -0.463 
564.85297  564.85298   y10 2+     0.018 
569.36571  569.36558   y5- H2O   -0.220 
587.37627  587.37627   y5     0.000 
590.68059  590.68024  [M- H2O - NH3+3H] 3+  -0.593 
595.85384  595.85361   a*10 2+    -0.386 
596.35610  596.35600         [M- H2O +3H] 3+   -0.168 
600.84601  600.84568   (b*10- H2O) 2+   -0.558 
609.85130  609.85130   b*10 2+     0.004 
615.32492  615.32445   a*5-2NH3   -0.764 
620.35147  620.35101   b5- H2O - NH3   -0.742 
627.86949  627.86952   (a*11- H2O - NH3)2+   0.048 
628.90045  628.90021   y112+    -0.382 
 C-24 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
631.36744  631.36799   a*5 - H2O    0.863 
632.86167  632.86197   (b*11-2 H2O - NH3)2+   0.482 
636.38276  636.38227   (a*11- H2O)2+   -0.774 
636.87505  636.87485   (a*11- NH3)2+   -0.306 
637.37801  637.37798   b5- H2O   -0.047 
639.38805  639.38820   (b11- H2O)2+    0.235 
641.86695  641.86635   (b*11- H2O - NH3)2+  -0.931 
645.38805  645.38815   a*11 2+      0.159 
649.37801  649.37810   a*5     0.139 
650.38022  650.38037   (b*11 - H2O)2+    0.231 
650.87223  650.87239   (b*11 - NH3)2+    0.246 
655.38858  655.38856   b5    -0.031 
659.36236  659.36245   b*5- H2O    0.136 
659.38550  659.38539   b*11  2+    -0.171 
660.34638  660.34644   b*5- NH3    0.091 
677.37293  677.37292   b*5    -0.007 
682.44976  682.44983   y6- H2O    0.095 
692.39079  692.39115   (a*12 - H2O - NH3)2+   0.527 
697.38296  697.38320   (b*12-2H2O - NH3)2+   0.344 
700.46033  700.46031   y6    -0.029 
700.90406  700.90410   (a*12- H2O)2+    0.061 
701.39634  701.39597   (a*12- NH3)2+   -0.528 
703.90934  703.90906   (b- H2O)2+   -0.398 
705.89623  705.89632   b*12-2 H2O)2+    0.124 
706.38824  706.38807   (b*12- H2O - NH3)2+  -0.244 
709.90934  709.90941   a 2+     0.095 
714.90152  714.90147   (b*12- H2O)2+   -0.063 
715.39352  715.39337   b*12- NH32+   -0.217 
723.90680  723.90662   b*12 2+    -0.245 
731.46120  731.46084   y13-2H2O2+   -0.499 
734.41954  734.41982   b13-2H2O -2NH32+   0.377 
740.46649  740.46644   y13- H2O2+   -0.064 
740.95850  740.95819   y13- NH32+   -0.415 
748.44643  748.44707   b6- H2O - NH3    0.855 
748.93282  748.93270   a*13-H2O- NH32+  -0.154 
757.44609  757.44575   a*13- H2O2+   -0.446 
757.93837  757.93809   a*13- NH32+   -0.369 
759.46240  759.46294   a*6 - H2O    0.704 
762.43826  762.43825   b*13-2H2O2+   -0.016 
763.44742  763.44668   x7- H2O - NH3   -0.969 
765.47297  765.47302   b6- H2O    0.065 
766.45137  766.45086   a*13 2+    -0.665 
771.44354  771.44366   b*13- H2O2+    0.149 
771.49744  771.49747   y7     0.039 
780.44883  780.44873   b*13 2+    -0.125 
783.48354  783.48423   b6     0.881 
787.45732  787.45722   b*6- H2O   -0.127 
788.44134  788.44137   b*6- NH3    0.038 
793.47938  793.47907   y7+Na-H   -0.397 
 C-25 
THEORETICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
805.46789  805.46791   b*6     0.031 
809.98558  809.98602   b14- H2O2+    0.549 
811.97247  811.97192   b*14-2H2O2+   -0.674 
812.46448  812.46383   b*14- H2O - NH32+  -0.797 
815.98558  815.98493   a*14 2+    -0.790 
820.97775  820.97758   b*14- H2O2+   -0.207 
829.98303  829.98288   b*14 2+    -0.184 
854.53455  854.53452   y8- H2O   -0.041 
872.54512  872.54515   y8     0.034 
876.50501  876.50477   b7- H2O - NH3   -0.274 
894.52706  894.52680   y8+Na-H   -0.296 
898.48936  898.48962   b*7- H2O - NH3   0.295 
915.51590  915.51609   b*7- H2O    0.208 
916.49992  916.50003   b*7- NH3    0.120 
933.52647  933.52652   b*7     0.059 
964.58257  964.58261   y9-2H2O    0.041 
965.56659  965.56671   y9- H2O - NH3    0.124 
982.59313  982.59330   y9- H2O    0.168 
1000.60370  1000.60368   y9    -0.020 
1016.56358  1016.56347   b*8- H2O   -0.108 
1022.58564  1022.58542   y9+Na-H   -0.220 
1031.56325  1031.56371   b9- H2O -2NH3   0.446 
1034.57415  1034.57396   b*8    -0.179 
1087.60069  1087.60069   b*9- H2O    0.000 
1088.58471  1088.58361   b*9- NH3   -1.010 
1092.67753  1092.67757   y10-2H2O    0.037 
1093.66155  1093.66112   y10- H2O - NH3  -0.393 
1105.61126  1105.61118   b*9    -0.068 
1110.68809  1110.68805   y10- H2O   -0.041 
1128.69866  1128.69852   y10    -0.124 
1183.65820  1183.65776   b-*10 H2O - NH3  -0.376 
1190.69800  1190.69800   a10+Na-H    0.000 
1200.68475  1200.68416   b*10- H2O   -0.491 
1201.66877  1201.66925   b*10- NH3    0.399 
1218.69531  1218.69546   b*10     0.119 
1289.76881  1289.76965   a*11     0.651 
Mean -0.064  
St. Dv. 0.416 
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Table D-1.  Mass error of the direct infusion spectra of the reacted KM-11 peptide reacted in 
MeOH/H2O at 11 days of reaction. * indicates the ions used for calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSINGMENT 
ERROR 
(ppm) 
*  449.91665 449.91667 [M+3H]3+ 0.022 
*  469.25182 469.25172 [M+C2H2O2+3H]3+ -0.208 
488.58698 488.58690 [M+2(C2H2O2)+3H]3+ -0.158 
494.59050 494.59052 [M+2(C2H2O2) +H2O +3H]3+ 0.055 
513.92566 513.92571 [M+3(C2H2O2) +H2O +3H]3+ 0.055 
 D-2 
*  674.37134 674.37115 [M+2H]2+ -0.292 
*  703.37408 703.37391 [M+C2H2O2+2H]2+ -0.251 
723.37154 723.37178 [M+C2H2O2+2H]2+ 0.326 
732.37682 732.37680 [M+2(C2H2O2) +2H]2+ -0.027 
741.38211 741.38222 [M+2(C2H2O2) +H2O+2H]2+ 0.152 
770.38485 770.38514 [M+3(C2H2O2) +H2O+2H]2+ 0.378 
*  779.39013 779.39066 [M+3(C2H2O2) +2H2O+2H]2+ 0.680 
808.39287 808.39356 [M+4(C2H2O2) +2H2O+2H]2+ 0.853 
*  1347.73542 1347.73529 [M+H]
1+
 
-0.099 
Mean 0.074 
 St. Dv. 0.388 
 
Table D-2.  Mass error of the direct infusion spectra of the reacted KM-11 peptide reacted in PBS. * 
indicates the ions used for calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSINGMENT 
ERROR 
(ppm) 
*  449.91665 449.91682 [M+3H]3+ 0.368 
463.24829 463.24813 [M+C2O+3H]3+ -0.348 
*  469.25182 469.25193 [M+C2H2O2+3H]3+ 0.232 
474.58345 474.58321 [M+C2H2O3+3H]3+ -0.512 
488.58698 488.58678 [M+2(C2H2O2)+3H]3+ -0.407 
674.37134 674.37202 [M+2H]2+ 0.997 
685.36352 685.36304 [M+(C2-H2)+2H]2+ -0.697 
*  694.87048 694.87077 [M+C2O+2H]2+ 0.420 
*  703.37408 703.37375 [M+C2H2O2+2H]2+ -0.464 
723.37154 723.37172 [M+C4H2O3+C2O+2H]2+ 0.252 
*  732.37682 732.37654 [M+2(C2H2O2)++2H]2+ -0.384 
Mean 
-0.085 
 St. Dv. 0.519 
 
 
 
 D-3 
Table D-3.  Mass error of the direct infusion spectra of the reacted AcKM-11 peptide reacted in 
MeOH/H2O at 11 hours of reaction. * indicates the ions used for calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSINGMENT 
ERROR 
(ppm) 
*  463.92018 463.92027 [M+3H]3+ -0.194 
483.25534 483.25540 [M+C2H2O2+3H]3+ 0.115 
502.59050 502.59057 [M+2(C2H2O2)+3H]3+ 0.138 
*  508.59402 508.59371 [M+2(C2H2O2) +H2O +3H]3+ -0.600 
527.92918 527.92937 [M+3(C2H2O2) +H2O +3H]3+ 0.367 
695.37663 695.37677 [M+2H]2+ 0.204 
*  724.37937 724.37935 [M+C2H2O2+2H]2+ -0.021 
753.38211 753.38222 [M+2(C2H2O2)+2H]2+ 0.149 
762.38739 762.38752 [M+2(C2H2O2) +H2O+2H]2+ 0.166 
791.39013 791.39024 [M+3(C2H2O2) +H2O+2H]2 0.143 
*  800.39541 800.39578 [M+3(C2H2O2) +2H2O+2H]2+ 0.463 
820.39287 820.39328 [M+4(C2H2O2) +H2O+2H]2+ 0.003 
*  829.39815 829.39865 [M+4(C2H2O2) +2H2O+2H]2+ 0.603 
mean 0.075 
 
St. Dv. 0.315 
 
Table D-4.  Mass error of the direct infusion spectra of the reacted AcKM-11 peptide reacted in PBS. * 
indicates the ions used for calibration. 
THEORICAL 
(m/z) 
EXPERIMENTAL   
(m/z) ASSINGMENT 
ERROR 
(ppm) 
*  463.92018 463.92030 [M+3H]3+ 0.254 
483.25534 483.25545 [M+C2H2O2+3H]3+ 0.234 
*  695.37663 695.37683 [M+2H]2+ 0.291 
706.36880 706.36866 [M+(C2-H2)+2H]2+ -0.198 
*  715.37408 715.37370 [M+C2O+2H]2+ -0.536 
724.88104 724.88119 [M+C2H2O2+C2O+2H]2+ 0.203 
753.38211 753.38140 [M+2(C2H2O2)+2H]2+ -0.942 
*  1389.74597 1389.74599 [M+H]1+ 0.017 
 
Mean 
-0.084 
 D-4 
St. Dv. 0.448 
 
Table D-5.  DR(703)ECD(732) error analysis of the glycated KM-11 peptide in MeOH/H2O (50:50) for 
the precursor ion [M+2(C2H2O2)+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
* 243.18154     243.18154   c2     0.000 
   301.18702     301.18701   c‡2    -0.033 
   319.17983     319.17979   y3    -0.125 
   376.21050     376.21056   z4•-C3H6S    0.162 
   450.22952     450.22952   z4•     0.000 
   451.23735     451.23736   z4     0.033 
   466.24824     466.24820   y4    -0.086 
   478.76296     478.76303   c‡7• 2+     0.151 
   479.26687     479.26673   c‡7 2+    -0.292 
   495.32758     495.32761   c4•     0.050 
* 496.33541     496.33543   c4     0.040 
   499.26433     499.26435   (c‡7-H2O) 2+    0.045 
   523.27891     523.27894   z5•-C3H6S    0.059 
   530.79426     530.79449   a‡10 2+     0.433 
   535.32250     535.32256   c‡4-H2O    0.112 
   536.33033     536.33037   c‡4-H2O    0.084 
   543.29188     543.29177   (c‡8-H2O) 2+   -0.202 
   552.29716     552.29725   c‡8• 2+     0.158 
   552.80107     552.80116   c‡8 2+     0.154 
   553.33307     553.33309   c‡4•     0.045 
* 554.34089     554.34097   c‡4     0.144 
   572.29462     572.29442   (c#8•-H2O) 2+   -0.349 
   572.30652     572.30670   c‡9 2+     0.310 
   572.79853     572.79884   b‡9 2+     0.537 
   580.80789     580.80779   c‡9• 2+    -0.176 
   581.29990     581.30027   c#8• 2+     0.632 
   581.31181     581.31184   c‡9 2+     0.060 
   581.80381     581.80419   c#8 2+     0.645 
   590.80022     590.80009   y‡9 2+    -0.220 
   592.30398     592.30397   (c#8-2H2O) 2+   -0.017 
   592.79599     592.79641   (b#8-H2O) 2+    0.709 
   593.32798     593.32798   c#4•-H2O    0.000 
   594.33581     594.33612   c#4-H2O    0.530 
   597.29793     597.29802   z5•     0.151 
   598.30575     598.30586   z5     0.175 
   600.80535     600.80534   (c#9•-H2O) 2+   -0.017 
   601.30926     601.30937   (c#9-H2O) 2+    0.179 
   609.81063     609.81059   c#9• 2+    -0.070 
   610.31454     610.31463   c#9 2+     0.139 
   611.33854     611.33861   c#4•     0.106 
*  612.34637     612.34649   c#4     0.196 
   613.31665     613.31684   y5     0.310 
 D-5 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   619.80296     619.80315   y#9 2+     0.307 
   620.37472     620.37489   c‡5-H2O -•CONH2.   0.274 
   623.38617     623.38625   c5•     0.136 
   624.39399     624.39400   c5     0.016 
   628.84855     628.84904   (c‡10 -H2O) 2+    0.775 
   630.81360     630.81359   (y10 – NH3) 2+   -0.016 
   637.85384     637.85389   c‡10 2+     0.086 
   638.38528     638.38526   c‡7-•CONH2.   -0.039 
   639.33423     639.33402   [M-2H2O-2NH3+H] 2+ -0.328 
   646.37834     646.37809   c‡7-2H2O   -0.387 
   651.33749     651.33763   z6•- C3H6S    0.216 
   657.85129     657.85129   (c#10-H2O) 2+   -0.004 
   662.33823     662.33763   a#5-2NH3   -0.906 
   663.38108     663.38111   c‡5•-H2O    0.045 
   664.38891     664.38900   c‡5-H2O    0.143 
   666.85658     666.85613   c#10 2+    -0.667 
   674.37134     674.37117   [M+H] 2+   -0.252 
   678.38076     678.38081   a#5 -H2O    0.081 
   681.36726     681.36760   [M‡-•CONH2+2H] 2+   0.492 
   681.39165     681.39176   c‡5•     0.169 
   682.39947     682.39957   c‡5     0.147 
   685.36352     685.36377   [M‡-2H2O +2H] 2+   0.372 
   694.36880     694.36903   [M‡- H2O +2H] 2+   0.335 
   694.86081     694.86094   [M‡- NH3+2H] 2+   0.191 
   696.37020     696.37023   a‡8-2NH3-2H2O   0.043 
   696.39132     696.39138   a#5     0.086 
   703.37408     703.37415   [M‡+2H] 2+    0.100 
   705.36784     705.36777   b#5-H2O   -0.099 
   707.32214     707.32199   y6-2NH3   -0.212 
* 714.36626     714.36566   [M-2H2O+H] 2+  -0.833 
   714.85827     714.85805   [M-H2O-NH3+2H] 2+  -0.308 
   721.38656     721.38666   c#5•-H2O    0.139 
   722.39439     722.39455   c#5-H20    0.228 
   723.37154     723.37150   [M#-H2O+2H] 2+  -0.055 
   723.86355     723.86307   [M#-NH3+2H] 2+  -0.663 
   724.34131     724.34064   b‡6-3NH3   -0.918 
   725.35651     725.35645   z6•    -0.083 
   726.36433     726.36445   z6     0.158 
   732.37682     732.37662   [M#+2H] 2+   -0.273 
   735.42602     735.42604   b6     0.020 
   739.39712     739.39720   c#5•     0.101 
   740.40495     740.40518   c#5     0.311 
   748.43385     748.43384   c‡6-•CONH2-H2O  -0.013 
   751.44475     751.44476   c6•     0.020 
   752.45257     752.45263   c6     0.080 
   757.41038     757.41009   b‡6-H2O   -0.376 
   766.44442     766.44490   a‡6     0.626 
   774.43692     774.43709   c‡6-2H2O    0.220 
 D-6 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   788.42877     788.42929   a#6-2H2O    0.660 
   791.43966     791.43979   c‡6•-H2O    0.164 
   792.44749     792.44763   c‡6-H2O    0.183 
   793.43151     793.43192   b‡6     0.523 
   806.43934     806.43945   a#5-H2O    0.143 
   809.45023     809.45034   c‡6•     0.142 
   810.45805     810.45821   c‡6     0.197 
   824.44990     824.44994   a#6     0.049 
   833.42642     833.42644   b#6-H2O    0.024 
   834.41044     834.41063   b#6-NH3    0.228 
   849.44514     849.44519   c#6•-H2O    0.059 
   850.45296     850.45309   c#6-H2O    0.147 
   851.43699     851.43708   b#6     0.112 
   867.45570     867.45585   c#6•     0.167 
* 868.46353     868.46377   c#6     0.276 
   882.49443     882.49517   b7     0.833 
   895.50226     895.50248   a‡7-H2O    0.240 
   898.51315     898.51327   c7•     0.128 
   899.52098     899.52100   c7     0.022 
* 913.51283     913.51298   a‡7     0.164 
   921.50533     921.50552   c‡7-2H2O    0.206 
   938.50807     938.50838   c‡7•-H2O    0.330 
   939.51590     939.51612   c‡7-H2O    0.239 
   953.50774     953.50748   c#7-•CONH2-H2O  -0.273 
   956.51864     956.51875   c‡7•     0.120 
   957.52646     957.52668   c‡7     0.230 
   966.48657     966.48666   y8     0.093 
   971.51831     971.51857   a#7     0.268 
   980.49483     980.49493   b#7-H2O    0.102 
   981.47885     981.47885   b#7-NH3    0.000 
   996.51355     996.51378   c#7•-H2O    0.231 
   997.52138     997.52152   c#7-H2O    0.145 
   998.50540     998.50537   b#7    -0.025 
  1002.57576    1002.57597   a8     0.209 
  1014.52412    1014.52441   c#7•     0.291 
*1015.53194    1015.53213   c#7     0.187 
  1042.57067    1042.57051   c‡8-•CONH2-H2O  -0.153 
  1045.58156    1045.58210   c8•     0.512 
  1046.58939    1046.58954   c8     0.143 
  1060.58124    1060.58149   a‡8     0.236 
  1072.54485    1072.54486   z‡9•-C3H6D- H2O   0.006 
  1082.56559    1082.56515   a#8-2H2O   -0.406 
  1085.57648    1085.57719   c‡8•-H2O    0.654 
  1086.56655    1086.56604   y9-2H2O   -0.469 
  1086.58431    1086.58442   b9     0.106 
  1088.53459    1088.53418   y9-2NH3   -0.377 
  1090.55542    1090.55517   z‡9•-C3H6S   -0.228 
  1099.59213    1099.59206   c‡8-•CONH2.-H2O  -0.064 
 D-7 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
  1100.57615    1100.57661   a#8-H2O    0.413 
  1102.60302    1102.60307   c9•     0.041 
  1103.61085    1103.61103   c9     0.163 
  1104.59487    1104.59510   c‡7     0.208 
  1112.53976    1112.54031   c#8-H2O-NH3    0.490 
  1117.60270    1117.60314   a‡8     0.394 
  1118.58672    1118.58658   a#8    -0.125 
  1125.59520    1125.59428   c‡9-2H2O   -0.817 
  1126.57922    1126.57950   b‡9-H2O    0.249 
  1127.56324    1127.56360   b#8-H2O    0.319 
  1128.54726    1128.54620   b#8-NH3   -0.939 
  1129.53733    1129.53824   z‡9•-H2O-NH3    0.806 
  1130.55033    1130.55014   z#9•-C3H6D-H2O  -0.172 
  1142.59794    1142.59870   c‡9•-H2O    0.665 
  1143.60577    1143.60595   c‡9-H2O    0.162 
*1144.58978    1144.58986   c#8-H2O    0.066 
  1145.57380    1145.57353   b#8    -0.240 
  1146.56388    1146.56396   z‡9•-H2O    0.074 
  1147.60471    1147.60411   b10-H2O-2NH3   -0.523 
  1148.56090    1148.55971   z#9•-C3H6S   -1.035 
  1157.59761    1157.59815   a#9-H2O    0.462 
  1160.60850    1160.60840   c‡9•    -0.090 
  1161.59656    1161.59531   a‡10-3NH3-H2O  -1.076 
  1161.61633    1161.61643   c‡9     0.086 
  1162.60035    1162.60021   c#8    -0.120 
  1164.57444    1164.57465   z‡9•     0.180 
  1175.60818    1175.60801   a#9    -0.145 
  1180.59316    1180.59327   y‡9     0.093 
  1184.58470    1184.58469   b#9-H2O   -0.008 
  1186.55879    1186.55984   z#9•-2H2O    0.885 
  1187.54281    1187.54191   z#9•-H2O-NH3   -0.758 
  1200.60342    1200.60405   c#9•-H2O    0.525 
  1201.61125    1201.61123   c#9-H2O   -0.012 
  1202.59526    1202.59499   b#9    -0.229 
  1204.56936    1204.56968   z#9•-H2O    0.270 
  1212.67564    1212.67590   c‡10-•CONH2-H2O   0.214 
  1215.68709    1215.68697   c10•    -0.095 
  1216.69491    1216.69532   c10     0.337 
*1219.62181    1219.62175   c#9    -0.049 
  1222.57992    1222.58001   z#9•     0.074 
  1230.68676    1230.68712   a‡10     0.293 
  1238.67926    1238.67933   c‡10-2H2O    0.057 
  1252.67111    1252.67060   a#10-2H2O   -0.407 
  1255.68200    1255.68196   c‡10•-H2O   -0.032 
  1256.68982    1256.69008   c‡10-H2O    0.203 
  1274.70039    1274.70054   c‡10     0.118 
  1288.69224    1288.69230   a#10     0.047 
  1297.66876    1297.66849   c#10-H2O-NH3   -0.208 
 D-8 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
  1303.72177    1303.72217   [M‡-HCONH2+2H] 1+•  0.307 
*1314.69530    1314.69572   c#10-H2O    0.316 
  1315.67933    1315.67923   b#10    -0.072 
  1330.70886    1330.70974   [M-NH3+H]1+    0.665 
  1331.71668    1331.71641   [M-NH3+2H] 1+•  -0.203 
1332.70587    1332.70508   c#10    -0.593 
1343.71668    1343.71657   [M‡-•CONH2-H2O +H] 1+ -0.082 
  1347.73540    1347.73538   [M +H] 1+   -0.015 
  1352.69321    1352.69317   [M‡-2H2O-NH3+H] 1+  -0.026 
  1353.70103    1353.70142   [M‡-2H2O-NH3+2H] 1+•  0.288 
  1354.68505    1354.68508   [M‡-H2O-2NH3+2H] 1+•  0.022 
  1361.72725    1361.72715   [M‡-•CONH2 +H] 1+  -0.073 
  1371.71159    1371.71146   [M‡-H2O-NH3+2H] 1+• -0.098 
  1383.71160    1383.71235   [M‡-•CONH2-2H2O +H] 1+  0.542 
  1387.73032    1387.73052   [M‡-H2O +1H] 1+   0.144 
  1388.73815    1388.73809   [M‡-H2O +2H] 1+•  -0.439 
  1401.72162    1401.72292   [M‡-H2O-•CONH2+1H] 1+  0.927 
  1402.70727    1402.70613   [M#-NH3-•CONH2+1H] 1+ -0.813 
*1405.74089    1405.74127   [M‡+1H] 1+    0.270 
  1411.70651    1411.70590   [M#-NH3- 2H2O +2H] 1+• -0.432 
  1412.69053    1412.68972   [M#-H2O-2NH3+2H] 1+• -0.573 
1419.73218    1419.73312   [M#-•CONH2+1H] 1+   0.662 
1428.70926    1428.70903   [M#-H2O-NH3+1H] 1+  -0.157 
1428.73306    1428.73350   [M#-2H2O +2H] 1+•   0.308 
1429.71708    1429.71703   [M#-H2O-NH3+2H] 1+• -0.035 
1445.73580    1445.73626   [M#-H2O +H] 1+   0.318 
1446.74363    1446.74433   [M#-H2O +2H] 1+•   0.487 
*1463.74637    1463.74554   [M#+H] 1+   -0.564 
mean 0.066  
St. Dv. 0.448 
 
Table D-6.  ECD(732) error analysis of the KM-11 peptide in MeOH/H2O (50:50) for the precursor ion 
[M+2(C2H2O2)+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
* 243.18154     243.18154   c2     0.000 
   301.18702     301.18690   c‡2    -0.398 
   319.17983     319.17973   y3    -0.313 
   376.21050     376.21044   z4•- C3H6S   -0.157 
   450.22952     450.22944   z4•    -0.178 
   451.23735     451.23726   z4    -0.188 
   466.24824     466.24852   y4     0.601 
   478.76296     478.76293   c‡7• 2+    -0.057 
   479.26687     479.26703   c‡7 2+     0.334 
   495.32758     495.32762   c4•     0.071 
 D-9 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   496.33541     496.33535   c4    -0.121 
   499.26433     499.26453   (c#7-H2O) 2+    0.406 
   523.27891     523.27891   z5•-C3H6S    0.002 
   530.79426     530.79464   a‡8 2+     0.716 
   535.32250     535.32246   c‡4•-H2O   -0.075 
   536.33033     536.33033   c‡4-H2O    0.009 
   552.29716     552.29703   c‡8• 2+    -0.240 
   552.80107     552.80116   c‡8 2+     0.154 
   553.33307     553.33308   c‡4•     0.027 
   554.34089     554.34082   c‡4    -0.126 
   571.80261     571.80264   (c‡9-H2O) 2+    0.052 
   572.29462     572.29446   (c#8•-H2O) 2+   -0.280 
   572.79853     572.79849   b‡9 2+    -0.074 
   577.30926     577.30948   c#4-H2O-NH3    0.381 
   580.80789     580.80822   c‡9• 2+     0.564 
   581.31181     581.31172   c‡9 2+    -0.146 
   589.35688     589.35695   b5-H2O    0.119 
   590.80022     590.80020   y‡9 2+    -0.034 
   592.30398     592.30395   (c#9-2H2O) 2+   -0.051 
   593.32798     593.32798   c#4•-H2O    0.000 
   594.33581     594.33618   c#4-H2O    0.631 
   597.29793     597.29790   z5•    -0.050 
   598.30575     598.30575   z5    -0.008 
   600.80535     600.80533   (c#9•-H2O) 2+   -0.033 
   601.30926     601.30921   (c#9-H2O) 2+   -0.087 
   609.81063     609.81032   c#9• 2+    -0.512 
   611.33854     611.33852   c#4•    -0.041 
   612.34637     612.34640   c#4     0.049 
   613.31665     613.31697   y5     0.522 
   619.80296     619.80242   y#9 2+    -0.871 
   623.38617     623.38612   c5•    -0.072 
   624.39399     624.39391   c5    -0.128 
   628.84855     628.84833   (c‡10-H2O) 2+   -0.354 
   637.85384     637.85375   c‡10 2+    -0.133 
   651.33749     651.33740   z6•-C3H6S   -0.137 
   657.85129     657.85125   (c#10-H2O) 2+   -0.065 
   657.86061     657.86025   [M-H2O+H] 2+   -0.547 
   658.35262     658.35274   [M-2NH3+H] 2+   0.182 
   662.33823     662.33783   a#5-2NH3   -0.604 
   663.38108     663.38104   c‡5•-H2O   -0.060 
   664.38891     664.38897   c‡5-H2O    0.098 
   665.37293     665.37317   b‡5     0.368 
   666.85658     666.85645   c#10 2++    -0.187 
   672.36198     672.36171   [M‡-•CONH2+2H] 2+  -0.405 
   674.37134     674.37164   [M+H] 2+    0.445 
   678.38076     678.38118   a#5-H2O    0.626 
   681.36726     681.36780   [M‡-•CONH2+H] 2+   0.785 
 D-10 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   681.39165     681.39164   c‡5•    -0.007 
   682.39947     682.39947   c‡5     0.000 
   685.85552     685.85511   [M-‡-H2O NH3+2H] 2+ -0.605 
       686.35972   ? 
   694.36880     694.36869   [M‡-H2O +H] 2+  -0.155 
   696.39132     696.39154   a#5     0.316 
   703.37408     703.37392   [M‡+H] 2+   -0.227 
   705.36784     705.36784   b#5-H2O    0.000 
   714.85827     714.85756   [M#-H2O-NH3+2H] 2+  -0.993 
   721.38656     721.38658   c#5•-H2O    0.028 
   722.39439     722.39441   c#5-H2O    0.035 
   723.37154     723.37147   [M#-H2O+2H] 2+  -0.097 
   723.37841     723.37911   b#5     0.975 
   723.86355     723.86322   [M#-NH3+2H] 2+  -0.456 
   725.35651     725.35621   z6•    -0.414 
   726.36433     726.36454   z6     0.282 
   732.37682     732.37667   [M#+2H] 2+   -0.205 
   735.42602     735.42595   b6    -0.102 
   739.39712     739.39712   c#5•    -0.007 
   740.40495     740.40511   c#5     0.216 
   751.44475     751.44481   c6•     0.087 
   752.45257     752.45246   c6    -0.146 
   774.43692     774.43659   c‡6-2H2O   -0.426 
   791.43966     791.43950   c‡6•-H2O   -0.202 
   792.44749     792.44746   c‡6-H2O   -0.032 
   806.43934     806.43969   a#6-H2O    0.440 
   809.45023     809.45032   c‡6•     0.117 
   810.45805     810.45814   c‡6     0.111 
   824.44990     824.44981   a#6    -0.109 
   833.42642     833.42642   b#6-H2O    0.000 
   834.41044     834.41085   b#6-NH3    0.491 
   849.44514     849.44517   c#6•-H2O    0.035 
   850.45296     850.45301   c#6-H2O    0.053 
   851.43699     851.43705   b#6     0.076 
   867.45570     867.45576   c#6•     0.063 
   868.46353     868.46363   c#6     0.115 
   898.51315     898.51339   c7•     0.262 
   899.52098     899.52088   c7    -0.111 
   921.50533     921.50488   c‡7-2H2O   -0.488 
   938.50807     938.50818   c‡7•-H2O    0.117 
   939.51590     939.51597   c‡7-H2O    0.080 
   956.51864     956.51874   c‡7•     0.110 
   957.52646     957.52658   c‡7     0.125 
   971.51831     971.51827   a#7•    -0.041 
   980.49483     980.49506   b#7-H2O    0.235 
   981.47885     981.47920   b#7-NH3    0.357 
   996.51355     996.51340   c#7•-H2O   -0.151 
 D-11 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   997.52138     997.52143   c#7-H2O    0.055 
   998.50540     998.50524   b#7    -0.155 
  1014.52412    1014.52437   c#7•     0.251 
  1015.53194    1015.53205   c#7     0.108 
  1042.57012    1042.56990   c‡8-H2O -•CONH2.  -0.211 
  1045.58156    1045.58182   c8•     0.244 
  1046.58939    1046.58950   c8     0.105 
  1060.58068    1060.58085   c‡8-•CONH2.    0.156 
  1072.54485    1072.54484   z‡9•-H2O -C3H6S  -0.013 
  1085.57648    1085.57573   c‡8•-H2O   -0.691 
  1086.58431    1086.58433   b9     0.023 
  1088.53459    1088.53474   y9-2NH3    0.138 
  1090.55542    1090.55545   z‡9•-C3H6S    0.028 
  1100.57615    1100.57637   a#8-H2O    0.195 
  1102.60302    1102.60288   c9•    -0.132 
  1103.61085    1103.61093   c9     0.072 
  1104.59487    1104.59500   c‡8     0.118 
  1118.58672    1118.58671   a#8    -0.009 
  1125.59520    1125.59487   c‡9-H2O -H2O   -0.293 
  1126.57922    1126.57934   b‡9-H2O    0.107 
  1127.56324    1127.56337   b#8-H2O    0.115 
  1129.53733    1129.53778   z‡9•-H2O-NH3    0.398 
  1130.55033    1130.55043   z#9•-C3H6S -H2O   0.085 
  1142.59794    1142.59840   c‡9•-H2O    0.403 
  1143.60577    1143.60581   c‡9-H2O    0.039 
  1144.58978    1144.58972   b‡9    -0.057 
  1145.57380    1145.57330   b#8    -0.441 
  1146.56388    1146.56382   z‡9•-H2O   -0.048 
  1160.60850    1160.60772   c‡9•    -0.676 
  1161.61633    1161.61629   c‡9    -0.034 
  1162.60035    1162.60031   c#8    -0.034 
  1164.57444    1164.57437   z‡9•    -0.060 
  1175.60818    1175.60880   a#9     0.527 
  1180.59316    1180.59331   y‡9     0.127 
  1184.58470    1184.58443   b#9-H2O   -0.228 
  1185.56872    1185.56860   b#9-NH3   -0.101 
  1185.58735    1185.58827   y10-2NH3    0.776 
  1186.55879    1186.55905   z#9•-2H2O    0.219 
  1201.61125    1201.61119   c#9-H2O   -0.046 
  1202.59526    1202.59479   b#9    -0.395 
  1204.56936    1204.56955   z#9•-H2O    0.162 
  1215.68709    1215.68737   c10•     0.234 
  1216.69491    1216.69509   c10     0.148 
  1219.62181    1219.62179   c#9    -0.016 
  1222.57992    1222.58013   z#9•     0.172 
  1230.68676    1230.68652   a‡10    -0.195 
 D-12 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
  1256.68982    1256.69011   c‡10-H2O    0.227 
  1274.70039    1274.70054   c‡10     0.118 
  1288.69224    1288.69227   a#10     0.023 
  1297.66876    1297.66818   b#10-H2O   -0.447 
  1303.72177    1303.72194   [M-HCONH2+2H] 1+•   0.130 
  1313.68231    1313.68204   [M-2NH3+H] 1+  -0.206 
  1314.69530    1314.69569   c#10-H2O    0.293 
  1315.67933    1315.67861   b#10    -0.543 
  1330.70886    1330.70824   [M-NH3+H] 1+   -0.462 
  1331.71668    1331.71650   [M-NH3+2H] 1+•  -0.135 
  1332.70587    1332.70541   c#10    -0.345 
  1343.71613    1343.71635   [M‡-•CONH2-H2O +H] 1+  0.164 
  1347.73540    1347.73533   [M+H] 1+   -0.052 
  1352.69321    1352.69251   [M‡-NH3-2H2O +H] 1+ -0.514 
  1353.70103    1353.70128   [M‡-NH3-2H2O +2H] 1+•  0.185 
  1354.68505    1354.68457   [M‡-2NH3-H2O +2H] 1+• -0.354 
  1361.72725    1361.72711   [M‡-•CONH2+H] 1+  -0.103 
  1370.70377    1370.70238   [M‡-NH3-H2O +H] 1+  -1.014 
  1371.71159    1371.71139   [M‡-NH3-H2O +2H] 1+• -0.149 
  1383.71160    1383.71174   [M‡-•CONH2-2H2O +H] 1+  0.101 
  1387.73032    1387.73054   [M‡-H2O +H] 1+   0.159 
  1388.73815    1388.73830   [M‡-H2O +2H] 1+•  -0.288 
  1401.72162    1401.72281   [M#-H2O-•CONH2+H] 1+  0.849 
  1402.70727    1402.70607   [M#-NH3-•CONH2+H] 1+ -0.855 
  1405.74089    1405.74137   [M‡+1H] 1+    0.341 
  1406.74871    1406.74837   [M‡+2H] 1+•   -0.533 
  1411.70651    1411.70596   [M#-NH3-2H2O +2H] 1+• -0.390 
  1419.73218    1419.73312   [M# -•CONH2+H] 1+   0.662 
1428.70926    1428.70903   [M#-NH3-H2O +H] 1+  -0.157 
1428.73306    1428.73359   [M#-2H2O +2H] 1+•   0.371 
  1429.71708    1429.71703   [M#-NH3-H2O +2H] 1+• -0.035 
  1445.73580    1445.73626   [M# -H2O +H] 1+   0.318 
  1446.74363    1446.74433   [M# -H2O +2H] 1+•   0.487 
  1447.72765    1447.72829   [M#-NH3 +2H] 1+•   0.446 
  1463.74637    1463.74554   [M# +H] 1+   -0.564 
mean -0.015  
St. Dv. 0.446 
 
Table D-7.  CAD(732) error analysis of the glycated KM-11 peptide in MeOH/H2O (50:50) for the 
precursor ion [M+2(C2H2O2)+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
* 284.16048     284.16053   b‡2     0.194 
   382.25610     382.25609   b3    -0.039 
 D-13 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
* 387.21391     387.21398   b‡3-H2O -H2O-NH3   0.181 
   404.24045     404.24046   b‡3-H2O -H2O    0.012 
   405.22447     405.22446   b‡3-H2O -NH3   -0.037 
   422.25102     422.25105   b‡3-H2O    0.071 
   423.23504     423.23505   b‡3-NH3    0.024 
   434.25102     434.25122   a#3-2H2O    0.461 
   439.23759     439.23758   (a‡7-H2O-NH3) 2+  -0.011 
* 440.26159     440.26157   b‡3    -0.034 
   441.75086     441.75092   b7 2+     0.141 
   444.23537     444.23551   b#3-3H2O    0.315 
   449.22170     449.22170   y4-NH3    0.011 
   452.74303     452.74272   (b‡7-H2O -H2O) 2+  -0.690 
   461.74831     461.74834   (b‡7-H2O +H]2+   0.054 
   462.24032     462.24042   (b‡7-NH3+H]2+   0.206 
   462.24593     462.24603   b#3-2H2O    0.206 
   462.28232     462.28220   b4-NH3   -0.260 
   463.22996     463.22990   b#3-H2O-NH3   -0.119 
   466.24824     466.24826   y4     0.043 
   470.75360     470.75356   b‡7 2+    -0.080 
   473.23250     473.23252   (b#7-2H2O-NH3) 2+   0.042 
   480.25650     480.25656   b#3-H2O    0.125 
   481.24052     481.24052   b#3-NH3    0.000 
   481.74577     481.74580   (b#7-2H2O) 2++    0.057 
   482.23778     482.23775   (b#7-H2O-NH3) 2+  -0.067 
   490.75106     490.75103   (b#7-H2O) 2++   -0.051 
   506.77179     506.77195   (b8-NH3) 2+    0.316 
   512.77179     512.77195   (a‡8-H2O-NH3) 2+   0.312 
   515.28506     515.28506   b82+    -0.005 
* 519.30378     519.30361   b‡4-H2O   -0.327 
   521.28506     521.28501   (a‡8-H2O ) 2+   -0.101 
   526.27724     526.27720   (b‡8-2H2O) 2+   -0.071 
   526.76925     526.76931   (b‡8-H2O -NH3) 2+   0.119 
   532.27724     532.27708   (a‡9-2H2O-NH3) 2+  -0.296 
   532.76925     532.76935   (a‡9-H2O-2NH3) 2+   0.192 
   535.28252     535.28260   (b‡8-H2O) 2+    0.149 
   535.77453     535.77469   (b‡8-NH3) 2+    0.299 
   537.31435     537.31472   b‡4     0.698 
   541.28252     541.28262   (a#8-2H2O) 2+    0.185 
   541.77453     541.77451   (a#8-H2O-NH3) 2+  -0.037 
   543.79579     543.79585   b9 2+     0.106 
   544.28780     544.28782   b‡8 2+     0.032 
   546.27469     546.27472   (b‡9-2H2O-NH3) 2+   0.046 
   546.76671     546.76667   (b#8-2H2O-NH3) 2+  -0.064 
   549.79579     549.79578   (a‡9-H2O) 2++   -0.023 
   550.28780     550.28776   (a#8-H2O) 2+   -0.077 
   554.78797     554.78807   (b‡9-2H2O) 2+    0.185 
   555.27998     555.28008   (b‡9-H2O -NH3) 2++   0.185 
 D-14 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   555.77199     555.77200   (b#8-H2O-NH3) 2+   0.022 
   556.28781     556.28789   b5-3NH3    0.144 
   561.77199     561.77215   (a#9-H2O-2NH3) 2+   0.289 
   563.79325     563.79332   (b‡9-H2O) 2+    0.124 
   564.28526     564.28528   (b#8-H2O) 2+    0.035 
   564.77727     564.77746   (b#8-NH3) 2+    0.336 
   569.79325     569.79319   (a#9-2H2O) 2+   -0.105 
   570.28526     570.28535   (a#9-H2O-NH3) 2+   0.158 
   572.79853     572.79855   b‡9 2+     0.031 
   573.29054     573.29053   b#8 2+    -0.022 
   574.78543     574.78541   (b#9-3H2O) 2+   -0.026 
   575.27743     575.27747   (b#9-2H2O-NH3) 2+   0.061 
   575.76945     575.76938   (b#9-H2O-2NH3) 2+  -0.113 
   577.30926     577.30945   b#4-H2O    0.329 
   578.79853     578.79849   (a#9-H2O) 2+   -0.073 
   582.81927     582.81952   (b10-H2O-NH3) 2+   0.433 
   583.79071     583.79079   (b#9-2H2O) 2+    0.141 
   584.28272     584.28276   (b#9-H2O-NH3) 2+   0.073 
   586.32218     586.32254   a‡5-H2O -2NH3   0.605 
   586.34037     586.34040   a10 2++     0.055 
   588.81927     588.81934   (b‡10-2H2O-CO-NH3) 2+  0.122 
   589.31128     589.31110   (a‡10-H2O-2NH3) 2+  -0.301 
   591.82455     591.82455   (b10-NH3) 2+    0.000 
   592.79599     592.79590   (b#9-H2O) 2++   -0.152 
   593.28800     593.28832   (b#9-NH3) 2+    0.539 
* 596.29011     596.29015   y5-NH3    0.075 
   597.33254     597.33255   (a‡10-2H2O) 2+    0.017 
   597.82455     597.82460   (a‡10-H2O-NH3) 2+   0.084 
   600.33782     600.33768   b10 2+    -0.237 
   601.80127     601.80126   b#9 2+    -0.021 
   601.81059     601.81068   (y10-NH3) 2++    0.154 
   602.81673     602.81679   (b‡10-2H2O-NH3) 2+   0.108 
   603.30873     603.30884   (b‡10-H2O-2NH3) 2+   0.174 
   606.33782     606.33781   (a‡10-H2O) 2+   -0.021 
   607.36744     607.36745   b5     0.008 
   610.32386     610.32392   y10 2+     0.098 
   611.33000     611.32999   (b‡10-2H2O) 2+   -0.012 
   611.82201     611.82209   (b‡10-H2O -NH3) 2++   0.135 
   613.31665     613.31685   y5     0.326 
   615.34311     615.34318   a‡10 2+     0.118 
   618.31402     618.31440   (a#10-H2O-2NH3) 2+   0.619 
   620.33528     620.33481   (b‡10-H2O ) 2+   -0.758 
   620.82729     620.82764   (‡10-NH3) 2+    0.564 
   621.80304     621.80276   (y‡10-NH3-H2O) 2+  -0.458 
   621.80804     621.80815   (y‡10- H2O-NH3) 2+   0.169 
   623.30619     623.30640   (b#10-2H2O-2NH3) 2+   0.332 
   623.81741     623.81766   x10 2+     0.409 
   626.33528     626.33529   (a#10-2H2O) 2+    0.016 
 D-15 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
* 629.34056     629.34002   b‡10 2++   -0.862 
   630.32132     630.32160   (y‡10- H2O ) 2+    0.448 
   631.32745     631.32754   (b#10-3H2O) 2+    0.135 
   631.81947     631.81956   (b#10-2H2O-NH3) 2+   0.150 
   635.34056     635.34058   (a#10-H2O) 2++    0.028 
   639.32660     639.32684   y‡10 2+     0.375 
   640.33274     640.33262   (b#10-2H2O) 2+   -0.183 
   640.82475     640.82487   (b#10-H2O-NH3) 2+   0.191 
   643.34761     643.34770   [M-NH3+H] 2+   0.140 
   644.34585     644.34634   a#10 2+     0.764 
   645.82624     645.82667   [M‡-2H2O-2NH3+H] 2+  0.666 
   647.36236     647.36241   b‡5- H2O    0.077 
   648.34638     648.34604   b‡5-NH3   -0.524 
   649.33802     649.33758   [b#10-H2O+H] 2+  -0.678 
   649.83003     649.83056   [b#10-NH3+H] 2+   0.816 
   651.86061     651.86063   [M+H] 2+    0.027 
   657.34479     657.34493   [M-NH3+H] 2+    0.205 
   658.34330     658.34332   b#10 2+     0.027 
   661.33040     661.32985   a#5-2NH3   -0.832 
   665.37293     665.37307   b‡5     0.218 
   665.85807     665.85791   [M+2H] 2+   -0.237 
   668.33697     668.33701   [M‡-2H2O-2NH3+2H] 2+  0.060 
   668.82898     668.82922   [M‡-H2O-3NH3+2H] 2+  0.359 
   671.85807     671.85812   [M‡-CO-NH3+2H] 2+   0.074 
   674.37134     674.37078   [M+2H] 2+   -0.830 
   676.85024     676.85033   [M‡-2H2O-NH3+2H] 2+  0.129 
   677.34225     677.34235   [M‡-H2O -2NH3+2H] 2+  0.144 
   680.86335     680.86352   [M‡-CO NH3+2H] 2+   0.246 
   683.83426     683.83465   [M#-H2O-3NH3+2H] 2+  0.567 
   685.36352     685.36354   [M‡-2H2O-NH3+2H] 2+  0.036 
   685.85552     685.85533   [M‡-NH3-H2O +2H] 2+ -0.284 
   687.35727     687.35714   b#5-2H2O   -0.196 
   688.34129     688.34102   b#5-H2O-NH3   -0.400 
   688.82644     688.82671   [M#-2H2O-3NH3+2H] 2+  0.395 
   691.85552     691.85558   [M#-2H2O-NH3+2H] 2+  0.079 
   692.34753     692.34781   [M#-H2O-2NH3+2H] 2+  0.397 
* 694.36880     694.36873   [M‡-H2O +2H] 2+  -0.097 
   694.86081     694.86050   [M‡-NH3+2H] 2+  -0.443 
   696.37020     696.37077   a‡6-2NH3-2H2O   0.819 
   696.84770     696.84772   [M#-3H2O-NH3+2H] 2+  0.029 
   697.33971     697.33982   [M#-2H2O-2NH3+2H]2  0.158 
   700.36880     700.36911   [M#-2H2O-CO+2H]2   0.443 
   700.86081     700.86083   [M#-H2O- NH3-CO +2H] 2+  0.032 
   703.37408     703.37361   [M‡+2H] 2+   -0.668 
   705.36784     705.36796   b#5-H2O    0.170 
   705.85299     705.85297   [M#-2H2O-NH3+2H] 2+ -0.028 
   706.34499     706.34520   [M#-H2O-2NH3+H] 2+   0.294 
 D-16 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
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   707.32214     707.32239   y6-2NH3    0.353 
   707.43111     707.43120   a6     0.127 
   714.85827     714.85798   [M#-H2O-NH3+2H] 2+  -0.406 
   718.39948     718.39941   b6-NH3   -0.097 
* 723.37154     723.37136   [M#-H2O+2H] 2+  -0.249 
   723.86355     723.86390   [M#-NH3+2H] 2+   0.484 
   724.34131     724.34158   b‡6-H2O -3NH3   0.380 
   732.37682     732.37692   [M#+2H] 2+    0.137 
   735.42602     735.42602   b6    -0.007 
   740.38383     740.38382   b‡6 -2H2O-NH3  -0.014 
   741.37523     741.37540   y6     0.229 
   757.41038     757.41043   b‡6-2H2O    0.073 
   758.39440     758.39448   b‡6-H2O -NH3    0.112 
   759.39841     759.39795   b‡6-2NH3   -0.612 
   765.43659     765.43584   a‡6    -0.980 
   769.41038     769.41025   a#6-3H2O   -0.162 
   770.39440     770.39452   a#6-2H2O-NH3    0.162 
   775.42094     775.42114   b‡6-H2O    0.258 
   776.40496     776.40482   b‡6-NH3   -0.180 
   787.42094     787.42111   a#6-2H2O    0.216 
   793.43151     793.43174   b‡6     0.296 
   797.40529     797.40543   b#6-3H2O    0.176 
   799.37333     799.37377   b#6-H2O-2NH3    0.550 
   805.43151     805.43169   a#6-H2O    0.230 
   815.41585     815.41599   b#6-2H2O    0.166 
   816.39987     816.39988   b#6-H2O-NH3    0.006 
   817.40390     817.40341   b#6-2NH3   -0.593 
   833.42642     833.42654   b#6-H2O    0.144 
   834.41044     834.41046   b#6-NH3    0.024 
   835.38072     835.38138   y7-2NH3    0.790 
   852.40727     852.40745   y7-NH3    0.217 
* 869.43381     869.43423   y7     0.483 
   882.49443     882.49463   b7     0.221 
   887.45224     887.45225   b‡7-2H2O-NH3   0.011 
   894.49443     894.49474   a‡7-H2O    0.341 
   904.47879     904.47920   b‡7-2H2O    0.459 
   905.46281     905.46273   b‡7-H2O -NH3    0.083 
   906.46682     906.46668   b‡7-2NH3   -0.160 
   912.50500     912.50555   a‡7     0.603 
   916.47879     916.47941   a#7-3H2O    0.682 
   917.46281     917.46283   a#7-2H2O-NH3    0.027 
   922.48935     922.48958   b‡7-H2O    0.249 
   923.47337     923.47340   b‡7-NH3    0.032 
   932.43348     932.43365   y8-2NH3    0.182 
   934.48935     934.48974   a#7-2H2O    0.417 
   940.49991     940.50006   b‡7     0.154 
   944.47370     944.47400   b#7-3H2O    0.318 
 D-17 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
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   946.44174     946.44140   b#7-H2O-2NH3  -0.359 
   952.49991     952.50005   a#7-H2O    0.142 
   962.48427     962.48418   b#7-2H2O   -0.088 
   963.46829     963.46857   b#7-H2O-NH3    0.296 
   964.47231     964.47215   b#7-2NH3   -0.161 
* 966.48657     966.48654   y8    -0.031 
   980.49483     980.49512   b#7-H2O    0.296 
   981.47885     981.47902   b#7-NH3    0.173 
  1012.53630    1012.53615   b-NH3    -0.148 
  1024.53630    1024.53637   a
 9-2NH3    0.068 
1029.56284    1029.56275   b8    -0.092 
1035.50467    1035.50402   b‡8-H2O-2NH3  -0.628 
  1041.56284    1041.56342   a‡8-H2O    0.552 
  1051.54720    1051.54778   b‡8-2H2O    0.556 
  1052.53121    1052.53117   b‡8-H2O -NH3   -0.043 
  1053.53524    1053.53494   b-2NH3   -0.280 
  1059.57341    1059.57330   a‡8    -0.104 
  1064.53121    1064.53088   a‡9-H2O -2NH3  -0.315 
*1069.55776    1069.55759   b‡8-H2O   -0.159 
1070.54178    1070.54202   b‡8-NH3    0.224 
  1074.51556    1074.51575   b‡9-H2O -H2O-2NH3   0.172 
  1075.49959    1075.49950   b‡9-H2O -3NH3  -0.079 
  1081.55776    1081.55790   a#8-2H2O    0.129 
  1082.54178    1082.54078   a‡9-2NH3   -0.924 
  1086.58431    1086.58408   b9    -0.207 
  1087.56832    1087.56831   b‡8    -0.014 
  1091.54211    1091.54247   b#8-3H2O    0.330 
  1092.52613    1092.52665   b‡9-H2O-2NH3   0.476 
  1092.54613    1092.54618   b‡9-H2O -2NH3   0.046 
  1099.56832    1099.56890   a#8-H2O    0.523 
*1105.56113    1105.56097   y9-NH3   -0.149 
  1108.56866    1108.56900   b‡9-H2O -H2O    0.311 
  1109.55267    1109.55251   b‡9-H2O -NH3   -0.149 
  1110.53670    1110.53659   b#8-H2O-NH3   -0.095 
  1110.55669    1110.55595   b‡9 -2NH3   -0.671 
  1121.55267    1121.55312   a#9-2H2O-NH3    0.397 
  1122.58768    1122.58734   y9    -0.303 
  1126.57922    1126.57900   b‡9-H2O   -0.195 
  1127.56324    1127.56304   b#8-H2O   -0.177 
  1128.54726    1128.54762   b#8-NH3    0.319 
  1144.58978    1144.58982   b‡9-H2O    0.031 
  1145.55605    1145.55582   y‡9-H2O -NH3   -0.201 
  1145.57381    1145.57481   b#8     0.873 
  1148.56357    1148.56421   b#9-3H2O    0.557 
  1150.53161    1150.53102   b#9-H2O-2NH3   -0.513 
  1156.58978    1156.59046   a#9-H2O    0.584 
  1162.58260    1162.58314   y‡9-H2O    0.469 
 D-18 
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(m/z) 
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  1163.56661    1163.56678   y‡9-NH3    0.142 
  1166.57414    1166.57403   b#9-2H2O   -0.090 
  1167.55815    1167.55854   b#9-H2O-NH3    0.330 
  1168.56218    1168.56222   b#9-2NH3    0.039 
  1171.67345    1171.67402   a10     0.486 
  1178.62310    1178.62249   a‡10-H2O -2NH3  -0.522 
*1180.59316    1180.59284   y‡9    -0.271 
  1184.58470    1184.58509   b#9-H2O    0.329 
  1185.56872    1185.56904   b#9-NH3    0.270 
  1199.66836    1199.66826   b10    -0.088 
  1202.59526    1202.59624   b#9     0.811 
  1202.61389    1202.61414   y10-NH3    0.204 
  1203.56153    1203.56258   y‡10-2H2O -NH3   0.872 
  1205.61019    1205.61045   b‡10-H2O-2NH3   0.216 
  1211.66836    1211.66921   a‡10-H2O    0.697 
  1219.64044    1219.64020   y10    -0.197 
  1221.65271    1221.65333   b‡10-2H2O    0.503 
  1222.63674    1222.63704   b‡10-H2O -NH3   0.249 
  1223.64075    1223.64100   b‡10-2NH3    0.200 
  1225.58227    1225.58283   y-2NH3    0.461 
  1229.67893    1229.67893   a‡10     0.000 
  1233.65271    1233.65335   a#10-3H2O    0.515 
  1234.63674    1234.63615   a#10-2H2O-NH3  -0.474 
*1239.66328    1239.66403   b‡10-H2O    0.605 
  1240.64730    1240.64747   b‡10-NH3    0.137 
  1242.60881    1242.60821   y‡10-H2O -NH3  -0.483 
  1246.58912    1246.58835   b#10-2H2O-2NH3  -0.622 
  1251.66328    1251.66334   a#10-2H2O    0.048 
  1254.63915    1254.63911   a#10-2NH3   -0.032 
  1257.67385    1257.67371   b‡10    -0.107 
  1259.63535    1259.63472   y‡10-H2O   -0.504 
1261.64763    1261.64874   b#10-3H2O    0.880 
1263.61567    1263.61500   b#10-H2O-2NH3  -0.475 
1279.65819    1279.65828   b#10-H2O    0.070 
1280.64222    1280.64258   b#10-H2O- NH3   0.281 
1297.66876    1297.66771   b#10-H2O   -0.809 
*1298.65278    1298.65182   b#10-NH3   -0.739 
mean 0.073  
St. Dv. 0.444 
 
Table D-8.  DR(703)ECD(732) error analysis of the KM-11 peptide in PBS for the precursor ion 
[M+2(C2H2O2)+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
* 301.18702     301.18704   c‡2     0.066 
 D-19 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   495.32758     495.32763   c4•     0.091 
* 496.33541     496.33515   c4    -0.524 
   501.79152     501.79192   a8 2+     0.797 
   517.31193     517.31194   c‡4•-2H2O    0.010 
   535.32250     535.32258   c‡4•-H2O    0.149 
   536.33033     536.33030   c‡4-H2O   -0.047 
   550.78672     550.78714   (a#8-H2O) 2+    0.767 
   552.80107     552.80141   c‡4 2+     0.606 
   553.33307     553.33315   c‡4•     0.154 
* 554.34089     554.34059   c‡4    -0.541 
   593.32798     593.32816   c#4•-H2O    0.303 
   594.27504     594.27559   (z#9•-H2O-NH3) 2+   0.917 
   594.33581     594.33585   c#4-H2O    0.076 
   606.83674     606.83631   (a‡10-H2O) 2+    -0.704 
   611.33854     611.33868   c#4•     0.221 
* 612.34637     612.34652   c#4     0.245 
   623.38617     623.38640   c5•     0.377 
   624.39399     624.39416   c5     0.272 
   628.34464     628.34412   (c‡10• -H2O) 2+   -0.828 
   663.38108     663.38130   c‡5•-H2O    0.332 
   664.38891     664.38905   c‡5-H2O    0.218 
   674.37134     674.37068   [M+2H] 2+   -0.979 
   681.39165     681.39187   c‡5•     0.330 
   682.39947     682.39971   c‡5     0.352 
   685.36352     685.36323   [M‡-2H2O+2H] 2+  -0.416 
   694.36880     694.36883   [M‡- H2O +H] 2+   0.047 
* 703.37408     703.37387   [M+H]2+   -0.299 
   705.36097     705.36042   b#5-H2O   -0.783 
   715.36478     715.36493   [M#-2H2O+2H] 2+   0.203 
   721.38656     721.38678   c#5•-H2O    0.305 
   722.39439     722.39463   c#5-H2O    0.339 
   723.37154     723.37169   [M#-H2O+2H] 2+   0.207 
   723.86355     723.86341   [M#-NH3+2H] 2+  -0.193 
   732.37682     732.37669   [M#+2H]2+   -0.178 
   739.39712     739.39734   c#5•     0.291 
   740.40495     740.40521   c#5     0.351 
   751.44475     751.44481   c6•     0.087 
   752.45257     752.45282   c6     0.332 
   791.43966     791.44000   c‡6•-H2O    0.430 
   792.44749     792.44775   c‡6-H2O    0.334 
   809.45023     809.45058   c‡6•     0.439 
   810.45805     810.45832   c‡6     0.333 
   849.44514     849.44537   c#6•-H2O    0.271 
   850.45296     850.45324   c#6-H2O    0.323 
   867.45570     867.45598   c#6•     0.317 
* 868.46353     868.46380   c#6     0.311 
   899.52098     899.52099   c7     0.011 
 D-20 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   938.50807     938.50816   c‡7•-H2O    0.096 
* 939.51590     939.51608   c‡7-H2O    0.197 
   957.52646     957.52659   c‡7     0.136 
   971.51831     971.51837   a#7     0.062 
   996.51355     996.51380   c#7•-H2O    0.251 
   997.52138     997.52150   c#7-H2O    0.125 
  1014.52412    1014.52423   c#7•     0.113 
*1015.53194    1015.53202   c#7     0.079 
  1046.58939    1046.58977   c8     0.363 
  1072.54485    1072.54471   z‡9•-C3H6D-H2O  -0.134 
  1085.57648    1085.57645   c‡8•-H2O   -0.028 
  1086.58431    1086.58423   b9    -0.069 
  1088.53459    1088.53485   y9-2NH3    0.239 
  1090.55542    1090.55533   z‡9•-C3H6S   -0.082 
  1100.57615    1100.57654   a#8-H2O    0.350 
  1103.61085    1103.61080   c9    -0.045 
  1104.59487    1104.59491   c‡8     0.036 
  1118.58672    1118.58661   a#8    -0.098 
*1143.60577    1143.60569   c‡9-H2O   -0.066 
  1144.58978    1144.58962   b‡9    -0.144 
  1146.56388    1146.56376   z‡9•-H2O   -0.100 
  1148.56090    1148.56001   z#9•-C3H6S   -0.774 
  1161.59253    1161.59226   c#8•    -0.228 
  1161.61633    1161.61614   c‡9    -0.164 
  1162.60035    1162.60024   c#8    -0.095 
  1164.57444    1164.57442   z‡9•    -0.017 
  1175.60818    1175.60817   a#9    -0.009 
  1186.55879    1186.55808   z#9•-2H2O   -0.598 
*1201.61125    1201.61103   c#9-H2O   -0.179 
  1204.56936    1204.56895   z#9•-H2O   -0.336 
  1215.68709    1215.68681   c10•    -0.226 
  1219.62181    1219.62142   c#9    -0.320 
  1222.57992    1222.57942   z#9•    -0.409 
  1256.68982    1256.68947   c‡10 -H2O   -0.282 
  1274.70039    1274.70010   c‡10    -0.228 
  1288.69224    1288.69208   a#10    -0.124 
*1314.69530    1314.69487   c#10-H2O   -0.331 
  1330.70886    1330.70790   [M-NH3+H] 1+   -0.718 
  1331.71668    1331.71581   [M- NH3+2H] 1+•  -0.653 
  1332.70587    1332.70509   c#10    -0.585 
  1343.71613    1343.71550   [M‡-•CONH2-H2O +H] 1+ -0.469 
  1347.73540    1347.73445   [M+H] 1+   -0.705 
1361.72670    1361.72674   [M‡-•CONH2 +H] 1+   0.033 
  1383.71160    1383.71012   [M-2H2O-•CONH2+H] 1+ -1.070 
  1387.73032    1387.73023   [M‡-H2O+H] 1+•  -0.061 
  1388.73815    1388.73787   [M‡-H2O+2H] 1+•  -0.598 
  1401.72162    1401.72179   [M#-H2O-•CONH2+1H] 1+  0.121 
 D-21 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*1405.74089    1405.74033   [M‡ +2H] 1+•   -0.391 
  1411.70651    1411.70516   [M#-NH3- 2H2O +1H] 1+ -0.956 
1419.73218    1419.73311   [M#-•CONH2+1H] 1+   0.655 
1428.73306    1428.73294   [M#-2H2O +2H] 1+•  -0.084 
1445.73580    1445.73632   [M#-H2O +H] 1+   0.360 
1446.74363    1446.74380   [M#-H2O +2H] 1+•   0.118 
1447.72765    1447.72669   [M#-H2O +2H] 1+•  -0.656 
*1463.74637    1463.74528   [M#+H] 1+   -0.745 
mean -0.077  
St. Dv. 0.497 
 
Table D-9.  DR(724)ECD(753) error analysis of the glycated AcKM-11 peptide MeOH/H2O (50:50) for 
the precursor ion [M+2(C2H2O2)+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   538.34597     538.34595   c4    -0.046 
   577.33307     577.33325   c‡4•-H2O    0.320 
   578.34089     578.34102   c‡4-H2O    0.225 
   595.34363     595.34378   c‡4•     0.252 
   596.35145     596.35156   c‡4     0.176 
   635.33854     635.33847   c#4•-H2O   -0.118 
   653.34911     653.34921   c#4•     0.153 
   654.35694     654.35695   c#4     0.023 
   665.39673     665.39662   c5•    -0.165 
   666.40455     666.40454   c5    -0.023 
   705.39165     705.39154   c‡5•-H2O   -0.149 
   706.39947     706.39940   c‡5-H2O   -0.099 
   723.40221     723.40229   c‡5•     0.111 
   724.41003     724.41009   c‡5     0.076 
   735.86355     735.86339   [M#-H2O-NH3+2H] 2+  -0.217 
   736.35556     736.35606   [M#-2NH3+2H] 2+   0.679 
   744.86883     744.86870   [M#-NH3+2H] 2+  -0.178 
   747.37841     747.37840   b#5-H2O   -0.007 
   753.38211     753.38192   [M#+2H] 2+   -0.246 
   763.39712     763.39742   c#5•-H2O    0.386 
   764.40495     764.40469   c#5-H2O   -0.340 
   781.40769     781.40769   c#5•     0.000 
   782.41552     782.41554   c#5     0.032 
   793.45531     793.45565   c6•     0.429 
   794.46313     794.46286   c6    -0.346 
   833.45023     833.44988   c‡6•-H2O   -0.414 
   834.45805     834.45853   c‡6-H2O    0.575 
   851.46079     851.46077   c‡6•    -0.023 
   852.46861     852.46860   c‡6    -0.018 
   891.45570     891.45583   c#6•-H2O    0.140 
 D-22 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   892.46353     892.46348   c#6-H2O   -0.056 
   893.44755     893.44744   b#6    -0.123 
   909.46627     909.46627   c#6•     0.000 
   910.47410     910.47426   c#6     0.181 
   941.53155     941.53170   c7     0.165 
   980.51864     980.51871   c‡7•-H2O    0.076 
   981.52646     981.52703   c‡7-H2O    0.581 
   998.52920     998.52958   c‡7•     0.381 
   999.53702     999.53715   c‡7     0.125 
  1039.53194    1039.53206   c#7-H2O    0.115 
  1040.51596    1040.51553   b#7    -0.413 
  1056.53468    1056.53537   c#7•     0.653 
  1057.54250    1057.54285   c#7     0.326 
  1102.59125    1102.59116   a‡8    -0.082 
  1145.59761    1145.59756   c‡8•    -0.044 
  1145.62142    1145.62127   c9    -0.127 
  1146.56388    1146.56378   z‡9•-H2O   -0.083 
  1146.60543    1146.60554   c‡8     0.092 
  1148.56090    1148.56026   z#9•-C3H6S   -0.556 
  1160.59673    1160.59644   c#8-•CONH2   -0.250 
  1164.57444    1164.57398   z‡9•    -0.395 
  1185.61633    1185.61626   c‡9-H2O   -0.059 
  1186.55879    1186.55902   z#9•-2H2O    0.194 
  1186.60035    1186.60058   b‡9     0.194 
  1203.62690    1203.62717   c‡9     0.228 
  1204.56936    1204.56956   z#9•-H2O    0.170 
  1204.61091    1204.61126   c#8     0.286 
  1222.57992    1222.58011   z#9•     0.155 
  1226.59526    1226.59499   b#9-H2O   -0.224 
  1242.61398    1242.61319   c#9•-H2O   -0.640 
  1243.62181    1243.62159   c#9-H2O   -0.177 
  1258.70547    1258.70603   c10     0.441 
  1261.63237    1261.63252   c#9     0.115 
  1297.69257    1297.69367   c‡10•-H2O    0.852 
  1298.70039    1298.69906   c‡10-H2O   -1.024 
  1315.70313    1315.70305   c‡10•    -0.061 
  1316.71096    1316.71132   c‡10     0.277 
  1331.71662    1331.71671   [M-CH3CONH2+2H] 1+•  0.204 
  1339.67933    1339.67923   b#10-H2O   -0.071 
  1345.73227    1345.73242   [M -HCONH2+2H] 1+•  0.113 
  1355.69805    1355.69830   c#10•-H2O    0.188 
  1356.70587    1356.70627   c#10-H2O    0.295 
1371.71153    1371.71171  [M‡-CH3CONH2-H2O +2H] 1+•  0.129 
  1374.71644    1374.71603   c#10    -0.295 
  1385.72718    1385.72814   [M‡ -•CONH2-H2O+H] 1+  0.690 
  1388.71433    1388.71409   [M‡ -CH3CONH2+H] 1+ -0.176 
  1389.72210    1389.72194   [M‡ -CH3CONH2+2H] 1+• -0.114 
 D-23 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
  1389.74597    1389.74615   [M‡ +H] 1+    0.133 
  1403.73726    1403.73867   [M‡-•CONH2+H] 1+   0.133 
  1411.70639   ? 
  1412.73815    1412.73784   [M‡- 2H2O +2H] 1+•  -0.216 
  1414.73517    1414.73485   [M#-H2O-C3H6S+2H]1+• -0.225 
      1429.71719   ? 
1429.74088    1429.74149   [M‡- H2O +H] 1+   0.427 
1430.74871    1430.74910   [M‡- H2O +2H] 1+•   0.273 
1443.73218    1443.73368   [M#-•CONH2- H2O +H] 1+  1.042 
1447.75145    1447.75256   [M‡+H] 1+    0.770 
1452.73306    1452.73363   [M#-3H2O+2H] 1+•  -0.392 
1461.74275    1461.74352   [M#-•CONH2+H] 1+   0.530 
1470.74363    1470.74342   [M#-2H2O+2H] 1+•   0.139 
      1487.74826   ? 
1505.75693    1505.75566   [M#+H] 1+   -0.845 
mean 0.086  
St. Dv. 0.493 
 
Table D-10.  CAD (753) error analysis of the glycated Ac-KM-11 peptide in MeOH/H2O (50:50) for the 
precursor ion [M+2(C2H2O2)+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
*  302.15329     302.15338   y3-NH3    0.313 
   319.17983     319.17993   y3     0.313 
   424.26667     424.26667   b3     0.000 
   446.25102     446.25074   b‡3-2H2O   -0.627 
   447.23504     447.23518   b‡3-H2O -NH3    0.313 
   449.22170     449.22172   y4-NH3    0.045 
   462.75614     462.75625   b7 2+     0.238 
   464.26159     464.26160   b‡3-H2O    0.032 
* 466.24824     466.24827   y4     0.064 
   474.24032     474.24041   (b‡7-H2O -NH3) 2+   0.179 
   482.27215     482.27214   b‡3    -0.021 
   482.75360     482.75352   (b‡7-H2O) 2+   -0.161 
   483.24561     483.24570   (b‡7-NH3) 2+    0.191 
   491.75888     491.75884   b‡7 2+    -0.081 
   499.25634     499.25584   a‡4-2NH3-H2O   -1.001 
   504.25650     504.25648   b#3-2H2O   -0.040 
   511.75634     511.75611   (b#7-H2O+H]2+  -0.445 
   522.26707     522.26708   b#3-H2O    0.029 
   523.25108     523.25121   b#3-NH3    0.239 
   527.77707     527.77689   (b8-NH3+H]2+  -0.346 
   533.77707     533.77707   (a‡8-H2O-NH3+H]2  -0.005 
   536.29035     536.29034   b8 2+    -0.009 
   540.27763     540.27736   b#3    -0.500 
 D-24 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   542.29035     542.29035   (a‡8-H2O) 2+    0.005 
   547.28252     547.28261   (b‡8-H2O) 2+    0.164 
   547.77453     547.77452   (b‡8-H2O -NH3) 2+  -0.018 
   551.29563     551.29554   a‡8 2+    -0.159 
   556.28780     556.28778   b9-NH3   -0.036 
   556.77981     556.77978   (b‡8-NH3) 2+   -0.058 
   561.31435     561.31429   b‡4-H2O   -0.098 
   562.28780     562.28764   (a#8-2H2O) 2+   -0.289 
* 564.80107     564.80101   b9 2+    -0.115 
   565.29309     565.29306   b‡8 2+    -0.044 
   570.80107     570.80105   (a‡9-H2O) 2+   -0.044 
   571.29309     571.29317   (a#8-H2O) 2+    0.149 
   575.29103     575.29133   x9 2+     0.521 
   575.79325     575.79323   (b‡9-2H2O) 2+   -0.035 
   576.28526     576.28524   (b‡9-H2O -NH3) 2+  -0.035 
   576.77727     576.77718   (b#8-H2O-NH3) 2+  -0.156 
   584.79853     584.79852   (b‡9-H2O) 2+   -0.021 
   585.29054     585.29055   (b#8-H2O) 2+    0.013 
   585.78255     585.78260   (b#8-NH3) 2+    0.081 
   593.80381     593.80384   b‡9 2++     0.042 
   594.29583     594.29577   b#8 2++    -0.093 
   595.79071     595.79061   (b#9-3H2O) 2+   -0.164 
   596.28272     596.28274   (b#9-2H2O-NH3) 2+   0.038 
   596.29011     596.29008   y5-NH3   -0.050 
   601.81059     601.81055   (y10-NH3) 2+   -0.066 
   604.79599     604.79594   (b#9-2H2O) 2+   -0.083 
   605.28800     605.28800   (b#9-H2O-NH3) 2+   0.000 
   607.34565     607.34572   a10 2+     0.115 
   610.32386     610.32384   y10 2+    -0.033 
   612.82983     612.82980   (b10-NH3) 2+   -0.053 
* 613.31665     613.31666   y5     0.016 
   613.80127     613.80127   (b#9-H2O) 2+   -0.004 
   614.29328     614.29326   (b#9-NH3) 2+   -0.037 
   618.33782     618.33756   (a‡10-2H2O) 2+   -0.425 
   618.82983     618.82975   (a‡10-H2O-NH3) 2+  -0.133 
   621.31604     621.31601   (y‡10-2H2O) 2+   -0.040 
   621.34311     621.34309   b10 2+    -0.024 
   621.80804     621.80804   (y‡10- H2O-NH3) 2+  -0.008 
   622.80656     622.80626   b#9 2++    -0.474 
   623.33000     623.33004   (b‡10- H2O -2H2O) 2+   0.068 
   623.82201     623.82197   (b‡10-2H2O-NH3) 2+  -0.060 
   624.31402     624.31388   (b‡10-H2O-2NH3) 2+  -0.220 
   627.34311     627.34309   (a‡10-H2O) 2+   -0.024 
   630.32132     630.32130   (y‡10-H2O) 2+   -0.028 
   630.81333     630.81333   (y‡10-NH3) 2+    0.004 
   632.33528     632.33527   (b‡10-H2O -H2O) 2+  -0.016 
   632.82729     632.82727   (b‡10-H2O -NH3) 2+  -0.032 
 D-25 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   636.34839     636.34838   a‡10 2+    -0.012 
   639.32660     639.32658   y‡10 2+    -0.031 
   641.34056     641.34055   (b‡10-H2O) 2+   -0.019 
   641.83257     641.83257   (b‡10-NH3) 2+   -0.004 
   647.34056     647.34052   (a#10-2H2O) 2+   -0.066 
   647.83257     647.83238   (a#10-H2O-NH3) 2+  -0.297 
   649.37801     649.37799   b5    -0.031 
   650.31877     650.31873   (y#10-2H2O) 2+   -0.069 
   650.34585     650.34581   b‡10 2+    -0.054 
   652.33274     652.33271   (b#10-3H2O) 2+   -0.042 
   652.82475     652.82468   (b#10-2H2O-NH3) 2+  -0.103 
   656.34585     656.34581   (a#10-H2O) 2+   -0.053 
   656.84779     656.84744   [M-NH3-H2O) 2+  -0.533 
   659.32406     659.32413   (y#10-H2O) 2+    0.110 
   659.81607     659.81598   (y#10-NH3) 2+   -0.133 
   661.33802     661.33800   (b#10-2H2O) 2+   -0.030 
   661.83003     661.83001   (b#10-H2O-NH3) 2+  -0.030 
   664.35262     664.35256   [M-HCONH2-NH3+2H] 2+ -0.500 
   665.35113     665.35114   a#10 2+     0.015 
* 668.32934     668.32911   y#10 2+    -0.344 
   670.34330     670.34329   (b#10-H2O) 2+   -0.019 
   670.83531     670.83531   (b#10-NH3) 2+   -0.004 
   672.86589     672.86579   [M-HCONH2+2H] 2+  -0.152 
   677.85807     677.85814   [M-H2O-NH3+2H] 2+   0.107 
   678.35008     678.35002   [M‡-H2O 2NH3+2H] 2+ -0.085 
   679.34858     679.34851   [b#10+H] 2+   -0.110 
   683.85807     683.85799  [M‡-HCONH2-2H2O+2H] 2+  -0.113 
   684.35008     684.34997  [M‡-H2O-HCONH2-NH3+2H] 2+ -0.157 
   685.85552     685.85536  [M‡-CH2CO-H2O-NH3+2H] 2+ -0.241 
   686.86335     686.86332  [M-HCONH2-H2O +2H] 2+  -0.044 
   689.34225     689.34219   [M‡-2H2O-2NH3+2H] 2+ -0.091 
   689.37293     689.37297   b‡5-H2O    0.065 
   690.35694     690.35704   b‡5-NH3    0.138 
   692.86335     692.86333   [M‡-HCONH2-H2O +2H] 2+ -0.029 
   694.36880     694.36879   [M‡-H2O-CH2CO+2H] 2+ -0.011 
   695.37663     695.37671   [M+2H] 2+   -0.115 
   697.85552     697.85552   [M‡-2H2O-NH3+2H] 2+ -0.007 
   698.34753     698.34749   [M‡-H2O -2NH3+2H] 2+ -0.064 
   701.86863     701.86856   [M‡-HCONH2+2H] 2+  -0.103 
   703.37408     703.37419   [M‡-CH2CO +2H] 2+   0.156 
   706.36880     706.36887   [M‡-2H2O+2H] 2+  -0.099 
   706.86081     706.86078   [M‡-H2O-NH3+2H] 2+  -0.039 
   707.32214     707.32230   y6-2NH3    0.226 
   707.35282     707.35277   [M‡-2NH3+2H] 2+  -0.067 
   712.86081     712.86092   [M#-HCONH2-2H2O+2H] 2+  0.158 
   713.35282     713.35277  [M#-HCONH2-H2O-NH3+2H] 2+ -0.067 
   715.37408     715.37417   [M‡-H2O+2H] 2+  -0.126 
 D-26 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   715.86609     715.86606   [M‡-NH3+2H] 2+  -0.042 
   717.85298     717.85289   [M#-3H2O-NH3+2H] 2+ -0.129 
   718.34499     718.34523   [M#-2H2O-2NH3+2H] 2+  0.331 
   721.37408     721.37419   [M#-2H2O-CO+2H] 2+   0.149 
   721.86609     721.86595   [M#-HCONH2-H2O+2H] 2+ -0.194 
   724.34869     724.34891   y6-NH3    0.304 
   724.37991     724.37994   [M‡+2H] 2+   -0.041 
   725.37293     725.37305   b6-H2O-2NH3    0.159 
   726.36626     726.36641   [M#-3H2O +2H] 2+  -0.206 
   726.85827     726.85826   [M#-2H2O-NH3+2H] 2+ -0.010 
   727.35028     727.35027   [M#-H2O-2NH3+2H] 2+ -0.007 
   729.36784     729.36797   b#5-2H2O    0.178 
   730.87137     730.87151   [M#-HCONH2+2H] 2+  0.185 
   735.86355     735.86349   [M#-H2O-NH3+2H] 2+  -0.082 
   736.35556     736.35551   [M#-2NH3+2H] 2+  -0.068 
   741.37523     741.37522   y6     0.013 
   744.37682     744.37678   [M#-H2O+2H] 2+  -0.057 
   744.86883     744.86878   [M#-NH3+2H] 2+  -0.070 
   747.37841     747.37834   b#5-H2O   -0.087 
   748.36243     748.36299   b#5-NH3    0.755 
   754.39948     754.39950   a‡6-2H2O-NH3    0.027 
   755.38350     755.38357   a‡6-H2O -NH 3    0.093 
   771.42602     771.42595   a‡6-2H2O   -0.097 
* 777.43659     777.43664   b6     0.064 
   799.42094     799.42093   b‡6-2H2O   -0.013 
   801.40898     801.40850   b‡6-2NH3   -0.599 
   811.42094     811.42101   a#6-3H2O    0.086 
   812.40496     812.40496   a#6-2H2O-NH3    0.000 
   817.43151     817.43150   b‡6-H2O   -0.006 
   829.43151     829.43208   a#6-2H2O    0.693 
* 835.44207     835.44209   b‡6-     0.024 
   839.41585     839.41535   b#6-3H2O   -0.602 
   857.42642     857.42625   b#6-2H2O   -0.198 
   858.41044     858.41025   b#6-H2O-NH3   -0.221 
   875.43699     875.43682   b#6-H2O   -0.188 
   876.42101     876.42084   b#6-NH3   -0.188 
   901.46789     901.46788   a‡7-2H2O-NH3   -0.011 
   902.45191     902.45215   a‡7-H2O -2NH3   0.266 
   924.50500     924.50495   b7    -0.054 
   932.43348     932.43353   y8-2NH3    0.054 
   946.48935     946.48969   b‡7-2H2O     0.359 
   947.47337     947.47336   b‡7-H2O -NH3   -0.011 
   948.47739     948.47768   b‡7--2NH3    0.306 
   949.46003     949.46004   y8-NH3    0.011 
   958.48935     958.48942   a#7-3H2O    0.073 
   959.47337     959.47328   a#7-2H2O-NH3   -0.094 
   964.49991     964.49993   b‡7-H2O    0.016 
   965.48393     965.48364   b‡7--NH3   -0.306 
 D-27 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   966.48657     966.48666   y8     0.093 
   976.49991     976.49907   a#7-2H2O   -0.865 
* 982.51048     982.51050   b‡7-     0.020 
   986.48427     986.48438   b#7-3H2O    0.117 
  1004.49483    1004.49478   b#7-2H2O   -0.050 
  1005.47885    1005.47836   b#7-H2O-NH3   -0.487 
  1022.50540    1022.50534   b#7-H2O   -0.054 
  1023.48942    1023.48989   b#7-NH3    0.464 
*1043.57849    1043.57839   a8    -0.101 
  1054.54687    1054.54648   b8-NH3   -0.365 
  1066.54687    1066.54738   a9-2NH3    0.483 
  1083.57341    1083.57369   a‡8-H2O    0.258 
  1093.55776    1093.55775   b‡8-2H2O   -0.009 
  1094.54178    1094.54191   b‡8-H2O -NH3    0.119 
  1095.54580    1095.54579   b‡8-2NH3   -0.009 
  1101.58398    1101.58432   a‡8     0.313 
  1112.55235    1112.55247   b‡8-NH3    0.112 
  1124.55235    1124.55252   a‡9-2NH3    0.156 
*1128.59487    1128.59487   b9     0.000 
  1129.57889    1129.57884   b‡8    -0.044 
  1133.55267    1133.55255   b#8-3H2O   -0.110 
  1134.53670    1134.53597   b‡9-H2O-2NH3  -0.639 
  1150.57922    1150.57937   b‡9-H2O -H2O    0.130 
  1151.56324    1151.56331   b‡9-H2O -NH3    0.061 
  1152.54726    1152.54718   b#8-H2O-NH3   -0.069 
  1152.56726    1152.56667   b‡9-2NH3   -0.512 
  1153.55128    1153.55084   b#8-2NH3   -0.381 
  1159.58946    1159.59005   a#8     0.513 
  1162.57922    1162.57883   a#9-3H2O   -0.335 
  1168.58978    1168.58988   b‡9-H2O    0.081 
  1169.57380    1169.57390   b#8-H2O    0.081 
  1170.55783    1170.55794   b#8-NH3    0.098 
  1186.60035    1186.60104   b‡9     0.581 
  1190.57414    1190.57445   b#9-3H2O    0.265 
  1192.54218    1192.54317   b#9-H2O-2NH3    0.834 
  1208.58470    1208.58501   b#9-2H2O    0.256 
  1209.56872    1209.56880   b#9-H2O-NH3    0.066 
  1210.57274    1210.57215   b#9-2NH3   -0.487 
 *1219.64044    1219.64059   y10     0.123 
  1224.59824    1224.59950   y‡10-H2O-NH3    1.025 
  1225.58227    1225.58236   y‡10-H2O -2NH3   0.078 
  1226.59526    1226.59535   b#9-H2O    0.069 
  1227.57929    1227.57919   b#9-NH3   -0.077 
  1241.62479    1241.62469   y‡10-H2O   -0.081 
  1241.67893    1241.67893   b10     0.000 
  1242.60881    1242.60870   y‡10-H2O -NH3  -0.089 
  1243.59283    1243.59273   y‡10-2NH3   -0.080 
 D-28 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
  1259.63535    1259.63549   y‡10-H2O    0.107 
  1260.61937    1260.61948   y‡10-NH3    0.083 
  1263.66328    1263.66317   b‡10-2H2O   -0.087 
  1264.64730    1264.64739   b‡10-NH3-H2O    0.071 
  1265.65132    1265.65173   b‡10-2NH3    0.324 
  1277.64592    1277.64572   y‡10    -0.157 
  1281.67385    1281.67376   b‡10-H2O   -0.066 
  1282.65786    1282.65788   b-NH3     0.012 
  1293.67385    1293.67355   a#10-2H2O   -0.228 
  1299.63027    1299.63034   y#10-2H2O    0.054 
  1299.68441    1299.68416   b‡10    -0.192 
*1300.61429    1300.61432   y#10-H2O-NH3    0.023 
mean 0.023  
St. Dv. 0.396 
 
Table D-11.  CAD(753) error analysis of the AcKM-11 peptide PBS for the precursor ion 
[M+2(C2H2O2)+2H]2+. * indicates the ions used for calibration. 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
* 302.15329     302.15304   y3-NH3   -0.827 
   424.26667     424.26659   b3    -0.189 
   446.25102     446.25102   b‡3-2H2O    0.000 
   449.22170     449.22170   y4-NH3    0.000 
   464.26159     464.26159   b‡3-H2O    0.011 
* 466.24824     466.24828   y4     0.086 
   473.74831     473.74837   (b‡7-2H2O) 2+    0.116 
   482.27215     482.27225   b‡3     0.207 
   504.25650     504.25644   b#3-2H2O   -0.119 
   511.75634     511.75634   (b#7-H2O) 2+    0.005 
   521.31943     521.31949   b4     0.115 
   522.26707     522.26712   b#3-H2O    0.105 
   522.29289     522.29302   a8 2+     0.249 
   536.29035     536.29032   b8 2+    -0.047 
   542.29035     542.29033   (a‡8-H2O) 2+   -0.028 
   547.28252     547.28253   (b‡8-2H2O) 2+    0.018 
   556.28780     556.28773   b9-NH3   -0.126 
   564.80107     564.80113   b9 2+     0.097 
   565.29309     565.29312   b‡8 2+     0.062 
   567.27998     567.28032   (b‡9-2H2O-NH3) 2+   0.604 
   571.29309     571.29315   (a#8-H2O) 2+    0.114 
   575.79325     575.79307   (b‡9-H2O) 2+   -0.313 
   576.28526     576.28543   (b‡9-H2O -NH3) 2+   0.295 
   584.79853     584.79858   (b‡9-H2O) 2+    0.081 
   585.29054     585.29048   (b#8-H2O) 2+   -0.107 
 D-29 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   593.80381     593.80392   b‡9 2+     0.177 
   594.29583     594.29582   b#8 2+    -0.008 
* 596.29011     596.29025   y5-NH3    0.235 
   599.80381     599.80393   (a#9-H2O) 2+    0.192 
   601.81059     601.81053   (y10-NH3) 2+   -0.100 
   603.82455     603.82467   (b10-H2O-NH3) 2+   0.199 
   604.79599     604.79617   (b#9-2H2O) 2+    0.298 
   605.28800     605.28808   (b#9-H2O-NH3) 2+   0.132 
   607.34565     607.34572   a10 2+     0.115 
   610.32386     610.32397   y10 2+     0.180 
   612.33782     612.33775   (b10-H2O) 2+   -0.118 
   612.82983     612.82974   (b10-NH3) 2+   -0.151 
   613.31665     613.31701   y5     0.587 
   613.80127     613.80118   (b#9-H2O) 2+   -0.151 
   621.34311     621.34310   b10 2+    -0.008 
   622.80656     622.80665   b#9 2+     0.153 
   627.34311     627.34320   (a‡10-H2O) 2+    0.147 
* 630.32132     630.32139   (y‡10-H2O) 2+    0.115 
   632.33528     632.33520   (b‡10-2H2O) 2+   -0.127 
   632.82729     632.82753   (b‡10-H2O -NH3) 2+   0.379 
   636.34839     636.34851   a‡10 2+     0.189 
   639.32660     639.32681   y‡10 2+     0.328 
   641.34056     641.34041   (b‡10-H2O) 2+   -0.238 
   649.37801     649.37793   b5    -0.123 
   650.31877     650.31882   (y#10-2H2O) 2+    0.069 
   650.34585     650.34600   b‡10 2+     0.238 
   656.34585     656.34597   (a#10-H2O) 2+    0.190 
   656.84779     656.84759   [M-2NH3-H2O+H] 2+  -0.304 
   659.32406     659.32422   (y#10-H2O) 2+    0.246 
   659.81607     659.81619   (y#10-NH3) 2+    0.186 
   661.33802     661.33796   (b#10-2H2O) 2+   -0.091 
   661.83003     661.83037   (b#10-H2O-NH3) 2+   0.514 
   664.35289     664.35280   [M-HCONH2-NH3+2H] 2+ -0.139 
   665.35113     665.35152   a#10 2+     0.586 
   668.32934     668.32971   y#10 2+     0.554 
   670.34330     670.34353   (b#10-H2O) 2+    0.339 
   671.36236     671.36291   b‡5-2H2O    0.819 
   677.85807     677.85839   [M-H2O-NH3+2H] 2+   0.476 
   678.35008     678.35045   [M-2NH3+2H] 2+   0.549 
   679.34858     679.34880   b#10 2+     0.316 
   686.86335     686.86334   [M-NH3-HCONH2+2H] 2+ -0.015 
   689.37293     689.37335   b‡5-H2O    0.617 
   695.37663     695.37683   [M+2H] 2+    0.288 
   694.86081     694.86089   [M‡-CH2CO -NH3+2H] 2+  0.119 
   706.36880     706.36830   [M‡-2H2O +2H] 2+   0.707 
   707.32214     707.32246   y6-2NH3    0.452 
   707.35282     707.35336   [M‡-2NH3+2H] 2+   0.767 
* 707.38349     707.38396   b‡5     0.664 
 D-30 
THEORETICAL 
(m/z) 
EXPERIMENTAL     
(m/z) ASSIGNMENTS 
ERROR 
(ppm) 
   707.86234     707.86220   [M-H2O +2H]2+  -0.201 
   717.85298     717.85226   [M#-3H2O+2H]2+  -1.006 
   718.34499     718.34428   [M#-2H2O-2NH3+2H]2 -0.992 
   724.37936     724.37956   [M‡+2H]2+    0.273 
   726.35695     726.35722   b6-3NH3    0.365 
   735.86355     735.86342   [M#-H2O-NH3+2H]2  -0.177 
   737.36293     737.36334   a‡6-2NH3-H2O   0.549 
   744.37682     744.37695   [M#-H2O+2H]2+   0.171 
   744.86883     744.86929   [M#-NH3+2H]2+   0.614 
   754.39948     754.39894   a‡6-2H2O-NH3   -0.716 
   771.42602     771.42626   a‡6-2H2O    0.305 
   777.43659     777.43654   b6    -0.064 
   799.42094     799.42059   b‡6-2H2O   -0.438 
   811.42094     811.42099   a#6-3H2O    0.062 
   812.40496     812.40518   a#6-2H2O-NH3    0.271 
   817.43151     817.43206   b‡6-H2O    0.679 
* 835.44207     835.44261   b‡6     0.646 
   857.42642     857.42675   b#6-2H2O    0.385 
   875.43699     875.43644   b#6-H2O   -0.623 
   901.46789     901.46826   a‡7-2H2O-NH3   0.410 
   924.50500     924.50515   b7     0.162 
   932.43348     932.43410   y8-2NH3    0.665 
   946.48935     946.48855   b‡7-2H2O   -0.845 
   949.46003     949.46028   y8-NH3    0.263 
   958.48935     958.48963   a#7 -3H2O    0.292 
   964.49991     964.50011   b‡7-H2O    0.202 
   966.48657     966.48650   y8    -0.072 
   982.51048     982.51053   b‡7     0.051 
   988.45231     988.45177   b#7-H2O-2NH3   -0.541 
  1022.50540    1022.50604   b#7-H2O    0.631 
  1043.57849    1043.57822   a8    -0.264 
  1071.57341    1071.57289   b8    -0.485 
  1093.55776    1093.55885   b‡8-2H2O    0.997 
  1111.56832    1111.56780   b‡8-H2O   -0.472 
  1128.59487    1128.59383   b9    -0.921 
  1133.55267    1133.55236   b#8-3H2O   -0.278 
  1150.57922    1150.57802   b‡9-2H2O   -1.043 
1169.57380    1169.57447   b#8-H2O    0.569 
  1186.60035    1186.60037   b‡9     0.017 
1213.68402    1213.68414   a10     0.103 
*1219.64044    1219.63975   y10     0.556 
  1226.59526    1226.59616   b#9-H2O    0.734 
  1241.67893    1241.67882   b10    -0.089 
  1259.63535    1259.63649   y‡10-H2O    0.905 
  1281.67385    1281.67348   b‡10-H2O   -0.288 
  1299.63027    1299.63099   y#10-2H2O    0.554 
  1299.68441    1299.68450   b‡10     0.069 
 D-31 
*1300.61429    1300.61449   y#10-H2O-NH3    0.154 
mean 0.101  
St. Dv. 0.471 
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ABSTRACT: Glycation by endogenous dicarbonyl metabolites
such as glyoxal is an important spontaneous post-translational
(PTM) modiﬁcation of peptides and proteins associated with
structural and functional impairment. The aim of this study was
to investigate types and site of PTM of glyoxal-derived advanced
glycation end-products−in the neuropeptide substance P by
ultrahigh-resolution Fourier transform ion cyclotron resonance
(FTICR), mass spectrometry, and tandem mass spectrometry
(MS/MS) experiments. The main site of PTM by glyoxal was the
side chain guanidine moiety of the arginine residue. Binding site
identiﬁcation has been achieved by electron capture dissociation,
double-resonance electron capture dissociation, and collision-
activated dissociation, with assignment of the modiﬁed amino
acid residue with mass error <1 ppm.
Glyoxal (ethanedial), an α-dicarbonyl compound (alsoknown as α-oxoaldehyde), is a physiological metabolite. It
is formed by the degradation of glucose,1 glucose-modiﬁed
proteins (degradation of Schiﬀ’s base adduct and Amadori
product),2 the autoxidation of glycolaldehyde from the
oxidation of serine residues by hypochlorite in the phagocyte
respiratory burst,3 lipid peroxidation, and degradation of
nucleotides.4,5 Glyoxal and related dicarbonyl metabolites
(such as methylglyoxal or 3-deoxyglucosone) react mainly,
but not exclusively, with guanidine groups of arginine residues
of peptides and proteins. These reactions are spontaneous and
part of complex parallel and sequential reactions, in which
monosaccharides and related metabolites modify proteins,
known as the Maillard reaction,6 or glycation.2 Dicarbonyl-
derived glycation products are called advanced glycation end-
products (AGEs). Important AGEs quantitatively formed from
methylglyoxal are the arginine residue-derived hydroimidazo-
lone, Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)ornithine (MG-
H1), and Nω-carboxymethylarginine (CMA), and lysine
residue-derived Nε-carboxymethyl-lysine (CML), and the
glyoxal-derived bis(lysyl)imidazolium cross-links (GOLD,
glyoxal−lysine dimer7). CML is also formed by the oxidative
degradation of N-fructosyl-lysine residues in proteins glycated
by glucose.8
Glycation of proteins is commonly measured via the HbA1c
test, and the values are used in diabetes treatment. Glycation by
glyoxal and related dicarbonyls occurs also in physiological
systems. Arginine-directed glycation is insidious because
arginine residue-derived AGEs have increased molecular
volume and change in electrostatic charge, producing structural
distortion and loss of electrostatic interactions. Arginine
residues have high probability of location at functional sites
of proteins, and functionally important arginine residues are
often hot spots for dicarbonyl glycation leading to protein and
enzyme inactivation or dysfunction.8 Increased dicarbonyl
glycation occurs in aging and chronic disease (particularly
diabetes and its complications9,10nephropathy,11,12 retinop-
athy, neuropathy,13 and heart disease11), where increased
formation of dicarbonyls and decreased in situ activity of their
metabolism leads to increased dicarbonyl-derived AGEs and
pathogenesis.14,15
A method for detection of dicarbonyl-derived AGEs is stable
isotope dilution analysis with tandem mass spectrometry after
exhaustive enzymatic hydrolysis of peptide and protein
substrates.16 Identiﬁcation of dicarbonyl glycation within
proteins has been achieved by mass spectrometric peptide
mapping and proteomics17−20 with collision-activated dissoci-
ation (CAD),21−23 electron capture dissociation (ECD),24,25
and electron-transfer dissociation26 capabilities, fragmentation
techniques widely applied to determine the site of the post-
translational modiﬁcations (PTMs).27−37 In this study, the
dicarbonyl glycation reaction is studied through glyoxal binding
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to the neuropeptide substance P using Fourier transform ion
cyclotron resonance mass spectrometry (FTICR-MS). Sub-
stance P has the amino acid sequence RPKPQQFFGLM and
normally contains an amidated C-terminus. Thus, the
guanidino group of arginine, the amino group of lysine, the
N-terminus, and the amidated C-terminus are the potential
glyoxal glycation sites for substance P. The glyoxal-derived
AGEs were fragmented by ECD, double resonance electron
capture dissociation (DR-ECD), and CAD, and glyoxal binding
site was assigned within 1 ppm error (accurate mass
assignments are available in the Supporting Information).
■ MATERIALS AND METHODS
Materials. Substance P and substance P acetate salt,
ammonium acetate (∼99.6%), triethylamine, ammonium
phosphate monobasic, and acetic acid (≥99% pure) were
purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.).
Methanol (LC−MS grade), ethanol (HPLC grade), and
isopropyl alcohol (IPA, GLC pesticide grade) were purchased
from Fisher Scientiﬁc (Loughborough, Leicestershire, U.K.)
and were used without further puriﬁcation. All aqueous
solutions were prepared using water from a Milli-Q water
system (Millipore Inc., Durham, U.K.). Microdialysis cassettes
(GeBa ﬂex-tube, 1 kDa cutoﬀ), were obtained from Chembio
Diagnostic Systems, Inc. (Hertfordshire, U.K.). Glyoxal
solution (∼39% in water) was purchased from TCI Europe
(Zwijndrecht, Belgium). High-purity glyoxal solution was
diﬃcult to obtain because higher concentration favors the
formation of glyoxal dimers and trimers through dioxolane
rings.38 Nuclear magnetic resonance analysis of glyoxal solution
showed hydrolysis and dimer species, as previously reported by
Whipple.39
Substance P Glycation. In vitro glycation with glyoxal was
performed with substance P (1 mg/mL) or amidated substance
P (1 mg/mL). The concentration of anhydrous glyoxal reacted
with substance P was estimated of around 800 μmol/L, based
in the presence of hydrated, dimer, hemiacetals, hemiketal, and
bicyclic structures. The reaction was carried out at 37 °C in
MeOH/H2O (50:50), 100% water, and phosphate buﬀer [30
mM ammonium phosphate monobasic (NH4H2PO4) and 30
μL triethylamine (N(CH2CH3)3) pH 7.5], for 21, 21, and 12 h,
respectively. The samples reacted in phosphate buﬀer were
dialyzed against water and 10 mM CH3COONH4 over a period
of 24 h, dried, and redissolved in MeOH/H2O (50:50). Prior to
injection in the FTICR-MS, samples were prepared to a
concentration of ∼1 to 5 pmol/μL using electrospray solution
(composed either of MeOH or EtOH/IPA/acetic acid/H2O;
50:10:1:39). Methanol was used as a glyoxal polymerization
inhibitor instead of acetonitrile, which promotes glyoxal
dimerization.40
Mass Spectrometry. The experiments were performed in a
12 T solariX FTICR-MS (Bruker Daltonics, Coventry, United
Kingdom). The sample was ionized in positive mode with a
capillary voltage of 4.5 kV. To perform ECD, the parent ion
was isolated in the quadrupole (Q1) and accumulated in the
collision cell (1−15 s). After being transferred and trapped in
the inﬁnity cell,41 low-energy electrons (<1 eV) were generated
with an indirectly heated dispenser cathode42 (1.3 V and 1.7 V)
for 150 and 250 ms. Double-resonance ECD (DR−ECD)43,44
was performed in the cell varying the ejection pulse between
120 and 220 ms. The laser pulse for the infrared multiphoton
dissociation (IRMPD)45,46 experiment was kept at 90 ms
followed by electron injection. CAD experiments were
performed in the collision cell prior to selection of the
precursor ion in the quadrupole with potentials around 5−
15 V. The data was processed with DataAnalysis software 4.0
SP 3 (Bruker Daltonics) and internally calibrated.
■ RESULTS AND DISCUSSION
Experiments were carried out in phosphate buﬀer, because of its
biological relevance, and in MeOH/H2O (50:50), in order to
develop the method aiming to determine the types of AGEs
and its binding site for amidated substance P. Figure 1a shows
doubly [M + 2H]2+ and triply charged [M + 3H]3+ ions from
unmodiﬁed amidated substance P. The spectrum also shows
four more doubly charged ions, [M + C2O + 2H]
2+, with a net
increase of 39.9949 Da, [M + C2H2O2 + 2H]
2+, with the net
addition of 58.0055 Da, and A and B. A and B showed a mass
diﬀerence of 14.0156 Da (CH2), with respect to both modiﬁed
ions, and were identiﬁed as ion/molecule reaction ions with
methanol and were eliminated when the reaction was carried
out in 100% water and ethanol was used in the electrospray
solution, Figure 1b. The reaction in phosphate buﬀer, sprayed
in methanol-containing solution, showed the same ions
discussed above for Figure 1a. The glyoxal-derived AGE
observed ions [M + C2O + 2H]
2+ (m/z 694.3688) and [M +
C2H2O2 + 2H]
2+ (m/z 703.3741) are formed following the
pathway reaction showed in Scheme 1, for both reaction
solutions (MeOH/H2O and phosphate buﬀer). Scheme 1
shows the possible structures that may be formed by glyoxal
and dihydrated glyoxal; in particular structures e and f were
identiﬁed, by De Haan et. al.,47 to coexist in a 3:1 ratio. Thus,
the glyoxal-derived AGEs formed by the net addition of C2O
and C2H2O2 were fragmented by ECD and CAD in order to
identify the glyoxal binding site.
Substance P Modiﬁed by C2O. Figure 2a shows the ECD
spectra of the parent ion [M + C2O + 2H]
2+ in MeOH/H2O
(50:50), with two kind of c fragment ions: unmodiﬁed c4−c10
and modiﬁed c†4−c†10. A dagger symbol was added to the
Figure 1. (a) Spectrum of glyoxal-derived AGEs in MeOH/H2O
(50:50), electrosprayed with a solution containing MeOH, IPA, H2O,
and acetic acid. (b) Spectrum of glyoxal-derived glycation products
(AGEs) in 100% H2O, electrosprayed with a solution containing
EtOH, MeOH, IPA, H2O, and acetic acid.
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standard Roepstorﬀ nomenclature48 (c/z), to diﬀerentiate the
ions with the glyoxal modiﬁcation. The radical z9
• fragment ion,
water loss, y9, and side chain losses were also observed, but the
pair c1/z10
•, c3/z8
•, c†1/z10
•, and c†3/z8
•, together c2 and c
†
2 were
absent in the spectrum. Figure 2a additionally shows the
unmodiﬁed doubly charged [M + 2H]2+ ion, which is not usual
during ECD experiments, because the capture of low-energy
electrons by the molecule generates the charge reduce radical
species ([M + C2O + 2H]
2+ + e− becomes [M + C2O + 2H]
+•)
and not the loss of the modiﬁcation. Thus, an isolation
spectrum of the parent ion [M + C2O + 2H]
2+ was acquired in
order to determine if the [M + 2H]2+ ion originated during
quadrupole isolation. The isolation spectra of the parent ion [M
+ C2O + 2H]
2+ shows a low abundance of the molecular ion
[M + 2H]2+ indicating that loss of C2O is a low-energy, facile
process. The presence of the [M + 2H]2+ ion indicates that
during isolation some small, unknown, amount of energy was
given to the parent ion [M + C2O + 2H]
2+, which activates it
causing loss of the modiﬁcation and generating the [M + 2H]2+
ion. The [M + 2H]2+ ion may therefore be responsible for the
secondary fragmentation (c4−c10) observed during the ECD
experiment.
Additionally, because the [M + 2H]2+ ion and the c4−c10 ions
were formed during ECD, preisolation yielded no new
information about their provenance. So, in order to test if
they were secondary fragments formed from the [M + 2H]2+
ion, double-resonance ECD49 was used to eject the ion [M +
2H]2+ during the ECD experiment of the parent ion [M + C2O
+ 2H]2+. The notation adopted for the double-resonance
experiments is represented as DR(X)−ECD(Y), where X is the
m/z value of the ejected fragment and Y corresponds to the m/
z value of the parent ion. The DR(674.37)−ECD(694.36)
spectrum of glycated, amidated substance P for the parent ion
[M + C2O + 2H]
2+ (Figure 2b) exhibited similar features as
those described above for the ECD spectrum, but the diﬀerence
lies in the absence of c8, c9, c10, z7
•, and z5
•. The observed
relative intensities of the cn and c
†
n fragment ions (n = 2−10)
were normalized to check that the observed c fragment ions
were secondary fragments from the unmodiﬁed doubly charged
ion [M + 2H]2+. The normalized relative intensity (Ii) was
calculated by application of eq S-1 (Supporting Information)
Scheme 1. Glyoxal-Derived AGEs Based in the Presence of Monohydrate and Dihydrate Species in Glyoxal Reagent (∼39%) in
Watera
aStructures: a, Schiﬀ base at the N-terminus or amine group of lysine; b, Schiﬀ base at the guanidine group of arginine; c, 3-hydroxyimidazole; d, 2-
imino-5-hydroxyimidazoline; e, 2-imino-imidazolidinone (also known as a creatinine side chain); f, cross-linking between amino group of lysine with
the N-terminus; g, 3,4-dihydroxyimidazoline; h, 2-imino-imidazolidine.
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and plotted in Figure 3. Ii of the c fragment ions decreased and
Ii of c
† and z9
• fragment ions increased during the DR−ECD
experiment. Thus, based on those results, it is inferred that all c
fragment ions observed in the DR−ECD and ECD spectrum
are secondary fragments of the unmodiﬁed [M + 2H]2+ ion and
are derived from a long-lived radical intermediate species
(millisecond to microsecond time frame).49 Additionally, from
Figure 3, the radical fragment z9
• is considered a long-lived
species49 and is a fragment from the doubly charged modiﬁed
species.
The c†n fragment ions locate the C2O modiﬁcation within
four residues of the N-terminus, and the presence of z9
• and y9
in Figure 2b, indicate an unmodiﬁed lysine. Thus, this glyoxal-
derived AGEs for substance P is located at the arginine residue
and more speciﬁcally at the guanidine group.49 The guanidine
group reacts with glyoxal causing the loss of water and resulting
in the net addition of C2O (39.9949 Da), which can form
Figure 2. Glyoxal-derived AGEs of substance P for the parent ion [M + C2O + 2H]
2+ in MeOH/H2O (50:50): (a) ECD spectrum; (b)
DR(674.37)−ECD(694.37) spectrum with ejection of [M + 2H]2+. The symbol ? indicates unassigned peaks by the current understanding of the
fragmentation mechanism, and ∗ indicates background peaks where not isotopologues were observed.
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structure b and/or structure c (hydroxyimidazole) shown in
Scheme 1.
Substance P Modiﬁed by C2H2O2. Figure 4 shows the
DR(674.37)−ECD(703.37) spectrum of the parent ion [M +
C2H2O2 + 2H]
2+ with unmodiﬁed cn and modiﬁed c
‡
n (n = 4−
10) fragment ion. The double-dagger (‡) symbol is added to
the standard Roepstorﬀ nomenclature to identify the modiﬁed
fragments. z9
• radical fragment ion, side chain losses, and up to
two losses of water from the c‡ fragment ions are observed in
Figure 4, with absence of c2, c
‡
2, c
†
1/z10
•, and c†3/z8
• fragment
ions. Thus, according with those results the modiﬁed c‡n (n =
4−10) fragment ions locate the modiﬁcation C2H2O2 toward
the N-terminus and the presence of z9
• indicate that the lysine
is unmodiﬁed. This modiﬁcation is located also at the arginine
residue (Scheme 1, structures e and f), where glyoxal dihydrate
(94.0266 Da, C2H6O4) binds to the guanidine group forming
the dihydroxyimidazoline group by the loss of two molecules of
water.
All the results of the ECD and DR−ECD spectra for the
parent ions [M + C2O + 2H]
2+ (Figure 2), and [M + C2H2O2 +
2H]2+ (Figure 4), shared three features. First, the absence of
the complementary pair c†1/z10
•, c†3/z8
•, c‡1/z10
•, and c‡3/z8
•
that is due to proline; which requires cleavage of two bonds in
order to observe the fragments.51 Second, c2 was absent in the
ECD spectrum (Figure 2a), but appeared in the DR−ECD
spectrum (Figure 2b), whereas c†2 and c
‡
2 were completely
absent, which is attributed to the low abundance of the c2
fragment ion from unmodiﬁed substance P, rarely observed in
the ECD spectrum.52,51 Third, the loss of water from every c†
and c‡ fragment ion, is attributed to the glyoxal modiﬁcation.
So, it was hypothesized that hydrogen bond interactions may be
involved for both glyoxal modiﬁcations, which may be broken
during the ECD event causing the loss of water. Thus, IRMPD
was applied to amidated substance P, prior to the ECD
experiment, in order to facilitate disruption of the noncovalent
interactions (Supporting Information, Figure S-1). The
obtained relative intensity of the c†n and c
†
n − H2O (n = 4−
10) fragment ions was normalized using eq S-1 (Supporting
Information) and plotted in Figure 5. It is observed that Ii of c
†
n
− H2O (n = 4−10) during the IRMPD−ECD experiment
increased in all observed fragments. Thus, use of infrared
heating to disrupt the hydrogen bonding network induced
water loss from the glyoxal-derived AGEs.
On the basis of the previous results it is possible to propose
an ECD mechanism for the loss of water of the glyoxal-derived
AGEs for substance P. Therefore, after the electron is captured
in the peptide, it is suggested that the modiﬁed guanidine group
at the arginine residue loses water forming the imidazole radical
moiety, as shown in Scheme 2a. Moreover, for the
dihydroxyimidazoline group, it is proposed that the capture
of the electron initially generates the loss of one molecule of
water forming an intermediate structure. The imidazole ring
(structure II in Scheme 2b) is formed by an extra loss of water
that is not driven by the radical, although the energy deposited
during electron capture, as well as the additional stabilization
energy from conjugation of the π system with the radical, would
promote this additional loss.
Figure 3. Comparison of the relative intensity of the cn and c
†
n (n = 2−
10) fragment ions of the parent ion [M + C2O + 2H]
2+ for the ECD
and DR(674.37)−ECD(694.36) spectra of glyoxal-derived AGEs for
the normal form of substance P (amidated at the C-terminus). The
relative intensity of each cn and c
†
n fragment ion was calculated by
application of eq S-1 (Supporting Information) where Ii is the relative
intensity of the ion.
Figure 4. DR(674.37)−ECD(703.37) spectrum with ejection of [M +
2H]2+ of the parent ion [M + C2O2H2 + 2H]
2+. The symbol ? indicates
unassigned peaks by the current understanding of the fragmentation
mechanism, and ∗ indicates background peaks where not isotopo-
logues were observed.
Figure 5. Comparison of relative intensity of the c†n and c
†
n − H2O
fragment ions for the DR(674.37)−ECD(694.37) and IRMPD−ECD
spectra of glycated amidated substance P. The relative intensity was
calculated using eq S-1 (Supporting Information), only considering the
relative intensity of the c†n and c
†
n − H2O fragment ions.
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Fragmentation with CAD, for both glyoxal-derived AGEs
(modiﬁcations with net addition of C2O and C2H2O2), for
amidated substance P agrees with the ECD and DR−ECD
results, and the spectra are shown in the Supporting
Information (Figure S-2, Tables S-5 and S-6). Moreover,
similar results were obtained about the types (net addition of
C2O and C2H2O2) and binding sites of glyoxal-derived AGEs
formed for the free acid form of substance P. DR(674.86)−
ECD(694.86), DR(674.86)−ECD(703.86), and CAD results
for both types of glyoxal-derived AGEs for the free acid form of
substance P are available in the Supporting Information (Figure
S-3, Tables S-7−S-10).
Additionally, as was mentioned before, similar glyoxal-
derived AGEs formed for amidated substance P were observed
under biological conditions (modiﬁcations with net addition of
C2O and C2H2O2). Thus, further analysis of the DR−ECD and
CAD spectrum of both parent ions [M + C2O + 2H]
2+ and [M
+ C2H2O2 + 2H]
2+ showed that glyoxal-derived AGES and
dihydrated glyoxal-derived AGEs are modiﬁed at the guanidine
group in the arginine moiety (refer to Figure S-4 and Tables S-
11−S-14 in the Supporting Information). This preferred
glycation site, that does not change at physiological conditions
(pH 7.5), can be explained from the high pKa of arginine
compared with lysine or the N-terminus amino group (pKa
12.48, 10.53, and 9.0, respectively).50 Moreover, studies of
glyoxal with only arginine found that protonation of one of the
three nitrogen atoms at the side chain did not limit the
reactivity of the guanidine group, and products at the N-
terminus (α-amino group) rarely happen.49 Glycation at the
amide group of glutamine residues was not observed that can
be attributed to the lowest nucleophilicity (low basicity) of the
lone pair of the nitrogen atom. Thus, it can be concluded that
diﬀerent conformers may be present as a result of glycation by
glyoxal, particularly the creatinine conformer generated at the
guanidine group of arginine, which is used as a biomarker in
renal failure. Although in this work no evidence was found for
intramolecular or intermolecular cross-linking, the formation of
imidazolone (a common product found in methylglyoxal-
derived glycation products)53 or diglycation54 longer reaction
times may show otherwise.
Scheme 2. Proposed Reaction Mechanism of the Loss of Water after Electron Capture Dissociation from the Glyoxal-Derived
Glycation Products (AGE) Formed at the Guanidine Groupa
a(a) The AGE product formed at the guanidine group (open ring) loses one molecule of water after electron capture generating the radical
imidazole moiety structure I. (b) The 3,4-dihydroxyimidazole (structure II) loses one molecule of water after electron capture generating the
intermediate structure, but the extra loss of water that originates the radical imidazole moiety structure III is not driven by the capture of another
electron.
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■ CONCLUSIONS
In studying the types of glyoxal-derived AGEs, at physiological
conditions (pH 7.5), of amidated and free acid form of
substance P by FTICR-MS, use of CAD, ECD, and double-
resonance ECD experiments allowed conﬁdent assignment of
the binding site to the side chain guanidine group of arginine.
The intermediates hydroxyimidazoline and dihydroxyimidazo-
line products, at the arginine residue, were also detected by
DR−ECD and CAD fragmentation. In the ECD, DR−ECD,
and IRMPD−ECD experiments carried out a characteristic loss
of water from every modiﬁed c†n and c
‡
n fragment was observed.
Thus, it is proposed that the electron is captured at the
modiﬁcation site and subsequent water occurs in addition to
the typical fragmentation pattern of the peptide at the
backbone N−Cα bond.
This work represents a ﬁrst approach to understand glycation
by α-dicarbonyl compounds and the types of glyoxal-derived
AGEs formed, including the potential artifacts given by the use
of methanol during sample preparation. However, further
research needs to be carried out in order to determine whether
same types of glyoxal-derived AGEs are formed in other
peptides under similar solution conditions and temperature. In
order to extend this research into analysis of clinical samples,
additional understanding of competitive binding between the
residues and between peptides in complex biological samples
will be needed. However, the current research has deﬁned some
of the fundamental chemistry involved in glyoxal binding to
arginine-containing peptides.
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